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Abstract 
Bacterial pneumonia affects a disproportionate number of elderly in the UK, with 
substantial morbidity and mortality. Mounting evidence implicates removable 
dentures as a potential nidus for respiratory pathogens to form a pathogenic reservoir 
which could seed colonisation and infection of respiratory tissues in susceptible 
individuals. However, research evaluating the denture-associated microbiome in 
patients with an active pneumonia diagnosis is lacking. This research had two primary 
aims. Firstly, unrestricted characterisation of denture-associated bacterial 
communities in pneumonia patients and long-term care home residents, through 16S 
rRNA gene metataxonomic sequencing. Secondly, development of a model denture 
acrylic-associated biofilm incorporating clinically relevant respiratory pathogens, to 
allow exploration of inter-microbial and host-microbial interactions in infection and 
testing of novel anti-biofilm strategies.  
There were significant shifts observed in species composition, diversity and richness 
in denture-associated microbiota of pneumonia patients. Importantly, the relative 
abundance of putative respiratory pathogens was significantly increased in 
pneumonia patients compared with respiratorily healthy care home residents. The 
magnitude of this increase was approximately tripled in denture-associated bacterial 
communities compared with other oral sites examined. 
An in vitro denture-acrylic biofilm model was developed incorporating the respiratory 
pathogens Staphylococcus aureus and Pseudomonas aeruginosa. This model was 
extensively characterised using a range of techniques and showed excellent 
scalability to high throughput applications. Subsequent infection of epithelial tissue 
models revealed the role of P. aeruginosa in instigating tissue invasion and 
disruption. A potential novel function for the pseudomonal aprA gene, encoding 
alkaline protease was suggested; providing a competitive advantage to this 
microorganism in mixed-species infections. A range of novel antimicrobial 
compounds was screened for biocidal activity and successfully incorporated into 
silicone biomaterials. However, antimicrobial activity of several tested compounds 
was abated in biomaterials. Highly controlled microwave energy delivery using a 
cavity resonator showed considerable promise as a denture sterilisation modality. 
This work was novel in several aspects. The in vitro model was the first model of 
denture-associated biofilms to incorporate respiratory pathogens, and subsequent 
molecular characterisation revealed the biogeography of microorganisms within the 
biofilm and in tissue infections. The models were subsequently employed in a high 
throughput screening assay wherein novel antimicrobial compounds  and antibiofilm 
methods were tested. The clinical study was the first to examine the denture-
associated oral microbiome in pneumonia patients, with novel insights into changes 
in bacterial composition associated with respiratory infection.
1CHAPTER 1: INTRODUCTION 
1.1: Microbial biofilms 
Biofilms can be defined as "aggregates of microorganisms in which microbial cells 
are frequently embedded in a self-produced matrix of extracellular polymeric 
substances (EPS) that are adherent to each other and/or a surface" (Vert et al. 2012). 
Biofilms are the preferred form of microbial growth and represent a ubiquitous and 
highly adaptable mode of life, permitting the colonisation of an unparalleled range of 
ecological niches (Donlan 2002). The biofilm lifestyle confers a survival advantage to 
microorganisms compared with a planktonic mode of growth and permits greater 
microbial diversity through modulation of nutrient and metabolite gradients, oxygen 
tension and pH to produce unique micro-environments (Stewart and Franklin 2008). 
In humans and all higher animals, microbes exist on all body surfaces, and can form 
biofilms on a number of host tissues (Cho and Blaser 2012). During health, a number 
of highly regulated homeostatic mechanisms maintain a stable population of 
microbial species, which are beneficial or neutral to the host, developed through co-
evolution. Such microbial communities are considered "commensal". However, 
because of their protective features, microbial biofilms are the predominant 
mechanism by which disease pathogenesis, transmission and resistance to both host 
defences and therapeutic intervention is enabled (Lewis 2001).  
1.1.1: The developmental model of biofilm formation 
The establishment of microbial biofilms has been studied for several decades 
(O’Toole et al. 2000). From early observational data which enabled little insight into 
complex and varied biofilm architectures, advances in imaging techniques, 
microelectrodes and molecular methods have opened a window into the structural 
intricacy, micro-environmental heterogeneity and hierarchical genetic control of the 
biofilm lifecycle (Azeredo et al. 2017).  
While far from conclusive, and not without competing explanations, the 
developmental model of biofilm formation (Figure 1) is a useful framework for 
examining the events which lead to microbial biofilm assembly (O’Toole et al. 2000; 
Monds and O’Toole 2008). In this model, biofilms form in discreet, ordered stages: 
reversible attachment of microbes to a surface, then "irreversible" adherence 
mediated by specific adhesive proteins (adhesins). Following commitment to surface-
adherent growth, clonal growth of microcolonies and production of extracellular 
polymeric substance (EPS) ensues. During subsequent maturation of the biofilm, the 
majority of structural organisation is generated, alongside a number of important 
2genotypic and phenotypic changes, followed finally by dispersal of planktonic 
microorganisms to colonise new areas.  
1.1.1.1: Attachment 
The first stage in colonisation of a surface is, unsurprisingly, attachment of cells from 
bulk liquid phase to the surface, although a notable and important exception to this is 
P. aeruginosa in the cystic fibrosis lung, where microbial biofilms are found in the 
mucus layer rather than attached to epithelium (Moreau-Marquis et al. 2008). On 
dental surfaces, preconditioning first occurs through an adsorbed glycoprotein pellicle 
(Hannig et al. 2004). Components from saliva are the predominant source of this 
acquired pellicle, including mucins, statherins and proline rich proteins (PRPs). 
Indeed, saliva has an important role in coordinating the pattern of initial attachment 
of microbes to dental surfaces to maintain a healthy "commensal" oral microbiota 
(Siqueira et al. 2012). 
Figure 1.1.1: Developmental model of biofilm formation.
The upper segment provides a conceptualisation of the stages of biofilm development, while the lower 
segment is composed of corresponding photomicrographs of Pseudomonas aeruginosa biofilm 
development. 
1) Initial ("reversible") attachment of microbes to a surface 
2) Adhesion ("irreversible") of cells by expression of substrate-specific adhesins 
3) Growth of clonal microcolonies with deposition of EPS marks the onset of biofilm formation 
4) Maturation of biofilm leading to complex structure and a climax community 
5) Dispersal of planktonic cells from the biofilm surface 
(Image from Monroe 2007) 
3The attachment of microorganisms to surfaces occurs in a stochastic manner. 
However, a number of factors other than the presence of an acquired pellicle have 
been found to influence patterns of surface colonisation. A number of studies have 
demonstrated an association between growth medium, cation concentration, nutrient 
sources, pH, temperature and proclivity of microbes to attach to a surface. Marshall 
et al. (1971) applied the Derjaguin, Landau, Verwey and Overbeek (DLVO) theory of 
colloidal stability to model the interactions of non-specific forces which may govern, 
at least in part, behaviour of negatively charged cell surfaces and substrates (Figure 
1.2). This model is supported by work from Rijnaarts et al. (1999) which demonstrated 
enhanced binding affinity between microbes and substrate following increases in the 
ionic strength of liquid medium. 
DLVO theory provides a helpful framework to describe the interaction of microbial 
surfaces with electronegative substrates. However, because it is derived from a 
model of uniform particulate behaviour, it lacks the complexity to account for certain 
cell attributes which may contribute to more variable biological responses. 
While protein-mediated adhesion and hydrophobic interactions are conventionally 
considered to feature more prominently in the "irreversible" adhesion stage; 
Figure 1.1.1.1: A schematic of the principle electrostatic interactions that influence microbial 
attachment 
DLVO theory describes the principle forces thought to govern the stochastic attachment of microbial 
cells to surfaces. Negatively charged microbial surfaces (blue) interact with substrate surfaces (red) 
by weak repulsive electrostatic forces. An interpolation of these forces by cations in growth medium 
(green) may provide a counter-ion bridge between the two surfaces.  
A) At low concentrations of ions, there is minimal mediation of repulsive electronegative surface 
charges, resulting in weak or no attraction. 
B) Stronger cation concentrations in growth medium provides a counter-ion screen, resulting in 
strong electrostatic interactions between surfaces, and a more stable attraction.
4variations in growth conditions can lead to altered patterns of constitutive surface 
protein expression, which will in turn alter surface charge (McEldowney and Fletcher 
1986; Goulter et al. 2009). Indeed, the heterogeneous topographies of cell surfaces, 
which present a rich and varied configuration of glycoproteins, lectins and other 
components, means that nano-scale interactions may differ entirely from bulk cell 
behaviour due to electronegative membranes or cell wall components such as 
lipopolysaccharide (LPS) and peptidoglycan (PG). 
1.1.1.2: Adherence 
In contrast to the non-specific and stochastic attachment of microbes to surfaces, 
adherence is considered to be an active commitment to a surface lifestyle, with 
production of specific adhesins to anchor cells to the underlying substrate (Dunne 
2002). The ligand-receptor interactions which mediate adherence may be both 
species and substrate-specific (An and Friedman 1998; Katsikogianni and Missirlis 
2004). In addition, many of the surface molecules involved are multifunctional, and 
may have roles in cell-cell adherence, either intraspecies, such as the inter-cellular 
adherins of Staphylococcus aureus (Foster et al. 2014), interspecies or even 
interkingdom, such as sspA and sspB of Streptococcus gordonii, which can bind both 
oral mucosal surface components and promote adherence of Candida albicans to the 
bacteria (Wright et al. 2013). 
1.1.1.3: Growth and maturation 
Adhesion is an active cellular process, thus is metabolically demanding and requires 
allocation of resources (Beceiro et al. 2013). However, once stable attachments are 
formed, microbes are able to repurpose efforts to propagation by clonal growth to 
produce microcolonies. Additional cells may be encouraged to adhere to surface 
components of microbes, adding to growth and increasing colony diversity (Rickard 
et al. 2003). It is at this juncture that the production of EPS may begin, marking the 
true beginnings of a biofilm. This extracellular matrix material is critical in affording 
spatial structure and protection, as well as providing a cache of nutrients, enzymes 
and a fluid reservoir. The EPS matrix also provides a readily adherent substrate which 
permits further recruitment of a range of microbes to the nascent biofilm (Flemming 
et al. 2007).  
Early morphological examinations of biofilms by electron microscopy (EM) gave the 
misleading notion that these were merely densely stacked piles of cells with no real 
structure or organisation. This was due to artefacts generated in the preparation of 
biofilms for imaging (Surman et al. 1996). However, more recent advances in 
5imaging, most notably the advent of confocal laser scanning microscopy (CLSM), has 
provided cross-sectional observation of relatively unperturbed biofilms in situ. Such 
techniques have revealed structural organisation and coordination within microbial 
biofilm communities, including water and waste channels, complex topographies and 
spatial order (Reichhardt and Parsek 2019).  
Molecular techniques have allowed researchers to gain insight into the genetic 
control of biofilm features and have revealed the presence of cell-cell signalling, 
termed quorum sensing (QS), which allows microbes to sense their environment and 
communicate in a cooperative manner (Wolska et al. 2016). In addition, 
microelectrode studies have revealed the diversity of microniches which result from 
oxygen, nutrient and pH gradients (Stewart and Franklin 2008). It is the presence of 
so many environments within biofilms which results in the startling number of 
microbial species which can form such climax communities, despite an external 
environment which may not favour their survival. In in vitro experiments the use of 
growth medium drastically alters these nutrient gradients, as media is typically much 
more nutrient rich than physiological environments. Similarly, the choice of biofilm 
development method (such as static batch models compared with flow-based 
assays), incubation atmosphere and frequency of medium replenishment all provide 
strong environmental changes with consequent impact on biofilm structure, viability 
and composition (Lebeaux et al. 2013). 
1.1.1.4: Dispersal 
An important feature of biofilms in relation to human diseases is the process by which 
planktonic cells may detach and disperse to colonise new sites (Kaplan 2010). The 
nature of biofilm dispersal is largely unknown. Experimental evidence suggests that 
a transition from laminar flow to static culture conditions typically results in initiation 
of dispersal events. It has been proposed that this may indicate a starvation response 
similar to that seen in fruiting bodies of Myxococcus xanthus, due to depletion of 
nutrients in the growth medium under batch culture conditions (Hunt et al. 2004). The 
potential for aspiration of planktonic cells or fragmented biofilm from the oral cavity is 
thought to be the primary mechanism linking the oral microbiome to respiratory 
infection in humans (Kaplan 2010). 
1.1.2: Biofilms in health and disease - a brief overview 
While biofilms are a ubiquitous mode of microbial life and provide pivotal support to 
most ecosystems and biological processes, they are associated with a wide range of 
human infectious diseases (Hall-Stoodley et al. 2004). An important colonisation site 
6in health is the aerodigestive tract, where microbes benefit the wellbeing of their 
human hosts by a number of means. The most well-characterised example of host-
microbial synergy is the role of the gut microbiome in digestion (Shreiner et al. 2015). 
A secondary means of maintaining health relates to the stability and resistance to 
colonisation by atypical, potentially pathogenic microorganisms of the oral 
microbiome (Marsh 2006). It is likely that commensal microorganisms associated with 
health are selected in host tissues through co-evolution to procure a symbiotic 
relationship, which provides such species with a competitive advantage in adhering 
to and surviving on human tissue surfaces (Rosenberg and Zilber-Rosenberg 2011).  
However, a number of factors may alter the host-microbiome relationship, leading 
either to the invasion of the commensal microbiome by atypical, pathogenic species, 
or changes within the commensal microflora in response to an altered host 
environment which causes the emergence of virulence and can initiate infectious 
disease. Much of the biomedical literature focuses on the role of such pathogen-
harbouring microbial biofilms in human disease, particularly with regard to healthcare 
device-associated infections (Donlan 2001; Deva et al. 2013; Percival et al. 2015). 
Previous work from our group has examined the role of pathogenic biofilms in urinary 
catheter-related infection (Malic et al. 2014), colonisation of endotracheal tubes by 
oral biofilms containing putative respiratory pathogens which could seed respiratory 
infection (Sands et al. 2017) and the role of denture-associated biofilms in the 
pathogenesis of denture stomatitis (Morse et al. 2019).  
An alternative model of biofilm-related pathogenicity has been described in the dental 
literature, termed the "keystone pathogen" hypothesis (Hajishengallis et al. 2012). 
This concept is derived from observations of enhanced virulent traits of normal oral 
microorganisms, typically considered to be commensal, in response to a low-level 
"keystone" species (posited to be P. gingivalis by the authors). This is thought to be 
primarily mediated through the ability of P. gingivalis to modulate the local host 
environment through invasion and persistence within gingival epithelial cells; with 
concomitant inhibition of the innate immune response by degrading IL-8, and 
subversion of leukocyte killing through gingipain production (Imamura 2003; Darveau 
2010). These actions can drive dysbiotic changes in the gingival microbiome, with 
unrestricted growth of other pathogenic species normally kept in check by normal 
host immunity. Additionally, there is emerging evidence that specific interspecies 
interactions such as between P. gingivalis and S. gordonii leads to enhanced 
virulence and periodontal disease severity compared to either species alone in a 
murine infection model (Daep et al. 2011). While the mechanisms behind such 
interactions are poorly understood, these observations challenge the traditional 
7paradigm of pathogenicity and virulence; underpinning the importance of 
metagenome- and transcriptome- focussed studies in disentangling the complex 
mechanisms that lead to microbial disease (Duran-Pinedo and Frias-Lopez 2015). It 
should be noted that while the microbiome proper includes all microbes within an 
environment: viruses, archaeae, bacteria, fungi and protozoa; the term microbiome 
in this thesis will refer only to the bacterial microbiome, unless otherwise specified. 
1.1.3: Challenges in biofilm eradication 
The formation of biofilms by microbes is a complex and metabolically costly process 
which temporarily reduces growth and reproduction of the constituent 
microorganisms. However, there are a number of long-term survival advantages 
afforded to biofilm-associated life which far outweigh this immediate detriment. Many 
such advantages are manifest in the difficulties encountered in eradicating microbial 
biofilms, summarised in Figure 1.1.3. A notable example is provided by the work of 
Ceri et al. (1999) who found that the concentration of a range of antimicrobials 
required to eradicate S. aureus, P. aeruginosa and E. coli in biofilm form was 
increased up to 1000-fold compared to these strains in planktonic form. While there 
are a number of industrial and environmental situations in which biofilm eradication 
poses a substantial challenge, for brevity only biofilms relevant to medical infections 
shall be considered in this section.  
Figure 1.1.3: Potential mechanisms of microbial resistance to antimicrobial agents related to 
biofilm formation.  
(Image from Sherrard et al. 2014)
81.1.3.1: Extracellular polymeric substances (EPS) 
The hallmark feature that separates true microbial biofilms from mere aggregates of 
cells, is the production of extracellular polymeric substances (EPS). The specific 
components of this encompassing matrix differ markedly between microbial species 
and the external environment (Flemming et al. 2007). Frequently, a combination of 
polysaccharides, proteins (including extracellular enzymes) and extracellular DNA 
(eDNA) are present. The functions of the EPS matrix are multifaceted; EPS gives 
form and structure to biofilms, enhancing adhesion while affording protection to 
microbial cells from physical disruption, dehydration, damage from ultraviolet light, 
predation and host immune cells. The antigen profile of microbes in biofilms is 
markedly different compared with their planktonic counterparts is typically reduced, 
making biofilm populations a potentially less immunogenic stimulus (Sanchez et al. 
2011).
EPS confers a number of important physico-chemical properties to biofilms. Many 
EPS components are involved in the adhesion of microbes to surfaces and each other 
in the initial colonisation process, for instance, polysaccharide intercellular adhesin 
(PIA) serves a fundamental role in the adhesion of many strains of Staphylococcus 
aureus and Staphylococcus epidermidis to a range of surfaces, and also promotes 
biofilm formation through enhancing cell-cell interactions (Formosa-Dague et al. 
2016). Similarly, lectins produced by Pseudomonas aeruginosa (LecA and LecB) are 
important mediators of biofilm formation, primarily by stabilising exopolysaccharide 
chains (Tielker et al. 2005; Diggle et al. 2006). 
Many EPS components are charged and can therefore sequester inorganic ions and 
water. This provides protection against desiccation. In fact, enhanced EPS 
production has been observed in response to dehydration in soil-residing microbes, 
underscoring its importance in trapping water (Roberson and Firestone 1992). The 
hydrated environment of cross-linked polysaccharide and protein chains results in 
viscoelastic behaviour. Both EPS production and the degree of cross-linking are 
enhanced in conditions of increased shear flow (Stoodley et al. 2002). Additionally, 
electrostatically repellent interactions between certain EPS components provides 
resistance to compression and collapse (Ehret and Böl 2013). The combination of 
enhanced adhesion and physical robustness results in protection of biofilm-
associated microorganisms from mechanical disruption and removal from surfaces 
(Peterson et al. 2015).  
A further consequence of trapped cations is the restricted permeability of EPS to 
charged antimicrobials, such as chlorhexidine, or aminoglycoside antibiotics.  
9The impact of EPS on P. aeruginosa biofilms has been studied extensively, due to 
the frequent involvement of this species in multi-drug resistant infections. Biofilm 
penetration by the cationic aminoglycoside antibiotic tobramycin was studied by 
Tseng et al. (2013), who observed penetration of fluorescent-labelled tobramycin in 
mucoid (alginate-producing) strains was limited in a concentration-dependent 
manner. Adding metal cations at sub-MIC levels markedly improved tobramycin 
biofilm penetration, supporting the notion that the primary mechanism of diffusion 
limitation was electrostatic interaction with matrix components.  
Similar results were found in studies of chlorhexidine penetration into a mixed-
species oral biofilm model using confocal laser scanning microscopy (CLSM) to 
observe uptake of the fluorescent dye Calcein AM (CAM) indirectly via increased 
membrane permeability, which was inferred to indicate cell death (Takenaka et al. 
2008). The authors selected a biofilm region from the corner of a flow-cell device to 
analyse antimicrobial action. The corner of this device was selected because it 
allowed for greater accumulation of biomass, and the decreased flow-rates limited 
diffusive transport of test agents within the biofilm. It was observed that the deepest 
regions of the biofilm (100 µm) were apparently entirely unaffected by chlorhexidine. 
Interestingly, the same study demonstrated that biofilm penetration by a biotene 
mouthrinse, which contains a number of ionic salivary antimicrobial peptides, was not 
hindered from reaching the deepest regions of the biofilm. This may be due to the 
incorporation of non-ionic surfactants such as poloxamer 407 in the formulation of 
this product. Similar formulation strategies may offer a potential solution to the limited 
diffusion of chlorhexidine and other locally-delivered, charged antimicrobials. 
In addition to these constituents, EPS can act as an extracellular store of both ions 
and nutrients, protecting the inhabitant microorganisms from starvation. In some 
cases, EPS exopolysaccharides such as dextrans and levans produced by oral 
streptococci are themselves a nutrient reserve for times of privation (Colby and 
Russell 1997). To enable metabolism of matrix-associated nutrients, the EPS also 
contains numerous extracellular enzymes. Importantly, these may also include 
enzymes capable of inactivating some antimicrobials, such as -lactamases 
produced by a wide range of microorganisms in response to exposure to penicillins 
(Ciofu et al. 2000).
1.1.3.2: Altered environmental niches 
Mature biofilms may be several millimetres thick, with an intricate array of nutrient, 
gaseous and metabolite gradients. This leads to a highly diverse milieu, the full extent 
of which is only now becoming appreciated, that permits the coexistence of many 
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divergent species within a biofilm (Stewart and Franklin 2008). An obvious 
consequence of biofilm formation is the accumulation of a high number of 
microorganisms, which can be densely packed. This could result in exhaustion of an 
antimicrobial agent before the entire population is eradicated, although this is rarely 
a problem in reality. However, a number of environmental factors beyond this simple 
concentration-population mismatch have been proposed to explain the stark 
differences in antimicrobial tolerance of microbial biofilms compared with their 
planktonic counterparts. 
EPS provides structural features which control nutrient delivery to areas of biofilms, 
such as the archetypal mushroom-like colonies formed by P. aeruginosa biofilms, 
with water channels coursing between ‘stalks’, supplying nutrients and permitting 
removal of waste metabolic by-products. The selective permeability of the EPS 
results in gradients of gases, nutrients and metabolites, which can help support 
complex polymicrobial communities, with many constituent species that would 
otherwise be unable to survive (Flemming and Wingender 2010). A pertinent example 
of this is seen in the work of Welch et al. (2016), where the presence of obligate 
anaerobes such as Actinomyces and Prevotella species is found in supragingival 
plaque, despite an oxygenated external environment (Figure 1.1.3.2A-D). The 
aerobic metabolic activity of superficial species results in an increasingly anoxic 
environment in deeper regions of biofilm, with an intermediate region that may contain 
small numbers of aerobes and anaerobes but is dominated by facultative aerobes 
including streptococci and lactobacilli, because of the selective advantage their 
metabolic flexibility confers. There are, however, apparent exceptions to this rule. 
Porphyromonas species can be seen to localise to the superficial regions of the 
biofilm in Figure 1.1.3.2E despite higher oxygen tension in these areas. The authors 
speculate that lesser-known species of Porphyromonas e.g. P. catoniae and 
P. pasteri, with at least some aerobic tolerance might have been identified by the 
probes, rather than P. gingivalis, which is frequently isolated in subgingival, but rarely 
isolated from supragingival plaque. This explanation partly addresses this 
unexpected finding, but it seems likely that specific binding sites and species-specific 
metabolic synergy are important factors in permitting Porphyromonas species to out-
compete other aerobes in this micro-environment.  
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Figure 1.1.3.2: Photomicrographic projections of ex vivo supragingival plaque samples imaged 
using Combinatorial Labelling and Spectral Imaging FISH (CLASI-FISH). 
A) Superimposition of multispecies plaque biofilm showing presence of Prevotella species 
superficially located in plaque biofilm
B) Superimposition of multispecies plaque biofilm showing superficial location of Porphyromonas
species and substantial Actinomyces species throughout biofilm
 (Images from Welch et al. 2016) 
Similarly, waste-products, such as lactate from superficial aerobes which would be 
toxic in high concentrations, are a source of nutrients to underlying fermenters like 
Veillonella species (Takahashi 2015). Biofilm communities are replete with such 
synergistic relationships between diverse species. Similar synergism is exhibited 
following challenge with some antimicrobials. It has been found that mixed biofilms 
of Streptococcus mutans and Veillonella parvula are able to survive treatment with 
chlorhexidine in much greater numbers than single-species biofilms of either species, 
using a viable colony plate-count method (Kara et al. 2006). Similarly, mixed biofilms 
of S. aureus and P. aeruginosa can tolerate a number of antimicrobials which are 
normally effective against one or both species (DeLeon et al. 2014). The mechanisms 
involved in such interactions are poorly understood.  
1.1.3.3: Metabolic changes 
Alterations in microbial metabolism within biofilms are primarily derived from two 
factors. Firstly, environmental changes to generate divergent microniches within 
biofilms lead to concomitant variations in metabolic pathways (detailed in the above 
section). Secondly, there are inherent changes in microbial metabolism associated 
with biofilm formation, which has led to the concept of the ‘biofilm lifestyle’. This may 
simply reflect the environmental conditions within the biofilm, with a relatively high 
density of microbes and scarcity of space and resources. Consequently, most 
microbes, particularly in the deeper regions of a biofilm, exhibit marked reductions in 
B 
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metabolic and biosynthetic activity (Anderson and O’Toole 2008). The majority of 
antimicrobials target biosynthetic pathways in active and reproducing cells, such as 
the ß-lactam, macrolide and aminoglycoside classes.  Several studies have found 
starved planktonic cells are able to tolerate such antimicrobials, while 
chemotherapeutics which exert their effects by alternative mechanisms, such as 
lipoglycopeptides and imidazole derivatives, retain effectiveness (Hurdle et al. 2011). 
Some metabolites can act as signalling molecules, such as the autoinducer 2 (AI2) 
quorum sensing molecules produced by the LuxS enzyme as a by-product of the 
methyl cycle (Whitely et al. 2017). AI2 is a universal interspecies and interkingdom 
signal, which is highly conserved across bacterial and archaeal species, in addition 
to many eukaryotes. AI2 and the luxS pathway were initially identified in Vibrio harveyi
because of their role in regulating bioluminescence in this species. However, AI2 is 
produced by a wide range of species and can influence biofilm formation and 
interactions between oral bacteria, including S. gordonii, S. mutans and P. gingivalis 
(McNab et al 2003; Yoshida et al. 2005). Knockout studies have demonstrated both 
altered biofilm architecture and abrogation of co-aggregation between such species 
(Wang et al. 2017). 
1.1.3.4: Microbial interactions  
Within biofilm communities, microbial populations are organised in close proximity, 
through both specific receptor-mediated co-localisation, and ecological phenomena 
governed by limitations in space and resources within a given microniche (Burmølle 
et al. 2014). Microorganisms also interact dynamically with their host environment. 
The net impact of the microbial community contributes to maintenance of health for 
much of life, but changes in either the host environment or microbial population may 
be of detriment to the host and result in harm. When the interactions between host 
and microbe, or within microbial communities are beneficial to both organisms, as 
has been recently observed in polymicrobial biofilms containing both F. nucleatum 
and P. gingivalis (El-Awady et al. 2019), this is termed a ‘synergistic’ relationship. 
Here the authors noted enhanced biofilm formation and proliferation by both species 
when grown together compared to either species alone. More frequently documented 
relationships entail benefit to one organism from the relationship, such as microbial 
colonisation of host surfaces facilitating the acquisition nutrients, shelter and a 
suitable habitat; while the corresponding organism (typically the host) receives 
negligible benefit or harm. Such interactions are considered ‘commensal’. The 
majority of host-microbe interactions are typically considered commensal in nature. 
In some instances, the interaction between organisms results in harm to one, usually 
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to the benefit of the other. Microorganisms which are considered harmful to human 
health are termed ‘pathogens’. Many historically significant infectious diseases which 
drove dramatic advances in medical microbiology are examples of classical 
pathogenic relationships. Of particular relevance is the influence of any number of 
possible bacterial respiratory pathogens in the development of pneumonia. 
Outside of the interactions outlined above, further classical ecological relationships 
can be considered relevant to microbial populations. One such relationship of 
considerable importance is the role of competition in the establishment of a stable 
oral microbiome in health, and the influence of environmental perturbations in 
destabilising established communities (Sultan et al. 2018). If a disturbance is of 
enough magnitude, this could drive changes in the composition of microbial 
communities towards more pathogenic populations or functional behaviours, termed 
dysbiosis. This ‘ecological catastrophe’ (Marsh 2003) will be explored in greater detail 
in later sections. 
More recently, a novel means of microbial interactions has emerged, the importance 
of which is as yet not fully understood, but increasingly appears likely to be 
substantial: Quorum Sensing (QS). First formally identified through the luxI and luxR 
luminescence genes of Vibrio fischeri, which respectively coordinate the production 
a homoserine lactone molecule and its autoresponsive transcriptional activator, it was 
not until the late 1990s that similar pathways and molecules were shown to serve key 
functions in important pathogens such as S. pneumoniae (Stroeher et al. 2003; 
Trappetti et al. 2011) and S. aureus (Cheung et al. 2004; Qazi et al. 2006). These 
small molecules all shared common structures and were able to readily diffuse 
throughout a biofilm, and through a number of experiments on Vibrio species were 
implicated in the sensing of population density. A resultant behaviour thought to be 
regulated through QS is the production of ‘public goods’; extracellular substances 
that benefit not only the producer, but its nearby neighbours (Whitely et al. 2017). 
Further work has suggested that such behaviour only occurs in the presence of 
sufficient nutrient surfeit (Dandekar et al. 2012), which not only promotes survival of 
the ‘altruistic’ microbial cell, but also serves to regulate the proportion of passive 
beneficiaries within a population (sometimes referred to as ‘cheaters’). Importantly, it 
has been shown that QS is not limited to intra-species relationships, but can affect 
behaviour between different species, or even result in inter-kingdom interactions. The 
most well-established example of this is found in the interactions between the P. 
aeruginosa QS pathways lasI and rhlI, which govern the genetic transcription of a 
number of virulence factors, and C. albicans QS molecule farnesol, which governs 
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morphological switching of this microbe from the yeast to hyphal form (Fourie et al. 
2016).  
Not only has experimental evidence shown that each microorganism is able to sense 
the QS molecules of the other, but these molecules appear to have been 
‘weaponised’ to influence behaviours of each species. P. aeruginosa adhesion to 
candidal hyphae appears to be QS dependent from knockout studies and may be 
implicated in the production of a number of virulence factors which enable killing of 
candidal cells. Similarly, C. albicans behaviour changes in the presence of 
pseudomonal QS molecules in a concentration-dependent manner, marked by 
switching from hyphal to yeast form. The candidal QS molecule farnesol which 
regulates this behaviour has also been found to inhibit the production of virulence 
factors by P. aeruginosa. While such behaviours point towards mechanisms aimed 
at promoting survival of one species over the other, the ecological context of these 
traits remains unclear. There remains the possibility of further interactions and 
pathways as yet undiscovered which may change our understanding of microbial QS.  
1.1.3.5: Mobile genetic elements and transferred resistance 
Microbes are capable of ‘horizontally’ transferring genomic DNA through three 
primary mechanisms; transformation, conjugation and transduction (Frost et al. 
2005). Transformation was first discovered in the respiratory pathogen S. 
pneumoniae in 1928 (Griffith), although it was not until work by Avery et al. (1944) 
that DNA was identified as the key molecule which was internalised through this 
process. The uptake of extracellular, free DNA from the environment requires the 
recipient microbe to be capable of binding, processing and internalising in single-
stranded form, followed by integration of this DNA with chromosomal genomic DNA. 
This state, termed ‘competence’ is not constitutively present in the majority of 
microorganisms, and may in fact be regulated in part by QS (Shanker and Federle 
2017). Extracellular DNA may be present in the environment due to lysis of cells in 
death, or actively excreted DNA either as a constitutive process during growth or in 
response to specific stimuli. At present, experimental evidence exists for a 
combination of all the above sources contributing to the environmental pool of 
extracellular DNA (Lorenz and Wackernagel 1994). 
Conjugation involves direct cell-cell transfer of genetic material, in a process 
analogous to sexual reproduction in Eukaryotes. Most pertinent to the field of 
infectious diseases has been the finding that microbes are able to transfer genes 
encoding antimicrobial resistance traits (Llosa et al. 2002). This process appears to 
be dependent upon Type IV pili for both Gram-positive and Gram-negative 
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microorganisms. Despite considerable heterogeneity in protein structure and specific 
mechanisms across different bacterial species, the fundamental pathways appear to 
be highly conserved, suggesting that conjugation confers an important evolutionary 
advantage (Lawley et al. 2004; Goessweiner-Mohr et al. 2015). This notion is 
reinforced by the complexity and energy cost of coordinating detection of cell-cell 
contact (a feature unique to conjugation among microbial horizontal gene transfer 
(HGT) mechanisms), with subsequent cleavage, replication and packaging of DNA 
into a circular plasmid form, ‘unzipping’ of double-stranded DNA with transport and 
secretion of one strand, then replication of the complementary strand by both donor 
and recipient cells prior to integration with chromosomal DNA (Griffiths et al. 2000). 
The potential to increase genetic diversity among a bacterial population or potentially 
exchange genes which confer survival between individual cells is clear, although the 
regulation of the processes which drive conjugation are yet to be fully understood. 
The most recently discovered means of bacterial HGT, transduction, requires viral 
vectors for genetic material in the form of bacteriophages. Three primary forms of 
transduction have been identified at present (Van Hoek et al. 2011): generalised, 
which involves the essentially random, erroneous incorporation of bacterial DNA into 
viral capsids; specialised, wherein entire genes adjacent to the phage genome 
position in the infected bacterial chromosome are restricted and packaged into viral 
capsids; and lateral transduction, which has been shown to exist in S. aureus only to 
date, and can involve a substantial number of genes more distant to the phage DNA 
in the bacterial chromosome (Chen et al. 2018). 
All methods of HGT can lead to acquisition of antimicrobial resistance by microbes. 
However, more recently a growing appreciation for the role of transduction in both 
antimicrobial resistance and virulence genes has emerged. A recent report 
documented the potential for Gram negative bacilli in the oral microbiome to act as a 
reservoir of antimicrobial resistance, in addition to harbouring greater pathogenic 
potential for both oral and systemic disease (Dupin et al. 2015). 
1.1.3.6: Persister cells - a phenotypic aberration 
Persister cells present a unique challenge to medical microbiology and may provide 
one of the primary mechanisms behind the recalcitrance of biofilm-associated 
infections to antimicrobial chemotherapy (Lewis 2010). The available evidence 
suggests that within a given microbial population, a small proportion of cells will enter 
an ostensibly dormant state, which renders them tolerant to the majority of 
antimicrobials (the notable exception being fluoroquinolones, which possess the 
additional advantage of generally demonstrating good penetration through biofilm 
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matrix). Despite extensive research aiming to establish predictive factors for persister 
formation, and the genetic control thereof, efforts thus far have largely been fruitless 
in offering meaningful opportunities to overcome the problem of persister cells (Lewis 
2007). Regulation of persister formation can be linked to specific genes, such as tisB
in E. coli, but while knockout studies have shown elimination of this gene reduces 
persister formation substantially, the high level of redundancy in persister regulation 
means it is unlikely that a convenient therapeutic target will be identified that can 
reliably abrogate the formation of persister cells (Lewis 2010). Indeed, a number of 
current antibiotics have been shown to increase the number of persisters in a 
microbial population, likely through induction of the general ‘SOS’ stress response 
pathways. In this manner, conventional antimicrobial therapy may actually act as a 
selective pressure for persister cell formation (Phillips et al. 1987; Miller et al. 2004). 
The problem of persister cells is compounded massively in the context of 
polymicrobial biofilm-mediated infections. When encapsulated in the EPS matrix, 
antigenic cell material is shielded from immune surveillance, and cells are effectively 
sequestered from phagocytosis (Vuong et al. 2004). In addition, many of the microbial 
interactions outlined in section 1.1.3.4 favour persister cell survival, as ‘altruistic’ 
actions by surrounding cells may better facilitate survival of essentially dormant, 
passive cells. The biofilm environment itself is conducive to persister formation: 
mature biofilms contain a population primarily in the stationary growth phase, and 
nutrient privation, population density and waste product accumulation all provide a 
chronic, high-stress environment which may drive persister formation through the 
‘SOS’ response (Nguyen et al. 2011). Furthermore, the biofilm matrix can slow the 
penetration of a number of antimicrobials or may contain extra-cellular enzymes 
which can inactivate antimicrobial agents (Olsen 2015). This results in lower 
concentrations of antimicrobial which take longer to reach a bactericidal 
concentration and therefore ‘buys time’ for persister formation to occur as a response 
to increasing, but non-lethal, stress levels. When antimicrobial levels fall following 
treatment, biofilm matrix and a small number of surviving persister cells will now be 
in a relatively low-stress environment, as competition is reduced due to massively 
decreased population density. The same gene-switching processes that result in 
persister formation may now reverse, and these surviving cells can repopulate the 
biofilm (Balaban et al. 2004). It is important to note that while the above narrative is 
helpful to understand the potential mechanisms by which persister cells contribute to 
biofilm recalcitrance, the switching from active to dormant phenotype appears to be 
almost entirely stochastic, with the likelihood of either state dependent on the net 
balance of surrounding stressors.  
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Importantly, persister cells have been identified as contributing to the recalcitrance of 
respiratory infection to antimicrobial therapy by P. aeruginosa in cystic fibrosis 
patients (Mulcahy et al. 2010). This finding was present despite no inherent increase 
in antimicrobial resistance of clinical isolates. Staphylococcus aureus in the stationary 
growth phase has been found to produce an exceptionally high number of persister 
cells, with the entire population demonstrating substantial increases in antimicrobial 
tolerance (Keren et al. 2004). This has proven pivotal in recalcitrant S. aureus 
infections failing to respond to vancomycin and linezolid despite no resistance to 
either antibiotic being detected (Welsh et al. 2011). Promisingly, combination of 
antibiotic treatment and chemotherapeutics which activate relevant antimicrobial 
targets have been found to eradicate biofilms in chronic wounds (Conlon et al. 2013). 
Although only isolated cases of such treatment have been reported at present, 
bespoke, targeted combination therapies formulated on precise understanding of the 
mechanisms in persister formation offer an important last line of defence against 
highly recalcitrant, biofilm-mediated infections.  
1.2: The Oral Ecosystem
In response to the inception of the field of microbial ecology, our view of the oral 
cavity includes an appreciation for the range of highly diverse and dynamic 
environmental niches, in a state of dynamic equilibrium with the microbial 
communities which populate them. Any change to either environment or microbial 
populations may cause extensive and potentially irreversible sequelae to both host 
and microbiome. 
1.2.1: The diverse habitats of the oral cavity 
The oral cavity is an anatomical space bounded by the lips and cheeks externally, 
and the pillars of fauces at the junction of the oropharynx internally (Berkovitz et al. 
2017). In reality, it is continuous with the oropharynx, which connects the oral cavity 
with the digestive and respiratory tracts. The continuity between the external 
environment and the respiratory and digestive tissues makes the oral cavity a critical 
interface in the body. Indeed, it is difficult to imagine a scenario in which the oral 
cavity is not at least passively involved in the pathogenesis of respiratory infections 
by acting as a conduit, with emerging evidence suggesting that ecological shifts 
within the oral cavity and dysbiotic changes in the oral microbiome may directly seed 
respiratory infection, as outlined in later sections. There are a number of 
environments in the oral cavity which are unique, and substantial contrast between 
different niches available to microbial communities therein (Figures 1.2.1A & B). 
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Here, the total number of unique species-level OTUs  is plotted against number of 
sequencing reads as a rarefaction curve (Figure 1.2.1A). The steepness of the 
rarefaction curve relates to diversity, with saliva having the most diverse microbiota. 
Of the specific oral sites, the tongue shows greatest diversity. Figure 1.2.1B 
demonstrates the relative abundance of different genera across oral sites. Of note, 
Candida is not included in this analysis, but is commonly found on mucosal surfaces, 
particularly the palatal mucosa of denture-wearers.
Figure 1.2.1: 
A) Phylogenetic diversity of bacterial samples from one individual at different oral sites indicated by 
rarefaction curves.
 (Image from Simon-Soro et al. 2013) 
B) Relative abundance of selected bacteria in different ecological niches within the oral cavity. (Kerr 
and Tribble, 2015). 
B 
A 
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1.2.1.1: Non-keratinised, shedding surfaces 
The soft tissues of the oral cavity are lined with mucosa; a membrane comprising 
stratified squamous epithelial cells overlying a fibroblast rich connective tissue layer 
called the lamina propria. A feature of all oral mucosa is the maturation of epithelial 
cells from proliferation in the deepest basal layer to most superficial layer, with 
morphological changes reflective of tissue function accumulating throughout the 
maturation process (Figure 1.2.1.1). The oral mucosa can be divided based on 
anatomical, functional or histological differences. However, in reality these three 
conceptual fields are intimately intertwined in biology. The broadest subdivision of 
oral mucosal surfaces is to differentiate keratinised and non-keratinised surfaces. 
The flattened surface cells of non-keratinised epithelium develop cytoplasmic 
filaments which lend elasticity, while losing many of the organelles seen in deeper 
layers (Berkovitz et al. 2017). All mucosal surfaces are continuously shed and 
replenished by cells maturing from the underlying layers. This process is termed 
desquamation. The mechanisms underpinning desquamation remain unclear. 
However, the process is an important facet of innate immunity – by continuous 
shedding of the mucosal surface, colonisation and establishment of mature microbial 
biofilms is impaired. By surface area, non-keratinised mucosa forms the majority of 
the oral cavity lining (Nanci et al. 2017). It lines the lips, soft palate, floor of mouth, 
ventral tongue, buccal tissues and non-attached portion of the alveolar gingivae. Non-
keratinised mucosa comes into contact with polished denture surfaces, but typically 
has minimal contact area with the denture-fit surface. As the polished denture 
surfaces tend to be smoother and less porous, exposed to saliva and masticatory 
friction, these sites are less likely to accumulate substantial biofilm outside of very 
poor denture hygiene or dentures which are in disrepair, the influence of dentures on 
the non-keratinised tissues is likely lower than in the denture-bearing mucosa. 
However, these surfaces may still provide relatively sheltered niches that allow 
substantial pathogenic bioburden to accumulate, such as the reflection of the sulci in 
individuals who do not remove their dentures.  
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1.2.1.2: Keratinised, shedding surfaces 
The remaining oral surfaces, namely the vermillion border of the lips, attached 
gingiva, dorsal tongue and hard palate, are covered by keratinised mucosa. While 
typically the mucosa of the vermillion border of the lip and dorsum of the tongue are 
termed specialised mucosa due to their atypical structures and more specialised 
functional roles (Berkovitz et al. 2017, Nanci et al. 2017); these and the other 
keratinised mucosal sites have a clear role in masticatory function. Thus, all oral 
keratinised mucosa can be considered a form of masticatory mucosa without this 
being mutually exclusive with other, specialised functions. 
While keratinised mucosa shares a number of morphological similarities with non-
keratinised mucosa, such as the relationship of the epithelial layer with the underlying 
lamina propria, and the maturation process from basal layer to superficial layer, a 
number of important differences emerge during maturation of the epithelial cells 
(Figure 1.2.1.2). The morphological changes that occur during maturation are 
considerably more marked in keratinised epithelium, with considerable accumulation 
of tonofilaments and keratohyalin granules in the intermediate cell layers, coupled 
with flattening of the cells and reduction in organelle content. The granules contain 
profilaggrin, which is released extracellularly and self-assemble into a densely cross-
linked matrix which act as a barrier between cells. In the superficial layer, epithelial 
cells lose all normal ultrastructural features, with total absence of organelles. They 
are filled entirely with tonofilaments and filaggrin matrix, the combination of which are 
called keratin, eponymous for this cell type (Nanci et al. 2017). The thickness of the 
Figure 1.2.1.1: Maturation of the non-keratinised epithelial 
tissues. 
The basal layer (lowest on image) lies at the lamina propria, at the 
deepest part of the epithelium. This cell layer is highly proliferative 
and provides the cells which make up the overlying layers. As the 
epithelial cells travel superficially through continued replacement 
by proliferation of the basal layer, they undergo the process of 
maturation. As maturation progresses there are distinctive 
morphological changes which allow the broad subdivision of 
epithelial tissue into layers. With each superseding layer, there is 
a progressive flattening of the cells, as much of the organelle 
content is lost, although nuclei are retained. In the superficial 
layer, cells have a flattened appearance and are called ‘squames’. 
(Nanci 2017, © Elsevier 2018) 
21
keratinised layer varies in different areas and can thicken in response to stimuli such 
as chronic trauma, termed hyperkeratosis (Rubin 1949). 
Critically, the keratinised epithelium of the hard palate and tongue have 
macroscopically complex topographies, due to the presence of the palatal rugae and 
taste buds. In the case of the dorsal tongue, microscopic invaginations also exist 
between the specialised papillae. This results in highly heterogeneous environments, 
may lead to relatively sheltered micro-niches which could shield denizen microbes 
from salivary cleansing. During masticatory function, these surfaces are typically 
exposed to frictional forces, which accelerate the normal desquamative processes 
and can disrupt local microbial communities. The impact of removable dental 
prostheses on shielding the palatal microbiota from such effects is unclear, but 
certainly these may promote areas of stagnation, in addition to acting as a vector for 
environmental, extraoral microbes to be acquired and transported directly to colonise 
the palatal mucosa during prolonged intraoral contact times. Certainly, despite 
constant desquamation, the dorsal tongue microbiome appears to be more diverse 
in composition than most other oral sites, which reflects the complex environment 
offered by this site (Simon-Soro et al. 2013). 
The gingival tissues, because of their intimate relationship with the teeth, are best 
considered separately. 
1.2.1.3: The dental tissues 
The dental tissues make the oral cavity a unique site in the body; where hard, non-
shedding tissues are directly connected to the epithelial tissues of the gingivae and 
Figure 1.2.1.2: Maturation of the keratinised epithelial tissues 
follows a similar process to the non-keratinised tissues.
The progressive changes in cell morphology are more pronounced 
however, as all organelle content and even cell nuclei are lost and 
replaced with densely packed fibrillar material. At the most superficial 
layer, the tight-junctional attachment of cells forms an impermeable 
barrier which makes differentiating individual cells difficult. In some 
instances, nuclei are retained, although in a dense, compacted 
(pyknotic) form. Epithelial tissue with such cells is referred to as 
‘parakeratinised’, and can be considered as an intermediate tissue 
type interposing non-keratinised and keratinised tissues. (Nanci 
2017 © Elsevier 2018) 
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exposed to the external environment. The outer tooth surface exposed to the mouth 
is formed by enamel, a highly mineralised tissue which is composed of approximately 
96% inorganic hydroxyapatite crystals, which proffer the hard-wearing resilience 
needed for mastication (Berkovitz et al. 2017). Deep to the enamel is dentine, a 
tubular tissue which is approximately 70% hydroxyapatite mineral, with the remaining 
30% comprising mainly collagen protein. The porous nature of dentine makes this 
tissue essentially continuous with the deepest tooth tissue; the pulp. This soft, vital 
tissue contains neurovascular bundles and cells responsible for dentine formation, 
maintenance and repairs. The portion of the tooth not exposed to the mouth in health, 
but instead anchored to the supporting alveolar bone of the jaws by the specialised 
connective tissue fibres of the periodontal ligament is termed the root. This differs 
from the coronal tooth in that the outer tissue is comprised of cementum, which is 
approximately 50% mineral content, 50% collagen. The dentinal-periodontal complex 
is illustrated in Figure 1.2.1.3A. 
Figure 1.2.1.3A: Basic anatomy of the dentinal-periodontal complex (longitudinal sectional view)
Of note, the cementum is not indicated, but is represented by that part of the tooth surface into which 
the periodontal fibres are anchored. The relationship between cemento-enamel junction, approximately 
coincident with the apical attachment of the junctional epithelium can also be appreciated.  
(Image from Clerehugh et al. 2013) 
The tooth root is anchored to bone by a specialised connective tissue called the 
periodontal ligament, which contains collagen fibre bundles traversing the 0.15 – 
0.38 mm space from alveolar bone to cementum tissue (Nansi 2017). Coronal to the 
level of the alveolar bone crest, similar fibres extend from tooth to the free gingivae, 
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contributing to gingival architecture. In addition to collagen, various elastic fibres, 
fibroblasts, neurovascular bundles are contained within a glycosaminoglycan ‘ground 
substance’ matrix (Berkovitz et al. 2017). 
The gingivae form a mucosal ‘collar’ to surround each tooth. In health, the gingival 
mucosa attaches to the cementum immediately below the border of cementum and 
enamel. There is a protuberance of gingival tissue coronal to this attachment, of 
approximately 2-3 mm, which is termed free gingiva in reference to the absence of 
direct attachment to adjacent hard tissues. This results in a space between the tooth-
facing gingival epithelium and the coronal enamel, termed the gingival sulcus. The 
portion of the gingiva that attaches to the cementum is termed the junctional 
epithelium. It ranges from 1 – approximately 30 cells in thickness from the most apical 
to coronal extent respectively. Unlike most epithelial tissues, this specialised region 
consists only of a germinative layer of cuboidal cells and a layer resembling the 
stratum spinosum in thicker portions. This epithelium is highly permeable, which 
permits the diapedesis of leukocytes critical to the maintenance of this vulnerable 
tissue (Bosshardt and Lang 2005).  
The gingival sulcus is a key site in the aetiopathogenesis of periodontal disease, 
which is one of the most prevalent microbial diseases worldwide (Peterson and 
Ogawa 2012). The tooth, offering a non-shedding surface, is readily colonised by 
microbes. The sequence of colonisation is to some extent determined by the 
presence of a coating of salivary glycoproteins, termed the salivary pellicle, which 
occurs essentially instantaneously on the clean tooth surface (Kerr and Tribble 2015). 
The role of saliva in orchestrating colonisation and in providing antimicrobial actions 
will be detailed in Section 1.2.2.4.  
Typically, the community dynamics of early dental biofilms are predominated by 
commensal early colonisers, with a lower number of strict anaerobes and putative 
pathogenic species which occurs within the first few minutes of exposure of the dental 
surface (Marsh 2000). If allowed to mature over several hours to days however, 
biofilm diversity increases, as microniches develop within the biofilm architecture. As 
the biofilm grows and matures, colonisation extends into the deeper regions of the 
gingival sulcus, where oxygen tension is lower, and nutrient availability is limited. 
Typically this process starts between 2 – 7 days (Uzel et al. 2011) This is facilitated 
by the complex metabolite chains allowing newly acquired species to subsist from 
the waste products of their biofilm neighbours, combined with the acquisition and 
propagation of anaerobic late colonisers which require the establishment of suitable 
hypoxic environments to thrive (Socransky and Haffajee 2005). In response to the 
detection of microbial antigens in close approximation to the vulnerable junctional 
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epithelium, plus the direct impact of microbial toxins and metabolites, gingival 
inflammation ensues. This leads to the classical phenotype of gingivitis: oedema, 
erythema and occasionally symptoms of discomfort or pain. Such signs and 
symptoms result from local vasodilation and an increase in both vascular and tissue 
permeability, facilitating recruitment of neutrophils and other leukocytes to eradicate 
the microbial insult (Honda et al. 2006). 
In a large proportion of the population, a homeostatic balance is subsequently 
reached, wherein a low level of chronic inflammation is adequate to control, but not 
necessarily eliminate the microbial population. However, due to a combination of both 
microbial and host factors (particularly, but not exclusively, a degree of 
dysfunctionality in the immune response), the immune system is unable to manage 
the microbial insult, and can indeed contribute damage to host cells by release of 
non-specific cytotoxic compounds in response to foreign antigens, such as proteases 
(Cekici et al. 2014). Such prolonged and escalating inflammatory response results in 
migration of the junctional epithelium apically, away from the source of the insult. This 
leads to the formation of a deepened sulcus, termed a periodontal pocket (Figure 
1.2.1.3B). As the epithelium migrates apically, the supporting alveolar bone is 
resorbed concomitantly; the clinical hallmark of periodontal disease. Untreated, such 
processes can progress until the periodontal support for a tooth is completely 
undermined, resulting in tooth loss or a number of other adverse local sequelae. 
Further to the local effects of periodontal disease, increasing evidence supports links 
between periodontitis and a number of systemic diseases, including pneumonia. 
Many such diseases result in large part from an increase in circulating pro-
inflammatory signals, such as cardiovascular and metabolic diseases (Bullon et al. 
2009). However, as will be discussed in a later section, there is now a considerable 
volume of evidence to support the direct role of dysbiotic shifts in microbial 
communities in seeding respiratory infection. 
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Figure 1.2.1.3B: The periodontal pocket (longitudinal sectional view)
The hallmark feature of the periodontal pocket is the presence of true attachment loss, resulting from 
migration of the junctional epithelium apically from the cementoenamel junction. There is resorption of 
alveolar bone in conjunction with apical translocation of the junctional epithelium, which results in loss 
of hard and soft tissue support to the tooth.  
(Image from Clerehugh et al. 2013) 
1.2.1.4 Artificial surfaces 
Far from a modern phenomenon, the introduction of artificial prosthesis in the oral 
cavity is known to have been utilised since antiquity (Stern and Sreter 1996). The 
materials of choice in modern dentistry include composite resins, glass ionomer 
cements, a variety of ceramics, metal alloys, and polymethyl methacrylate (PMMA). 
As dental implants continue to increase in popularity, titanium and closely related 
alloys are used with growing frequency. The potential implications of this change, 
particularly in later life and if subject to inadequate maintenance and hygiene 
measures are substantial, but beyond the scope of this review.  
An altered microbial community composition has been reported for a range of dental 
materials. Several studies have examined the microbiota associated with orthodontic 
appliances (both traditional fixed and removable appliances, and more recent clear 
retainers). Koopman et al. (2015) found an increase in the relative abundance of 
periodontal pathogens such as Selenomonas and Porphyromonas species during 
treatment with fixed orthodontic appliances, but microbiome composition returned to 
that of baseline by 12 weeks post-treatment. A further study (Wang et al. 2019) 
compared the salivary microbiome of patients treated with fixed orthodontic 
appliances or removable Invisalign© appliances to untreated controls. Similar 
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changes in community composition were noted, with an increased relative 
abundance of phyla and genera associated with periodontal disease. However, oral 
hygiene was not assessed in this study, and this may have acted as an important 
confounder. In contrast, biofilms formed on dental composites have been shown to 
differ only slightly from those present on enamel (Conrads et al. 2019). While there 
was a significant increase in species richness in biofilms grown on composite 
materials compared with enamel surfaces, the magnitude of change (an 
approximately 25% increase) was of questionable clinical significance. Other artificial 
surfaces, such as drinking bottles, pacifiers and other restorative materials might be 
expected to impact the oral microbial composition, yet there is a dearth of research 
into these materials. 
Approximately 19% of the UK population wears a full or partial removable denture 
(Adult Dental Health Survey 2009). PMMA and some metal alloys (typically cobalt-
chromium) are typically used in removable prostheses.  Unlike the majority of intra-
coronal restorations and fixed prostheses, these materials form an interface with the 
oral mucosa, which potentiates the accumulation of microbes by forming areas of 
stagnation shielded from cleansing by saliva and masticatory friction. Like the dental 
hard tissues, such surfaces are non-shedding, and thus without effective cleaning, 
biofilm formation can proceed uninterrupted. In principle, this poses little problem, as 
the ability to remove such prostheses should facilitate thorough cleaning by patients. 
However, individuals in institutionalised care settings, or frail elderly populations who 
are likely to have multiple comorbidities may lack the motivation, dexterity or mental 
capacity to effectively clean such prostheses (Coulthwaite and Verran 2007). Oral 
care provided by staff in institutional care settings can often be suboptimal due to a 
number of barriers. Care staff often have insufficient training in oral health; many 
have an inherent declivity to engage in thorough oral hygiene because this is seen 
as invasive or repellent to some staff; and residents may be highly resistant to oral 
care, particularly if affected by dementia or other cognitive impairments. Many 
residents refuse to remove their dental prostheses, or to relinquish control of oral 
hygiene in an attempt to retain independence, despite mental or physical impairments 
that may hinder their ability to conduct such care optimally. Finally, oral and denture 
care may simply be a low priority in comparison to other care needs and be omitted 
or neglected due to these competing demands and time or resource pressures 
(Johnson et al. 2017). 
A further challenge to effective denture cleansing is the presence of surface 
imperfections, cracks or degradation with age (Figure 1.2.1.4A & B). While it is 
typically recommended that dental prostheses be replaced approximately every 5 – 
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7 years; this is sometimes not pragmatic for a number of reasons. It may be financially 
non-viable for an individual, or declining motor control may limit a patient’s ability to 
adapt to a new prosthesis, even when techniques are employed to copy the shape 
of previous dentures. Access to dentistry for frail elderly patients or those in 
institutional care settings may be limited, and compliance may decline in 
concordance with progressive cognitive impairment such as dementia. The presence 
of cracks or surface imperfections provides sheltered niches that can shield 
microbes, even from diligent hygiene measures. In particular, C. albicans hyphae 
have been shown to infiltrate surface imperfections to anchor mycelial biofilms to 
acrylic biomaterials (Ramage et al. 2004).  
Another frequently encountered clinical problem is atrophy of the alveolar ridges 
which support dentures. This is particularly problematic in the mandible, where 
progressive atrophy can lead to translocation of the mental foramen from the lateral 
surface of the body of the mandible to the edentulous ridge crest. Pressure on the 
prosthesis during function can then elicit compressive neurogenic pain, which can be 
sufficiently severe to impede adequate nutrition in some cases. Similarly, pressure 
exerted on atrophic ridges can elicit pain directly due to inadequate thickness of the 
alveolar processes. Techniques to avert this issue are limited, and therefore denture 
soft lining materials, typically polyvinylsiloxane-based, are often employed to cushion 
compressive forces and distribute pressure over a wider surface area (Ettinger 1993). 
These lining materials are readily infiltrated by C. albicans hyphae, and degenerate 
at a rapid rate compared to PMMA, to form an irregular, roughened surface that 
promotes accumulation of microbial biofilm (Bulad et al. 2004). To overcome the 
issue of enhanced microbial accumulation on denture soft lining materials, a number 
of researchers have attempted to incorporate antimicrobial agents into the silicone 
materials used, with variable success (Lefebvre et al. 2001; Chladek et al. 2011; 
Bueno et al. 2015). 
A final feature of removable prostheses that has received surprisingly little 
consideration in the literature is the potential role of denture biomaterial surfaces as 
a vector for environmental microbes to enter the oral cavity (Nair et al. 2016). Current 
advice recommends removal of dentures overnight to reduce the risk of denture 
stomatitis; while many patients who struggle to tolerate denture-wearing for long 
periods opt only to wear their prostheses for functional or aesthetic occasions such 
as meal times or when in public. Storage of removable dentures when not worn is 
highly variable, ranging from a variety of denture cleanser solutions, a glass of water, 
or dry storage. It is not uncommon for patients to simply store their prostheses in a 
pocket or place them loosely upon a convenient surface. Improper storage may 
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provide an opportunity for atypical, environmental microbes with pathogenic potential 
to adhere to the acrylic biomaterial surface of the denture, with sufficient time to 
effectively colonise, propagate and form early biofilm structures prior to reinsertion of 
the prosthesis. In an immunocompetent individual in a community setting, this 
transient influx of atypical microbes may pose little threat under normal 
circumstances, as the combination of host immune response and colonisation 
resistance of the host microbiome may neutralise the alien colonisers. However, in 
institutional care settings where endemic outbreaks of highly virulent putative 
respiratory pathogens such as Methicillin resistant S. aureus (MRSA), Klebsiella 
pneumoniae, Haemophilus influenza and P. aeruginosa are relatively frequently 
reported (Cassone and Mody 2015), the potential for the acquisition of a pathogenic 
microbial reservoir via removable prostheses in susceptible individuals is substantial. 
Subsequent development of respiratory infection depends on the interplay of multiple 
stochastic factors to result in dysbiotic modulation of the oral ecosystem that exceeds 
an individual’s immune defence capacity.  
Figure 1.2.1.4: Changes of the denture fit surface with age
A) An aged denture with poor denture hygiene. Note the acrylic fracture (lower left of image) and 
accumulation of debris and calculus around the crack (indicated by arrows) 
B) A new denture provided for the same patient. Note the relatively smooth surface and lack of 
stain, debris and calculus.
(Images from Babiuc et al. 2009)
1.2.2: Modulation of the oral ecosystem 
With recognition of the complexity of the oral microbiome and the vast, variable 
landscapes offered by the oral cavity, the language of microbiology has adopted 
much of the terminology of ecology. In this paradigm, the influence of one or more 
factors relating to the host, occurring within microbial populations or occurring as a 
side-effect of certain dental or medical interventions (i.e. iatrogenically) can lead to 
A B
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dysbiosis: a shift in community composition within the oral microbiome that results in 
deleterious effects to the host (Azarpazhooh and Leake 2006). An important point to 
acknowledge in reference to the seeding of infection at distant sites, such as 
pneumonia, is that here dysbiotic change does not necessarily result in noticeable 
detriment to the host in every case (at least not in a clinically detectable manner), but 
instead increases the stochastic risk of seeding and developing the disease. This is 
a slight, but critical modification to the ‘ecological plaque hypothesis’ first applied to 
dental caries and periodontal disease (Marsh 1991, Marsh 1994).  
Perturbation of the oral microbiome can occur by two primary mechanisms, 
summarised in Figure 1.2.2. The influence and interactions of a range of factors can 
combine to drive dysbiotic community shifts (Figure 1.2.2A). Some factors can be 
considered ‘modifiable’ behaviours (e.g. smoking, dietary composition, oral hygiene); 
some are classically considered ‘modifiable’ (e.g. medications affecting salivary flow 
or immune factors, antimicrobial agents) but from a pragmatic, individual perspective 
are typically unavoidable without incurring more severe health sequelae; while some 
are essentially unmodifiable (e.g. genetic differences, baseline salivary flow rates and 
composition). This can either result in the disproportionate growth of one or more 
species which is either classically pathogenic (Hornef 2015), or a ‘pathobiont’ – 
commensal in health, but disease-causing under certain circumstances (Figure 
1.2.2B). Such changes occur through both direct effects of the ecological pressure(s), 
and through other indirect effects of the same pressures on the host. For example, 
an individual may receive antibiotics to combat a severe urinary tract infection. In 
addition to the direct effects of oral antibiotics eradicating a large proportion of the 
resident oral microbiome, providing the opportunity for colonisation by opportunistic 
pathogens or the promulgation of pathobionts which happen to be resistant to the 
antibiotic used, the systemic effects of the infection may lead to an increase in pro-
inflammatory markers. Simultaneously, appetite and sleep may be reduced, leading 
to further changes in the microbial composition and increased stress levels. This in 
turn can result in increased sympathetic nervous tone, which decreases salivary flow. 
During ill-health, oral hygiene might be expected to decrease in effectiveness, 
particularly if the individual suffering from a disease is rendered bed-bound. The 
interplay of these factors will result in a net reduction in the effectiveness of the 
immune response, further dysregulating the normal control mechanisms of the 
commensal oral microbiome. Of note, despite close approximation to both the 
oropharynx and respiratory tissues, the nasal microbiome has been shown to have 
little impact on the lung microbiome in health (Sakwinska et al. 2014). There is 
surprisingly scant evidence regarding perturbations in the nasal bacteriome in 
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pneumonia, but a Swiss cross-sectional study in children found that nasal microbial 
communities enriched for S. pneumoniae, H. influenzae and M. catarrhalis were 
associated with an increased risk of pneumonia. Furthermore, rhinovirus infection is 
a known risk factor for subsequent pneumonia development and has been shown to 
increase the acquisition of S. pneumoniae within the nasal microbiome (Karppinen et 
al. 2017). Overall, there is a surprising lack of evidence regarding compositional 
changes in the nasal microbiome in pneumonia patients, however. 
It is possible that in institutionalised care settings, where opportunistic pathogens are 
frequently isolated (Kokubu et al. 2008), initial colonisation by such microorganisms 
could be maintained at a low level. Subsequent change of any ecological factors that 
govern this relationship could result in overgrowth of this acquired pathogen to drive 
dysbiotic changes.  
Figure 1.2.2: The ecological selection model of dysbiotic changes in the oral microbiome as a 
driver of disease 
a) A broad range of factors can exert a selective pressure on the oral ecosystem, often with 
interplay between several factors.
b) This in turn drives either propagation of indigenous pathobionts or permits acquisition of and 
colonisation by exogenous opportunistic pathogens from the environment. The combination of 
environmental disturbance and microbial dysbiosis are synergistic. Eventually, this pathogenic 
microbiome can drive local disease, or seed infection of distant tissues.
(Killian et al. 2016, © Springer Nature, Creative Commons CC BY License.) 
Another putative iatrogenic factor which could perturb the normal microbial 
composition of the oral cavity is the presence of biomaterial surfaces such as 
removable dentures. The role of such prostheses as vectors for opportunistic 
pathogens to gain entry to the oral cavity in sufficient numbers for successful 
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colonisation has been outlined in section 1.2.1.4. However, a further mechanism by 
which the presence of dental prostheses may promote colonisation by atypical, 
potentially pathogenic microbes is the very presence of an artificial biomaterial 
surface.  
The ‘normal’ oral microbiome has evolved in tandem with the host, with a finely 
orchestrated relationship whereby specific binding sites on host surfaces, or via the 
glycoproteins of the salivary pellicle, combined with regulation by host immune cells 
and antimicrobial peptides, results in an overall commensal relationship overall 
(Sultan et al. 2018). Denture acrylic differs from the natural non-shedding dental 
enamel surface in hydrophobicity, surface free energy, chemical composition, surface 
roughness and isoelectric point (Müller et al. 2009). Consequently, the composition 
of salivary pellicle and microbial adhesive behaviour on acrylic surfaces differs from 
enamel (Svendsen and Lindh 2009). The evolved biochemical adhesion pathways 
that regulate ‘normal’ colonisation of the oral cavity by predominantly commensal 
microbes (Pedersen and Belstrøm 2019.) may therefore be bypassed, allowing more 
resilient or rapidly growing environmental pathogens to outcompete typical oral 
microbes. A key to such atypical microorganisms’ survival and formation of robust 
biofilms recalcitrant to removal is likely influenced by the shelter from saliva provided 
by dentures. 
1.2.3: The multifaceted roles of saliva 
Saliva plays an important role in modulating the adhesion of microbes to oral 
surfaces, including PMMA biomaterials (Kerr and Tribble, 2015). It contains a range 
of glycoproteins which, as well as lubricating the oral tissues, selectively adsorb to 
oral surfaces to mediate attachment of commensal organisms such as streptococci 
and actinomyces. This film of salivary constituents is termed the acquired salivary 
pellicle (Dawes et al. 2015). The presence of the salivary pellicle on teeth is thought 
to be one of the major factors influencing the establishment of a ‘healthy’ microbiome, 
as oral microbes have evolved specialised adhesion lectins, adhesins, which bind 
targets within typical pellicle components, outlined in Figure 1.2.3. 
Although little evidence exists regarding differences between the salivary pellicle 
present on teeth compared with artificial surfaces such as dentures and endotracheal 
tubes, there is a suggestion that pellicle composition differs both in ratio and presence 
of certain constituents. In particular, pellicles on denture surfaces were found not to 
contain mucin 7, cystatins or proline-rich-proteins, which could contribute to different 
patterns of adhesion (Edgerton and Levine, 1992). In addition, the presence of oral 
inflammation often associated with ill-fitting dentures may result in the incorporation 
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of serum components into the pellicle, which is thought to contribute to increased 
Candida bioburden and thus is implicated in development of denture stomatitis 
(Ramage et al. 2004). The implications of these findings regarding colonisation of 
such surfaces by respiratory pathogens are unknown and more research is needed 
to elucidate their significance. Despite small differences, the pellicle likely offers 
similar advantages overall to adherent microorganisms on any non-shedding surface, 
namely the provision of ligands for binding, and reduction of surface charge, which 
favours adhesion (Cavalcanti et al. 2016). 
Figure 1.2.3: Saliva receptors for bacterial adhesins 
Salivary components offer a variety of potential targets for bacterial adhesion by highly adapted oral 
bacterial species (early colonizers). Oral prostheses may feature alterations in pellicle composition or 
reduced pellicle coating and thus alter the patterns of colonisation. 
Key: solid lines – adhesins, dashed lines – surface fibrils, GP – glycoprotein, PRP – proline rich proteins, 
SPC – salivary pellicle component, PSA – parotid salivary agglutinin, SmSP – submandibular salivary 
protein. 
(Image from Kerr and Tribble, 2015) 
Saliva has other important functions related to pellicle formation and maintenance of 
a commensal oral microbiome. Many immunologic components are present within 
saliva such as histatins, cystatins, IgA, lysozyme and lactoferrin (Humphrey and 
Williamson, 2001). A putative role of mucins is to localise these antimicrobial 
substances to the tissues. For instance, by binding to statherin and histatins, mucins 
5b and 7 can concentrate them on oral surfaces (Linden et al. 2008). These actions, 
combined with salivary buffering, clearance and subsequent deglutition, help to 
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ensure the oral microbiome is regulated. Changes in health, behavioural factors such 
as smoking, polypharmacy and age-related changes can alter salivary flow, 
composition and pH (Vissink et al.1996). Such changes may have a significant role 
in the development of not only oral, but systemic diseases of oral origin. Many such 
factors are present in individuals in institutionalised care. The majority of residents 
are frail elderly individuals with multiple comorbidities and a high medication burden 
(Gordon et al. 2013). 
1.2.4: The oral microbiome in health and disease 
The constituent, commensal oral microbiome has a role in maintaining both local and 
systemic health through a number of different mechanisms, summarised in Figure 
1.2.3. Some health-associated facets of the microbiome are related to metabolic 
functions of the microbiome (Huttenhower et al. 2012), and may be more pronounced 
in the gut proper, such as regulation of the cardiovascular system (Hansen et al. 
2015) and antioxidant activities (Menni et al. 2019). However, the possibility for 
dysbiotic changes within the oral microbiome to result in deleterious effects to the 
cardiovascular system are clear from the link between metabolic syndrome and 
periodontal disease, despite the much greater population present within the gut 
(Koren et al. 2011). Whether periodontal pockets provide a reservoir of pathogenic 
species which can seed colonisation of the gut has received limited exploration, 
although early data suggests this may be the case. Lourenço et al. (2018) found that 
not only did the gut microbiome contain more periodontopathogens in periodontitis 
patients compared to health controls, but that overall gut microbiome diversity was 
reduced in such individuals. As with all molecular studies, such research is limited by 
an inability to distinguish living from dead microbes. Furthermore, the possibility of 
confounding factors, particularly given the small sample size analysed, cannot be 
excluded. 
Other microbiome features in health, such as resistance to colonisation by 
exogenous pathogens, play critical roles in the potential association of dentures, 
colonisation by PRPs and the development of pneumonia. 
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Figure 1.2.4: Beneficial effects of the commensal microbiome to the host 
The role of the host microbiome, particularly in the gut, is a growing field of research. Links between 
microbial nitrite/nitrate metabolic pathways and cardiovascular health have been identified. The role of 
the gut microbiome in neonates in facilitating normal immune development has been inferred through a 
combination of in vitro studies and cross-sectional observations. Much of the research surrounding pre 
and pro-biotics has found that modulating the gastro-intestinal microbiome can result in an anti-
inflammatory effect. Similarly, disruption of the developing microbiome leads to reduced intestinal 
antioxidant levels.  
(Image from Killian et al. 2016 © Springer Nature, Creative Commons CC BY License.) 
1.2.4.1: Symbiotic relationships of host and oral microbes 
The role of the gut microbiome in maintaining both local and systemic health is well-
documented (Shreiner et al. 2015). However, evidence specific to the role of the oral 
microbiome is comparatively limited. Much interest has been focussed on the 
potential pathogenic roles of the oral microbiome in both local and systemic disease, 
with effects on health framed tangentially as simply the absence of changes 
associated with such diseases. Some limited cross-sectional data has suggested that 
the ‘core’ salivary microbiome can be split into two function groups: a Prevotella or 
Neisseria predominated group (Takeshita et al. 2015). The former may be associated 
with poorer periodontal (including plaque and bleeding indices, periodontal pocket 
depth and tooth loss) and systemic health (such as smoking history, high body mass 
indices and increasing age), while the latter more health-associated. Clearly, this data 
is not suggestive of causality, although even in the best-established cases of model 
disease organisms in the oral cavity, such as S. mutans in caries (Simón-Soro and 
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Mira 2015), or P. gingivalis in periodontal disease (Olsen et al. 2017), it is highly 
challenging to satisfy every condition of causation required to demonstrate a 
traditional pathogenic role, capable of satisfying Koch’s postulates under every 
circumstance. 
One area where the influence of the commensal oral microbiome has been well-
documented is the induction of ‘immune tolerance’. Many oral streptococci are able 
to suppress local immune responses, which not only ensures their continued survival, 
but also leads to the maintenance of normal, healthy oral tissues, despite frequent 
contact with foreign antigens in the form of the oral microbiome, food and other 
substances (Devine et al. 2015). This action does not appear to reduce immune 
response to pathogens, as can be inferred from the increase in pathogenic microbiota 
in chronically immunosuppressed individuals (Diaz et al. 2013).  
The oral microbiome also contributes to metabolism of dietary nitrates, which can 
enhance cardiovascular health (Blekkenhorst et al. 2018). Dietary nitrates are 
reduced to nitrites by resident microbes such as Rothia and Neisseria species 
(Vanhatalo et al. 2018). When swallowed, nitrites can be converted to nitric oxide, 
which reduces blood pressure through peripheral vasodilatory activity (Tousoulis et 
al. 2012) and may reduce endothelial pathoses and platelet aggregation (Riddell and 
Owen 1997). Cumulatively these effects could reduce atherogenic change and risk 
of adverse cardiovascular events, although evidence to date has focussed only on 
vascular function in healthy populations. Research exploring the potential for 
modulation of the oral microbiome to reduce adverse cardiovascular outcomes in at-
risk populations is much needed. 
Besides the above examples of microbial function either directly or indirectly shaping 
health, the oral microbiome can reduce colonisation of oral surfaces by pathogenic 
species through conferring resistance through both passive and active mechanisms. 
1.2.4.2: Microbiome diversity and resistance 
The concept of colonisation resistance was first derived from observations of 
increased susceptibility of individuals to intestinal Salmonella infection following 
antibiotic treatment (Bohnhoff et al. 1954). Subsequent experiments in mice 
demonstrated that microbes from healthy individuals’ faeces could reduce the risk of 
colonisation by Salmonella enteritidis (Bohnhoff et al. 1964). The same concept is 
today applied through faecal transplant therapy to eradicate recalcitrant 
Clostridium difficile infection in patients, which is a potential sequela of broad-
spectrum antibiotic treatment (Kassam et al. 2013). 
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More recently, an appreciation for the role of the resident commensal oral microbiome 
in providing colonisation resistance has developed. The mechanisms of colonisation 
resistance can be broadly classified as passive or active. 
Passive colonisation resistance occurs through normal microbial activity, either due 
to establishment of a large population of commensal species prior to colonisation by 
potential pathogens, or due to the evolved advantage of the resident oral microbiome 
in the oral cavity. As has previously been discussed, oral and salivary binding sites 
have likely co-evolved with commensal oral microbes to maximise the ability of such 
microorganisms to occupy available oral niches. Additionally, such microbes are 
highly adapted to metabolise the available nutrients and induce immune tolerance to 
permit their continued presence and survival. It is not necessary for oral microbes to 
outcompete alien opportunists for all available nutrients – only a single limiting 
substrate is enough to prevent effective colonisation by exogenous microbes (Litvak 
and Bäumler 2019). Oral microbial communities exist largely as biofilms, with 
complex, dynamic interactions including co-dependent metabolite pathways and 
synergistic relationships (Huang et al. 2011). This means that would-be colonisers 
must not only overcome adaptations that confer a selective advantage for the 
environment, but also co-evolved inter-microbial adaptations that further shape the 
environment and communities within. 
Active resistance to colonisation relates to direct antagonistic activity of microbes to 
exogenous species (Sorbara and Pamer 2019). While it may be argued that such 
activity is primarily used by microbes to compete with other endogenous species, and 
even within the same species for individual competition, the effects on exogenous 
species are likely far more pronounced due to the co-evolution of endogenous 
microbial communities under such selective pressures (Hibbing et al. 2010). Many 
microbes produce antimicrobial substances, such as surfactants, antibiotics, 
antimicrobial peptides and a variety of substances secreted through Type VI 
secretion systems (Chassaing and Cascales 2018). While much of our knowledge of 
such substances is derived from studies of the gut and vaginal microbiome, there is 
increasing interest in application of pre, pro and synbiotics to the oral cavity (Devine 
and Marsh 2009). Avenues explored to date include prevention of caries, periodontal 
disease and oral candidiasis. However, modulation of the oral microbiome through 
such approaches as a means of reducing systemic disease is an area that remains 
to be explored. 
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1.2.4.3: The oral microbiome as a pathogenic reservoir 
That the oral microbiome can harbour microbes with pathogenic potential is evident 
from the presence of oral diseases, such as dental caries (Burne et al. 2012), 
periodontal disease (Liu et al. 2012) and oral candidiasis (Morse et al. 2019), where 
a role for oral microbial aetiology is convincingly established. To demonstrate 
contribution by the oral microbiome to systemic diseases is far more complex, 
however. Microbes must be shown to be present in the oral microbiome prior to the 
development of the disease in question, rather than simply to be able to colonise the 
oral cavity as a consequence of changes associated with the disease. They then 
must either exert effects to contribute to the pathogenesis of the disease through 
direct translocation to the disease site, or by inducing a host response with 
deleterious consequences at the disease site (Hill 1965). While the oral microbiome 
comprises fungi, bacteria, viruses, archaea and protozoa; the majority of research to 
date has focussed on the bacterial microbiome. Some researchers are beginning to 
unravel the importance of fungal and viral microbiota more recently. For brevity and 
relevance to the study methods reported in this thesis, only the bacterial microbiome 
will be considered in the following sections. 
In the case of the association of periodontal disease with cardiovascular disease, 
there is evidence to support both dissemination of oral bacteria into the bloodstream 
(Haraszthy et al. 2000), and adverse proinflammatory mediators in response to the 
microbial insult to the periodontium. In the case of respiratory infection, the challenge 
is not in identifying a pathway for microbes to the lungs, which is obvious by their 
anatomical contiguity. Instead, the requirement to demonstrate causation beyond 
reasonable doubt is to demonstrate that colonisation of the oral microbiome by the 
relevant putative respiratory pathogenic species occurs prior to the development of 
respiratory infection, rather than simultaneously or subsequently (Rogers et al. 2013). 
1.2.4.4: Pathogens and virulence - a matter of context 
The terminology of microbial infection is sometimes ill-defined, with terms frequently 
being used interchangeably and without thought to the meaning implied through 
specific definitions. An example of this is in the use of the term ‘virulence factor’, often 
used to describe any microbial function that is directly deleterious to the host 
(Casadevall and Pirofski 2009). Many authors also describe surface adhesins, factors 
relating to immune evasion or survival within the host environment as virulence genes 
when present in a microbial species considered pathogenic. When similar, 
sometimes identical factors are present in typically commensal species, however, 
these same virulence factors could now be considered beneficial, and even described 
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as part of the mutualistic relationship between host and microbes. This is inaccurate 
and confusing. Instead, the classification of Wassenaar and Gaastra (2001) below is 
helpful for clarifying the attribution of virulence in pathogenic microbes.  
Figure 1.2.4.4: Differentiation of true virulence from virulence-associated or virulence life-style 
genes 
(Figure from Wassenaar and Gaastra 2001) 
Of note, this classification refers specifically to genetic regulation of virulence, but can 
easily be adapted to virulence factors themselves. 
Adoption of this model can help contextualise terms such as commensals, 
opportunistic pathogens (pathobionts) and true pathogens. Under these definitions, 
only microorganisms capable of producing true virulence genes can be considered 
exclusive pathogens, while both commensal microbes or pathobionts may possess 
virulence-associated or virulence life-style genes. Interestingly, horizontal gene 
transfer between species means that an analysis of species composition alone within 
microbial communities is not necessarily predictive of pathogen presence (Martínez 
et al. 2007). Instead, analysis of microbial function through transcriptomics, 
proteomics or metabolomics is needed (Vayssier-Taussat et al. 2015). 
1.2.4.5: Pathogenic potential of the oral microbiome
In light of the above definitions, can the archetypal pathogenic oral microbe 
associated with oral caries; and can S. mutans be considered a true pathogen? A 
39
brief exploration of the often-touted virulence traits of S. mutans (Banas 2004) casts 
some doubt: 
• Enhanced adhesion (both sucrose-independent and sucrose-mediated) 
• Enhanced biofilm formation 
• Lactate metabolic pathway-mediated acidogenesis 
• Enhanced aciduricity 
None of these traits are unique to pathogens, are shared by most streptococci (Cotter 
and Hill 2003), although acidogenesis and aciduricity are enhanced in S. mutans.
Furthermore, caries can occur in the absence of S. mutans. As our understanding of 
the caries microbiome evolves, the role of community interactions and functional 
redundancy has shown that the role of S. mutans is likely overstated, despite this 
microorganism still being a key player in the development of caries for most 
individuals (Banas and Drake 2018). It seems likely therefore, that this species is 
typically an opportunistic pathogen, with no true virulence factors. 
The role of the indigenous oral microbiome in the pathogenesis of systemic disease 
has also been explored. Infective endocarditis can arise in susceptible individuals; 
especially those with prosthetic heart valves, as a result of bacteraemia during 
invasive dental procedures (Habib et al. 2009). Streptococci of oral origin have been 
identified in blood cultures from patients with infective endocarditis, although it should 
be noted that prior invasive dental treatment, oral health and other key aetiological 
factors were unknown for this cohort (Douglas et al. 1993). Outside of this acute and 
somewhat predictable aetiology, the role of the oral microbiome in atherosclerotic 
changes and ischaemic heart disease (IHD) is more complex. Associations between 
severe periodontal disease and IHD have been found which cannot be explained by 
the interaction of confounders such as diabetes, smoking and BMI alone (Humphrey 
et al. 2008). The triad of microorganisms most frequently associated with severe 
periodontal disease: P. gingivalis, Fusobacterium nucleatum and Aggregatibacter 
actinomycetemcomitans have all been found to be capable of directly invading the 
periodontal tissues to gain entry into the bloodstream (Reyes et al. 2013). These 
microorganisms have been isolated from atherosclerotic plaque and are able to 
mediate local inflammation and coagulation to contribute directly to disease 
(Haraszthy et al. 2000). Furthermore, circulating pro-inflammatory mediators are 
increased in response to the chronic inflammatory environment of the periodontal 
pocket, which may also contribute to disease pathogenesis (Loos et al. 2000). This 
mechanism of disseminated inflammation is likely the primary means by which 
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periodontal disease negatively impacts glycaemic control and insulin sensitivity in 
diabetics, as no convincing direct role for the oral microbiome has been discovered 
to date (Preshaw et al. 2012). 
A growing area of research recently has been the putative role of the 
periodontopathogens P. gingivalis, Prevotella intermedia and Tannerella forsythia in 
the development of rheumatoid arthritis (Martu et al. 2017). Porphyromonas gingivalis 
is of particular interest in the pathogenesis of this disease due to its ability to 
citrullinate proteins, which provides a possible mechanistic pathway for the 
development of the autoantibodies responsible for rheumatoid arthritis (Cheng et al. 
2017). To date, there have been no interventional studies exploring the impact of 
periodontal treatment on individuals at risk of severe rheumatoid arthritis, likely due 
to the challenges of identifying a suitably large, homogeneous group of such 
individuals (van der Pouw Kraan et al. 2003). 
There is limited evidence to support a role for the oral microbiome in the pathogenesis 
of both oral and gastrointestinal cancers (Ahn et al. 2012), and a number of 
inflammatory gastrointestinal diseases (Lucas López et al. 2017). However, the 
intimate relationship of microbial community composition with key risk factors such 
as smoking, alcohol and diet make it highly challenging to unravel specific 
mechanistic pathways. Furthermore, the role of the immune system and interactions 
between host immunity and the microbiome add another layer of complexity which 
may mask the underlying associations. However, the possibility of the oral 
microbiome influencing gut health is intriguing for three main reasons:
1) The resident gut microbiome might be expected to override the impact of the 
smaller oral microbial population 
2) The oral microbiome is more accessible for analysis and direct interventional 
studies (dietary interventions have a number of non-specific actions that may 
confound effects) 
3) The common mechanism of the oral microbiome seeding infective diseases or 
shaping the pathogenesis of disease at distant but anatomically contiguous sites 
parallels the putative role of the oral microbiome in the pathogenesis of respiratory 
infections 
There is a range of evidence to support the role of both the indigenous oral 
microbiome in pneumonia, as well as the potential for the oral microbiome to harbour 
exogenous PRPs following colonisation in susceptible individuals. This comes from 
three primary areas – ventilator associated pneumonia in intubated intensive care 
patients (O’Grady et al. 2012); aspiration pneumonia in individuals with reduced 
neuromotor function (Paju and Scannapieco 2007), such as stroke patients; indirect 
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evidence linking pneumonia to colonisation of the oral cavity and oropharynx in 
susceptible individuals without a known aspiration event , using oral health as a proxy 
marker (Awano et al. 2008). These mechanisms and their inherent commonalities will 
be explored later to derive a unified model of the oral microbiome in pneumonia. 
1.2.4.6: Dysbiosis and ecological shifts 
During health, the oral microbiome is largely stable, with established microbial 
populations resisting colonisation by atypical species through a variety of means 
(Human Microbiome Project Consortium, 2012). However, a number of exogenous 
factors may ‘destabilise’ the environment and alter the composition and behaviour of 
the microbiome, leading to potentially harmful outcomes to the host (Marsh PD, 
2003). This alteration of the oral ecosystem is considered more complex than simply 
an influx of pathogenic organisms, as typically commensal populations have been 
found to demonstrate increased virulence-associated or virulent lifestyle traits during 
such changes (Yost et al. 2015). This change in the microbiome is termed dysbiosis. 
Of note, such alterations usually result in a decrease in species diversity, although 
whether this is a cause or symptom of the predominance by more virulent species is 
unclear (Cho and Blaser, 2012). A notable exception to this trend is the periodontal 
pocket, where typically increasing diversity is associated with increased disease 
severity (Abusleme et al. 2013), perhaps due to the generation of a new anaerobic 
niche in deeper periodontal pockets, and the availability of new substrates and 
binding sites generated from the host inflammatory response.  
1.2.4.6.1: Local sequelae of dysbiosis 
The link between pathogenic alterations in the oral microbiome and local disease is 
clear in plaque-associated diseases such as periodontitis and dental caries. 
Additionally, the potential for prosthesis-related microbes to cause disease by similar 
mechanisms is typified by chronic erythematous candidiasis – an inflammatory 
condition which affects the palatal mucosa of denture wearers. 
A significant sequela of inflammatory changes within the oral cavity is the alteration 
of the environment due to exudate of serum, immunological changes and in more 
severe cases breakdown of the superficial mucosal layers. These changes have 
been postulated to favour colonisation of mucosal surfaces by atypical organisms 
(Scannapieco FA, 1999). For instance,  hydrolytic salivary enzymes associated with 
periodontal disease may contribute to degradation of fibronectin in the oral 
epithelium, increasing the binding affinity of microbes such as P. aeruginosa (Woods 
et al. 1981). Periodontal microbes themselves, particularly P. gingivalis can directly 
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degrade mucosal surfaces through release of proteolytic enzymes to expose 
subepithelial adhesive targets for atypical microbes including respiratory pathogens 
(Gibbons et al. 1990). Release of pro-inflammatory cytokines such as IL1, IL6, IL8 
and TNF by oral mucosa and in saliva in response to microbial antigens may impact 
interactions between respiratory pathogens and these may impact both local host-
microbe interactions and for oral microbes and secreted cytokines to enter the 
airways by microaspiration, impacting their behaviour. The release of 
proinflammatory cytokines has chemotactic functions. An example is neutrophil 
recruitment following IL8 release. Neutrophils release proteolytic enzymes and 
reactive oxygen species in response to contact with foreign antigens, further 
damaging the epithelial surfaces (Uriarte et al. 2016). Alternatively it may be that oral 
microbes suppress such immunogenic cascades to permit unchallenged colonisation 
by atypical pathogens. Porphyromonas gingivalis has been found to inhibit IL8 
secretion from oral epithelial cells, which aids invasion of the cells (Darveau et al. 
1998). The implications of such behaviour in respiratory tissues remains unclear. 
1.2.4.6.2: Systemic sequelae of dysbiosis 
The potential for systemic disease to be influenced by oral health is well established. 
Several conditions linked to oral disease, including bacterial endocarditis (Han and 
Wang, 2013), cardiovascular disease (Tonetti and Dyke, 2013) and diabetes mellitus 
(Preshaw et al. 2012) have been extensively described in the literature. Given this 
precedent, it is not unreasonable to expect the oral cavity to exert influence of 
development of lower respiratory tract infections.  
A key consideration in the pathogenesis of respiratory infections is the inherently 
stochastic nature of the processes involved. In the case of aspiration pneumonia, the 
disease process mirrors infective endocarditis: a well-defined event leads to a bolus 
inoculum of microbes reaching the infection site (Marik 2010). A greater oral 
bioburden, with higher virulence potential is more likely to result in successful 
infection of the site. Likewise, a greater chance of inoculation occurs in the presence 
of higher aspiration frequency (van der Maarel-Wierink et al. 2011). In the case of 
pneumonia that occurs without a known aspiration event however, the exact 
mechanism is unclear. It could be that ‘silent’ aspirations, which have been 
extensively documented, lead to inoculation of infective microorganisms in the lungs 
(Zaloga 2002). Alternatively, sequential colonisation of the oropharynx, upper 
respiratory tissues and finally, infection of the lungs may occur as microbes propagate 
directly (Palmer et al. 2001; Ewan et al. 2009). This possibility seems particularly 
plausible in the case of highly motile microbes such as P. aeruginosa, which can be 
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observed to coordinate dispersion from an established biofilm and is capable of 
swarming across a surface to seed a new colony at a distant site (Hall-Stoodley and 
Stoodley 2005). Finally, the possibility of inhalation of lower numbers of microbes 
which escape trapping by respiratory epithelial cilia during inhalation, and generate a 
chronic, low level bioaerosol to the deeper respiratory tissues conveyed by moist air 
cannot be entirely excluded. It should be noted that some pneumonias are best 
explained by direct inhalation of aetiological microbes, such as fungal spores (Murray 
et al. 2019).
1.3: Pneumonia 
The 2010 World Health Organisation (WHO) report “Global Burden of Diseases” (Lim 
et al. 2013) ranks lower respiratory tract infections as the fourth leading cause of 
death overall, and the most common cause of death due to infection. While in 
developing countries pneumonia accounts for a high proportion of childhood deaths, 
in more economically developed Western countries, such as the UK, much of Europe 
and the USA, pneumonia affects a disproportionate number of elderly patients, with 
a tenfold increase in European cases noted when patients are older than 65 years of 
age (Welte et al. 2012). Mortality due to pneumonia follows a similar trend, with 85% 
of deaths occurring in individuals over the age of 60 (Myles et al. 2009). 
In reality the term pneumonia describes a clinical phenotype of acute inflammation in 
the lower respiratory tract (McLuckie 2009), rather than a specific infective process. 
Indeed, not all pneumonias are infective in aetiology. Pneumonias can be caused by 
any of bacteria, fungi, viruses or protozoa; and polymicrobial infections containing 
multiple species and kingdoms may occur (Cillóniz et al. 2011; Torres et al. 2014). In 
the UK, the majority of pneumonias are bacterial in aetiology (Welte et al. 2012). 
Signs and symptoms of pneumonia vary with severity, but include cyanosis, 
tachycardia and tachypnoea, characteristic chest sounds, cough, dyspnoea, fever, 
malaise, myalgia and pleurisy (McLuckie 2009). In severe cases requiring 
hospitalisation, a chest x-ray may be taken, with the finding of radiopaque 
consolidation in the lung space considered highly suggestive of pneumonia (Mittl Jr 
et al. 1994) in conjunction with supportive clinical findings (Figure 1.3). Definitive 
diagnosis can often be challenging due to the lack of specific symptoms associated 
with pneumonia (Dicpinigaitis et al. 2009). 
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1.3.1: The lungs and respiratory tissues in health 
The respiratory system is responsible for supplying atmospheric oxygen to the blood, 
in exchange for carbon dioxide and other metabolic waste products. The respiratory 
tract begins with the nares and mouth, and includes the oral cavity and nasal cavity, 
which then merge in the pharynx. Subsequently, air passes through the larynx into 
the trachea. From this passage, there are approximately 23 iteratively narrower 
branching divisions which terminate in the alveolar air sacs (Lumb 2016). These sacs 
provide a large total surface area which is intimately associated with a dense vascular 
supply, to allow for the exchange of oxygen and carbon dioxide vital to respiration by 
diffusion (Weibel 1973). 
Inspiration of air occurs through autonomically driven contraction of the diaphragm 
and intercostal muscles, which expand the chest cavity (Plum 1970). The lung tissues 
have inherent elasticity, and so the generation of negative pleural pressure leads to 
expansion of the lungs. In turn, this pressure vector leads to conductance of air from 
the mouth and nose, through the respiratory tracts to the alveoli. Subsequently, 
respiratory muscle relaxation results in a diminished chest cavity volume, which, 
aided by the elastic potential of the lungs, drives air outwards (Faffe and Zin 2009). 
The distal airways are lined by a surfactant-rich fluid, which reduces friction and helps 
to prevent collapse of the tissues (Goerke 1998). Typical respiratory rates at rest are 
highly variable, but in adults usually range from 12 – 20 breaths per minute (RCUK 
2015). The neurological networks which interact to regulate breathing are highly 
complex. A number of psychological, physiological or pathological states can affect 
respiratory drive. In addition, it is possible to exert conscious control over breathing 
for a period of time.  
Figure 1.3: Chest radiograph of a 
patient with consolidation in the 
middle lobe of the right lung (circled) 
secondary to pneumonia. Often, 
radiographic signs are less apparent 
and can be highly subjective.  
(Image from Khadanga et al. 2015 © 
Nepal Journals Online CC-BY-NC 
license).
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An important feature of respiratory function is reflexive responses to foreign bodies 
or irritants in the respiratory tract: sneezing, coughing, laryngeal closure and 
bronchoconstriction (Shannon et al. 2004). A reflex similar to coughing, the expiration 
reflex, is particularly important in protecting the lungs from aspiration injury. In 
coughing, an inspiratory phase first occurs, followed by a complex expulsion 
mechanism involving coordinated closure then opening of the glottis to generate a 
high intrathoracic pressure and high-velocity expiratory airflow to ensure increased 
shear forces, which increase the change of dislodging and expelling foreign bodies 
(Chang 2006). The expiration reflex involves the same expulsive phases, without 
preceding inspiration, as this would only serve to draw in aspirated matter further into 
the lungs (Tatar et al. 2008). In addition to neuromuscular protection against 
aspiration, the respiratory epithelium is able to contribute to clearance of foreign 
material directly.  
1.3.1.1: Key features of the respiratory epithelium 
The respiratory tissues are lined by mucosa containing ciliated epithelial cells and 
mucus-producing goblet cells. The cilia represent the first immunological agent of the 
respiratory tissues, removing foreign particles and microbes indiscriminately. Goblet 
cells constitutively secrete mucin glycoproteins, which combine with water to form a 
viscoelastic gel: mucus. There is a continuous layer of mucus covering the respiratory 
epithelium of the larger airways, which serves to entrap inhaled particulate matter 
and microbes. Ciliated cells are specialised epithelial cells have hair-like protrusions 
which beat at a rate of approximately 12-14 beats per second. Ciliary movement 
towards the head occurs by protuberance of the cilia during the effective stroke, 
followed by deformation of the cilia during the recovery stroke. The net effect of this 
hysteresis movement pattern is to propel the mucus layer away from the distal 
airways, carrying any entrapped microbes or inhaled particles with it (Lumb 2016). 
Inhaled microbes may also be chemically inactivated in the lungs. The distal airways 
secrete surfactant proteins and lysozyme in their respiratory lining fluid, which can 
opsonise foreign antigens, agglutinate microbes, or can even have direct bactericidal 
activity by increasing membrane permeability (Wu et al. 2003). The airway lining fluid 
also contains immunoglobulins, primarily IgA in the upper respiratory tracts, while IgG 
predominates in the distal airways (Lumb 2016). Upon detection of foreign antigens, 
epithelial cells release a number of pro-inflammatory cytokines and chemokines to 
attract phagocytes, primarily macrophages, into the respiratory tissues (Boyton and 
Openshaw 2002). While respiratory cells produce anti-proteases to limit inadvertent 
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damage to the lungs by leukocyte proteolytic enzymes, in severe infections such 
enzymes may contribute to tissue damage (Garcia-Verdugo et al. 2010). 
Changes in ciliary function, mucus production and composition, and immune function 
can occur with specific disease conditions, lifestyle factors, and with age. These can 
affect lung function and predispose individuals to increased risk of respiratory 
infection. 
1.3.1.1.1: Immunology of the respiratory tissues 
The components of the  immune system can be subdivided into cellular and humoral 
elements, and may contribut to innate or adaptive immunity, with substantial cross 
talk between these 4 domains (Chaplin 2010). Following initial bacterial antigen 
presentation in the lungs, ciliary clearance constitutively removes the majority of 
microbes. However, if the quantity or virulence of the infective microbes is sufficient 
to prevent adequate removal, antigenic load from membrane-bound molecules, 
matrix components, metabolites and virulence factors will increase. This must pass 
through the mucus layer to reach the epithelium. Dendritic cells present within the 
respiratory epithelium (termed sentinel cells) and extend cellular processes through 
the epithelium to ‘sense’ the lung environment (Burleson et al. 2015). These immune 
cells, respiratory epithelial cells and fibroblasts all possess membrane bound pattern 
recognition receptors, capable of recognising conserved microbial components such 
as LPS, flagellin and lipotechoic acids. Some receptors can also detect damage to 
tissues, eliciting an immune response in both mechanical and infective trauma. 
Macrophages are also constitutively present within the alveoli and are capable of 
recognising foreign antigens through the same mechanisms, leading to phagocytosis 
and killing of microbes (Kugathasan et al. 2008). 
The most well-known pattern recognition receptor is the Toll-like receptor family. 
These tranmembrane proteins form dimers upon contact with either pattern or 
damage associated molecular patterns (PAMPs or DAMPs respectively). Dimer 
formation triggers an intracellular cascade that regulates cytokine production, 
typically upregulating production of pro-inflammatory cytokines (Kawasaki and Kawai 
2014). Additionally, both macrophages and dendritic cells phagocytose antigenic 
matter, digesting it and subsequently migrating to lymph tissue to present microbial 
material to T-cells, thus activating the adaptive immune system. The ability of 
macrophages to act as antigen presenting cells is contentious, with mixed evidence 
available, but it appears that alveolar macrophages at least possess this ability. They 
likely play a secondary role to dendritic cells, however (Kugathasan et al. 2008). 
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Activation of pro-inflammatory cytokines within macrophages and epithelial cells 
initiates a number of events. Firstly, further recruitment of circulating macrophages 
and neutrophils is coordinated with local vasodilation and increased vascular 
permeability to enable migration from the vessels into damaged tissues. Neutrophils 
are the primary cell of the innate immune system during acute inflammation and 
possess an arsenal of enzymes and other antimicrobial strategies such as reactive 
oxygen species and neutrophil extracellular traps (discussed further in Section 1.3.2). 
Neutrophils are also capable of directly phagocytosing microbes. In response to IL-
17 secretion by dendritic cells, epithelial cells upregulate production of antimicrobial 
peptides (Eddens and Kolls 2012).  
Additionally, both epithelial cells and alveolar macrophages produce a range of 
complement proteins. These proteins contribute to both innate and adaptive immunity 
by several mechanisms. Activation of the C3 either by the classical pathway in 
response to the Fc domain of antigen—bound immunoglobulins, or upon binding to 
microbial surface lectins results in opsonisation by the lectin pathway, clumping 
microbes and facilitating phagocytosis by macrophages and dentritic cells. C3 can 
also coordinate with C5 to promote pro-inflammatory signals and upregulate 
migration and activation of monocytes, as well as providing a substrate for further 
opsonisation. Any of the three complement pathways can result in formation of the 
Membrane Attack Complex by C5-9, which directly induces pore formation in target 
cells resulting in lysis and death. Complement also serves as a regulatory mechanism 
for antigen presenting cells – presence of activated C3 or C5 promotes T-cell 
activation by dentritic cells (Pandya and Wilkes 2014). 
Natural killer cells are constitutively present within the lungs in health, forming up to 
20% of the lymphocyte population. There is some evidence that these cells can be 
induced by bacteria to release lytic enzymes following activation of Toll-like receptors, 
in a manner analogous to neutrophils. However, their role in early bacterial infection 
may be minor, with stronger evidence for a prominent contribution to antiviral 
defences (Cong and Wei 2019). 
These early activities of the innate immune system occur within the first few hours of 
infection. After approximately 12 hours, T-cell activation and clonal expansion, 
coupled with antibody production by B lymphocyte-derived plasma cells begins to 
play a more significant role in the immune response, allowing a more targeted 
reaction to specific antigens (Burleson et al. 2015). Antigen presentation by dentritic 
cells (and possibly alveolar macrophages in the lungs) to T-helper (CD4+) and 
cytotoxic (CD8+) T cells in lymph tissue results in maturation and proliferation of 
these cells, which are primed to respond to the specific antigen presented. T-helper 
48
cells subsequently activate B-cells (Parker 1993). A subset of both T and B cells form 
memory cells, which remain dormant for long periods of time, but can rapidly 
reactivate following contact with the ‘memorised’ antigen. In the lungs, a subset of T-
helper cells, Th1 cells are primarily responsible for enhancing phagocytosis of 
microbes and directing the activity of cytotoxic T cells. These cells directly kill 
microbes through release of intracellular granules containing hydrolytic enzymes and 
other cytotoxic contents. They are also responsible for inducing apoptosis or lysis of 
infected host cells, particularly in viral infections (Burleson et al. 2015). 
Activated B cells can form plasma cells, responsible for antibody production. Initially, 
low affinity IgM is produced, conferring broad activity against microbes. 
Subsequently, class switching occurs to IgA, IgE or IgG, with much higher specificity 
to target antigens (Manis et al. 2002). Antibodies, like complement, can opsonize 
antigens, enhancing phagocytosis. They may also neutralise the activity of certain 
microbial toxins. In addition to cytokine production, antibodies activate the 
complement cascade to upregulate lysis by the membrane attack complex 
(Bebbington and Yarranton 2008).  
The entire immunological process is coordinated within the lung by the zymogen 
cascades of complement, pro-inflammatory cytokine release and antibody 
production, to ensure a rapid immune reponse is mounted against the infectious 
threat. A side effect of such processes can be substantial tissue damage mediated 
by non-specific immune activity. This can increase the morbidity of pneumonia 
despite resolution of the initial infective process (Bordon et al. 2013).  
1.3.1.2: Important lung changes with age 
The respiratory tissues can undergo changes over the course of an individual’s life, 
both as a consequence of local, neuromuscular age-related changes and immune 
senescence. Additional physiological impairment can occur as the cumulative result 
of lifestyle factors, particularly smoking, and the effect of comorbidities which can 
impact on respiratory, neuromuscular and immune function (Sharma and Goodwin 
2006). 
Age-related kyphosis of the thoracic spine, degeneration of the thoracic vertebrae 
due to osteoporosis and calcification of the rib cage can lead to decreased chest 
compliance (the ability of the chest to expand during inhalation) independent of lung 
compliance. In addition, diaphragmatic contractile strength decreases by up to 25% 
in individuals over the age of 65, leading to less effective ventilation with each breath 
(Tolep et al. 1995).  
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Within the lungs themselves, there is a gradual loss of normal alveolar anatomy and 
parenchymal tissue which can lead to collapse of the distal airways; effectively 
reducing functional lung volume (Miller 2010). Damage to the respiratory tissues can 
occur due to environmental factors, illness or behavioural factors such as smoking or 
malnutrition. These factors are cumulative, such that even relatively minor effects can 
amount to a significant decrease in lung function over many years. Longitudinal 
observational studies have found that decline in lung function can occur from the age 
of 35 onwards, and the rate of decline may double after an individual reaches 70 (Xu 
et al. 1995). This may relate to both a reduction in functional alveolar surface area 
and thickening of the alveolar-capillary membrane, where gaseous diffusion takes 
place. The epithelial cilia also reduce in beat rate, reducing the speed of clearance 
for mucus and foreign material that entered the lungs (Lowery et al. 2013). 
In addition to the well-documented general immune senescence that occurs in old 
age, there are specific changes that occur within the lungs (Pawalec and Larbi 2008). 
A shift towards a more pro-inflammatory state occurs, with increased IgA and IgM, 
and increased CD4+:CD8+ T-cell ratio and increase in neutrophil number detected 
in respiratory fluid samples (Meyer 2001; Lowery et al. 2013). Alveolar macrophage 
behaviour also changes, with a greater proclivity for production of toxic oxygen 
radicals in response to foreign antigens (Meyer et al. 1996). In concordance, the 
respiratory lining fluid contains a lower quantity of anti-proteases and antioxidants 
(Moliva et al. 2014). These changes can compound to result in a low-grade, chronic 
inflammatory environment in the respiratory tissues. 
Beyond changes that directly affect the respiratory tissues and lung function, a 
number of factors combine to increase the risk of translocation of antigenic material, 
including microbes, to the distal airways. Aspiration events account for approximately 
5-15% of all pneumonias acquired in the community in the elderly and is an 
independent predictor of mortality (Kikawada et al. 2005). Additionally, it has been 
found that asymptomatic ‘silent’ aspirations can occur in up to 71% of pneumonia 
patients, suggestive that this may be a primary factor in the development of 
pneumonia and highlighting the potential for the oral microbiome to seed respiratory 
infections (Kikuchi et al. 1994). 
In the elderly, there is a decline in the contractile strength of the masticatory muscles, 
which can result in difficulty adequately chewing food prior to deglutition. This is 
especially pronounced in denture-wearing individuals. Motor control by the muscles 
of the tongue is crucial in initiation of swallowing. Elderly individuals showed atrophy 
of the tongue muscles and increases in fibrotic tissue, which impacted lingual motor 
control and could increase aspiration risk (Steele and Cichero 2014). Coupled with 
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such changes, there is an age-related decrease in saliva production, which may be 
secondary to comorbidities or medications (Percival et al. 1994). Saliva helps to 
agglutinate chewed food and provides lubrication to expediate food bolus transit 
during swallowing (Pedersen et al. 2002). 
Once initiated, swallowed food passes into the pharynx, where the peristaltic action 
of the pharyngeal constrictor muscles ensures transition of the food bolus into the 
oesophagus (Donner et al. 1985). Videofluoroscopic studies have found that although 
pharyngeal peristalsis remains unaffected in elderly individuals, there is a delay in 
the neuromuscular coordination of pharyngeal swallowing, which increases the 
incidence of coughs after swallowing, and often necessitates multiple swallows to 
clear food from the pharynx (Bours et al. 2009; Humbert et al. 2009).  
Swallowed food from the pharynx passes into the oesophagus through the upper 
oesophageal sphincter. This sphincter accumulates connective tissue with age, 
leading to constriction, which can further delay passage of food from the pharynx 
(Shaw et al. 1995). Oesophageal peristaltic ability declines with age, leading to 
increased transit time of food in the oesophagus (Gregersen et al. 2008). This can, 
in turn, lead to further increases in the delay to food leaving the pharynx. 
These factors contribute in varying amounts to dysphagia – difficulty swallowing. A 
background of comorbidities including cerebrovascular accident (stroke), gastro-
oesophageal reflux disease or chronic obstructive pulmonary disease have been 
found to significantly increase the risk of dysphagia symptoms in elderly individuals 
(Roy et al. 2007). Studies on individuals with, or at risk of, dysphagia are limited, but 
one group (Pinto et al. 1994) compared the swallowing reflex of elderly individuals 
with cerebrovascular disease with health age-matched controls. A delay in 
pharyngeal swallowing was found, which suggested an increase in aspiration risk. 
Importantly, this could include silent aspirations which are highly challenging to 
identify due to the absence of overt symptoms (Smith et al. 1999).  
The combination of changes associated with aging in the respiratory tissues proper, 
the oral cavity, immune system and the additional burden of comorbid conditions, 
environmental exposures and medication-related changes cumulatively contribute to 
increase the pathogenic potential of the oral microbiome, risk of aspiration of 
microbes into the distal airways, and likelihood of any aspirated microbes overcoming 
the immune system to instigate infection. Until recently, it was thought that the healthy 
lung was a sterile environment. However, as our understanding of the microbiome in 
health and disease has developed alongside highly sensitive and culture-
independent techniques to analyse microbial communities, it has become apparent 
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that like most areas originally considered to be sacrosanct from the microbial world, 
the lungs are actually a complex and dynamic ecosystem. 
1.3.1.3: An ecological model of the respiratory tissues 
Early culture-dependent studies led to the belief that the lungs were a sterile site in 
health, with the introduction of microbes only in infection (Dickson et al. 2013). 
However, contemporary molecular methods that do not rely on isolation and culture 
of microorganisms have demonstrated that the lungs are a diverse ecosystem with 
dynamic microbial communities (Moffatt and Cookson 2017). The implications of this 
finding could be transformative: pneumonia could, like many diseases of the gut and 
oral cavity, be developed through ecological catastrophes which perturb the resident 
microbiota, rather than simply the result of an inoculum of infective microbes. The 
majority of research today has focussed on the respiratory bacteriome. However, as 
growing attention is provided to the roles of fungi and viruses in the ‘omics’ fields, it 
is likely that the role of such microorganisms will soon be explored in greater detail 
(Norman et al. 2014). 
The majority of the studies to date have been cross-sectional in nature, with 
insufficient sample sizes and diverse methodologies and reporting criteria. In the 
domain of high-throughput sequencing, where error propagation or methodological 
biases is an acknowledged problem in data interpretation, even small differences in 
methods can result in highly different findings (Pollock et al. 2018). A further barrier 
to making inferences from microbiological samples in the lungs is potential 
contamination of samples from the pharynx, oral cavity and environment. 
Investigation of the lung microbiome is inherently invasive, which is a potential barrier 
to participation in such studies (Moffatt and Cookson 2017). 
The majority of research to date suggests that in health the lung microbiome is 
derived from members of the oral and upper respiratory tract microbiota, rather than 
the external environment or gastrointestinal tract proper (Dickson et al. 2014; 
Venkataraman et al. 2015; Faner et al. 2017). Although this may be hampered by the 
contribution of contaminants as discussed above, there is sufficient evidence that the 
community composition differs from that of the oral cavity or pharynx to support the 
existence of a separate, derivative microbiome within the lungs. It should be noted 
that research regarding the lung microbiome in health is very limited, but has found 
species from the Pseudomonas, Streptococcus and Staphylococcus genera in the 
healthy lung (Erb-Downward et al. 2011). There is currently insufficient data to draw 
inferences about changes in community composition in disease, compounded by the 
striking biogeographic variations noted at different lung sites.  
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Dickson et al. (2014) have proposed a three-point model of the respiratory 
ecosystem. The first concept is the view of the lung biogeographical landscape as an 
adapted island model, originally used in ecology (MacArthur and Wilson, 1963). Here, 
the transition from the larger airways to the most distal airways can be seen as a 
series of islands emanating from the mainland of the oral cavity and pharyngeal 
spaces. The community diversity depends on the net migration rate of microbial 
species, which is constrained by a number of factors. The closer the next ‘island’ of 
respiratory tissue is, the greater the chances of immigration. As each island increases 
in species richness and diversity, competition for finite resources increases, leading 
to extinction. Additionally, coughing, ciliary clearance and the immune system further 
limit the maximum sustainable climax community at a given site. Additionally, an 
increase in the microbial bioburden of the oral cavity and pharynx lead to a greater 
increase in immigration rates. Any of the above factors may change over time, and 
in elderly individuals, many of the host factors that limit the size of microbial 
populations in the airways are impaired to some extent. This model links closely to 
the previously outlined mechanism of perturbation of the oral microbiome, which 
could introduce novel, atypical exogenous pathogens as well as total bioburden, to 
lead to both an increase in microbial immigration and community virulence traits to 
the distal airways. 
The second concept proposed by Dickson et al. is that there is a heterogeneous 
distribution of microorganisms that reflects the environmental conditions of each 
respiratory tissue ‘island’, beyond simply decreasing diversity and richness. From the 
perspective of the oral microbiome, this is hardly a paradigm shifting revelation. The 
logic of this concept relies on the same factors that likely determine the 
biogeographical distribution of species in the oral cavity: changes in habitats due to 
environmental gradients in any factor such as surface binding factors, pH, oxygen 
tensions or anatomically determined niches can provide a selective advantage for 
certain species over others (Xu et al. 2015). Current sampling methods typically rely 
on bronchoalveolar lavage, which collects from a large, non-specific volume of the 
lung. There is currently no convincing data to support this concept from clinical 
studies therefore, but findings from the gut (Donaldson et al. 2016), oral cavity (Bik 
et al. 2010), and a trend towards appreciating the increasing parallels with ecology in 
the microbial world (Robinson et al. 2010) all point towards this concept being likely 
true. 
The third concept unifies the prior two conceptual schemata to explain the 
pathogenesis of pneumonia. As the lung ecosystem is a complex, adaptive system 
with many interacting and interdependent factors, small changes in a given factor do 
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not necessarily yield proportionate effects. Instead, the principle of emergent 
properties is applied to explain the apparently spontaneous development of a 
seemingly coordinated disease phenotype as the result of a large number of simple 
interactions within the ecosystem. This is essentially the application of a systems 
biology approach to host-microbiome interactions. Here, the factors critical for the 
pathogenesis of pneumonia: low biodiversity, high microbial bioburden and a 
dysregulated host inflammatory response, can be seen not to necessitate a single 
major catastrophic event such as gross aspiration, but can be understood in the 
context of a convoluted series of clinically undetectable events.  
This model has been borne out to some extent in subsequent research by a group 
from the same centre (Venkataraman et al. 2015). Here, it was found that the lung 
microbiome in healthy individuals was primarily composed of species which had 
originated in the oral cavity, with increased similarity to the tonsillar microbiome 
compared to gingival sites. When compared to samples obtained by oral rinse, there 
was only minimal difference in the relative abundances of lung microbiome samples 
(R2 = 0.86). However, in respiratory disease, there was a departure from the predicted 
neutral distribution of species in lung microbial communities, suggesting active 
selection of certain species. Similarly, it is known that in the lungs of cystic fibrosis 
patients, infection by P. aeruginosa and other typical pathogens is related strongly to 
changes in the host environment (Folkesson et al. 2012). A number of studies have 
demonstrated that microbial diversity in the lungs of individuals with stable cystic 
fibrosis is high (Surette 2014; Carmody et al. 2015; Coburn et al. 2015), suggesting 
that fundamentally the same ecological principles apply, simply with altered 
environmental pressures. As previously mentioned, the above principles apply most 
strongly to bacterial infections, unlike pneumonia due to fungal spores (Murray et al 
2019), which may occur by direct inhalation of an infective inoculum. A key 
component of the environmental pressures which can shape microbial communities 
in the lung is the role of the host inflammatory response. 
1.3.2: Inflammatory responses in the lungs 
Inflammation is the result of the immune response to foreign antigens. Inflammatory 
responses are protective against microbial insult in the majority of instances and 
neutralise infective threats effectively. However, in some diseases, either a 
dysregulated or exaggerated inflammatory response, or even a proportional 
inflammatory response in some tissues can lead to increased morbidity and mortality 
due to both local and systemic sequelae (Bordon et al. 2013).  
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The innate immune system is the first line of defence against microbial infection. In 
the distal airways, the alveolar epithelial barrier forms the interface between the 
external environment and the pulmonary blood supply. It is therefore a highly 
vulnerable site which requires elaborate, highly effective protection. This comes in 
part from the entrapment and subsequent removal of inhaled matter by the epithelial 
cilia and mucus layer in the higher airways (Bals and Hiemstra 2004). Alveolar 
surfactant also has immunological roles in addition to contributing to lung compliance 
(Goerke 1998). Surfactant contains a number of antimicrobial peptides, proteolytic 
enzymes and reactive oxygen species, which act in a non-specific manner. Contact 
with antigenic material results in the production of a number of pro-inflammatory 
cytokines and chemokines by the respiratory epithelium (Knapp et al. 2005). Two of 
the four surfactant proteins also act as chemokines and are able to agglutinate and 
opsonize foreign cells (Waters et al. 2009). The immunoglobulins; primarily IgG, IgA 
and IgE are also present in the airway lining fluid, which can coordinate vasodilation 
and diapedesis of leukocytes (Burnett 1986). 
The first immune cells to contact microbial antigens in the lungs are dendritic cells, 
present in the respiratory epithelial layer, and alveolar macrophages in the surfactant 
and mucus layers. The dendritic cells are responsible for engulfing antigenic material 
and presentation of antigens to T cells residing in lymph nodes, thus bridging the 
innate and adaptive immune systems (Serti et al. 1986). The resident alveolar 
macrophage population is able to phagocytose invading microorganisms (Goldstein 
et al. 1974). Additionally, both macrophages and epithelial cells secrete pro-
inflammatory cytokines and chemokines in response to contact with microbial 
antigens, to recruit neutrophils (Delclaux and Azoulay 2003). Neutrophils, like the 
alveolar macrophages, are able to travel through the capillary endothelium and 
epithelial cell layer, now permeabilised primarily due to the action of VEGF and TNF- released by the airway epithelial cells. Like macrophages, neutrophils are able to 
phagocytose and digest microbes. However, the reagents used to kill microbes by 
neutrophils in endosomes, such as reactive oxygen species and proteolytic enzymes, 
can be released into the surrounding environment, either accidentally or in an attempt 
to eradicate necrotic or infected host cells. This can lead to further injury to the lungs 
which may result in worse outcomes (Craig et al. 2009). A recently discovered 
neutrophil mechanism of extracellular killing; neutrophil extracellular traps (NETs) 
have received considerable attention due to evidence suggesting that these may 
contribute to host cell damage for some time after the infective episode has ceased 
(Papayannopoulos 2018). Kolaczkowska et al. (2015) found that tissue damage was 
reduced if NET formation by neutrophils was blocked. Subsequently, CD4+ and 
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CD8+ T lymphocytes, with B lymphocytes provide the next line of defence in the 
lungs. B lymphocytes are able to produce pathogen-specific antibodies, while T 
lymphocytes can differentiate further to kill infected host cells, microbial cells and 
further mediate inflammatory responses (Moldoveanu et al. 2015).  
Much of the host immune response is stimulated and coordinated through the 
production of pro-inflammatory cytokines and chemokines, produced not only by 
immune cells but the epithelium. There is growing interest in these markers, as 
specific patterns of cytokines may help to differentiate microbial infection from other 
respiratory diseases, thus offering diagnostic potential. 
1.3.2.1: Diagnostic potential of inflammatory markers 
A number of inflammatory mediators have been evaluated for their potential to act as 
either a diagnostic aid in pneumonia, or to enhance prognostication of individuals with 
respiratory infection. These range from relatively non-specific markers of systemic 
inflammatory burden, such as C-reactive protein (Menéndez et al. 2009), to more 
specific attempts to determine the likely aetiological microorganism through analysis 
of the profile of a number of key cytokines (Shankar et al. 2016). Typically, 
inflammatory markers are researched in the hospitalised population, likely out of the 
logistic convenience of access to potential participants and increased likelihood of 
proof-of-concept in more severe disease presentations. As with much of the research 
relating to pneumonia, targeting populations in the community and hospital settings, 
with varying risk of developing pneumonia over time, ideally tracking such individuals 
from health, through a period of respiratory infection would be the most effective way 
to assess potential biomarkers for both diagnosis and prognostication. This would be 
highly challenging, prohibitively expensive and ethically questionable, however 
(Goossens and Little 2006). 
The use of systemic, host-derived biomarkers could potential offer an alternative to 
current methods of microbiological investigation, which is highly unreliable in guiding 
diagnosis of pneumonia. While rapid methods such as MALDI-TOF and culture-
independent techniques offer the potential for rapid identification of microbes directly 
from obtained samples (Xiao et al. 2012), the sampling process itself can be 
unreliable and prone to false negative results (Huijts et al. 2013). Similarly, grading 
disease severity in individuals is highly subjective, and typically involves the use of 
multifactorial scoring systems, with considerable disagreement among experts 
regarding decision-making around admission of pneumonia patients (Niederman 
2009).  
The ideal properties of biomarkers (Christ-Crain et al. 2008) are to allow: 
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1) Rapid diagnosis 
2) Prognostication 
3) Guidance for therapy/treatment 
Another consideration is the balance between false positive: false negative results 
(i.e. type I: type II error rate). Arguably, false negatives are more problematic in 
principle, as this could further delay identification of disease and therefore treatment 
for patients with respiratory infection. However, it should be noted that overtreatment 
is not without consequence, for both individual patients and the wider population. 
Antimicrobial resistance is reported to be an impending crisis facing developed 
nations (Roca et al. 2015), and already outbreaks of microbial infections 
demonstrating resistance to all available antibiotics have been reported (Kuo et al. 
2004; Souli et al. 2008). Pneumonia typically affects frail, elderly individuals with pre-
existing morbidity. In this group in particular, injudicious use of antibiotics could lead 
to further systemic sequelae that reduce survival, or quality-of-life in the event of 
survival (Pea 2015). When combined with the non-specific nature of many of the 
signs and symptoms of pneumonia, it is therefore critical to explore potential 
biomarkers in this population.  
1.3.2.2: Potential biomarkers for bacterial pneumonia 
Biomarkers evaluated for pneumonia are typically combined with clinical signs and 
symptoms to attempt to corroborate disease outcomes. One study (Müller et al. 2007) 
analysed the combination of 5 key clinical features with procalcitonin, which is 
produced by a range of cells in response to microbial infection, and C-reactive 
protein, which is produced by hepatocytes in response to raised circulating levels of 
IL-6. They found an increase in diagnostic accuracy of CAP from 0.79 to 0.92 by 
including these biomarkers with clinical features. This finding adds to a growing 
evidence base of the role of procalcitonin for identifying a range of microbial 
infections. Use of this marker in point-of-care testing has grown, with rapid, high 
sensitivity devices now available (Masiá et al. 2017). Similarly, procalcitonin has been 
evaluated as a therapeutic guide, with a 50% reduction in antibiotic use demonstrated 
in one randomised controlled trial (Christ-Crain et al. 2004), and a reduction in 
duration of antibiotic treatment by 7 days in a separate trial (Christ-Crain et al. 2006). 
A number of cytokines have also been explored for their potential utility in both 
diagnosis and prognostication of pneumonia. However, there are a number of 
challenges in measuring circulating levels of cytokines. The concentration of many 
molecules, particularly IL-1 and TNF are often below the window of linearity for most 
testing methods, rendering measurement highly variable and unreliable. Most 
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circulating cytokines vary in level substantially over time and are short-lived (Christ-
Crain and Opal 2010). 
Levels of circulating IL-6 and IL-10 have been used in a prospective cohort study in 
CAP patients to predict the risk of fatal complications 90 days following discharge 
(Yende et al. 2008). These findings were seen despite no notable differences in 
disease severity, comorbidities or experience of sepsis during hospitalisation. 
Additionally, the majority of subjects had normal clinical signs and apparent clinical 
stability. This corroborates the findings of a previous multicentre cohort study which 
evaluated plasma IL-6, IL-10 and TNF levels in patients who had developed sepsis 
secondary to CAP (Kellum et al. 2007). Again, higher levels of both IL-6 and IL-10 
were associated with increased mortality at 90 days. While these studies provide 
prognostication aids which may help guide treatment, they offer diagnostic potential 
for sepsis secondary to pneumonia, but not pneumonia itself. 
One longitudinal study followed a group of healthy elderly individuals (n=3,075) over 
a 6.5-year period (Yende et al. 2005). Levels of circulating TNF, IL-6, and CRP were 
measured within 2 weeks of baseline. The primary outcome for the study was 
development of CAP, using a Time-to-Event (TTE) analysis. A total of 161 
participants developed CAP over the course of the study. Elevated levels of both TNF 
and IL-6 were individually predictive of CAP development, albeit weakly, while 
elevation of both markers in an individual led to an odds ratio for CAP of 2.8 (95% CI 
2.3 - 5.6), regardless of other risk factors. CRP was not predictive of pneumonia risk. 
The utility of serum TNF-a has also been shown as a biomarker in prognostication of 
functional impairment following CAP in a single-centre study of 301 hospitalised 
pneumonia patients (El Solh et al. 2006). Functional impairment, in turn, may predict 
a higher change of future readmission and death. 
Endeman et al. (2011) evaluated a panel of key inflammatory mediators, including IL-
1, IL-6, IL-8, IL-10 and IL-12 in patients hospitalised with CAP (n=201). While levels 
of cytokine expression in the acute phase response were highly variable, with more 
than a 5-log range of the levels of IL-6, there was a statistically significant association 
between the levels of IL-6 and IL-1RA with pneumonia caused by Streptococcus 
pneumoniae. More recently, a retrospective analysis of BAL fluid samples from lung 
transplant patients with pneumonia, tracheobronchitis or colonisation without 
respiratory infection demonstrated that the levels of a panel of cytokines including IL-
1b in pneumonia samples were significantly higher than those of colonised samples 
(Shankar et al. 2016). Unfortunately, the authors did not report any assessment of 
difference in cytokine profiles with differing infective microorganisms, but this may 
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have been prohibited by the small sample size of this study. This study is important 
however for showing the potential value of locally expressed cytokine levels, rather 
than circulating levels in determining infection status.  
1.3.3: Aetiologies and epidemiology of pneumonia 
Pneumonia occurs due to an inflammatory response in the lungs, causing fluid 
accumulation and thus respiratory distress. This is normally, but not exclusively, the 
result of infection. The source of infection may be from multiple putative sources 
including the oral cavity, and oral prostheses. While certain microorganisms are 
commonly associated with lower respiratory tract infections (Table 1.3.3), in a large 
proportion of cases, the causative organism remains undetected (Andruska et al. 
2015). To date, no robust microbiologic data exists for patients who are treated on 
an outpatient basis rather than in the hospital setting, presumably due to the difficulty 
of recruiting, monitoring and following such patients up over time. Aetiological 
microorganisms of pneumonia can be viral, bacterial, fungal, or polymicrobial (Cillóniz 
et al. 2016). In the UK and much of Europe, however, bacterial pneumonia is the 
most frequent presentation (Torres et al. 2014). 
A wide range of possible risk factors exist for pneumonia. Of note amongst these is 
oral hygiene, which has been implicated both directly and indirectly as an 
independent risk factor (Almirall et al. 2008, Torres et al. 2013).  
Pneumonia can occur due to a wide number of insults to the respiratory system, and 
thus multiple different classification systems have been proposed. However, the most 
widely accepted classification divides the disease according to the setting in which it 
was acquired, either community or hospital, with a further group of patients 
demarcated by immunosuppression (Ewig et al. 2010). Notably, pneumonia in 
immunosuppressed patients is frequently due to atypical microorganisms, with the 
fungus Pneumocystis jirovecii a common pathogen (Kazanjian 2020). This triad of 
pneumonia can be further subdivided, for instance, patients who suffer with CAP can 
be separated into those who are treated successfully in an outpatient setting, and 
those who require hospitalisation, suggesting more severe disease. Likewise, 
hospital acquired pneumonia (HAP) can be grouped by those patients who 
contracted pneumonia 48-72 h after onset of mechanical ventilation (ventilator 
associated pneumonia, VAP) and those who did not. 
These groupings are important because they are purported to be associated with 
different microbial aetiological profiles and thus may inform treatment decisions. For 
instance, VAP patients hold the greatest risk of infection by multidrug resistant 
(Porzecanski and Bowton, 2006) pathogens such as Pseudomonas aeruginosa and 
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extended spectrum -lactamase (ESBL) producing Enterobacteriaceae, while CAP 
patients treated on an outpatient basis are more likely to be infected with 
Streptococcus pneumoniae, or a viral source (Welte et al. 2012).  
More recently the American Thoracic Society (ATS) has proposed a fourth addition 
to the pneumonia classification system (Hospital-Acquired Pneumonia Guideline 
Committee of the American Thoracic Society & Infectious Diseases Society of 
America, 2005), termed healthcare-associated pneumonia (HCAP). The introduction 
of HCAP as a category has been controversial. Proponents suggest that patients who 
are in frequent contact with hospital and healthcare settings, such as nursing home 
residents, healthcare workers and at-home dialysis users can present with 
pneumonia that would be traditionally classified as CAP yet features microbial profiles 
and outcomes more closely in alignment with HAP. There is therefore a call for more 
aggressive, broad-spectrum treatment in such cases due to an increased risk of MDR 
organisms. However, this argument is obfuscated by the large number of overlapping 
risk factors present in this cohort of patients. While some large studies in the USA 
and Europe have supported this classification (Kollef et al. 2005, Carratalà et al. 
2007), work by Chalmers et al. (2011) suggests that, at least in the UK, the different 
profiles are more related to an increased number of comorbidities, treatment 
restrictions (such as do not resuscitate orders), functional impairments, and poorer 
immune status. Indeed, a systematic review examined the predictive power of the 
HCAP classification to determine risk of infection by MDR organisms. It was found 
that this classification discriminates the risk of MDR infections poorly and leads to 
considerable overtreatment of patients when comorbidities and age were accounted 
for (Chalmers et al. 2014). In response to this finding, scoring systems which evaluate 
risk of MDR pathogens on an individual patient basis have been developed, with 
promising results (Webb et al. 2016). The current classification system used in most 
of Europe and the USA is summarised in Figure 1.3.3. 
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Due to the diverse settings in which pneumonia is found, little meaningful insight is 
gleaned by considering pneumonia at a global level. Likewise, the division of 
pneumonias into CAP, HAP and VAP is entrenched in literature, so aggregate data 
across all forms of pneumonia is lacking. Of relevance to the UK, multiple studies in 
the USA and various regions of Europe have considered mortality and morbidity 
related to pneumonias, as well as the economic burden involved.  
Overall, CAP mortality in Europe was 27% at 6 months following diagnosis (Walden 
et al. 2014). Estimated mortality in a UK cohort was found to be highly related to 
patient age, with patients under the age of 65 demonstrating mortality of 5.6%, while 
patients over the age of 85 had a 47.2% mortality rate (Welte et al. 2012). This is 
likely due to the high number of comorbidities in such patients, but may also reflect 
the summation of risk factors for virulent, or antibiotic-resistant pathogens in this 
group, such as poor functional status (Murcia et al. 2010), poor oral hygiene and 
higher risk of previous hospitalisation or nursing home residence (Yoshikawa and 
Marrie, 2000). 
Mortality due to VAP has been a source of controversy, with historical estimates of 
crude mortality misrepresenting the true attributable mortality due to VAP rather than 
Figure 1.3.3: Schematic of pneumonia classification
The triad of pneumonia categories is represented by CAP, HAP and pneumonia in immunocompromised 
individuals. Both CAP and HAP are further subdivided – these additional categories provide useful predictors 
of both aetiologic microbes and outcomes. However, the more recent classification of HCAP by the ATS as a 
form of CAP with aetiology and outcome more closely related to HAP has been contentious. This is primarily 
due to possible confounding by failing to acknowledge overlap between HCAP and immunocompromised 
cohorts, amongst other individual factors such as functional status and treatment restrictions (indicated by 
dashed lines). Adapted from ATS guidelines (2005) and Ewig et al. (2010). 
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comorbidities. A meta-analysis of intervention data by Melsen et al (2013) found that 
overall, the directly attributable mortality rate in VAP was 13%. In this analysis, 
trauma and medical patients demonstrated close to zero attributable mortality, 
presumably due to the high number of competing pathoses likely to result in death in 
the ICU, not least the aetiologic cause of ICU admission. However, surgical patients 
who developed VAP had an attributable mortality of 69%. 
Table 1.3.3: Common aetiologic bacteria in pneumonia
Species Type of pneumonia 
most commonly 
associated with
References
Streptococcus 
pneumoniae 
CAP Welte et al. 2012, Spoorenberg et al. 2014, Quartin et al. 2013, Jones RN, 2010 
Haemophilus influenzae CAP/HAP/VAP Welte et al. 2012, Spoorenberg et al. 2014, Quartin et al. 2013, Jones RN, 2010 
Legionella spp. CAP Welte et al. 2012, Spoorenberg et al. 2014, Jones RN, 2010 
Staphylococcus spp. CAP/HAP/VAP Welte et al. 2012, Spoorenberg et al. 2014, Quartin et al. 2013, Jones RN, 2010 
Moraxella catarrhalis CAP Welte et al. 2012, Jones RN, 2010
Mycoplasma
pneumoniae
CAP Welte et al. 2012, Spoorenberg et al. 2014, Jones RN, 2010 
Chlamydophila spp. CAP Welte et al. 2012, Spoorenberg et al. 2014, Jones RN, 2010 
Coxiella burnetii CAP Welte et al. 2012, Spoorenberg et al. 2014
Pseudomonas 
aeruginosa
HAP/VAP Quartin et al. 2013, Jones RN, 2010
Acinetobacter spp. VAP Quartin et al. 2013, Jones RN, 2010
Klebsiella spp. HAP/VAP Quartin et al. 2013, Jones RN, 2010
Escherichia coli HAP Quartin et al. 2013, Jones RN, 2010
Enterobacter spp. HAP/VAP Quartin et al. 2013, Jones RN, 2010
Proteus mirabilis HAP/VAP Quartin et al. 2013, Jones RN, 2010
1.3.4: Diagnostic and treatment challenges in bacterial pneumonia 
Diagnosis of pneumonia is challenging (Ottoson and Evans, 2014), and successful 
initial antimicrobial therapy is a significant predictor of survival for both CAP (Bartlett 
et al. 2000) and HAP (Lynch JP, 2001) patients. By definition, CAP, HAP and VAP 
diagnoses are based on the likely setting for acquisition of the pneumonia. 
Additionally, CAP can be modified based on individual risk factors (Webb et al. 2016) 
or using the umbrella HCAP grouping (ATS 2005) to stratify risk of MDR pathogen 
presence. Mild cases of CAP tend to be the result of atypical infectious organisms 
such as mycoplasma pneumoniae or seasonal viral outbreaks. VAP is particularly 
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challenging to diagnose, due to the nonspecific nature of clinical signs and absence 
of reliable diagnostic biomarkers due to competing inflammatory ‘noise’ from critical 
illness. It can be further differentiated (Dias et al. 2013) into early onset (within 72-
96 h onset of mechanical ventilation), or late onset (after 96 h onset of mechanical 
ventilation). Late onset VAP patients have significantly poorer outcomes, are more 
commonly infected with MDR microorganisms such as P. aeruginosa and methicillin-
resistant S. aureus (MRSA).  
Diagnosis by microbiological culture is often possible in VAP patients due to relative 
ease and acceptability of access to the distal airways by either bronchoalveolar 
lavage or protected specimen brushing. When present, both diagnostic methods offer 
reasonable specificity, but lack adequate predictive value to singularly support or 
negate clinical diagnosis (Woske et al. 2001). The high number of cases in which no 
causative organism is found for pneumonias by culture methods suggests that the 
clinical utility of these is poor. However, present culture-independent molecular 
techniques are costly, and have not yet replaced conventional methods in 
widespread clinical practice within the NHS.  
On a population basis, the rapid increase in antibiotic resistance, particularly 
concerning in light of the dearth of new antibiotic development, presents a growing 
challenge for clinicians (Laxminarayan et al. 2013). Concerns about driving antibiotic 
resistance through unnecessary prescription of broad-spectrum antibiotics must be 
balanced against the need for rapid and aggressive empirical treatment in severe 
cases of pneumonia. Guidelines from the European Respiratory Society for treatment 
of CAP emphasise the need to stratify patients by severity of illness, to modify 
treatment according to results of bacterial cultures where indicated, and to attempt to 
treat patients on an outpatient basis due to both savings in cost and reduction in 
mortality and morbidity associated with nosocomial infections (Espana et al. 2003). 
Likewise, the joint ATS/IDSA guidelines for treatment of VAP emphasise avoidance 
of broad-spectrum therapy in cases of low severity and with a low index of suspicion 
for the presence of resistant pathogens. 
Often severe cases of pneumonia require empiric treatment which cannot be deferred 
until microbiologic investigations have been reported to inform therapeutic strategy. 
The identification of biomarkers for early diagnosis of pneumonias and specific 
pathogens or resistance profiles has gained interest in light of this, particularly in VAP 
patients where antibiotic resistance and associated mortality can be high.  
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1.3.5: The oral ecosystem and pneumonia – an integrated model 
The association between the oral microbiome and pneumonia is complicated by the 
presence of multiple interdependent confounders which can modulate the oral 
ecosystem through both local and systemic effects. Many of these factors may 
simultaneously affect the host response systemically and the ecosystem of the lung 
directly.  
Factors can be broadly divided into host, microbial and iatrogenic factors (Figure 
1.3.5). Host factors can be locally impactive, such as anatomical niches, or systemic, 
such as poorly controlled diabetes. A third subdivision includes factors which are 
primarily behavioural in origin, such as smoking. In reality, no particular host factor 
fits neatly into one subcategory outside of innate anatomical variance. For instance, 
reduction in oral hygiene could be primarily a behaviourally driven choice (Lenová 
et al. 2006) or localised to specific areas of the dentition. The resultant gingival 
inflammation could have systemic effects which alter immune function (Jeffcoat et al. 
2014; Liljestrand et al. 2018). Alternatively, reduced effectiveness of oral hygiene 
could be secondary to neuromotor impairment with associated loss of functional 
independence (Arai et al. 2003). Likewise, poorly controlled diabetes is clearly a 
systemic condition, but may be driven by behavioural changes in dietary intake 
(Kavanagh et al. 2010). Altered diet, particularly excessive sugar intake may have 
local effects, encouraging proliferation of cariogenic microbes in dental plaque (Staat 
et al. 1975). While smoking is clearly behavioural in that it is an active choice, nicotine 
addiction is considered to be a medical condition (Benowitz 2010). Smoking has well-
documented impact on oral health (Millar and Locker 2007), the systemic immune 
response (Sopori 2002) and the lungs (Jayes et al. 2016). It is therefore highly 
challenging to separate the impact of such factors on the oral microbiome from their 
effects on interdependent systems and tissues. 
Microbial factors, while clearly driven by the local oral environment and regulated by 
the immune system, can be considered as an independent set of risk factors. The 
virulence potential of the microbiome as a whole can be modified by spontaneous 
mutation, horizontal gene transfer, and the acquisition of exogenous pathogens from 
the environment (Jenkinson and Lamont 2005). Pathogenicity must be inferred in the 
context of the oral ecosystem, which varies between individuals and over time. 
Interactions between microbes, may both shape the microbial community 
composition at a given site and enhance host tissue damage, either directly or 
indirectly. For example, competitive interactions between P. aeruginosa and 
C. albicans result in the modulation of virulence factor expression by both 
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microorganisms, mediated primarily by quorum sensing signalling pathways (Fourie 
et al. 2016).  
A third set of factors which receive less attention in the literature are iatrogenic 
sequelae of healthcare. The most widely documented example is the impact of a 
range of medications on the oral ecosystem, due to their immunomodulatory effects, 
influences on salivary flow and composition and direct impact on the composition of 
microbial communities (Ciancio 2004). Use of a steroid inhaler is a known risk factor 
for the development of oral candidiasis, with the Candidal growth correlating with the 
strength, frequency and site of the steroid inhaler dose. Similarly, treatment with 
medications that induce xerostomia, or most notably the use of radiotherapy in head 
and neck oncology patients increases caries risk substantially (Gupta et al. 2015). 
The use of broad-spectrum antibiotics is known to reduce the diversity of the salivary 
microbiome, although it appears that unlike the gut microbiome, this recovers 
relatively rapidly after completion of antibiotic therapy (Zaura et al. 2015). 
Contact with institutionalised care settings is a known risk factor for acquisition of 
highly virulent pathogens associated with a variety of infections recalcitrant to 
treatment (Friedman et al. 2002). This includes both P. aeruginosa and S. aureus, 
which are frequently resistant to first-line antibiotics, compounding medical 
challenges (Nordmann et al. 2007). Individuals in intensive care are at risk of dental 
plaque colonisation by these organisms (Zhanel et al. 2008). Similarly, there is an 
increased rate of colonisation of the oral microbiome in nursing home residents by 
potential pathogens (Ewan et al. 2009). Such institutions create a focal point where 
many systemically unwell individuals with variable functional and cognitive status are 
gathered, often with multiple long-term medications or medical treatments and in 
frequent contact with the hospital environment. All of these factors increase the risk 
of acquiring environmental pathogens and a host environment that could lead to 
dysregulated, disproportionate growth of opportunistic pathogens to drive dysbiosis 
of the oral microbiome. 
The presence of artificial surfaces directly disrupts the oral ecosystem, by creating 
multiple new niches for colonisation. The acrylic biomaterial surface itself offers new 
binding sites for microbial attachment and is likely to feature an adsorbed salivary 
pellicle which differs in composition from elsewhere in the oral cavity (Svendsen and 
Lindh 2009). Masticatory function is typically reduced in denture wearing individuals, 
which not only results in changes in nutritional status and diet but can also lead to 
reduced desquamation and shear stress on microbial biofilms as softer foods are 
preferred (Emami et al. 2013). The interface between the denture-fit surface and 
mucosa results in an area of stagnation where any resident microbes are shielded 
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from saliva and shed squames are retained in situ, providing a novel source of 
nutrients to microbes (Coulthwaite and Verran 2007). Dentures are also removable, 
and so may directly acquire microbes from the surrounding environment or hands, 
acting as a vector for translocation of substantial colonies of atypical, potentially 
pathogenic species to the oral cavity. 
It is proposed here that the changes to the oral microbiome known to accompany 
intubation in mechanically ventilated patients in intensive care units (Sands et al. 
2017) parallel the introduction of dentures in perturbing the oral ecosystem. This in 
turn, coupled with altered host factors can drive dysbiotic changes in the oral 
microbiome and thus increase pneumonia risk. As has been previously outlined, the 
oropharynx provides the primary habitat which seeds the respiratory microbiome, and 
therefore it is reasonable to assume that an increased abundance of putative 
respiratory pathogens in the oral cavity could result in increased immigration of such 
species to the respiratory tissues (Dickson et al. 2014). The likelihood of successful 
colonisation of the lungs shares many common risk factors with denture-wearing, frail 
elderly populations, such as functional impairment, immune senescence and a range 
of comorbidities (Felton 2009; van der Maarel-Wierink et al. 2011).  
The presence of an endotracheal tube provides a direct conduit to the airway by 
bypassing the normal protective cough and swallow reflexes. This device also 
necessitates open-mouth posture, which encourages drying of the oral cavity, and 
may increase the potential for contact with environmental pathogens (Munro and 
Grap 2004). While dentures do not share such features, frail elderly populations are 
at higher risk of dysphagia, have been shown to asymptomatically micro-aspirate oral 
contents frequently, and may have reduced saliva flow due to age-related changes 
or secondary to medications or disease (Zaloga 2002; van der Maarel-Wierink et al. 
2011). The mechanisms underpinning the acquisition of environmental pathogens or 
overgrowth of opportunists in the oral cavity, migration of such species to the distal 
airways, successful colonisation and propagation of pathogens to overwhelm the 
immune response culminating in the development of bacterial pneumonia are 
essentially unchanged regarding the influence of the endotracheal tube in VAP and 
dentures in other forms of pneumonia. 
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Figure 1.3.5: Factors which can modulate the Oral Ecosystem 
A number of interdependent factors govern the oral environments and therefore the composition of 
microbial communities that reside within each habitat. These can be subdivided further, although such 
divisions are arbitrary, with considerable overlap and interaction between each. The presence of artificial 
biomaterial surfaces such as endotracheal tubes or dentures can be considered an iatrogenic factor 
which may influence microbiome composition. Factors can summate to encourage the acquisition and 
accumulation of putative respiratory pathogens which can increase the risk of pneumonia in susceptible 
individuals. 
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1.4: Aims 
The overall aims of this project were: 
• Development and characterisation of a denture acrylic biofilm model incorporating 
respiratory pathogens (WP1) 
• Evaluation of microbe-microbe and epithelial-microbe interactions in an oral 
mucosal tissue model infected with denture acrylic biofilms (WP2) 
• Exploration of denture-associated microbiomes and associated salivary cytokines 
in pneumonia patients, compared with care home residents with no respiratory 
infection.   (WP3) 
• Development of novel antimicrobial silicone denture-liner materials to prevent 
biofilm formation (WP4) 
• Evaluation of a novel microwave delivery system to eradicate denture acrylic 
biofilms (WP5) 
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CHAPTER 2: DEVELOPMENT AND CHARACTERISATION OF A MODEL 
ACRYLIC BIOFILM INCORPORATING ORAL 'COMMENSAL' 
MICROORGANISMS AND PUTATIVE RESPIRATORY PATHOGENS 
2.1: Introduction 
It is well-documented that microbial life on surfaces exists predominantly in the form 
of multi-kingdom and multi-species communities called biofilms, rather than 
planktonically (Stoodley et al. 2002). This is especially pertinent to the healthcare 
setting, with estimates that approximately 80% of all healthcare-associated infections 
(HAIs) are related to microbial biofilms (NIH, 2002). Typically, biofilm formation is 
conceptualised into discrete stages in a developmental model (Figure 2.1); presented 
as a highly orchestrated sequence of events that parallels portrayals of multicellular 
organism development, including the manifestation of emergent properties, 
cooperative and coordinated growth and maturation (Flemming et al. 2016). 
However, this interpretation is not substantiated by direct evidence, and much of the 
observational data purported to support such a schema could be plausibly considered 
through a number of alternative narratives (Eberl et al. 2001, Ghigo JM 2003, Nadell 
et al. 2008, Oliveira et al. 2015).  
Figure 2.1: The developmental model of biofilm formation  
a) Initial (reversible) adhesion of microbes to a surface or substrate 
b) Attachment (Irreversible) of microbes with early deposition of Extracellular Polymeric Substrate (EPS) 
c) Early biofilm maturation by clonal expansion of colonising microbes and formation of basic biofilm 
architecture 
d) Maturation proper – here continued clonal expansion of colonising microbes is coupled with binding 
and attachment of further microbes, which may be from different species, to EPS components. 
e) Biofilm dispersal – in response to certain molecular signals, population density and environmental 
changes, microbes may return to planktonic form to seed colonisation of new sites. 
(Image from Davies D, 2003) 
Much of the applied research that uses in vitro biofilm models to test anti-biofilm or 
antimicrobial products, decontamination or sterilisation methods, or the impact of 
biomaterial surfaces relies on simple approaches to generating biofilms, with 
69
microbes typically added as a bolus inoculum. Some groups have attempted to 
mirror the developmental model of biofilm formation by adding representative 
microbial species in a sequence intended to parallel the order of successional 
colonisation that would occur in vivo, although the validity of such an approach is 
debateable (Foster and Kolenbrander, 2004; Ammann et al. 2013; Violant et al. 
2014). The majority of methods developed for biofilm modelling are focussed 
primarily on different options for analysis, with an increasing emphasis on monitoring 
biofilm development over time, or accurately assessing the diffusion and activity of 
molecules of interest within biofilms (Azeredo et al. 2017). 
2.1.1: Approaches to in vitro biofilm development 
Historically, most clinically directed biofilm models used devices that made analysis 
over time impossible, requiring samples to be sacrificed at each point of examination. 
The use of flow chambers has enabled dynamic biofilm development to be examined 
over time; using microscopy or serial sampling of the biofilm (Tolker-Nielsen and 
Sternberg, 2011). More recently, microfluidic devices have been employed to 
examine a wide range of biofilm physicochemical properties and monitor the 
development of biofilms under a variety of conditions over time (Kim et al. 2012). 
Such devices also allow a high level of control over the spatial organisation of the 
biofilm and environmental factors, making them ideal for perfusion models or 
assessment of the impact of different surface chemistries or nanotopographies. 
The simplest methods used to model biofilms involve a batch system (McBain 2009), 
wherein a microbial inoculum is applied to a surface for a period of time (typically 
between 30 min  4 h), followed by rinsing to remove non-adherent microbes and the 
addition of growth medium. The samples are then incubated for 24 h or longer; a time 
period which is broadly accepted to mark the point at which biofilm maturation begins 
for many microorganisms. Many tests including the majority of minimum biofilm 
eradication concentration (MBEC) protocols use this 24 h interval as an endpoint 
(Ceri et al. 2001). The ability to perform multiplex assays using microtitre plates or 
more complex equipment such as a Calgary device (Figure 2.1.1.1), has led to this 
method being popular for screening antimicrobial or anti-biofilm compounds (Ceri et 
al. 1999). However, biofilms generated using batch systems typically feature reduced 
extracellular polymeric substrate and simpler architectural structure, limiting their 
ecological and clinical validity (Wang et al. 2014, Hödl et al. 2014). Owing to their 
simplicity and capacity for high throughput assays, a batch biofilm modelling system 
selected for the work presented in this and subsequent chapters. 
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Figure 2.1.1.1: The Calgary biofilm device  
A) A modified 96-well microtitre plate with PTFE pegs on the lid. These rest within growth medium 
or microbial inoculum, to allow microbial colonisation and biofilm formation over time on their surface. 
B) Once the experimental endpoint is reach, the pegs can be inverted for further processing and 
analysis of biofilms. 
(Image from PhysOrg 2011 https://phys.org/news/2011-12-method-toxins-oilsands.html) 
A number of alternative modelling techniques have been introduced which overcome 
some of the limitations of the batch system, albeit with reduced throughput; increased 
technical demand, cost; and in many cases a requirement for specialist equipment. 
Many of the systems also employ a continuous flow of nutrient rich medium, which 
substantially increases the risk of contamination through operator error.  
Several variations can be found of the rotary biofilm reactor, where samples are 
grown on coupons attached to rotors in a cylindrical container containing growth 
medium. After inoculation, the rotors spin to create flow of medium, which generates 
shear stress on the biofilms; influencing EPS deposition, biofilm structure and 
composition to more closely mirror those found in many natural environments. This 
system can be employed in either a batch format, with a standing reservoir of 
medium, or using a continuous infusion of growth medium and removal of waste 
medium via an exit port at a set height on the cylindrical chamber (Figure 2.1.1.2). 
Thus, both rate of nutrient delivery and simulated flow rate can be manipulated 
(McBain 2009). Such systems offer the ability to control flow, nutrient and waste 
delivery, but are prone to contamination and allow only a maximum of 24 samples 
per run, requiring the same experiemental conditions to be met within a single 
experiment. They are also less suitable for antimicrobial testing where only a limited 
quantity of antimicrobial is available for testing owing to the large quantities of media 
employed. 
A B 
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Figure 2.1.1.2: Bioreactor design and experimental setup 
A) Cross sectional diagram of typical bioreactor design (image from Gomes et al. 2014)
B) The CDC biofilm bioreactor is probably the most well-known and widely used bioreactor 
 (image from Williams and Bloebaum 2010)
C) Basic experimental setup for bioreactor studies (image from      
http://www.biocleanh2020.eu/index.php/project/esrsfh/esr3m © BioClean Project) 
A similar format is featured in the Constant Depth Film Fermenter (CDFF). However, 
this device uses coupons placed in wells which are arranged to create a depression 
in which biofilm formation can occur. Again, culture medium is fed by flow into the 
chamber, but is directed to each sample through a scraper bar that brushes against 
the upper surface of the wells (Figure 2.1.1.3). Consequently, once the biofilm has 
grown to the full height of each well, any additional microbes are removed from the 
surface. Over time, this generates biofilms with a highly even surface topography, 
allowing excellent standardisation for perfusion modelling and facilitating easier 
analysis by 3-D microscopy such as CLSM. It has also been claimed that this method 
is particularly relevant to oral biofilm modelling, as the scraping action simulates 
brushing or frictional forces from movement of the tongue, lips and buccal surfaces; 
while the thin layer of growth medium applied intermittently over time may be 
representative of pulsatile nutrient spikes in the oral cavity (Pratten 2017). However, 
the same limitations for antimcirobial assays are true of this method, and the scraping 
action across a fixed biofilm layer may lead to an artificially regular surface which 
could impact biofilm behaviour by changing surface:volume ratios and affecting 
nutrient exchange, chemical penetration, and microtopography. 
A B 
A B C 
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[Overleaf] Figure 2.1.1.3: The constant depth film fermenter (CDFF)  
A) The assembled CDFF (empty)
B) Schematic of CDFF demonstrating how biofilm thickness is controlled by the scraper 
 blade (images from Pratten 2017)
A number of different devices (Figure 2.1.1.4) involve the transverse flow of growth 
medium across a surface upon which a biofilm is seeded. The first such device to 
employ this design was the Robbins device, which consisted of coupons mounted 
on a cylindrical pipe so that their surfaces enter the liquid stream. The modified 
Robbins device derived from this (McCoy et al. 1981) uses a square-section tube, 
with sample ports allowing removal of individual samples without disrupting the 
remaining samples. This permits both high throughput analysis and time-series 
experiments to be undertaken. Due to their linear design, both methods result in a 
nutrient gradient forming across the samples as growth medium is used by each 
biofilm it passes (Hall-Stoodley et al. 1999). Similarly, as a consequence of metabolic 
activity by the constituent microbes, an inverse toxin gradient may form across the 
samples. The impact of such changes along the device length have not been 
characterised, although there is some evidence of differences in microbial adhesion 
across the sample positions (Linton et al. 1999). These systems are highly applicable 
to systems with a constant shear flow, such as water pipes. However, their relevance 
to oral biofilms may be limited, as microniches in the oral cavity are exposed to 
negligible shear  flow for long periods of time followed by sudden, extensive shear 
and frictional forces. An experimental setup with a timed period of pump activity to 
mimic this activity could be a useful model for oral biofilms however. While throughput 
is generally better in these devices, there is still a limited ability to assay a large 
number of samples with different experimental conditions simultaneously. The ability 
to apply antimicrobials present in limited quantity also remains problematic. 
Figure 2.1.1.4: The modified Robbin’s device 
Note that specimen plugs protrude into the flowing growth medium. This makes the modified Robbin’s 
device similar to a Calgary device in setup, with the added benefit of being able to manipulate shear 
stress and continuously replace nutrients through flow of medium. 
(Image from Gu et al. 2015, © Gu, W 2015, Creative Commons Attribution License). 
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Similar methods include flow-cell devices, such as modified chamber slides with 
growth medium drip-fed across the surface or fed by peristaltic pump. These devices 
offer an advantage over the modified Robbins device in that samples are held in 
parallel, so that nutrient availability is equivalent for each biofilm. However, this 
comes at the cost of the number of biofilms that can be generated per run. A major 
advantage of many such devices is the capability to image samples in real time, 
permitting evaluation of biofilm development under different conditions; diffusion rate 
of substances through the biofilm; or biological effects of compounds, without the 
need to sacrifice samples for analysis. Microfluidic biofilm modelling devices offer a 
promising means to combine the benefits of flow-based methods with the higher 
throughput offered by bioreactors. Presently such devices are not frequently 
employed in biofilm research, but a number of groups have demonstrated their 
effectiveness for evaluating biofilm development, anti-biofilm surfaces and 
antimicrobial compounds (Kim et al. 2010; Skolimowski et al. 2010; Hong et al. 2012). 
2.1.2: Influence of adherence patterns on biofilm development 
Adhesion of microbes to a surface is considered by most researchers to mark the 
initiation of biofilm development. Consequently, extensive research to characterise 
factors affecting adherence and surface retention of microbes has been undertaken 
(Garrett et al. 2008; Dufrêne 2015; Carniello et al. 2018). In the oral cavity, surfaces 
are rapidly coated with a glycoprotein salivary pellicle, which could modulate innate 
surface characteristics (Lendenmann et al. 2000). However, there is some evidence 
that underlying surface properties are maintained through this layer (Teughels et al. 
2006). Alternatively, artificial saliva formulae can be used, which aim to replicate such 
preconditioned surfaces. 
Two key properties of a surface have been found to exert significant influence on 
levels of microbial colonisation and retention by microorganisms: surface roughness 
and surface free energy (SFE). A threshold Ra value of 0.2 µm has been widely 
accepted as the point at which microbial adhesion is enhanced, with a general finding 
that further increases in Ra lead to concomitant increases in adhesion (Teughels et 
al. 2006). No maximum threshold for roughness has been defined, although it seems 
intuitive that beyond a certain level, the only increase in microbial surface coverage 
will be due to an increased surface area presented by a highly rough material for 
colonisation. In contrast, a recent systematic review by Dutra et al. (2018) suggested 
that no specific threshold roughness value exists, and any polishing procedure 
appears to decrease microbial adherence, regardless of roughness. The underlying 
mechanisms which may explain this observation have not yet been elucidated.  
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In general, the more hydrophobic a surface is (i.e. lower SFE), the greater the 
microbial adherence. However, this may be species and even strain specific. 
Importantly, SFE and surface roughness interact, meaning that an increase in surface 
roughness of a material tends to increase hydrophobicity of an already hydrophobic 
(contact angle less than 60°) material, while more hydrophilic materials (contact angle 
greater than 86°) increase in hydrophilicity with increasing roughness. Materials with 
a contact angle between 60-86° appear to undergo no change in SFE with changes 
in surface roughness (Teughels et al. 2006). 
The majority of research evaluating impact of surface properties on microbial 
adhesion is conducted in vitro, often using mono-species biofilms, and so the 
applicability of this evidence to the clinical setting is questionable. It is likely that 
surface imperfections that shield microbes from mechanical removal and shear 
forces in the oral cavity will play a significant role in directing biofilm formation, but 
such conditions are highly difficult to reproduce robustly in the laboratory. Importantly, 
modifications to SFE may influence surface chemistry. Similarly, polishing 
procedures may alter the surface chemistry by exposing molecules not normally 
present in high quantities on a finished material surface. Given the potential for such 
compositional changes; the influence of microbial species, strain, cell-cycle stage and 
receptor-mediated interactions to alter initial patterns of adherence, it is difficult to 
reach any meaningful conclusion with reliability. Further in vivo verification of the 
influence of surface properties on microbial adhesion is needed. 
It is also contentious whether initial patterns of adhesion have any meaningful impact 
on eventual biofilm formation (Miller et al. 2015). Specific interactions between the 
salivary pellicle with microbes (Scannapieco 1994; Ruhl et al. 2004; Nobbs et al. 
2011), and microbes with one-another (Kolenbrander 2000; Jenkinson and Lamont 
2005; Peters et al. 2010) are well-documented and could hypothetically exert 
influence over the composition, structure and resilience of the mature biofilm. 
However, a number of additional factors may be of greater importance in a clinical 
setting. 
When considering removable prostheses such as dentures, there is considerable 
tensile and shear force exerted through saliva interposing the mucosa and the 
denture-fit surface. Such forces will occur maximally during insertion and removal of 
the prosthesis – indeed, the surface tension of saliva helps retain dentures, 
particularly in the case of complete maxillary dentures. However, there will also be 
submaximal, cyclical loading during masticatory function and speech, due to 
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functional movement of the denture against the underlying mucosa. Such forces may 
cause disruption of the outer surfaces of the biofilm. 
The salivary pellicle may contribute to initial patterns of adhesion, which may 
influence biofilm composition through species-specific interactions promoting 
adhesion of certain microbes, or similarly inhibiting colonisation. Saliva is also 
continuously washed over the surface of the established biofilm, and contains many 
components with antimicrobial activity, as well as potential nutrients and buffers 
which can modulate the local microenvironment (de Almeda et al. 2008; van’t Hof et 
al. 2014). However, it has been shown that the biofilm matrix helps to shield the 
constituent microorganisms from host defences, either by screening antigenic sites 
or inhibiting the diffusion of antimicrobial agents (Stewart and Costerton 2001; Otto 
2006; Limoli et al. 2015). Consequently, once a mature biofilm has been established, 
there may be little effective antimicrobial activity from host defences. This is 
particularly true of biofilms colonising the denture fit surface, as the acrylic biomaterial 
shields the biofilm from the oral cavity, forming an area of stagnation (Chandra et al. 
2001). 
Another crucial factor to consider is the role of lifestyle factors such as diet, smoking 
and the effects medications or medical conditions on shaping biofilm development 
and composition. The pulsatile bursts of substrate availability associated with nutritive 
intake can vary drastically in frequency, quantity and composition. One of the primary 
factors which may influence biofilm behaviour is nutrient availability (Jefferson 2004); 
and, particularly in the case of carbohydrate fermenting microbes including most 
streptococci, life in the oral cavity likely consists of long periods of starvation between 
meals. An adaptation to this condition is the sequestration of dietary sugars in the 
extra-cellular polymeric substrate in the form of dextrans and glucans (Lemos et al. 
2005). These biofilm matrix components serve as structural matrix components which 
enhance both adhesion and resistance to removal for the microbial communities, 
while simultaneously providing a reserve of nutrients in case of prolonged periods of 
starvation. Where carbohydrate intake is limited, there is a decrease in the relative 
abundance of Streptococcus mutans with a concomitant increase in Streptococcus 
sanguinis in dental plaque biofilms (De Stoppelaar et al. 1970). Smoking is an 
important lifestyle factor known to contribute to a wide range of oro-pharyngeal and 
systemic diseases. Tobacco smoke can drive dysbiotic changes in oral biofilms 
through a number of mechanisms. Decreases in oxygen tension favours an increase 
in facultative or strict anaerobic species, including streptococci (Wu et al. 2016). 
Additionally, tobacco smoke leads to a more acidic salivary pH, which favours acid-
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tolerant microbes (Grover et al. 2016). These factors combined may contribute to the 
increase in dental caries found in smokers (Benedetti et al. 2013).  
Cigarette smoke contains an abundance of toxicants which may directly modulate 
microbial communities while simultaneously encumbering host defence cells and 
stimulating a pro-inflammatory response. The effects of such compounds have been 
shown to contribute to biofilm formation by a number of putative respiratory 
pathogens (PRPs) through a variety of (likely synergistic) mechanisms. In laboratory 
experiments using S. aureus, biofilm formation has been found to be induced by 
tobacco smoke through stimulation of accessory regulator A (sarA) and required for 
biofilm formation (rbf) genes. Concomitantly, fibronectin binding protein A (fnbA) gene 
expression is upregulated, promoting adherence to mucosal surfaces. The available 
evidence suggests that these effects are mediated through increased oxidative 
stress, with antioxidant treatments abrogating biofilm formation (Kulkarni et al. 2012). 
Similarly, experiments with P. aeruginosa have found that induction of genes 
associated with pili and flagellae assembly, with concurrent suppression of key 
quorum sensing genes promotes biofilm formation in the presence of tobacco smoke 
components (Antunes et al. 2012). Overall, there are limited mechanistic insights into 
the direct effects of tobacco smoke on microbial behaviour and virulence.  
An important factor that differentiates biofilms colonising removable biomaterial 
surfaces, such as dentures, is the increased likelihood for the introduction of 
environmental contaminants. Upon removal and insertion, dentures come into 
contact with fingers, possibly other inert surfaces, and may be left in vessels for 
extended periods of time which may be open to the environment. In care facilities and 
other environments where endemic outbreaks of highly virulent, potentially drug-
resistant microorganisms are not infrequent, this may result in a substantial increase 
in the likelihood of colonisation and infection by PRPs, particularly if denture hygiene 
is suboptimal. To date, there has been no high-quality research evaluating such 
routes to infection. Indeed, to reliably trace contaminants and identify the precise 
point of infection would be highly challenging to assess on even a modest scale. 
2.1.3: Synergy and competition in biofilms - impact on virulence 
The introduction of atypical microbial species, which may include PRPs, to ‘normal’ 
denture-associated oral biofilms may result in unpredictable changes in behaviour of 
constituent microorganisms, due to the nature of the interactions between such 
species. While the majority of dental research has understandably focussed on the 
development of ‘normal’ oral microbial communities and orofacial diseases, there has 
been interest in the interactions between key pathogenic microbes frequently 
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implicated in respiratory infection and nosocomial disease and members of the 
typically commensal oral microbiota. The most thoroughly studied of such 
microorganisms are: Candida albicans, which is widely considered to be an 
opportunistic pathogen in immunocompromised patients; Pseudomonas aeruginosa, 
particularly in the context of cystic fibrosis, ventilator-associated pneumonia and 
chronic wound infections; and S. aureus, which is isolated from a wide range of 
healthcare-associated infections (Percival et al. 2015). 
Cystic fibrosis is a genetic disorder that affects multiple organs. In the lungs, 
deficiency in chloride ion transport across the epithelial membrane leads to reduced 
mucociliary clearance and increased viscosity of mucous secretions (Flume et al. 
2009). Individuals with cystic fibrosis are susceptible to respiratory infection, 
particularly by P. aeruginosa. In the 1980s, research first began to acknowledge the 
potential for oropharyngeal colonisation by P. aeruginosa to be a likely antecedent to 
colonisation and infection of respiratory tissues. Several studies examined 
interactions between P. aeruginosa and predominant oral microbes such as 
streptococci and Actinomyces species; focussing on coaggregation behaviour to offer 
insight into the successful colonisation of the oropharynx by this atypical, Gram-
negative aerobe, despite the preestablished mature microbial communities that 
populated this environment (Komiyama and Gibbons 1984; Komiyama et al. 1985). 
Further research by Komiyama et al. (1987) found that of 22 strains of P. aeruginosa
isolated from a total of 17 cystic fibrosis patients, there were between 73 – 96% 
positive coaggregation reactions with commensal oral microbes. Biochemical 
inhibition testing suggested that these reactions were protein-mediated and not 
lectin-dependent, although this characterisation was not exhaustive. More recently, it 
has been found that periodontal pathogens enhance invasion of respiratory epithelial 
cells by P. aeruginosa, and these species co-localise within cells (Pan et al. 2009). 
While this study did not examine specific interactions between the two species, the 
important biological effects on human tissues make this an interesting avenue of 
research to pursue. Importantly, such research reinforces the paradigm of 
colonisation of the oral cavity by PRPs to form a nidus which can seed infection of 
respiratory tissues. 
There is a lack of research examining possible interactions between S. aureus and 
the oral microbiome, particularly in the context of respiratory infection. However, 
interactions of both P. aeruginosa and S. aureus, with the polymorphic fungus 
C. albicans are perhaps some of the most extensively studied in medical 
microbiology. Of note, evidence from animal models (Carlson 1987; Roux et al. 2009; 
Roux et al. 2013), and limited evidence from clinical studies of pneumonia and 
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chronic wound patients have demonstrated that polymicrobial infections involving 
combinations of any of this triad of microbes appears to result in increased virulence, 
and worse outcomes in the infected host, when compared to mono-microbial 
infections alone (Liou et al. 2001; Schlecht et al. 2015; Serra et al. 2015). This finding 
is especially interesting as the majority of interactions between P. aeruginosa and 
C. albicans are thought to be antagonistic, while those between S. aureus and 
C. albicans appear to be primarily mutualistic or synergistic. Complicating matters 
further, some authors have suggested that the nature of interactions between 
P. aeruginosa and S. aureus differ in nature depending on the sequence of events. 
Each of these relationships will be elaborated in more detail below. 
Pseudomonas aeruginosa produces an extensive arsenal of virulence factors (or 
virulence-associated factors), which may act on host tissues and other microbes. Of 
particular note, the secreted phenazine pyocyanin, which has pleiotropic effects, 
appears to be responsible for the killing of Candida hyphae by P. aeruginosa in co-
culture models, in addition to type IV pili and lectin-mediated interactions (Fourie et 
al. 2016). Regulation of such behaviour occurs through key quorum sensing 
molecules, which have been characterised extensively in knockout studies. 
Pyocyanin also inhibits germ tube formation by C. albicans to prevent hyphal 
formation and ensure the fungus remains in yeast form. However, the interactions 
are not unidirectional. The candidal quorum sensing molecule farnesol, associated 
with the yeast cell morphology, inhibits phenazine synthesis and thus pyocyanin 
production in P. aeruginosa (Cugini et al. 2007). Another clinically important 
consequence of inhibition of this pathway is the disruption of rhamnolipid production, 
which is associated with P. aeruginosa swarming motility. This ability has been 
suggested to contribute to the pathogenesis of ventilator-associated pneumonia by 
P. aeruginosa (Köhler et al. 2010).
Both farnesol and pyocyanin are damaging to host tissues, primarily through the 
generation of reactive oxygen species (Fourie et al. 2016). Thus, competitive or 
inhibitory interactions between microbes can lead to increased damage to host cells 
and initiation of a pro-inflammatory cascade, as host tissues suffer the destructive 
impact of inter-kingdom warfare. Such changes likely further encourage colonisation 
and proliferation of both species, as inflammatory changes and increased 
permeability of the mucosal lining offers new binding sites. In contrast, there is 
evidence to support a commensal relationship between S. aureus and C. albicans in 
mixed infections. Like P. aeruginosa, S. aureus is frequently implicated in 
nosocomial, and particularly medical device-associated infection, and endemic 
outbreaks of methicillin-resistant S. aureus (MRSA) can result in high levels of 
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morbidity and mortality in institutional care settings (Albrich and Harbarth 2008). 
Isolation of both C. albicans and S. aureus from bloodstream infections is common, 
and associated with increased length-of-stay, and poorer outcomes. In murine 
models of infection, inoculation with both microorganisms results in increased 
mortality (Peters and Noverr 2013). 
The potential for synergism between these two microbes has been explored in 
laboratory studies. Interestingly, the S. aureus strain ATCC 25923, a clinical isolate 
frequently employed in research due to its ability to form biofilm readily in vitro, failed 
to form meaningful biofilms in serum compared to brain-heart infusion media. 
However, when co-cultured with C. albicans, a dense polymicrobial biofilm was 
generated; suggesting that C. albicans was required to initiate adhesion in the 
experimental conditions used (Harriett and Noverr 2009). Unlike P. aeruginosa, the 
staphylococcal cells appeared to preferentially associate with candidal hyphae when 
examined by fluorescence and scanning electron microscopy. It has also been found 
that vancomycin tolerance is increased in dual species biofilms compared with 
S. aureus monotypic biofilms. However, to date, neither detrimental nor beneficial 
effects conferred to C. albicans when grown with S. aureus have been described. 
There was no difference in microbial biomass, resistance to antifungals such as 
amphotericin B, nor any difference in invasive potential in C. albicans in dual versus 
mono-species biofilms.  
The term ‘microbial hitchhiking’ refers to the utilisation of one microorganism by 
another to invade tissues. There is good evidence that S. aureus can gain access to 
tissues and the bloodstream through this mechanism. The hyphal morphology of 
C. albicans is responsible for invasive behaviour, and S. aureus has been found to 
have a strong affinity for the agglutinin-like sequence 3 adhesin (Als3p) – a cell wall 
protein specific to candidal hyphae. Murine models have demonstrated close 
coaggregation of S. aureus allowing translocation through the mucosal barrier in 
murine models. Als3p knockout mutants of C. albicans were unable to form hyphae 
or invade tissues, and this was accompanied by the absence of S. aureus invasion 
of tissues and the bloodstream, corroborating this finding (Schlecht et al. 2015). 
While interactions between S. aureus and C. albicans appear to favour the bacteria 
without conferring any benefit to the yeast, there may be as yet undiscovered 
advantages to Candida in such a relationship. Further research is needed to explore 
such interactions in the context of the host response, given the importance of both 
microorganisms in nosocomial infection. 
A more complex relationship appears to exist in polymicrobial biofilms comprising 
both P. aeruginosa and S. aureus. Here, the nature of interactions between these 
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two bacteria has been examined primarily in the context of chronic wounds, as 
colonisation by either species is associated with delayed healing, promulgation of 
chronic inflammation and increased morbidity. These microorganisms pose the 
additional challenge of frequent multi-drug resistance which, when combined with the 
increased antimicrobial tolerance conferred by the biofilm lifestyle and typically poor 
perfusion of chronic wounds, can lead to highly recalcitrant infections. 
Initial adherence to the epithelial cell surface and colonisation of tissues by S. aureus
is highly efficient. Staphylococcus aureus possesses a number of surface adhesins 
which bind with high affinity to mucosal components, such as the fibronectin-binding 
proteins FnBPA and FnBPB, the fibrinogen-binding Clumping Factors ClfA and ClfB 
and the various “sas” surface proteins; among others (Foster et al. 2014). Findings 
from an in vitro ‘wound-like model’ suggest that when co-inoculated together, 
S. aureus initially inhibits attachment and growth of P. aeruginosa (DeLeon et al. 
2014). Yet, in culture-media co-inoculation of both species results in the eradication 
of viable S. aureus by P. aeruginosa. When S. aureus was allowed to colonise the 
wound model and form a biofilm over a 48 h period, addition of P. aeruginosa resulted 
in successful secondary colonisation by this microorganism. While the mechanisms 
of this interaction were not evaluated, these findings suggest that either changes in 
S. aureus metabolism and gene expression mean that Pseudomonal attachment is 
no longer inhibited, or staphylococcal biofilm matrix components provide alternative 
binding sites for this species. 
Additionally, once established biofilms had formed in wound models, antibiotic 
tolerance increased for both P. aeruginosa and S. aureus for gentamicin and 
tetracycline, albeit only crossing the threshold of statistical significance in the case of 
the latter. Gentamicin is a cationic molecule and is susceptible to interactions with 
charged components of biofilm matrix. However, tetracycline resistance is primarily 
conferred by intrinsic efflux activity in Gram negative bacilli such as P. aeruginosa, 
and so the mechanism promoting resistance within S. aureus remains unclear. 
These findings were corroborated by Alves et al. (2018), who found that despite 
S. aureus predominating in early co-culture biofilms, later attachment and growth of 
P. aeruginosa on pre-established S. aureus biofilms was enhanced. This result 
seemed to be mediated by surface proteins, although the specific mechanisms were 
not examined. The authors built upon findings of previous research by showing 
increased adherence to a human keratinocyte monolayer by P. aeruginosa in co-
culture infections, with simultaneous increased internalisation of S. aureus cells. The 
authors interpreted this as an increase in invasivity of S. aureus, although whether 
this was due to a change in behaviour of this species or secondary to enhanced cell 
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membrane disruption by P. aeruginosa was not explored. Interestingly, both healing 
time in a scratch wound assay and pro-inflammatory response by keratinocytes to 
infection was highest in P. aeruginosa monotypic infections; lowest in S. aureus
infections; and demonstrated an intermediate response in co-culture infections. 
Naturally, most mechanistic research exploring microbial interactions is conducted in 
the laboratory setting, using simple, reductionist models to provide a setting in which 
confounders can be highly controlled. Caution is therefore needed when 
extrapolating such findings to clinical settings, where subtle nuances combine 
iteratively to drastically alter the environmental context that microbial actions take 
place in. This concept intersects with the notion of emergent properties that has been 
promoted within the field of systems biology. Improvements in microbial sampling 
from biofilms such as LASER-capture microdissection, which allows isolation of 
specific microorganisms from a given biofilm environment; combined with high 
throughput ‘omics’ methodologies, which allow open and unrestricted exploration of 
community composition, gene and protein expression, and metabolic profiling may 
converge to facilitate the detailed characterisation and simultaneous ‘antireductionist’ 
experimental design needed to generate clinically driven hypotheses. However, in 
vitro studies still have a crucial role in validating such hypotheses in greater detail 
and elaborating the mechanisms and pathways involved.  
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2.2: Aims 
The primary aims of this work package were to: 
1. Develop a simple in vitro biofilm model on denture acrylic incorporating 
representative oral microbes and putative respiratory pathogens S. aureus and 
P. aeruginosa
2. Characterise the model biofilms using a range of quantitative and qualitative 
techniques
3. Evaluate the impact of microbial interactions on the expression of a range of 
virulence-associated genes of putative respiratory pathogens S. aureus and 
P. aeruginosa
Hypotheses 
• Preconditioning of acrylic surfaces by artificial saliva will increase attachment, 
adherence and biofilm biomass of the oral commensals S. sanguinis, A. viscosus and 
C. albicans, but not P. aeruginosa or S. aureus
• Initial attachment and adhesion levels will impact biofilm composition for each 
species tested
• Biofilm species will occupy distinct biogeographical niches within the biofilm
• Co-habitation in biofilms with oral commensal microbes will modulate virulence gene 
expression by P. aeruginosa and S. aureus compared with single species biofilms
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2.3: Materials and Methods 
2.3.1: Production of polymethyl methacrylate (PMMA) coupons 
Oracryl powder and liquid monomer were combined in a 1:1.5 (w/v) ratio and mixed 
thoroughly until smooth and without air bubbles. The mixture was poured into a 
Polytetrafluoroethylene (PTFE) mould which was compressed between two glass 
slides to provide a smooth, polished finish and reduce surface irregularities in the 
material. The mould produced discs of 3 mm thickness and 10 mm diameter. After 
allowing the material to cure for at least 1 h at room temperature, samples were 
removed from the mould, any sharp surfaces or irregularities removed with 120 grain 
silicone carbide paper, then soaked in water for at least 5 days prior to use, to remove 
any uncured monomer. Coupons were sterilised by autoclaving at 121 ºC for 15 min 
prior to use.  
Sterile acrylic samples were aseptically transferred into either 10 ml of artificial saliva 
(AS), or 10 ml of water in sterile universal containers and incubated aerobically at 
37 °C for 24 h prior to use. After a single use, coupons were disposed. 
2.3.2: Preparation of artificial saliva preconditioning solution 
The formulation of AS solution used has previously been published (Russel and 
Coulter, 1975) and used by our research group in a number of studies. Briefly, 5.0 g/L 
proteose peptone (Oxoid), 2.5 g/L porcine stomach mucin (Oxoid), 2.0 g/L yeast 
extract (Oxoid), 1.0 g/L lab lemco powder (Oxoid), 0.35 g/L sodium chloride (Fisher), 
0.20 g/L potassium chloride (Fisher), 0.20 g/L calcium chloride dehydrate (Fisher) 
were combined in 1 L of distilled water. The solution was aliquoted into 100 ml glass 
bottles and autoclaved at 121°C for 15 min. A 40% (w/v) urea solution  was filter 
sterilised and 125 µl/L added to the AS solution immediately prior to use. 
2.3.3: Selection and culture of microbial strains 
Three species were selected to represent normal oral commensal microbes, 
frequently found in high abundance within the oral cavity. Two potentially pathogenic 
bacteria, both associated with a high severity of pneumonia and frequently isolated 
from health care associated infections were also used. The strain and rationale for 
each species is detailed in Table 2.3.3A. 
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Table 2.3.3A: Reference strains used for in vitro biofilm model 
Microorganism Strain  Rationale Isolated 
from
Candida 
albicans
ATCC 90028 Common commensal yeast 
found on high number of denture 
surfaces. Strain is effective at 
forming biofilms. 
Blood 
Streptococcus 
sanguinis
NCTC 7863 Representative early coloniser of 
oral cavity 
Bacterial 
endocarditis 
Actinomyces 
viscosus
ATCC 15987 Representative anaerobic early 
coloniser of oral cavity 
Periodontal 
disease 
Staphylococcus 
aureus
NCTC 6571 Pathogenic species commonly 
isolated in respiratory infections 
and healthcare associated 
infections 
Not 
specified 
Pseudomonas 
aeruginosa
ATCC 15692 Pathogenic species associated 
with increased severity of 
pneumonia and high likelihood of 
antibiotic resistance 
Infected 
wound 
Microbial species were incubated for 24-48 h under appropriate conditions 
(summarised in Table 2.3.3B). One colony was then aseptically transferred into a 
suitable liquid growth medium and incubated in the same conditions for 8-12 h 
(aerobes) or 18-24 h (A. viscosus) to approximate mid-log phase of growth. 
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Table 2.3.3B: Growth conditions for microbial species 
Microorganism Agar Growth Medium 
(10ml)
Growth 
Conditions
Candida 
albicans 
Sabouraud Dextrose 
Agar (SDA, LabM) 
Yeast Nitrogen Base 
(YNB, BD Difco) 
supplemented with 
100mmol d-glucose 
(Fisher Scientific) 
(~1.7 mmol/L NaCl, 
100 mmol/L glucose) 
Aerobic 
incubator at 
37 °C 
Streptococcus 
sanguinis 
Colombia Agar 
(LabM) 
supplemented with 
5% defibrinated 
horse blood (TCS 
Biosciences) plus 
Colistin and Nalidixic 
acid 
Brain heart Infusion 
broth (BHI, Lab M) 
(~11 mmol/L glucose, 
100 mmol/L NaCl) 
Pseudomonas 
aeruginosa 
Pseudomonas 
selective agar 
(LabM) 
supplemented with 
Cetrimide and 
Nalidixic acid 
Staphylococcus 
aureus 
Mannitol Salt Agar 
(MSA, Lab M) 
Actinomyces 
viscosus 
Fastidious Anaerobe 
Agar (FAA, Lab M) 
Fastidious Anaerobe 
Broth (FAB, Lab M) 
(no glucose, 
~50 mmol/L NaCl) 
Anaerobic 
Incubator at 37 
°C 
2.3.4: Inoculation of microbial species for adherence assays and biofilm 
generation 
Bacteria were diluted to approximately 1-1.5x108 CFU/mL (0.5 McFarland standard) 
by optical density (OD) at 600 nm, using a spectrophotometer. Candida was diluted 
to approximately 1x107 CFU/mL (1.0 McFarland standard). Inocula were prepared 
either as single species suspensions or combined in equal volumes to produce a 
mixed inoculum.  
2.3.5: Attachment assays 
In a 6-well plate, triplicate acrylic samples preconditioned by 24 h submersion in 
either water or AS solution were aseptically placed. A 50 µL inoculum of the test 
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microbial suspension (single species or mixed) was added to the surface of each 
disc. PMMA coupons were then rinsed in PBS immediately to remove any non-
adherent microorganisms then placed into new 6-well plates. Negative controls 
consisted of acrylic coupons processed as above and incubated without an inoculum 
present. 
2.3.6: Adherence assays 
Adherence assays were prepared in an identical manner to that described in section 
2.3.5. However, after inoculation of the test microbial suspension, PMMA coupons 
were incubated aerobically at 37ºC for 90 min prior to rinsing in PBS. Negative 
controls consisted of acrylic coupons processed as above and incubated without an 
inoculum present. 
2.3.7: Biofilm generation and maturation 
PMMA coupons were inoculated as described above, with either a single species or 
mixed microbial suspension. Following inoculation, test coupons were incubated 
aerobically at 37ºC for 90 min and rinsed in PBS to remove non-adherent 
microorganisms. Coupons were then transferred to a new 6-well plate, containing 
3 mL FAB, so that the PMMA samples were submerged in culture medium, before 
incubation for 72 h. Every 24 h, spent culture medium was removed by pipetting, and 
new, fresh media added. PMMA coupons were not rinsed at 72 h prior to analysis. 
Negative controls consisted of acrylic coupons processed as above and incubated 
without an inoculum present. 
2.3.8: Characterisation of biofilms 
As the model biofilms were intended for subsequent use in evaluation of antimicrobial 
treatments, quantitative cell-viability was an important outcome measure. Two 
methods to measure viability were assessed: culture of recovered viable organisms, 
and confocal laser scanning microscopy of microorganisms on acrylic coupons, after 
staining with the BacLight Live/Dead kit (Thermofisher Scientific, Loughborough, UK). 
A graphical summary of biofilm characterisation experiments is provided in figure 
2.3.8. 
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Figure 2.3.8: Flow diagram of experimental input and analyses
Single species biofilm (per 
species) 
6 experimental replicates per run, 
each experiment conducted a total 
Mixed (5) species biofilm
6 experimental replicates per run, 
each experiment conducted a total 
of 3 times
2 species biofilm (P. aeruginosa
with S. aureus) 
6 experimental replicates per run, 
each experiment conducted a total 
of 3 times
3 species biofilm (S. 
sanguinis, A. visocosus and 
C. albicans) 
6 experimental replicates per 
run, each experiment 
Culture analysis (spiral 
plater) 
Microscopic analysis 
(Live/Dead stain, CLSM) 
Culture analysis (spiral 
plater) 
Microscopic analysis 
(Live/Dead stain, CLSM) 
Culture analysis (spiral 
plater) 
Microscopic analysis 
(Live/Dead stain, CLSM) 
PNA FISH for spatial 
analysis (CLSM) 
qPCR for gene 
expression (P. 
aeruginosa and S. aureus 
genes evaluated only) 
0 min 
72 h 
90 min 
Single species biofilm 
(P. aeruginosa and S. aureus only) 
6 experimental replicates per run, 
each experiment conducted a total 
of 3 times
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2.3.8.1: Recovery and culture of viable microorganisms 
Following rinsing of PMMA coupons in attachment and adherence assays, or 72 h 
growth in biofilm assays, coupons were immediately transferred to a 10 mL glass 
bijou containing 1 mL PBS. Samples were vortex mixed for 1 min at maximum speed 
to remove adherent cells, and the resultant cell suspension transferred by pipetting 
to a sterile 1.5 mL microcentrifuge tube. Following this, 1:10 serial dilutions were 
performed to appropriate concentrations, and 50 mL of these final dilutions was 
applied to an appropriate selective agar plate (Table 2.3.3B) using a spiral plater 
(WASP – Don Whitley, Sheffield, UK). The plates were then incubated aerobically at 
37°C for 24-48 h. Microbial colonies were counted for each species and colony 
forming units per ml (CFU/ml) calculated. A validation of the effectiveness of vortexing 
to remove adherent cells was undertaken by staining the coupons with Live/Dead 
stain and imaging them after this procedure had been undertaken. 
2.3.8.2: Confocal laser-scanning microscopy (CLSM) of biofilms using 
Live/Dead stain 
One µl each of SYTO-9 and propidium iodide (PI) from the BacLight Live/Dead assay 
kit were aseptically added to 998 µl of distilled water, mixed by inversion, and 
protected from light. Ten µl of this working solution was added to PMMA coupons 
which had been treated as above for attachment, adherence or biofilm assays. The 
coupons were incubated with the stain at room temperature for 30 min and protected 
from light. Negative controls were processed identically and stained to provide a 
standard for filtering out autofluorescence on images (acrylic autofluoresces strongly 
in both imaging channels used). 
Following incubation, a coupon was inverted onto a glass (0.17 mm) coverslip and 
viewed at x400 (for Candida or mixed inocula) or x630 magnification using a Leica 
SP5 confocal laser-scanning microscope. The excitation wavelengths used were 
488 nm (green; live cells) and 561 nm (red; dead cells); while the emission filters 500-
550 nm (green) and 570-620 nm (red) were applied. Images were recorded from 5 
randomly selected areas on each coupon. For attachment and adherence assays, 
single-plane images were recorded. For biofilm assays, a 3-dimensional "Z-stack" 
was obtained by recording successive images from the acrylic surface to the outer 
extent of the biofilm (assessed manually) at 1 µm intervals. 
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2.3.8.2.1: Quantitative analysis of CLSM images using COMSTAT software 
Images and Z-stacks were analysed using the COMSTAT 2.1 plug-in in ImageJ. 
Image files were converted to the OME-TIFF format for analysis. Subsequently files 
were opened using the COMSTAT plugin and threshold values calibrated to reduce 
background noise for images. For each image-set (n=45), 3 images were randomly 
selected for thresholding. Both LIVE and DEAD channels were viewed independently 
for the purpose of thresholding. A threshold value that offered maximum noise 
reduction with minimum loss of obviously in-focus cells was manually selected and 
applied globally to all images.  COMSTAT analysis to provide surface area coverage 
(µm2) in attachment and adherence assays was undertaken. For biofilm assays, 
biovolume (µm3) was calculated. 
2.3.8.2.2: Preparation of biofilms for Peptide Nucleic Acid-Fluorescence in situ 
Hybridisation analysis (PNA-FISH) 
The methodology for PNA-FISH conjugation to biofilms were adapted from 
approaches previously employed within our group (Sands et al. 2017, Cavalcanti et 
al. 2015). 
PNA probes were obtained according to the sequences described in Table 2.3.8.2.2; 
specific for P. aeruginosa and S. aureus, in addition to a universal bacterial probe. 
Lyophilised stocks were reconstituted aseptically in sterile, nuclease-free water and 
mixed by gentle pipetting. From this, 100x master stock aliquots were created for 
each probe, protected from light and frozen for future use at -20°C. From each stock, 
the respective working concentration for each probe was prepared in FISH 
hybridization solution prepared according to the method outlined in Perry-O'Keefe et 
al. (2001). 
Table 2.3.8.2.2: PNA probe sequences
Target 
species 
Working 
Concentration
Probe Sequence Reference
Universal 
Bacterial
300 nM CTGCCTCCCGTAGGA Perry-O’Keefe et 
al. 2001 
P. aeruginos
a
300 nM AACTTGCTGAACCAC Coull & 
HyldigNielsen 
(2003) 
S. aureus 450 nM GCTTCTCGTCCGTTC Perry-O’Keefe et 
al. 2001 
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Candida albicans was labelled using a ready-made probe solution available as part 
of the AdvanceDx Yeast Traffic Light kit (AdvanDX, Vedbaek, Denmark). All probes 
were protected from light during the procedure wherever possible, and kept at 4 °C. 
Biofilms containing either mixed or single species inocula (for P. aeruginosa and 
S. aureus) were prepared as detailed in section 3.3.7, then fixed by immersion in 
neutral buffered saline solution for at least 1 h. Similarly, positive controls for the 
representative PRP species were prepared by heat-fixing a smear of each 
microorganism onto a glass slide. Following fixation, samples were gently washed in 
100 µl PBS x3. This washing procedure was repeated between every subsequent 
step described. To each biofilm, 50 µl of lysozyme (Sigma Aldrich, Gillingham, UK) 
solution at a concentration of 10 mg/ml was added; after which samples were 
incubated at 37°C for 30 min. Subsequently, samples were incubated with 50 µl of 
proteinase K (Sigma Aldrich, Gillingham, UK) solution at a concentration of 0.1 mg/ml 
at 37°C for 30 min. Finally, biofilms containing S. aureus were treated with lysostaphin 
(Sigma Aldrich, Gillingham, UK) solution at a concentration of 0.1 mg/ml and 
incubated at 37°C for 1 h.  
To each single species biofilm, and positive control for S. aureus and P. aeruginosa 
50 µl of the respective PNA probe solution was added. The remaining probes were 
homogeneously combined and 50 µl added to each mixed biofilm sample. Samples 
were then incubated in a humidified box, protected from light, at 55°C for 2 h to enable 
hybridisation of the probes. Following this, samples were flooded with 200 µl pre-
warmed FISH washing solution prepared as per Perry-O'Keefe (2001) and incubated 
for a further 15 min at 55°C. This step was repeated twice, after which excess 
washing solution was removed by carefully blotting the edge of each sample with 
absorbent paper. Samples were mounted on glass slides with 25 µl of Vectashieldä
mounting medium (Vectorlabs, Orton Southgate, UK) and enclosed with 12 mm 
circular 0.17 mm glass coverslips, sealed with a commercially available nail varnish.  
2.3.8.2.3: CLSM of PNA-FISH labelled biofilms 
PNA treated samples prepared as described in section 2.3.8.2.2 were imaged using 
a Leica SP2 confocal-scanning laser microscope. The excitation spectra and 
emission filters used are outlined in Table 2.3.8.2.3.  
3-Dimensional Z-stacks were recorded at 0.1 µm intervals, using a scanning 
resolution of 1024-1024 pixels and x4 line-averaging. From these multilayer Z-stacks, 
3-Dimensional projections were generated using the Leica proprietary image 
processing software.  
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Table 2.3.8.2.3: Excitation and Emission Spectra for PNA probes 
Target 
species 
Fluorophore Excitation Wavelength (nm) Emission Frequency (nm)
Universal 
Bacterial
CY3 561 550–610 
P. 
aeruginosa
FITC 488 498–540 
S. aureus Cy5 633 635–700 
2.3.8.3: Preparation of biofilms for scanning electron microscopy (SEM) 
Biofilms were prepared on acrylic coupons as described in section 2.3.7. At the 72 h 
timepoint, each acrylic coupon was submerged in 2 ml of gluteraldehyde solution 
(3% v/v) overnight to fix biofilm samples. After gentle washing with PBS, samples 
were sequentially placed in 50, 70, 90 then 100% ethanol for 30 min each to 
dehydrate biofilms. Samples were then transferred directly into a 1:2 solution (v/v) of 
hexamethyldisilazane (HMDS; Sigma Aldrich, Gillingham, UK):ethanol, followed by a 
2:1 solution of HMDS:ethanol for 30 min each. Finally, samples were immersed in  
100% HMDS solution and left loosely covered in a fume cabinet overnight, until all 
HMDS had evaporated. Samples were subsequently sputter-coated with gold in a 
vacuum chamber, under an Argon atmosphere. Coated samples were then carefully 
mounted onto SEM stubs, using carbon adhesive discs. 
2.3.8.3.1: SEM of biofilms  
Biofilms were viewed using a Tescan VAGA SEM and imaged at between 5 – 20 kV 
to assess both surface coverage and more detailed morphological and ultrastructural 
features of biofilms. Due to samples rapidly becoming highly charged, even at 
moderate magnification, focus was obtained, then the field of view moved 
immediately prior to image capture.  
2.3.8.4: Generation of biofilms for gene expression analysis 
Biofilms were prepared for gene expression analysis using the methods described in 
section 3.3.7. However, only S. aureus and P. aeruginosa single-species biofilms 
were prepared; a combined S. aureus and P. aeruginosa mixed biofilm, a mixed 
‘commensal’ biofilm and a mixed biofilm containing all 5 species as used in previous 
sections.  
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2.3.8.5: Extraction of bacterial RNA from model biofilms 
A number of methods were evaluated for extraction of bacterial RNA from the model 
biofilms on acrylic coupons. Initially, the Qiagen RNeasy proprietary method; a 
modification of this method employing phenol-chloroform-isoamyl alcohol from earlier 
work within the group (Cavalcanti et al. 2015); the FastPro Blue RNA extraction 
proprietary method, which has previously been reported to result in good RNA yields 
from microbial biofilms (França et al. 2012) were trialled. Finally, a hybrid method was 
found to provide the best yield and quality of RNA from biofilms. This was performed 
using a combination of the FastPro Blue kit (MP Biomedicals, Santa Ana, CA, USA) 
and Qiagen RNeasy clean-up kit (Qiagen, Manchester, UK) and is described below. 
After 72 h aerobic incubation at 37ÊC, inoculated acrylic coupons were pooled in 
triplicate and placed in glass bijoux containing 1 ml of lysis buffer and 500 µg glass 
beads (500  750 µm size). These were vortex mixed at maximum speed for 1 min 
to remove biofilm cells from the acrylic surface. The resultant cell suspension was 
transferred by pipette into 1.5 ml screw cap tubes containing 500 µg glass beads 
(500  750 µm size)  and kept on ice. These samples were homogenised using a 
rotary bead-beater (BeadBlaster 24, BenchMark Scientific, Edison, NJ, USA) at a 
speed of 7 m/s for 30 s, followed by steeping samples in ice for 1 min, repeated a 
total of 3 times. Tubes were then centrifuged at 13,300 g for 3 min to pellet cell debris, 
and the supernatant transferred by pipette into a 1.5 ml microcentrifuge tube, being 
careful not to perturb the intermediate layer. The screw top tubes containing cell 
debris were discarded. 
To each microcentrifuge tube (containing approximately 500 µl of supernatant) 700 µl 
100% ethanol was added and mixed by pipetting. This liquid was transferred to a 
silica spin column from the Qiagen RNeasy clean-up kit, and centrifuged at 10,000 g
for 30 s. The flow-through was discarded, and the process repeated for any remaining 
lysate supernatant. Then, 350 µl RW1 buffer was added to each column, and again 
centrifuged at 10,000 g for 30s, with the flow-through discarded. Next, 80 µl of a 
DNAse I  RDD buffer (comprising 70 µl RDD buffer and 10 µl DNAse I solution) was 
carefully pipetted onto the membrane of each column and incubated at room 
temperature for 30 min. Following incubation, a further 350 µl RW1 buffer was added 
to each column and columns were centrifuged at 10,000 g for 30 s, with the flow-
through discarded. To each column, 500 µl RPE buffer was added. Columns were 
centrifuged as in prior steps and the flow-through discarded. This was repeated with 
a final centrifugation for 2 min to dry the spin columns. 
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To elute bacterial RNA, 10 µl RNase free water was carefully added to the spin 
column membrane, followed by centrifugation at 10,000 g for 1 min. This process was 
repeated for a total of 20 µl eluate. RNA eluate was transferred to a 200 µl 
microcentrifuge tube and kept on ice. Each sample was checked for yield and purity 
by photospectrometric absorbance at 260 and 280 nm using a NanoVue. Samples 
below a minimum threshold of 55 ng/µl (needed to generate a target RNA quantity of 
500 ng in reverse transcription reactions) were discarded, as were samples failing to 
give a 260:280 nm absorbance ratio of at least 1.8, indicating high levels of chemical 
or protein contaminants.  
2.3.8.6: cDNA synthesis by Reverse Transcription (RT) 
RNA samples were diluted in sterile, nuclease free water to achieve a quantity of 
approximately 500 ng RNA in 9 µl total volume. Reverse transcription was undertaken 
using a 2-step protocol, with the Precision nanoScriptä 2 kit (Primerdesign, 
Camberley, UK). To each of the above 9 µl RNA suspensions was added 1 µl random 
nonamer primers. Samples were briefly mixed by vortex, then annealed at 65°C for 
5 min in a thermocycler (G-storm, Gene-technologies, Braintree, UK), followed by 
immediate transfer to ice (before cooling of the thermocycler occurred).  
A reverse-transcriptase mastermix was then prepared, by combining 5 µl 4X buffer, 
1 µl dNTP mix, 3 µl RNase/DNase free water and 1 µl nanoScript 2 enzyme for each 
reaction. A 10 µl volume of the above mastermix was added to each sample and 
briefly vortex mixed at medium speed. The thermocycling parameters used for the 
second stage reverse transcription reaction were 25°C for 5 min followed by 42°C for 
20 min. The reaction was terminated by heat inactivation of the RT enzyme at 75°C 
for 10 min. Following completion of reverse transcription, cDNA was stored at -20°C 
for subsequent use in qPCR experiments. 
2.3.8.7: Quantitative PCR (qPCR) of targeted P. aeruginosa and S. aureus genes 
from model biofilms 
A range of P. aeruginosa and S. aureus genes were selected from extensive 
searching of the literature. Genes involved in adherence, biofilm formation, inter-
microbial interactions and associated with virulence in human infection were selected 
(Table 2.3.8.7A). Initially, primers were selected from the literature, but in a number 
of cases were found to provide poor amplification under the experimental conditions 
used. Consequently, a number of primers were redesigned using the PrimerQuest 
and OligoAnalyzer platforms from the Integrated DNA Technologies website 
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(https://www.idtdna.com/Primerquest/Home/Index and 
https://www.idtdna.com/calc/analyzer, respectively). Secondary primer structure 
reaction enthalpies were screened using the online mfold application 
(http://unafold.rna.albany.edu/?q=mfold), ensuring that the melting temperature (Tm) 
of any secondary products was at least 30°C below the Tm to be used for qPCR 
reactions. Target bacterial gene sequences were obtained via the KEGG genome 
database (https://www.genome.jp/kegg/genome.html), NCBI microbial genome 
browser (https://www.ncbi.nlm.nih.gov/genome/browse#!/prokaryotes/); and for 
P. aeruginosa genes, the pseudomonas genome database 
(https://www.pseudomonas.com/). Where possible, gene sequences were cross 
referenced using more than one database and were obtained for the specific strains 
used in qPCR experiments. Where gene sequences for the specific experimental 
strains used were not possible to obtain, confirmation that the genes existed in 
multiple strains was sought, with the assumption that such genes would therefore 
likely be present ubiquitously across the species. The revised primer sequences are 
detailed in Table 2.3.8.7B. 
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Table 2.3.8.7A: Target genes and primer sequences initially trialled for qPCR 
experiments 
S. aureus
Target 
gene
Primer Pair Gene Product 
and Function(s)
Reference
icaA* 5-GAGGTAAAGCCAACGCACTC-3 Polysaccharide 
intercellular 
adhesin. Roles in 
biofilm formation, 
colonisation of 
epithelial cells. 
Atshan et al. 
2013 5-CCTGTAACCGCACCAAGTTT-3
icaB* 5-ATACCGGCGACTGGGTTTAT-3
5-TTGCAAATCGTGGGTATGTGT-3
icaC* 5-CTTGGGTATTTGCACGCATT-3
5-GCAATATCATGCCGACACCT-3
icaD* 5-ACCCAACGCTAAAATCATCG-3
5-GCGAAAATGCCCATAGTTTC-3
fnbA* 5-AAATTGGGAGCAGCATCAGT-3 Fibronectin 
binding proteins 
A/B. 
Adhesion to 
epithelial cells.
5-GCAGCTGAATTCCCATTTTC-3
fnbB* 5-ACGCTCAAGGCGACGGCAAAG-3
5-ACCTTCTGCATGACCTTCTGCACCT-3
clfA* 5-ACCCAGGTTCAGATTCTGGCAGCG-3 Clumping factors 
A/B. 
Coaggregation 
and adhesion to 
plastic 
biomaterials.
5-TCGCTGAGTCGGAATCGCTTGCT-3
clfB* 5-AACTCCAGGGCCGCCGGTTG-3
5-CCTGAGTCGCTGTCTGAGCCTGAG-3
cna* 5-AATAGAGGCGCCACGACCGT-3 Collagen binding 
protein. Adhesion 
to epithelial cells.
5-GTGCCTTCCCAAACCTTTTGAGCA-3
hla* 5-GCAAATGTTTCGATTGGTCA-3 Alpha haemolysin.
Leucotoxin – 
allows escape 
after 
phagocytosis; 
entry to blood 
stream.
Burnside et al. 
2010 5-CCATATACCGGGTTCCAAGA-3
hld 5-TAATTAAGGAAGGAGTGATTTCAATG-3 Delta haemolysin.
Leucotoxin – 
allows escape 
after 
phagocytosis; 
entry to blood 
stream.
5-TTTTTAGTGAATTTGTTCACTGTGTC-3
spa* 5-CAAACGGCACTACTGCTGAC-3 Protein A.
Blocks 
phagocytosis, 
immune 
suppression and 
evasion.
5-CATGGTTTGCTGGTTGCTTC-3
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P. aeruginosa
Target 
gene
Primer Pair Gene Function(s) Reference
exoS* 5-CGTCGTGTTCAAGCAGATGGTGCTG-3 Exotoxins S/T.
Disrupt 
intracellular actin 
filaments and 
inhibits 
phagocytosis.
Fazeli and 
Momtaz 2014 5-CCGAACCGCTTCACCAGGC-3
exoT* 5-CAATCATCTCAGCAGAACCC-3
5-TGTCGTAGAGGATCTCCTG-3
exoU 5-GATTCCATCACAGGCTCG-3 Exotoxin U.
Phospholipase 
activity, promotes 
neutrophil 
migration.
5-CTAGCAATGGCACTAATCG-3
exoY* 5-TATCGACGGTCATCGTCAGGT-3 Exotoxin Y. 
Mechanism of 
action unclear but 
associated with 
increased 
virulence.
5-TTGATGCACTCGACCAGCAAG-3
aprA* 5-TGTCCAGCAATTCTCTTGC-3 Alkaline 
protease.Blocks 
complement 
opsonization, 
contributes to 
immune evasion.
5-CGTTTTCCACGGTGACC-3
toxA 5-GGT AAC CAG CTC AGC CAC AT-3 Exotoxin A.
Inhibits eukaryotic 
protein synthesis 
causing cell death.
5-TGA TGT CCA GGT CAT GCT TC-3
lasB 5-GGA ATG AAC GAA GCG TTC TC-3 Pseudolysin.
Downregulates IL-
6 to impair 
chemotaxis.
5-GGT CCA GTA GTA GCG GTT GG-3
algE 5-ATGTGTTCGGCGACATTT-3 Alginate 
biosynthesis. 
Adherence, biofilm 
formation, EPS 
constituent.
This study
5-TAGGTCTTGTCGAGGTTGT-3
algG 5-ACAAGCAGGTCAAGGAAC-3
5-CAGGAGATCAGGAACGGA-3
phzA 5-AACGGTTACAGCGGCACAGCCTGTTC-3 Phenazine 
biosynthetic 
pathway; 
Pyocyanin 
production. 
Biofilm formation, 
cell signalling, 
quorum sensing.
Ha et al. 2011
5-CTCGACCCAGAAGTGGTTCGGATCCTC-3
phzG* 5-TTTCCGAGTCCCTCACCGGGACCATC-3
5-CGCGCTCGCCGAGTTCGGC-3
pslA* 5-AAGATCAAGAAACGCGTGGAAT-3 Psl
exopolysaccharide 
biosynthesis. 
Colonisation of 
surfaces, biofilm 
formation.
Crabbé et al. 
2008 5-CACCGTACGGAACAGGATGTAG-3
pslD* 5-AACGTCGCCACCATCTATGAA-3
5-ATGCGACCGATGAACGGATA-3
pelA 5-CCTTCAGCCATCCGTTCTTC-3
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*Primers which showed poor amplification and were consequently redesigned (see Table 2.3.8.7B). 
5-TAGCCATACTGGGCCTCGAA-3 Pel
exopolysaccharide 
biosynthesis. 
Colonisation of 
surfaces, biofilm 
formation.
pelD 5-GATGCCGTTCTTCGTCTTCAA-3
5-CGGTCGCTCTGCAGCAA-3
lasI* 5-CGTGCTCAAGTGTTCAAGG-3 N-(3-oxo-
dodecanoyl)-
homoserine 
lactone 
biosynthesis and 
signalling. 
Autoinducer, 
quorum-sensing.
Sabharwal et al. 
2014 5-TACAGTCGGAAAAGCCCAG-3
lasR 5-AAGTGGAAAATTGGAGTGGAG-3
5-GTAGTTGCCGACGACGATGAAG-3
rhlI 5-TTCATCCTCCTTTAGTCTTCCC-3 N-(butanoyl)-
homoserine 
lactone 
biosynthesis and 
signalling. 
Autoinducer, 
quorum-sensing.
5-TTCATCCTCCTTTAGTCTTCCC-3
rhlR 5-TGCATTTTATCGATCAGGGC-3
5-CACTTCCTTTTCCAGGACG-3
lecA 5-CACCATTGTGTTTCCTGGCGTTCA-3 Lectins.
Adhesion to 
epithelial cells. 
Balasubramanian
D 
2013 
5-AGAAGGCAACGTCGACTCGTTGAT-3
lecB 5-AGACAGCGTAACAATCGAACGAGC-3
5-AGGACGCATCGTTCAGCCAATCTA-3
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Table 2.3.8.7B: Revised primer designs for target genes used in qPCR experiments 
1It was not possible to design an acceptable primer pair for fnbA or fnbB individually due to the short span 
of these genes, thus a primer pair which incorporated the combined sequences for these adjacent genes 
was used.
S. aureus
Target gene Primer Pair
icaA 5-TATTTACTGGATTGTCGGTTCA-3
5-CGTATCTTCAATCGTTTCACTTT-3
icaB 5-GCAGATGACGATTCACCTAAA-3
5-TGAGATTCAAATTGTGATTGACTAAC-3
icaC 5-AGGTCAATGGTATGGCTATTT-3
5-GCTGTGTTGTTCGTAAAGTAAT-3
icaD 5-ACTTATCGCTATATCTTGTGTCTT-3
5-TCTCTTCCTCTCTGCCATT-3
fnbAB1 5-CACGCTGATGTTGTTGAATATG-3
5-CTGTTGTATGATCGCTCACTG-3
clfA 5-AGTAGAGTTTAATACGCCTGATG-3
5-TGACATAGAGCGCCAAATTAT-3
clfB 5-AATCATCACCACAAACGATTTC-3
5-TCACTTGCCGTAACTTTATCA-3
cna 5-ACTGTATCACCGTCTAAGATAG-3
5-CCCACCTGTTCACCTTTA-3
hla 5-CACATATAGTCAGCTCAGTAACA-3
5-TATCAGAATCTGCGGCATTAG-3
spa 5-ACACGATGAAGCTCAACAA-3
5-ACTTTGGCTTGGATCATCTT-3
P. aeruginosa
Target gene Primer Pair
exoS 5-GCGTTTGGGACAGATTGA-3
5-ACCATCTGCTTGAACACG-3
exoT 5-ATGCGGTAATGGACAAGG-3
5-GATTCAGGTGCTGGTACTC-3
exoY 5-GATGACCGCCGATTATGAC-3
5-CATATCCTCCCTGCCATAGA-3
aprA 5-GACCTTCGGCAACTTCAG-3
5-TGTTCTGCTCTTCCCAGTA-3
phzG 5-GAAACCCTCGCCGACATC-3
5-AGAACTCCACCGACTCCA-3
pslA 5-GGGCTGGATTCATCGAGTA-3
5-GGAACATAATCACCGTGAGC-3
pslD 5-CAAACGCACCCTCCTCAT-3
5-GTAGCCTGGCGAGTTCTT-3
lasI 5-TAGGCGTGGAGAAGATGAT-3
5-GGGTCTTGGCATTGAGTT-3
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2.3.8.8.1: Screening of potential reference genes 
Five candidate reference genes, and their corresponding primer-pairs were selected 
from the literature for P. aeruginosa and S. aureus (Table 2.3.8.8.1). Primer efficiency 
was calculated using the LinRegPCR open source software (Ruijter et al. 2009). The 
stability of each candidate reference gene was assessed using the NormFinder 
plugin in Microsoft Excel.  
Primers were selected based on the consistency of most efficient amplification and 
stability of each candidate across all experimental conditions. Pairs of primers were 
also considered during the NormFinder analysis for improved stability.   
Table 2.3.8.8.1: Reference genes and primer sequences screened for qPCR 
experiments
S. aureus
Target 
gene
Primer Pair Gene Function(s) Reference
16S 5-GGGACCCGCACAAGCGGTGG-3 16S ribosomal RNA. 
Translation – 
structural component 
of 30s ribosomal 
subunit
Atshan et al. 2013
5-GGGTTGCGCTCGTTGCGGGA-3
pyk 5-ACTGCTGCTGGTTTATATCC-3 Pyruvate kinase.
Glycolytic enzyme.
This study
5-TGCAACCGAAATACCGATAG-3
rho 5-CAGATTTAGAACGCTCAGTAGAA-3 Transcription 
termination factor 
Rho. 
Regulates 
transcription.
This study
5-CACCTGATAATGTACGACCAC-3
gyrB 5-CCAGGTAAATTAGCCGATTGC-3 DNA gyrase subunit 
B.  Induce or relax 
DNA negative 
supercoiling, affects 
transcription and DNA 
replication
Rudkin et al. 2012
5-AAATCGCCTGCGTTCTAGAG-3
rpoB 5-GCGAACATGCAACGTCAAG-3 DNA-dependent RNA 
polymerase subunit B. 
Transcription.
Duquenne et al. 
2010 5-GACCTCTGTGCTTAGCTGTAATAGC-
3
P. aeruginosa
Target 
gene
Primer Pair Gene Function(s) Reference
proC 5-CAGGCCGGGCAGTTGCTGTC-3 Pyrroline-5-
carboxylate 
reductase. 
Amino acid 
biosynthesis. 
Savli et al. 2003
5-GGTCAGGCGCGAGGCTGTCT-3
rpoD 5-GGGCGAAGAAGGAAATGGTC-3 RNA polymerase 
sigma factor D. 
Promotes 
transcription, 
5-CAGGTGGCGTAGGTGGAGAA-3
100
particularly for cell 
growth.
fabD 5-GCATCCCTCGCATTCGTCT-3 Malonyl CoA-acyl 
carrier protein 
transacylase.  
Fatty acid 
biosynthesis.
5-GGCGCTCTTCAGGACCATT-3
ampC 5-AGATTCCCCTGCCTGTGC-3 Beta-lactamase 
precursor. Hydrolyses 
a broad range of Beta-
lactam antibiotics.
5-GGCGGTGAAGGTCTTGCT-3
pbp2 5-CCGCCACTACCCGCTGAAG-3 Penicillin binding 
protein 2. 
Peptidoglycan cell 
wall synthesis.
5-TGCCGTGCAACTCGCTCTC-3
2.3.8.8.2: qPCR conditions and data analysis 
All qPCRs were undertaken using the PrecisionâFAST qPCR Mastermix with LOW 
ROX (Primerdesign, Camberley, UK). Bacterial cDNA samples prepared as 
described in section 2.3.8.7 were thawed on ice, then diluted 1:5 in nuclease free 
water. Each 20 µl reaction volume consisted of: 10 µl PrecisionâFAST qPCR 
Mastermix solution, 8 µl of RNase/DNase free water, 1 µl of the relevant primer mix 
(0.5 µl of each forward and reverse primer) and 1 µl of template cDNA suspension.  
All reactions were aliquoted in duplicate in BrightWhite PCR 96 well-plates sealed 
with Optical adhesive seals (PrimerDesign, Camberley, UK). Negative controls were 
included by adding an additional 1 µl of nuclease-free water to reaction wells rather 
than RNA. 
The QuantStudio 6 Flex Real Time PCR system (Applied Biosystems™, California, 
USA) was used for thermocycling and fluorescence analysis for the reactions. 
Thermocycling parameters used were: an initial Hot Start Enzyme activation step of 
95 °C for 2 min, followed by 40 cycles of denaturation (95°C for 5 s) and annealing 
(60°C for 20 s). As a final step, upon completion of the 40 cycles, melt curve analysis 
was undertaken automatically for each reaction. Thresholds were applied 
automatically by the QuantStudio 6 software across all reactions, indicating a point 
at which all reactions were undergoing a logarithmic increase in fluorescence 
intensity. Cycle threshold values were obtained for each reaction, defined as the 
cycle number at which each reaction crossed the threshold line defined above. 
Changes in gene expression were calculated using the Pfaffl method (Pfaffl 2001) by 
imputing efficiencies for each primer calculated using the program LinRegPCR. The 
equation used was: 
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where: 
• R = ratio of gene expression 
• E = primer efficiency 
• DCP = change in crossing point (or cycle threshold) value 
• Target = gene of interest 
• Ref = reference (housekeeping) gene 
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2.4: Results 
2.4.1: Attachment of microbes to acrylic coupons - influence of preconditioning 
by AS and single or mixed inocula 
There was a difference in the impact of preconditioning with artificial saliva in single 
species and mixed species inocula (Figure 2.4.1A and B). In single species inocula, 
artificial saliva led to increased recovery of S. sanguinis from acrylic biomaterial 
surfaces compared to water alone. There was a trend for this effect on A. viscosus
also, although this did not reach the threshold of statistical significance. Overall, 
P. aeruginosa was recovered in substantially greater number compared to the other 
microorganisms evaluated, with an approximate 1 log greater recovery than any other 
microorganism. 
However, in the case of mixed inocula, there was a reduction in the number of 
pseudomonas colony forming units (CFU) recovered from acrylic coupons, with a 
concomitant increase in the number of S. sanguinis and A. viscosus. The impact of 
preconditioning by AS was enhanced for these microorganisms also, with both 
species demonstrating highly statistically significant increases in CFU recovery from 
acrylic surfaces preconditioned with AS. It was not possible to identify C. albicans
from samples, likely because P. aeruginosa grew heavily on the Sabouraud Dextrose 
agar used for Candida recovery. 
The impact of preconditioning with AS appeared to differ to culture analysis when 
microbial surface area coverage of acrylic biomaterials was analysed from CLSM 
images however (Figure 2.4.1C). Here the trend for S. sanguinis for higher area 
coverage by total cells and live cells on acrylic coupons preconditioned in water. This 
pattern was similar for C. albicans, S. aureus and P. aeruginosa. Only A. viscosus
demonstrated greater surface area coverage on acrylic biomaterial surfaces 
preconditioned with AS, although this did not reach the threshold of statistical 
significance. There was a high degree of variability noted in surface area coverage 
for all samples, which is reflected in the large error bars. When evaluating mixed 
inocula, there was an increase in both viability of microbes and surface area coverage 
of acrylic coupons after preconditioning with AS. However, as quantification of such 
images does not discriminate between species, it is not possible to ascertain if this 
increased surface area coverage is due to greater attachment of S. sanguinis and 
A. viscosus, as was seen in culture experiments. The overall area covered by mixed 
inocula was also substantially higher than the addition of each single species inocula 
(up to 10-fold greater). Representative CLSM photomicrographic images for each 
species and condition are displayed in Figure 2.4.1D-O. 
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Figure 2.4.1: Mean colony forming units recovered from acrylic surfaces rinsed immediately after 
inoculation  
A) Single species inocula 
B) Mixed species inocula 
AV – A. viscosus
CA – C. albicans 
SS – S. sanguinis 
SA – S. aureus 
PA – P. aeruginosa 
Note the logarithmic scale (log10 axis).
All samples were analysed in triplicate and experiments repeated twice.
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Figure 2.4.1C: Median surface area (µ m2) occupied by microbes on acrylic surfaces rinsed immediately 
after inoculation, detected by CLSM using Live/Dead stain. 
Error bars represent standard deviation. All acrylic samples were imaged at five random locations, in triplicate with 
experiments repeated 2 times. Note that scales differ for each inoculum.
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Figure 2.4.1: CLSM photomicrographs of microbial adherence assays on acrylic surfaces
D, E – A. viscosus F, G – C. albicans H, I – S. sanguinis J, K – S. aureus 
L, M – P. aeruginosa N, O – Mixed species inoculum  
D, F, H, J, L, N show microbes attached to acrylic surfaces preconditioned with artificial saliva 
E, G, I, K, M, O show microbes attached to acrylic surfaces preconditioned with water 
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2.4.2: Adherence of microbes to acrylic coupons - influence of preconditioning 
by AS and single or mixed inocula 
After 90 mins adherence time, there was a change in the proportions of microbes 
recovered from acrylic coupon surfaces, as well as a change in the impact of 
preconditioning with AS of single species inocula (Figure 2.4.2A). Both C. albicans
and S. aureus were recovered in lower quantities from AS preconditioned coupons 
compared to water preconditioning. In contrast, P. aeruginosa was recovered in 
significantly greater quantities from AS preconditioned acrylic surfaces. Both 
S. sanguinis and A. viscosus were recovered in approximately equal quantities from 
acrylic biomaterial surfaces preconditioned with either water or AS, in contrast to 
initial attachment patterns. 
In mixed inocula however (Figure 2.4.2B), S. sanguinis and A. viscosus retained the 
statistically significant increase in CFUs recovered from AS preconditioned acrylic. 
Again, it was not possible to identify C. albicans from mixed inocula. 
Findings from CLSM image analysis (Figure 2.4.2C) demonstrated an increase in 
surface area coverage from both viable and total S. sanguinis and A. viscosus single 
species inocula on AS preconditioned acrylic surfaces; corroborating the findings of 
culture studies. There was also a clear decrease in surface area coverage of 
P. aeruginosa and C. albicans. None of these findings met the threshold of statistical 
significance, due to the high variability between images. Interestingly in mixed 
species inocula, both the total surface area coverage and proportion of viable cells 
was decreased on acrylic biomaterial surfaces preconditioned with AS. Comparison 
between culture and CLSM studies for mixed inocula is tenuous at best, as no 
C. albicans grew in the presence of P. aeruginosa on SDA, while quantitative CLSM 
image analysis does not account for the contributions of different microbial species 
to surface area coverage. Representative CLSM photomicrographs are displayed in 
Figure 2.4.2D. 
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Figure 2.4.2: Mean colony forming units recovered from acrylic surfaces rinsed 90 min following 
inoculation 
A) Single species inocula 
B) Mixed species inocula 
AV – A. viscosus
CA – C. albicans 
SS – S. sanguinis 
SA – S. aureus 
PA – P. aeruginosa 
Note the logarithmic scale (log10 axis).
All samples were analysed in triplicate and experiments repeated twice.
5.0 5.5 6.0 6.5 7.0 7.5 8.0
A. viscosus
C. albicans
S. sanguinis
S. aureus
P. aeruginosa
Mean Log10 CFU/ml
Sp
ec
ie
s
Artificial Saliva
Water
p=0.0004
p=0.0006
p=0.0134
A
5.0 5.5 6.0 6.5 7.0
A. viscosus
C. albicans
S. sanguinis
S. aureus
P. aeruginosa
Mean Log10 CFU/ml
Sp
ec
ie
s
P<0.0001
P=0.0318
B
109
A r
t i f i
c i a
l  S
a l i
v a
W a
t e r
0
5
10
15
20
Preconditioning
Su
rfa
ce
 a
re
a 
µm
2
A. viscosus
A r
t i f i
c i a
l  S
a l i
v a
W a
t e r
0
1000
2000
3000
4000
Preconditioning
Su
rfa
ce
 a
re
a 
µm
2
C. albicans
A r
t i f i
c i a
l  S
a l i
v a
W a
t e r
0
500
1000
1500
2000
2500
P. aeruginosa
Preconditioning
Su
rfa
ce
 a
re
a 
µm
2
A r
t i f i
c i a
l  S
a l i
v a
W a
t e r
0
2000
4000
6000
Preconditioning
Su
rfa
ce
 a
re
a 
µm
2
S. sanguinis
A r
t i f i
c i a
l  S
a l i
v a
W a
t e r
0
200
400
600
800
Preconditioning
Su
rfa
ce
 a
re
a 
µm
2
S. aureus
A r
t i f i
c i a
l  S
a l i
v a
W a
t e r
0
1000
2000
3000
4000
Mixed species 90 min
Preconditioning
Su
rfa
ce
 a
re
a 
µm
2 Live
Dead
Figure 2.4.2C: Median surface area (µ m2) occupied by microbes on acrylic surfaces rinsed 90 
min after inoculation, detected by CLSM using Live/Dead stain. 
Error bars represent standard deviation. All acrylic samples were imaged at five random locations, in 
triplicate with experiments repeated 2 times. Note that scales differ for each inoculum.
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Figure 2.4.2: CLSM photomicrographs of microbial adherence assays on acrylic surfaces
D, E – A. viscosus F, G – C. albicans H, I – S. sanguinis J, K – S. aureus 
L, M – P. aeruginosa N, O – Mixed species inoculum  
D, F, H, J, L, N show microbes attached to acrylic surfaces preconditioned with artificial saliva 
E, G, I, K, M, O show microbes attached to acrylic surfaces preconditioned with water 
L
KJ
ON
M
112
2.4.3: Characterisation of acrylic biofilms 
2.4.3.1: Recovery of viable microorganisms by culture 
Analysis of biofilms at 72 h revealed that the impact of preconditioning of acrylic 
surfaces on initial attachment and adherence patterns did not appear to affect 
subsequent biofilm formation. For both single species (Figure 2.4.3.1A) and mixed 
species (Figure 2.4.3.1B) inocula, there was no difference in recovery rate from 
acrylic biomaterial surfaces preconditioned with AS or water for A. viscosus,
C. albicans, S. sanguinis or S. aureus.
In contrast to findings after 90 min of adherence, P. aeruginosa biofilms yielded a 
lower CFU recovery from AS preconditioned acrylic surfaces, compared to water, 
although the effect size was small. However, in mixed species biofilms, this trend was 
reversed, with increased recovery from AS preconditioned acrylic. Again, the effect 
size was relatively small, although consistent across samples. As was previously 
noted, it was not possible to identify viable C. albicans from mixed species biofilms 
on SDA, due to overgrowth of P. aeruginosa on these agar plates.  
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Figure 2.4.3.1: Mean colony forming units recovered from 72 h biofilms grown on acrylic 
surfaces 
A) Single species inocula 
B) Mixed species inocula 
AV – A. viscosus
CA – C. albicans 
SS – S. sanguinis 
SA – S. aureus 
PA – P. aeruginosa 
Note the logarithmic scale (log10 axis).
All samples were analysed in triplicate and experiments repeated twice.
2.4.3.2: Quantification of Live/Dead-stained biomass viewed by CLSM with 
COMSTAT 2.0 
As was found in earlier sections, quantitative analysis of CLSM images appear to 
corroborate culture studies. There was no clear difference in biomass within biofilms 
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grown on acrylic biomaterial surfaces preconditioned with either water or AS (Figure 
2.4.3.2A). Approximately 50% of microbes were viable in image analysis in the case 
of A. viscosus, C. albicans and mixed inocula. Both P. aeruginosa and S. aureus 
showed a smaller proportion of viable biomass (approximately 30%), while 
S. sanguinis biomass was comprised of around 60% viable cells. Mixed species 
biofilms had reduced biomass compared to single species biofilms in the case of 
A. viscosus, P. aeruginosa and S. aureus, and were approximately equivalent in 
biomass to single species biofilms of C. albicans and S. sanguinis. Example 3D 
projections of z-stacks recorded of mixed species biofilms are displayed in Figures 
2.4.3.2B and C. 
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Figure 2.4.3.2A: Median biomass (µ m3/µ m2) within 72 h biofilms grown on acrylic surfaces, 
detected by CLSM using Live/Dead stain. 
Error bars represent standard deviation. All acrylic samples were imaged at five random locations, in 
triplicate. With experiments repeated 2 times.
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Figure 2.4.3.2B and C: (filtered) 3D projections of mixed species biofilms captured by 
CLSM 
B) Mixed species 72 h biofilm grown on acrylic biomaterial surface preconditioned with artificial saliva 
C) Mixed species 72 h biofilm grown on acrylic biomaterial surface preconditioned with water
B
C
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2.4.3.3: Validation of culture recovery of viable organisms 
To establish the validity of vortex recovery of viable microbes, mixed species biofilms 
were grown and treated using the protocol in section 2.3.8.1. Subsequently, 
remaining biofilm cells were stained with Live/Dead stain and analysed as per section 
2.3.8.2. This demonstrated that the majority of biofilm cells were removed during 
vortex treatment and showed no preferential retention of viable cells from either AS 
or water preconditioned acrylic biomaterial surfaces (Figure 2.4.3.3).
2.4.3.4: Species distribution within biofilms detected by PNA-FISH and CLSM 
S. aureus, P. aeruginosa and C. albicans were successfully labelled by PNA-FISH 
probes (Figure 2.4.3.4 A-L). PNA-FISH labelling of biofilms generated on acrylic 
coupons demonstrated colocalization of both P. aeruginosa and S. aureus with the 
representative ‘commensal’ oral microbes S. sanguinis and A. viscosus
(Figure 2.4.3.4 D, H, L). Overall, there was limited identification of C. albicans (Figure 
2.4.3.4 B, D), which meant assessment of the spatial distribution of this species within 
the biofilm was not possible. 
Biofilms appeared to be predominated by P. aeruginosa, which tended to occupy the 
outer layers of the biofilm (Figure 2.4.3.4 H, L). Meanwhile the remaining bacteria 
were predominantly clustered in deeper biofilm regions and were not homogenously 
distributed throughout. 
AS W
0
2
4
6
8
10
B
io
m
as
s 
(u
m
3 /u
m
2 ) Live
Dead
Figure 2.4.3.2: Median biomass (µ m3/µ m2) within 72 h biofilms grown on acrylic 
surfaces, detected by CLSM using Live/Dead stain. 
Error bars represent standard deviation. All acrylic samples were imaged at five random 
locations, in triplicate with 2 experimental repeats. 
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(Overleaf) Figure 2.4.3.4: Photomicrographs of PNA-FISH labelled mixed species biofilms 
generated on acrylic biomaterial surfaces, imaged using confocal laser scanning microscopy. 
Red: universal bacterial probe 
Green: P. aeruginosa specific probe & C. albicans probe 
Blue: S. aureus specific probe 
A) Universal bacterial probe only 
B) P. aeruginosa and Yeast Traffic Light probe only (C. albicans indicated by arrows) 
C) S. aureus specific probe 
D) Composite, multi-channel image with all probes 
E) Universal bacterial probe only 
F) P. aeruginosa and Yeast Traffic Light probe only 
G) S. aureus specific probe 
H) Composite, multi-channel image with all probes – note the localisation of P. aeruginosa towards outer 
layers, with centralised clusters of oral bacteria and S. aureus coaggregates 
I) Universal bacterial probe only 
J) P. aeruginosa and Yeast Traffic Light probe only 
K) S. aureus specific probe 
L) Composite, multi-channel image with all probes – note coaggregates of oral bacteria and S. aureus
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2.4.3.5: SEM imaging of biofilms 
Examination of scanning electron photomicrographs at low magnification 
demonstrated that the majority of the acrylic coupon surface was coated with biofilm 
(Figure 2.4.3.5A). Images at higher magnifications (Figure 2.4.3.5B &C) revealed the 
morphology of biofilms more clearly, including areas of sparse coverage, which may 
indicate channels within the biofilm. In the most densely populated regions of the 
biofilm, individual microbial cells were not clearly demarcated, which may indicate 
extracellular polymeric substrate encasing the cells.
A
B
C
Figure 2.4.3.5: Scanning Electron 
Photomicrographs of biofilms on acrylic 
coupon surfaces 
A) 30x view demonstrating biofilm 
distribution across acrylic coupon 
surface
B) 560x view demonstrating abiotic 
spaces within biofilm, indicating 
possible water channels
C) 3000x view demonstrating example 
of abiotic region within biofilm. Note 
in dense biofilm regions, microbes 
are not well demarcated, suggestive 
of extracellular polymeric substrate 
coating.
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2.4.4: qPCR analysis of gene expression by P. aeruginosa and S. aureus -   
influence of oral commensal microbes 
2.4.4.1: Validation and optimisation of RNA extraction method – RNA purity and 
concentration assessed by nanodrop 
The methods of RNA extraction used resulted in different yields and quality of RNA 
elute from microbial biofilms (Table 2.4.4.1). The novel combination of the RNA 
FastPro Blue kit with a secondary Qiagen clean-up kit, both used according to the 
manufacturer’s instructions, was the only method that produced RNA of suitable 
purity (determined by A260/280 and A260/230 ratios over 2.0), with an adequate 
RNA yield for subsequent gene expression analysis. 
Table 2.4.4.1: Quantity and quality of microbial RNA eluted from biofilms using 
different methods of RNA extraction, as determined by Nanodrop
Method Conc. ng/mL 
(Median, MAD)
A260/280
(Median, MAD)
A260/230
(Median, MAD)
Qiagen RNeasy Kit 64 (34) 1.96 (0.133) 0.345 (0.244) 
Modified 
trizole/RNeasy
method
47.5 (32) 2.0535 (0.218) 0.184 (0.104) 
RNA FastPro Blue 
Kit
451 (155.3) 1.659 (0.089) 0.6245 (0.091) 
RNA FastPro Blue + 
Qiagen Cleanup
204.8 (84.4) 2.029 (0.035) 2.073 (0.257) 
2.4.4.2: Validation and selection of reference genes – efficiency and stability of 
expression 
There was relatively little variation between reference gene efficiency within single, 
dual and mixed species biofilms for all P. aeruginosa primer pairs analysed (Table 
2.4.4.2A) and S. aureus primer pairs excluding rho (Table 2.4.4.2B). Of the 
P. aeruginosa primer pairs, only proC and rpoD demonstrated reasonable efficiency 
(~90%) across all experimental conditions. The expression of rpoD across conditions 
was found to be more stable than that of proC following analysis by the Normfinder 
add-in for Microsoft Excel (Anderson et al. 2004), and so was selected as the 
reference gene for all experiments. 
For S. aureus, 4 primer pairs showed approximately 90% efficiency, while pyk 
performed substantially better, with 98% overall efficiency. The gene pyk was found 
to be most stably expressed across all experimental conditions and so was selected 
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as the reference gene for subsequent qPCR experiments. However, it should be 
noted that the overall stability of all reference genes analysed was relatively low. 
Table 2.4.4.2A: Efficiencies and stability of P. aeruginosa reference genes 
screened 
Gene Mean Primer Efficiency (SEM)
Single species Dual species Mixed species Overall
proC 1.87 (0.027) 1.93 (0.019) 1.90 (0.014) 1.90 (0.013)
rpoD 1.90 (0.025) 1.91 (0.016) 1.85 (0.006) 1.89 (0.012)
fabD 1.78 (0.020) 1.83 (0.028) 1.80 (0.014) 1.80 (0.013)
ampC 1.87 (0.020) 1.86 (0.016) 1.83 (0.008) 1.85 (0.009)
pbp2 1.68 (0.004) 1.64 (0.017) 1.62 (0.007) 1.64 (0.009)
Table 2.4.4.2B: Efficiencies and stability of S. aureus reference genes screened 
Gene Mean Primer Efficiency (SEM)
Single species Dual species Mixed species Overall
pyk 1.99 (0.030) 1.98 (0.021) 1.96 (0.015) 1.98 (0.010)
rho 1.58 (0.29) 1.54 (0.27) 1.73 (0.12) 1.61 (0.093)
16S 1.76 (0.056) 1.81 (0.057) 1.68 (0.041) 1.75 (0.034)
gyrB 1.96 (0.025) 1.89 (0.037) 1.90 (0.029) 1.90 (0.021)
rpoB 1.95 (0.014) 1.90 (0.031) 1.84 (0.017) 1.88 (0.018)
revA 1.984 (0.006) 1.92 (0.037) 1.85 (0.036) 1.90 (0.025)
ftsZ 1.92 (0.027) 1.90 (0.23) 1.83 (0.043) 1.88 (0.022)
2.4.4.3: Validation of primers – original primer efficiency 
A number of primers identified from published research assessed for amplification 
efficiency of P. aeruginosa, dual species and mixed species biofilms. Despite most 
primers showing reasonable amplification efficiency (Table 2.4.4.3), there appeared 
to be poor primer specificity when melt curve analysis was undertaken. 
Consequently, primers were redesigned from first principles as described in section 
2.3.8.8. 
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Table 2.4.4.3A: Primers initially screened for detection of P. aeruginosa gene 
expression
Gene of interest Mean Primer Efficiency SEM 
rhlI 1.80 0.026 
rhlR 1.84 0.018 
phzA 1.78 0.017 
pelA 1.89 0.010 
pelD 1.71 0.035 
lasR 1.89 0.023 
lecA 1.80 0.047 
lecB 1.69 0.057 
pslA 1.93 0.017 
pslD 1.91 0.010 
rpoD 1.87 0.021 
The primers used in S. aureus biofilm experiments gave no clear amplification 
product as determined by melt-curve analysis, and so it was not possible to calculate 
amplification efficiencies. Again, primers were redesigned from first principles using 
the process outlined in section 2.3.8.8.
2.4.4.4: Validation of primers – redesigned primer efficiency 
The amplification efficiency of the newly designed primers was again assessed and 
combined with melt curve analysis. Overall there was a substantial improvement in 
primer efficiency, although this tended to vary substantially across samples and 
experimental conditions. As the Pfaffl method corrects for primer efficiency when 
calculating changes in gene expression, a less parsimonious amplification efficiency 
threshold of 75-125% was applied for subsequent analysis of gene expression. 
Despite this, 4 primer pairs fell below this threshold, and thus data for the 
P. aeruginosa genes exoS, phzG, lasI and pelD were discarded due to poor reliability. 
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Table 2.4.4.4A: Redesigned primers for detection of P. aeruginosa gene 
expression
Gene of interest Mean Primer Efficiency SEM 
aprA 1.85 0.016 
algG 1.75 0.009 
algE 1.75 0.010 
exoS* 1.50 0.094 
exoT 1.81 0.030 
exoY 1.93 0.023 
phzG* 1.08 0.015 
lasI* 1.55 0.012 
pslA 1.92 0.017 
lasR 1.90 0.026 
pelA 1.89 0.010 
pelD* 1.70 0.036 
algU 1.88 0.017 
exoU 1.91 0.011 
lecA 1.81 0.046 
lecB* 1.67 0.072 
toxA* 1.50 0.097 
phzA 1.85 0.011 
rhlR 1.91 0.007 
lasB* 1.57 0.059 
pslD 1.90 0.012 
*amplification efficiency too low and thus excluded from further analysis. 
Table 2.4.4.4B: Redesigned primers for detection of S. aureus gene expression
Gene of interest Mean Primer Efficiency SEM
icaA 1.91 0.016 
icaB 1.90 0.015 
icaC 1.93 0.022 
icaD 1.86 0.019 
fnbAB 1.96 0.030 
clfA 2.06 0.020 
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2.4.4.5: Impact of single species or mixed species interactions on P. 
aeruginosa and S. aureus gene expression 
The majority of Pseudomonal genes analysed demonstrated a trend of decreased 
expression levels in dual species and mixed species biofilms compared to single 
species Pseudomonal biofilms (Figure 2.4.4.5A). Only in the case of exoU, exoY, 
algE and aprA did the decrease in gene expression reach the threshold of statistical 
significance. One notable exception to this trend was lecA, which showed an almost 
4-fold increase in expression, which was statistically significant. There was 
substantial variation in the levels of gene expression, as indicated by the wide error 
bars, and so any inferences made from such data must be guarded at best. 
Similarly, S. aureus gene expression was reduced or unchanged in mixed species 
biofilms when compared to single species biofilms (Figure 2.4.4.5B). Several genes 
showed a slight increase in expression level in dual species biofilms. However, the 
high variability of expression and small magnitude of effect renders the presence of 
any biological significance in such trends improbable. In keeping with this inference, 
no gene analysed demonstrated any statistically significant change in expression 
across the different experimental conditions analysed. The corresponding Ct values 
for P. aeruginosa and S. aureus are displayed in Figure 2.4.4.5C and D. 
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Figure 2.4.4.5A: Differential P. aeruginosa gene expression in single, two species 
(S.aureus and P. aeruginosa) and five species biofilms. Fold-change normalised to 
rpoD reference gene shown. All experiments were performed in duplicate wells, with 
2 experimental repeats. 2-way repeated measures ANOVA was performed on the 
difference in fold-change for each gene examined, using P. aeruginosa single 
species biofilms as control group. 
P values shown are adjusted significance using the two-stage step up method of 
Benjamini, Krieger and Yekutieli to control the false discovery rate (FDR). Q = 0.05.
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Figure 2.4.4.5B: Differential S. aureus gene expression in single species, two species 
(S. aureus and P. aeruginosa) and five species biofilms. Fold-change normalised to 
pyk reference gene shown. All experiments were performed in duplicate wells, with 2 
experimental repeats. 2-way ANOVA was performed on the difference in fold-change 
for each gene examined, using S. aureus single species biofilms as control group. 
P values shown are adjusted significance using the two-stage step up method of 
Benjamini, Krieger and Yekutieli to control the false discovery rate (FDR). Q = 0.05.
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Figure 2.4.4.5C: Differential P. aeruginosa gene expression in single, two species 
(S.aureus and P. aeruginosa) and five species biofilms. Ct values for genes shown in 
Figure 2.4.4.5A.
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Figure 2.4.4.5D: Differential P. aeruginosa gene expression in single, two species 
(S.aureus and P. aeruginosa) and five species biofilms. Ct values for genes shown in 
Figure 2.4.4.5B.
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2.5: Discussion 
This work package describes the development of a simple biofilm model on denture 
acrylic biomaterial surfaces, including both species considered to be commensal, 
normal oral microorganisms, and two well-established putative respiratory 
pathogens, which are also implicated in a wide range of ancillary healthcare 
associated infections. This model has undergone extensive characterisation as 
described within this chapter and thus provides a baseline for subsequent chapters 
investigating the impact of biofilm-mediated infections of tissue models and for testing 
of novel antimicrobial strategies. 
The advantage of the batch system employed in generating such biofilms for 
subsequent work is primarily the high-throughput capability of the system. This is 
invaluable when, as is the case for Chapters 5 and 6, a wide range of experimental 
conditions are screened to establish maximal efficacy. However, it should be noted 
that this method of biofilm development suffers from important limitations that may 
bias the results obtained. The simplicity of this system is a double-edged sword, as 
gains in throughput are tempered by reduced biological relevance: a sessile inoculum 
which is steeped in a highly nutrient rich growth medium, without exposure to shear 
stress, extensive starvation, and seeded at high concentrations which may 
themselves impact subsequent biofilm development through population-dependent 
quorum sensing mechanisms. It has consequently been noted that biofilms 
generated by this method typically show reduced organisation and quantity of the 
extra-cellular polymeric substrate matrix and are less recalcitrant to physical removal 
(McBain AJ 2009). The impact of such observations on clinical applications regarding 
antimicrobial resistance and interactions with host tissues is unclear at present. It  
could be conversely argued that the stagnant conditions of a batch system might 
better simulate the sheltered, nutrient poor niche on denture-fit surfaces. While shear 
and compressive forces within denture-associated biofilms may be high during 
masticatory function, this may be interspersed by long periods of low forces. The act 
of replenishing media exposes biofilms to brief shear flow during movement of the 
biofilm sample from the nutrient depleted well to a well with fresh media. This 
coincides with increased nutrients, which may mimic the increase in force and 
nutrients periodically encountered during eating. 
In keeping with previous reports, including work from our group, there was no clear 
impact of initial patterns of attachment and adhesion on subsequent biofilm 
development (Cerca et al. 2005; Morse D 2017). Species which showed higher rates 
of initial attachment in mixed species biofilms, such as S. sanguinis to acrylic surfaces 
preconditioned with AS (Figure 2.4.1B) were outgrown by P. aeruginosa by 72 h 
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(Figure 2.4.3B) despite an approximately 2-log reduction in initial attachment rates 
by the latter. This may simply reflect inherent differences in growth rates between 
such microorganisms. The impact of conditions for growth may also play a role, as 
changing media every 24 h could allow substantial build-up of toxins and waste 
products, for which P. aeruginosa is well known to harbour a high level of tolerance 
(Purschke et al. 2012; Gelatly and Hancock 2013). 
Similarly, despite impacting initial attachment and adhesion of representative oral 
bacteria in mixed biofilms, there was a loss of the impact of preconditioning acrylic 
biomaterial surfaces with AS (Figures 2.4.1 - 2.4.3). This again is unsurprising, as 
only the deepest layer of cells within a biofilm actually contact the surface, and 
plausible coaggregative interactions between all microorganisms included in this 
biofilm model have been described in the introduction to this chapter.  
An important consideration when assessing the validity of culture-dependent studies 
of biofilms is the ability to remove microbial cells from a surface (Portillo et al. 2013). 
Consequently, biofilms grown on acrylic surfaces were processed as if for culture, 
labelled with the BacLight Live/Dead stain, and the surfaces then examined using 
CLSM to assess both the total biomass and quantity of viable cells that remained 
adherent to each surface. While a substantial biomass remained following vortex 
processing of acrylic coupons, the majority of the retained microbes were non-viable. 
Importantly, there were no significant differences between either total microbial 
biomass or viable microbial biomass for acrylic coupons preconditioned with water or 
AS, which eliminates the possibility of differential recovery of microorganisms biasing 
the results of culture analysis in favour of either condition. A factor which remains 
unaddressed in these characterisation experiments is the possibility of incomplete 
penetration of either SYTO-9 or propidium iodine reagent in certain regions of the 
biofilm, which could similarly influence results. However, this method is widely 
employed in biofilm studies undertaken across a range of settings and fields, despite 
limited validation of its sensitivity and specificity in such applications (Netuschil et al. 
2014). 
Examination of the spatial orientation and potential co-localisation of microbial 
species using species specific, fluorophore-conjugated PNA probes with FISH, 
provides some insight into microbial interactions within biofilms. While there was 
considerable heterogeneity, P. aeruginosa was seen to preferentially occupy the 
outer biofilm layers in most micrographic sections (Figure 2.4.3.1 E-L), while 
S. aureus and S. sanguinis (identified by its classic coccal chain appearance in 
images) appeared to cluster more centrally. This likely reflects the aerophilic nature 
of P. aeruginosa compared with the facultative anaerobic nature of the other 
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microbes. It was not possible to readily identify A. viscosus within photomicrographic 
images, but the above logic suggests that this likely occupied positions within the 
deeper biofilm layers where oxygen tension was lowest. It should be noted when 
evaluating such images that the methods used to ensure hybridisation of PNA probes 
require harsh enzymatic treatment and prolonged, elevated temperatures. These will 
damage or denature biofilm structures, and may even affect cell behaviour and 
orientation, and so the observations gleaned from such images must be extrapolated 
with caution. Nevertheless, the findings corroborate previous research examining the 
spatial localisation of S. aureus and P. aeruginosa in wound models. 
In keeping with the majority of published studies attempting to explore gene 
expression within biofilms; particularly in the case of S. aureus, extraction of sufficient 
quantities of good quality RNA and subsequent analysis of gene expression by qPCR 
was highly challenging (Cury and Koo 2007; Atshan et al. 2012; Heera et al. 2015). 
Consequently, extensive laboratory time, effort and resources were invested in 
attempting to optimise experimental conditions. This included trialling numerous 
methods and combinations thereof for RNA extraction, redesigning the majority of 
primers used from first principles, and using alternative methods of analysis for primer 
efficiency estimation (LinRegPCR rather than standard curves, which would have 
increased costs and laboratory time considerably).  
An alternative approach could have been to focus on one or two target genes for 
S. aureus and P. aeruginosa, to ensure maximally robust data was generated. 
However, this would not be in keeping with the exploratory nature of this work 
segment, which was intended primarily to generate hypotheses for further 
exploration. To date, there have been few studies examining gene expression in 
mixed biofilm models incorporating S. aureus and P. aeruginosa. Certainly, none 
have evaluated the impact of incorporating these species within a biofilm model 
comprising normal oral microorganisms. Changes in gene expression and microbial 
behaviour are often strain-specific (Salama et al. 2000; Holden et al. 2004; Chugani 
et al. 2012). Thus, while the literature was consulted to identify target genes likely to 
be of relevance to colonisation of mucosal surfaces, biofilm formation and/or 
virulence-associated factors; it was felt that exploring a broad range of genes would 
provide the best insight into microbial behaviour when introduced to mixed species 
biofilms, and offer the greatest likelihood of identifying the pathways most strongly 
affected by such community interactions. 
Of note, all qPCR plates demonstrated a low level of amplification of no template 
controls (NTCs). However, the levels noted were typically several cycles higher than 
gene expression levels in the template RNA wells, and subsequent melt-curve 
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analysis demonstrated the products responsible to have a lower melting temperature 
than the genes of interest. This is suggestive of primer dimer formation, rather than 
significant reagent contamination (Bustin and Huggett 2017).  
The majority of S. aureus and P. aeruginosa genes analysed showed no statistically 
significant change in expression in dual species or mixed species compared to single 
species biofilms. However, there was an overall trend across most genes analysed 
towards decreased expression levels in dual and mixed species biofilms compared 
to when either microorganism was grown as a single species biofilm. This may in part 
reflect the loss of biomaterial surface area for each species (due to occupation by the 
other microbes) and concomitant increase in availability of alternative, adhesin-
independent binding sites on each microbe’s cell surface. It should also be noted that 
taken in conjunction with the findings of the PNA-FISH characterisation of biofilms 
and the localisation studies described in section 2.1.3, one reason for limited changes 
in gene expression in mixed compared with single species biofilms could be that there 
are relatively few S. aureus and P. aeruginosa cells directly interacting. As 
P. aeruginosa appears to preferentially occupy outer layers of the biofilm, while 
S.  aureus tends to reside more centrally in microcolonies, only the outermost cells 
would potentially contact the innermost cells of P. aeruginosa. Although soluble 
signalling molecules such as those associated with quorum-sensing may exert some 
activity, by definition these molecules are produced in response to the immediate 
surrounding environment (De Kievit 2009), and so sequestration of each species 
within its own micro-niche could account for gene expression behaviour within mixed 
species biofilms which is, at the community-wide level, largely indistinguishable from 
monoclonal biofilms. 
The pseudomonal lecA gene was increased in mixed biofilms. This encodes a 
glycoprotein-binding lectin receptor specific for galactoside moieties (Diggle et al. 
2006). Unfortunately, expression of the lecB gene was not possible to assess due to 
poor primer efficiency (Table 2.4.4.4A) and specificity (data not shown). However, 
Pseudomonal coaggregation has been documented with oral microbes through 
(although not exclusively) lectin-mediated interactions (Komiyama et al. 1984, 
Komiyama et al. 1987). The increase in the expression of lecA could therefore be 
reasonably interpreted as a result of interspecies coaggregation interactions. 
Limitations of the methods 
It is important to emphasise that beyond the methodological challenges encountered 
in analysing microbial gene expression within biofilms, a number of systematic 
shortfalls of the experimental design and modalities employed within this work 
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package limit the confidence with which inferences can be drawn from the findings 
reported. Firstly, as has previously been mentioned, the use of a batch system to 
generate biofilms, while advantageous in terms of throughput, has limited relevance 
in healthcare associated infections, particularly to as dynamic an environment of the 
oral cavity and denture surface, which is constantly undergoing periods of nutrient 
deprivation, variable shear forces, changes in oxygen tension and temperature (when 
inserted or withdrawn from the oral cavity) and intermittent exposure to host defences 
and commensal microbiota of the oral cavity. Despite regular changes in growth 
media, a proportion of cells included within the “biofilms” on acrylic coupons are likely 
to be deposited through sedimentation from the overlying media and may confound 
all analyses presented.  
The media used contained variable concentrations of glucose in single species 
biofilms; BHI contains approximately 11 mmol/L while the YNB used was 
supplemented with 100 mmol/L glucose. Physiological levels of fasting glucose in 
saliva are typically less than 1 mmol/L glucose, although this increases dramatically 
during meals (Bhattacharrya et al. 2018). Similarly, levels of electrolytes are much 
higher in growth media compared with oral fluids. Both factors are likely to have a 
substantial influence on biofilms development and may have affected the biofilm 
development seen. For mixed species biofilms, FAB was used as the growth medium. 
This contains no glucose and a very different concentration of other nutrients and 
ions compared with either BHI or YNB. This change in growth conditions may have 
exerted a stronger influence on growth rates and biofilm formation than interspecies 
interactions, and thus may have masked the true interactions between microbes.   
Growth curves were not undertaken for the studied microorganisms. This may have 
influenced adhesion and biofilm assays as different growth rates during the 90 min 
initial incubation period might have influenced the levels of adhesion and 
subsequently biased biofilm composition. The strains employed, with the exception 
of A. viscosus were not originally isolated from the oral cavity, nor were the 
representative pathogenic strains originally isolated from pneumonia patients. Given 
the high degree of variability in behaviour possible between strains, the results of this 
work must be supported by replication in more biologically relevant strains. Similarly, 
because only one strain for each species was examined, it is not clear if this 
behaviour is generalisable across the species. Replication with a range of biologically 
relevant strains would be an important feature of any future work. Another aspect of 
future work, given the importance and ubiquity of C. albicans on denture surfaces, 
would be to ensure culture recovery methods employed in characterisation of the 
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biofilm model allow the detection of C. albicans. Simply adding an antimicrobial, such 
as ciprofloxacin which has good activity against P. aeruginosa could achieve this. 
Any imaging method is essentially destructive to the biofilm, alters and dehydrates 
the ultrastructure (in the case of SEM), or is actively cytotoxic (in the case of CLSM).  
The use of qPCR generates bias in results due to the restrictive nature of this 
technique. While more unprejudiced methods exist, which offer a more global picture 
of gene expression, such as microarrays or RNA sequencing, significant further work 
would be required to ensure robust and relevant biofilm generation, and consistent 
high-quality RNA extraction was undertaken prior to implementing these far more 
expensive methods. With the sheer multitude of RNA extraction methods available, 
each tailored to a specific species or even strain, this would likely require separate 
methods (or at least substantial modifications of a single method) for P. aeruginosa 
and S. aureus, as the challenges posed by the radically different biofilm matrix and 
cell wall composition may preclude a universally applicable workflow. Given the 
redundancy of gene expression, and the complexity of regulatory networks governing 
protein translation, even the most fastidious study of gene expression must be 
proceeded by an evaluation of resultant protein production to demonstrate biological 
relevance. This was – due to both financial and time constraints – beyond the scope 
of this body of work to examine. 
Despite the limitations outlined above, this work package demonstrates the 
development of a mixed microbial biofilm on acrylic biomaterial surfaces which 
successfully incorporates putative respiratory pathogens. The extensive 
characterisation included provides a baseline for modelling biofilm-mediated 
infections in the following chapter, while the reliable generation of biofilms with a high-
throughput capacity allows subsequent investigation of novel anti-biofilm strategies, 
such as the use of microwave frequency electric field described in Chapter 6. The 
methods used within this section could easily be applied to biofilm models of 
increased complexity, or even ‘ex vivo’ models generated either by seeding biofilms 
with microbes recovered from the oral cavity by a number of means, or by the use of 
a removable oral device worn to generate a more clinical relevant biofilm, such as 
the enamel chips used in Palmer et al. (2001). 
138
CHAPTER 3: HOST-PATHOGEN INTERACTIONS IN AN ACRYLIC BIOFILM 
ORAL INFECTION MODEL 
3.1: Introduction 
The diversity of microbial communities within the oral cavity, combined with complex 
immune responses driven by both local and systemic factors has led to the fields of 
microbiology and immunology, in many respects, developing in silos. More recently, 
recognition has grown of the importance of host-pathogen interactions in 
understanding biofilm-mediated infections (Stappenbeck and Virgin 2016); the 
ultimate goal being the development of personalised medicine, with individualised 
treatments based on a comprehensive understanding of both host and microbial 
factors (Wilson ID 2009). This has also been identified as a key area for improved 
patient care in dentistry (Zarco et al. 2012) and respiratory medicine (Rogers and 
Wesselingh 2016). Clearly integration across a range of medical and related fields 
would be necessary to truly deliver holistic personalised healthcare. 
In the late 1990s, organotypic 3D tissue models of human epidermis, dermis and 
mucosa emerged as an alternative to animal models in research. These models were 
originally repurposed from biopsy-derived tissue sheets grown for treatment of burns 
and to be used as intra-oral grafts (Moharamzadeh et al. 2007). Such models 
afforded a number of advantages over animal testing; particularly higher throughput 
capacity at reduced cost, increased biological relevance and reliability for translation 
to clinical applications, and a means of avoiding the ethical quandaries of animal 
testing. While initially employed to test commercial products such as cosmetics for 
toxicity, corrosivity and other adverse effects, within a decade tissue models were 
being used as a means of investigating host-pathogen interactions in infection. 
3.1.1: The use of 3-dimensional tissues to model infection 
A number of groups have examined the pathogenesis of microbial infection using 
organotypic tissue models, with a diverse range of microbes, tissues, techniques and 
applications.   
One of the most commercially successful applications of such model tissues has 
been in the production of epidermis, or dermis-epidermis (full-thickness) skin models. 
Such tissue models have gained wide acceptance for the testing of toxicity 
(Pampaloni et al. 2009), corrosion (Fentem et al. 1998), phototoxicity (Lelièvre et al. 
2007) and irritation (Spielmann et al. 2007) of both pharmaceutical and cosmetic 
products. Subsequently, further protocols have been developed to investigate 
percutaneous absorption (Rozman et al. 2009) and to assess the effect of 
nanomaterials (Lee et al. 2009). 
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Early models of mucosal infection soon followed the increasing use of in vitro tissues. 
Of note, one of the first of such applications focussed on oral (and cutaneous) 
candidiasis (Korting et al. 1998; Schaller et al. 1998). This work helped to 
characterise the role of secreted aspartic proteinases (SAPs) in Candida virulence, 
through a combination of histopathological examination of sectioned infected tissues 
and qPCR analysis. The applicability of infection modelling was validated by the close 
morphological similarities between in vitro tissues and clinical biopsy samples from 
individuals with candidiasis. However, more recent analyses comparing cancer cell-
derived tissue models (such as the SkinEthic reconstituted human oral epithelium 
model used in this chapter) with normal human keratocyte-based models has 
demonstrated the closer in vivo likeness of the latter over the former (Yadev et al. 
2011). 
More recently, an organotypic model of gingival tissue has been established to mimic 
periodontal pockets (Bao et al. 2015a). These tissues were grown in a perfusion 
bioreactor, to which the researchers subsequently added a hydroxyapatite disc 
supporting a 24 h mixed species biofilm including 11 microorganisms to represent 
both normal oral bacteria and periodontal pathogens. In addition to biofilm 
composition with and without the presence of the tissue models, the production of a 
number of important cytokines by the tissue models in response to infection was 
evaluated. In a subsequent paper, the same group reported the secreted proteome 
of both periodontal tissue models and microbial biofilms during infection (Bao et al. 
2015b). The power of tissue models to drive hypothesis generation is thus likely to 
increase due to the enhanced capabilities of modern, ‘omics’ techniques to naively 
explore host-microbiome interactions in a high-throughput, reproducible and clinically 
relevant setting. 
3.1.2: Interactions between the oral mucosa and denture acrylic biofilms 
Much of the available literature exploring denture acrylic biofilms in oral mucosal 
infection has focussed heavily on the influence of Candida species, particularly 
C. albicans (Schaller et al. 1998; Schaller et al. 1999; Schaller et al. 2002; Bartie et 
al. 2004; Mostefaoui et al 2004; Moyes et al. 2010). This is unsurprising, as oral 
candidiasis is a frequently encountered clinical problem in denture-wearing patients. 
Recent work from our research group (Morse et al. 2018) evaluated the impact of 
single species candidal biofilms or mixed species biofilms containing both C. albicans 
and representative commensal oral bacteria in denture acrylic biofilm tissue infection 
models. Interestingly, the degree of tissue damage (characterised by quantification 
of lactate dehydrogenase release) induced by C. albicans monospecies biofilms was 
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reduced compared to mixed bacterial/Candida biofilms in keratinocyte-only tissue 
models, but these results were equivocal in full-thickness tissue models. It was 
speculated that such differences may reflect the protective nature of the highly 
keratinised surface presented by full-thickness mucosal models. Additionally, the 
influence of other factors, such as the production of antimicrobial peptides which has 
been reported in full-thickness, but not keratinocyte-only, tissue models cannot be 
excluded. 
The potential influence of putative respiratory pathogens within denture-associated 
biofilms has yet to be explored through oral mucosal tissue models. However, 
evidence from experiments evaluating microorganisms such as P. aeruginosa and 
S. aureus on mucosal models offers some insights into the potential impact that 
introducing these species to the denture microbiome may confer. 
Tsang and colleagues (1994) examined the impact of a clinical isolate of 
P. aeruginosa in a resected adenoid tissue model. It was found that 8 h infection with 
P. aeruginosa led to substantial epithelial cell damage, and importantly that 
adherence by microbial cells was enhanced in areas of epithelial damage. 
P. aeruginosa appeared to preferentially bind to mucus, damaged epithelial cells 
which had extruded from the surface, and the basement membrane rather than the 
intact epithelial surface. These findings have subsequently been replicated and 
expanded upon, with a multifactorial range of mechanisms being shown to coalesce 
in facilitating enhanced Pseudomonas adherence and pathogenesis (Reviewed in 
Crabbé et al. 2014). 
Co-infection of skin models by S. aureus and P. aeruginosa has been found to result 
in distinct patterns of localisation; with S. aureus tending to remain in the superficial 
epidermis, while P. aeruginosa invades into the lower dermis by 72 h (Shepherd et 
al. 2009). While limited evidence has shown that P. aeruginosa and S. aureus 
localise to occupy distinct spatial domains (DeLeon et al. 2014); there is a dearth of 
research evaluating each species segregation and behaviour within tissues using 
contemporary imaging techniques outside of the Shepherd et al. study. 
There has otherwise been limited use of in vitro organotypic 3-D tissue models to 
study S. aureus and P. aeruginosa infections; although a number of studies have 
evaluated various antimicrobial agents or disinfection methods (Schaller et al. 2004; 
Shepherd et al. 2011; Crabbé et al. 2017; Zheng et al. 2019). The majority of research 
continues to rely on either direct use of animal studies, or of ex vivo, biopsy-based 
animal tissue models (Wardenburg et al. 2007, Zhao et al. 2010, Anderson et al. 
2012). Some researchers have employed ex vivo human tissue models (Coolen et 
al. 2008), which arguably confer greater clinical validity to their in vivo counterparts. 
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However, standardisation is more challenging due to increased biological variability 
with the former, which may reduce experimental power to detect effects. As tissue 
engineering techniques improve further, it is likely that laboratory-generated tissue 
models will increase in popularity in microbiological (and a range of other) research. 
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3.2: Aims and Objectives 
The primary aims of this research Chapter were to: 
1. Develop and characterise an oral mucosal denture-acrylic biofilm infection model 
using standard histological techniques and PNA-FISH
2. Examine the impact biofilms containing putative respiratory pathogens on tissue 
viability and inflammatory markers
3. Evaluate the impact of host and microbial interactions on the expression of a range 
of virulence-associated genes of putative respiratory pathogens S. aureus and 
P. aeruginosa
Hypotheses 
• Denture-associated biofilm species composition will affect tissue damage, with 
two species pathogenic biofilms causing the highest levels of damage
• Microbes in tissue infections will show different invasive potential and occupy 
different niches within tissues
• Gene expression by S. aureus and P. aeruginosa in tissue infections will be 
modulated by the presence of oral commensal species
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3.3: Materials and Methods 
3.3.1: Generation of acrylic biofilms 
Single, two, three and five species biofilms were generated on acrylic coupons 
preconditioned with artificial saliva using the methods described in section 2.3.8.5. 
Only S. aureus and P. aeruginosa single species biofilms were evaluated. Two 
species biofilms consisted of a mixed inoculum of S. aureus and P. aeruginosa, while 
3 species biofilms consisted of the representative commensal species C. albicans, 
S. sanguinis and A. viscosus.  
3.3.2: Preparation of SkinEthic Reconstituted Human Oral Epithelium (RHOE) 
full-thickness tissue models 
Keratinocyte 3-dimensional oral mucosal tissue models were obtained from EpiSkin 
(Lyon, France). The keratinocytes were TR146 cells, which were originally isolated 
from a neck node in a 67-year-old female patient with a buccal squamous cell 
carcinoma. Upon receipt, tissues were aseptically removed from the manufacturer’s 
agar maintenance medium, with care taken to avoid damage to the tissues. Tissues 
were then placed in a cell-culture plate using the provided inserts each housing a 
polycarbonate membrane, with 0.4 µm pores facilitating nutrient exchange with the 
cells from the surrounding media. Immediately after adding the models to each insert, 
2 ml of the proprietary cell culture medium was added, ensuring that tissues were 
situated at the air-liquid interface. Tissues were then incubated for 12 h at 37ºC in 
5% (v/v) CO2 before infection. 
3.3.3: Infection of tissue models by acrylic biofilms 
Cell-culture plates were prepared with 2 ml of cell culture medium and incubated for 
1 h at 37ºC in 5% (v/v) CO2 to ensure equilibration of the culture medium prior to 
transfer of the tissues. Tissues were then transferred to new medium. Biofilms 
prepared as described in section 2.3.8.5 on acrylic coupons for 72 h were briefly 
rinsed in PBS to remove non-adherent cells, followed by inversion and gentle 
placement on tissue models using sterile forceps. Internal controls were prepared by 
inverting sterile acrylic coupons which had been preconditioned with artificial saliva 
onto tissues. In addition, one triplicate set of tissues were cultured under the same 
conditions without the addition of any acrylic coupons, to act as a negative control. 
Immediately upon infection, tissues were again incubated for 12 h at 37ºC in a 5% 
(v/v) CO2 atmosphere.  
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Figure 3.3.3: Flow diagram of experimental input and analyses 
Negative controls for tissue infections were: acrylic only, tissue-only control 
3.3.4: Processing of infected tissues 
After 12 h incubation of biofilm-infected tissues, tissues were removed from the 
incubator and each acrylic coupon was aseptically removed, taking care to minimise 
disturbance to the tissue surface. The cell-culture insert supporting each tissue was 
inverted and the polycarbonate membrane removed using a sterile scalpel and 
forceps. Each tissue model was then bisected along its diameter, with one half added 
to a screw cap pathogen lysis tube (FastPro Blue, MP Biomedicals, Santa Ana, CA, 
USA) containing 500 µg glass beads (500 – 750 µm in size) and 1 ml proprietary lysis 
buffer. These tubes were stored on ice prior to further processing. 
Mixed (5) species biofilm
6 experimental replicates per run, each 
experiment conducted a total of 3 times 
2 species biofilm (P. aeruginosa with 
S. aureus) 
6 experimental replicates per run, each 
experiment conducted a total of 3 times
3 species biofilm (S. sanguinis, 
A. visocosus and C. albicans) 
6 experimental replicates per run, each 
experiment conducted a total of 3 times
Single species biofilm (P. aeruginosa and 
S. aureus only) 
6 experimental replicates per run, each 
experiment conducted a total of 3 times
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One ml of spent medium from each tissue culture well was transferred by sterile 
pipetting to 1.5 ml microcentrifuge tubes cooled on ice for further use.  
3.3.4.1: Cryogenic preparation of tissues for histological processing 
The remaining half of each tissue model was coated in optimal cutting temperature 
compound (OCT) embedding medium then transferred to a cork insert in correct 
orientation for cryo-sectioning. Each tissue was then ‘snap-frozen’ by immersion in a 
beaker containing 100 ml isopentane, cooled to -160ºC in a liquid nitrogen flask for 
1 min. Upon completion of tissue fixation by ‘snap-freezing’, tissues were stored at  
-80ºC prior to further use. 
3.3.4.2: Microbial RNA extraction 
RNA extraction from infected tissue models was undertaken using the FastPro Blue 
kit (MP Biomedicals, Santa Ana, CA, USA) followed by further treatment using the 
Qiagen RNeasy clean-up kit (Qiagen, Manchester, UK) as described in Section 
2.3.8.6. Similarly, cDNA synthesis was undertaken using the methods described in 
Section 2.3.8.7. Resultant cDNA was stored at -20ºC prior to qPCR experiments. 
3.3.4.3: Lactate dehydrogenase (LDH) assay of tissue supernatant 
Spent cell culture medium from tissue models collected at the time of processing (as 
described in Section 3.3.4) was analysed using the Pierce Lactate Dehydrogenase 
Assay (Thermofisher Scientific, Loughborough, UK) in a 96-well microtitre plate, 
according to the manufacturer’s protocol for cell-mediated cytotoxicity. In addition to 
experimental controls, 100 µl of cell culture medium was added in triplicate to assay 
wells, to control for background absorbance.  
3.3.4.4: Histological processing and staining 
Samples prepared according to Section 3.3.4.1 were sectioned in 10 µm increments 
by a trained histopathologist, using a cryostat (Thermofisher Scientific, 
Loughborough, UK). Upon sectioning, samples were mounted onto glass slides and 
first examined using Haematoxylin and Eosin staining completed using the pathology 
laboratory’s automated processing equipment. Additional Gram staining was 
conducted by immersion in crystal violet for 60 s, Lugol's iodine for 60 s, acetone 
decolourisation for 5 s and counterstaining with carbol fuchsin for 30 s (washed with 
running tap water between each step). Further sections were then processed for PNA 
hybridisation and immunohistochemistry (IHC) labelling.  
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3.3.4.5: PNA-FISH, Immunohistochemistry and CLSM imaging 
Sectioned tissues were placed carefully onto charged glass slides (Superfrost Plus) 
and circumscribed with a wax pen (Dako) to contain subsequent reagents. The 
mounted tissues were immersed in 10% neutral-buffered saline for 30 min to fix 
samples, followed by washing in PBS for 10 min (x3). Excess moisture was removed 
from the slides using absorbent paper, taking care not to disturb the tissues. 
To each slide, 100 µl each of lysozyme (10 mg/ml) and protease K (0.1 mg/ml) was 
added, followed by incubation at 37ºC for 30 min. Slides were then washed with 
100 µl PBS (x2), and the excess liquid drained. 
Subsequently, mouse monoclonal pan-cytokeratin primary antibody (Santa Cruz 
Biotechnology, Wembley, UK) was diluted 10-fold with PBS, and 100 µl added to 
each slide. Slides were then incubated at room temperature whilst protected from 
light for 1 h. Slides were washed with 100 µl PBS for 5 min (x2), and the excess liquid 
drained. An Alexa-488 fluorophore-conjugated goat anti-mouse secondary antibody 
was diluted 10-fold in PBS, and again, 100 µl added to each sample. Samples were 
incubated at room temperature for a further 1 h whilst protected from light, followed 
by washing with 100 µl PBS (x2), and the excess liquid drained. 
PNA probes were used to label P. aeruginosa, S. aureus and C. albicans, in addition 
to a universal bacterial probe within tissues, following the method outlined in Section 
2.3.8.3.1. Control slides were prepared with single species smears of each microbe 
fixed and hybridised using the same methods as tissue samples. 
After PNA probe hybridisation and washing of samples in PBS, the excess liquid was 
drained from the surface of each sample. A 1 µg/ml solution of Hoechst 33258 was 
prepared in PBS, and 20 µl added to each sample to counterstain cell nuclei. Samples 
were incubated at room temperature for 10 min whilst protected from light. Samples 
were then washed with PBS for 5 min (x2), and excess moisture removed using 
absorbent paper, taking care not to disturb the mounted tissues. 
A drop of Vectashield mounting medium (H1100) was added to each sample, and 
0.17mm thick (#1.5) glass coverslips mounted to each slide. Coverslips were sealed 
using clear nail varnish and protected from light prior to imaging. 
CLSM imaging was undertaken as described in section 2.3.8.3.2, with the additional 
parameters for the pan-cytokeratin and Hoechst 33258 stains outlined in Table 
3.3.4.5. 
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Table 3.3.4.5: Excitation and Emission Spectra for Immunohistochemistry 
stains 
Target species Fluorophore Excitation Wavelength 
(nm)
Emission Frequency (nm)
Pan-
cytokeratin
Alexa 488 488 500-550 
Hoechst 
33258 
Hoechst 33258 405 410-480 
3.3.4.6: Bacterial gene expression analysis by qPCR 
Gene expression levels were analysed for S. aureus and P. aeruginosa using the 
optimised primer pairs described in Section 2.3.8.8. Initial screening of reference 
genes and evaluation of primer efficiencies for microbes within tissue models was 
performed using LinRegPCR as previously described in Section 2.3.8.8.1, with 
stability of reference genes assessed using the NormFinder plugin for Microsoft 
Excel. All qPCR reactions were undertaken using the reagents and conditions 
described in Section 2.3.8.8.2. Similarly, the Pfaffl method for changes in gene 
expression was used, with a threshold of 75-125% for primer efficiency applied. 
Reactions which failed to meet this threshold were excluded from subsequent 
analysis. 
3.3.4.7: Evaluation of tissue cytokine profiles by CBA using FACS analysis 
Spent tissue culture medium collected from tissues (see Section 3.3.4) was diluted 
1:5 in sterile PBS in a 1.5 ml microcentrifuge tube. This ‘tissue supernatant’ was then 
analysed for a panel of 6 pro-inflammatory cytokines (Table 3.3.4.7), using the 
proprietary multiplex cytometric bead array kit from BD Biosciences (Wokingham, 
UK) according to the manufacturer’s protocol for supernatant samples.  
Samples were analysed using a flow-assisted cell sorted (BD FACSCanto II, BD 
Biosciences, Wokingham, UK). The setup beads provided with the Human 
Inflammatory Cytokines Kit were used to calibrate the experimental parameters. 
Subsequently, standard curves were performed using the provided samples, to cover 
an 8-log range, with an additional negative sample. All samples were processed 
using medium speed and a total of 10000 observations per run. All samples were 
processed in a single experimental batch, to avoid the problem of variation between 
runs. 
Experimental data was analysed using the FACsuite software (BD Biosciences, 
Wokingham, UK) after manual noise-filtering and cytometric bead assignment to the 
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clusters observed. Subsequent analysis against the standard curve was undertaken 
according to the manufacturer’s instructions. 
Table 3.3.4.7: Cytokines detected in the multiplex cytometric bead array kit 
(according to assay handbook)
Cytokine measured Putative biological function 
IL-12p70 Induction of Th1 cells from naïve T cells, stimulates 
production of IFN-g and TNF-a, inhibits 
angiogenesis 
TNF Pyrexia, acute phase response stimulation, 
chemotaxis of neutrophils, stimulation of 
phagocytosis by macrophages 
IL-10 Induces B cell proliferation and production of 
antibodies; inhibits lipopolysaccharide-mediated 
induction of other pro-inflammatory cytokines 
IL-6 Acute phase response, stimulates prostaglandin E2 
production, stimulates neutrophil production 
IL-1b Pyrexia, stimulates prostaglandin and collagenase 
release, role in wound-healing through fibroblast 
growth induction 
IL-8 Neutrophil chemotaxis, stimulates phagocytosis, 
promotes angiogenesis, stimulates histamine 
release by mast cells  
3.3.5: Statistical analyses 
Fold-change in gene expression between experimental groups was normalised to 
reference genes using the Pfaffl method. Subsequently, 2-way ANOVA was 
performed on the D fold-change for each gene, using single species biofilm infections 
as the control group for both P. aeruginosa and S. aureus. Post-hoc correction for 
multiple comparisons was applied using the two-stage step up method of Benjamini, 
Krieger and Yekutieli to control the false discovery rate (FDR). The Q value selected 
was Q = 0.05. 
Statistical analysis of cytokine profiles from spent tissue model culture medium was 
undertaken using Microsoft Excel and Graphpad Prism 7.0. Analysis was undertaken 
using One-way ANOVA tests with post-hoc Dunnett test for multiple comparisons; 
the PMMA only, uninfected tissues were selected as controls.. The significance 
threshold was set at p<0.05.  
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3.4: Results 
3.4.1: Light microscopic analysis of tissue damage resulting from iofilm   
infection     
Visual inspection of photomicrographs demonstrated minimal perturbation of normal 
tissue morphology in uninfected controls (Figure 3.4.1 1A & B), although there was 
some evidence of breakdown within the epithelial strata, particularly superficially. It 
was unclear if this was related to processing artefact or represented true tissue 
damage.  Infection by 3 species commensal biofilms resulted in minimal disruption 
of epithelial integrity (Figure 3.4.1 2A), although there was some evidence of invasion 
by C. albicans hyphae (Figure 3.4.1 2B). S. aureus single species biofilm infection of 
tissues led to a greater disturbance of tissues (Figure 3.4.1 3A & B), with separation 
of the tissues from the underlying polycarbonate membrane and within cell strata. 
Infection of tissues with P. aeruginosa single species biofilms resulted in obliteration 
of normal tissue morphology, with destruction of cells and acantholytic changes within 
tissues (Figure 3.4.1 4A & B). In contrast to S. aureus, which showed limited invasion 
of tissues, P. aeruginosa was visible throughout the tissues and even spread beyond 
the most basal layer of cells.  
When tissues were infected by two species pathogenic biofilms containing both 
P. aeruginosa and S. aureus, there was again obliteration of normal tissue 
morphology (Figure 3.4.1 5A & B). However, there was a tendency for increased 
integrity of tissues compared to P. aeruginosa infections alone, with less evidence of 
cell destruction in the form of acantholytic spaces. Similarly, infection by 5 species 
mixed species biofilms containing both the representative commensal microbes and 
pathogens resulted in highly destructive changes within the tissues, but the level of 
tissue obliteration and invasion varied between lesser (Figure 3.4.1 6A) and greater 
(Figure 3.4.1 6B) than P. aeruginosa alone. 
[Overleaf] Figure 3.4.1: Histologically stained cross sections of biofilm infected epithelial 
tissue models visualised by light microscopy (x630) 
1) Negative (uninfected) control; A) Hematoxylin and eosin; B) Gram stain 
2) ‘Commensal’ biofilm infections; A) Hematoxylin and eosin; B) Gram stain
3) S. aureus biofilm infections; A) Hematoxylin and eosin; B) Gram stain
4) P. aeruginosa biofilm infections; A) Hematoxylin and eosin; B) Gram stain
5) Dual species ‘pathogenic’ biofilm infections; A) Hematoxylin and eosin; B) Gram stain 
6) Mixed species biofilm infections; A) H&E; B) Gram stain
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3.4.2: CLSM analysis of species-specific infection patterns using PNA-FISH 
To analyse the distribution of the representative pathogenic microbes during biofilm 
infection of tissue models, examination of PNA-FISH labelled microbes within 
infected tissues was undertaken using CLSM. In keeping with the observations in 
Section 3.4.1 using histological stains, uninfected tissues showed a uniform structure 
with minimal interruption of cells in a stratified organisation (Figure 3.4.2 A). 
Tissues infected with a 3 species commensal biofilm consisting of S. sanguinis, A. 
viscosus and C. albicans demonstrated minimal disruption to tissues, with 
disturbance of the most superficial epithelial cell layer only (Figure 3.4.2 B). Infection 
of tissues by P. aeruginosa single species biofilms led to loss of normal tissue 
morphology and deformation of normal epithelial cell morphology (Figure 3.4.2 C). 
Both cell outlines and nuclei appeared flattened and elongated. P. aeruginosa could 
be seen invading close to the basal layer of cells within tissues. Infection by S. aureus
single species biofilms led to limited disruption of tissues, although there was greater 
reduction in cross-sectional thickness compared to control or tissues infected by 3 
species commensal microorganisms (Figure 3.4.2 D). This was similar in 
appearance to tissues examined by light microscopy after histological staining 
(Figure 3.4.1 3A). The S. aureus PNA probe was not identified by CLSM, and there 
was limited identification of the universal bacterial probe within these samples, so it 
was not possible to make inferences about the level of tissue invasion in such biofilm 
infections. Two species pathogenic biofilm infection of tissues was not possible to 
examine, as all sections were unable to be visualised using CLSM. This may have 
been due to loss of samples from slide surfaces as a by-product of processing. 
However, the isolation of this to pathogenic biofilm infections only suggests that such 
an event occurred secondary to massive tissue destruction and loss of integrity of the 
samples. Infections of epithelial tissues by mixed biofilms (Figure 3.4.2 E) resulted in 
disturbance of tissue morphology and acantholytic body formation. However, the 
altered cell morphology observed in P. aeruginosa single species biofilm infection 
was not seen. This morphological change was observed in all P. aeruginosa infected 
tissues examined. However, the underlying mechanisms behind such effects are 
unclear. In mixed biofilm infections of tissues, P. aeruginosa was seen to be 
dispersed throughout tissues. Of note, S. sanguinis, identifiable by the typical string 
of cocci morphology, was also evident throughout the tissues, alongside singular 
coccal microorganisms presumed to be S. aureus. Whether this apparent invasivity 
is simply passive movement of microbes throughout tissues which have lost integrity 
secondary to P. aeruginosa invasion or reflects an actual change in microbial 
behaviour within mixed biofilms containing pathogens is not clear. 
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3.4.3: Lactate Dehydrogenase (LDH) release in response to different iofilm 
microorganisms 
LDH release from epithelial tissue models infected with microbial biofilms for 24 h 
was broadly consistent with the pattern of tissue damage seen in microscopic 
analysis (Figure 3.4.3.1). There was a low level of LDH release seen in tissues 
overlaid with uninfected acrylic coupons, and a similarly low level of LDH release in 
tissues infected with commensal biofilms on acrylic coupons. An increase in LDH 
release was seen in tissues overlaid with acrylic coupons supporting S. aureus single 
species biofilms, but this was highly variable, as can be seen by the wide error bars, 
and did not reach the threshold of statistical significance. In tissues infected by 
P. aeruginosa single species biofilms, there was a statistically significant increase in 
LDH production compared with uninfected acrylic coupons. This effect was also 
evident compared with 3 species commensal biofilm infections, although this was 
not statistically significant. Two species pathogenic biofilm infection of tissues 
resulted in further LDH release, which was statistically significantly greater than the 
response seen against both uninfected acrylic coupons and 3 species commensal 
biofilm infections. Infection by mixed biofilms containing both commensal 
microorganisms and pathogens resulted in an intermediate level of LDH release, 
which was similar in magnitude to S. aureus single species biofilms. 
When LDH release was analysed as fold change (relative to uninfected acrylic 
coupons), the difference in magnitudes of effect of species composition in infective 
biofilms became more apparent (Figure 3.4.3.2). There was a greater than 20-fold 
increase in LDH release in the two species pathogenic biofilm tissue infections, 
compared with an approximately 8-fold increase in both S. aureus single species 
biofilms and mixed species biofilms. The increase in tissue LDH release in response 
Figure 3.4.2: CLSM photomicrographs of tissue models labelled by IHC, infected by biofilms 
of varying composition, with constituent microbes labelled by PNA-FISH 
A) Negative (uninfected) control 
B) ‘Commensal’ biofilm infection 
C) P. aeruginosa biofilm infection 
D) S. aureus biofilm infection 
E) Five species mixed biofilm infection
Epithelial cells within tissues are labelled by pancytokeratin (green) with nuclei counterstained 
using Hoechst 33258 (blue).  
‘Commensal’ bacteria labelled with universal bacterial PNA probe (red) and C. albicans with 
Yeast Traffic Light system (green, approximately 10x larger than bacteria). S. aureus PNA probe 
failed to be detected, therefore S. aureus appears red and difficult to differentiate from 
‘commensal’ bacteria. P. aeruginosa labelled with species specific PNA probe (green).  
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to infection with P. aeruginosa single species biofilms was approximately 17-fold. In 
contrast, infection by 3 species commensal biofilms on acrylic coupons led to a less 
than 1-fold increase in tissue LDH release. 
3.4.4: Tissue cytokine responses to infection y acrylic iofilms 
3.4.5: Gene expression profiles of iofilm-associated P. aeruginosa and
S. aureus following tissue infection 
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Figure 3.4.3.1: LDH release in biofilm-infected tissue models (measured by 
spectrophotometric absorbance at 490 nm minus background absorbance at 680 nm)
Acrylic coupon, uninfected control 
Experiments performed in triplicate with 2 experimental repeats. Mean values shown. Error bars 
represent standard error of the mean. 
Adjusted P value following One-way ANOVA with Tukey post-hoc correction shown. 
Figure 3.4.3.2: Fold-change in LDH release in tissue models
Calculated from the data presented in figure 3.4.3.1, normalized to acrylic coupon, uninfected 
control. 
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There was a statistically significant upregulation in the expression of the 
Pseudomonal genes algE, which is involved in alginate secretion and aprA, which 
encodes alkaline protease (Figure 3.4.5A), while expression of RhlR, which 
represses transcription of quorum sensing genes was significantly decreased. 
However, the magnitude in fold-change for RhlR and algE was of questionable 
biological significance, both demonstrating an approximately two-fold change in 
expression levels. In contrast, aprA expression was upregulated over 200-fold in 
mixed species biofilm infections compared with single species infections. The 
majority of Pseudomonal genes analysed demonstrated a trend of increased 
expression levels in two and five species mixed biofilm infections compared to single 
species infections, in opposition to the findings seen when evaluating the same 
biofilms in Section 2.4.4.5.  
As was seen in Section 2.4.4.5, S. aureus gene expression showed no significant 
differences between single, two and five species mixed biofilm infections of epithelial 
tissue models (Figure 3.4.5B). There was a high degree of variability in expression 
between experimental repeats, which may reflect the technical challenges of 
extraction sufficient quantity and quality of RNA from S. aureus biofilms. 
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Figure 3.4.5A: Differential P. aeruginosa gene expression in single, dual and mixed 
species infections. Fold-change normalised to rpoD reference gene shown. All 
experiments were performed in duplicate wells with 2 experimental repeats. 
2-way repeated measures ANOVA was performed on the difference in fold-change 
for each gene examined, using P. aeruginosa single species infections as control 
group. 
P values shown are adjusted significance using the two-stage step up method of 
Benjamini, Krieger and Yekutieli to control the false discovery rate (FDR). Q = 0.05.
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Figure 3.4.5B: Differential S. aureus gene expression in single species, two and five 
species infections. Fold-change normalised to pyk reference gene shown. All 
experiments were performed in duplicate wells with 2 experimental repeats. 
2-way repeated measures ANOVA was performed on the difference in fold-change 
for each gene examined, using S. aureus single species infections as control group. 
P values shown are adjusted significance using the two-stage step up method of 
Benjamini, Krieger and Yekutieli to control the false discovery rate (FDR). Q = 0.05.
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Figure 3.4.5C: Differential P. aeruginosa gene expression in single, two species 
(S.aureus and P. aeruginosa) and five species biofilms. Ct values for genes shown in 
Figure 2.4.4.5A.
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3.4.6: Cytokine expression y epithelial tissue models in response to denture-
acrylic associated iofilm infections 
There was no significant difference in the expression levels of IL-12p70, TNF, IL-10 
or IL-8 between experimental groups (Figure 3.4.6). Surprisingly, IL-6 levels were 
decreased in P. aeruginosa, two or five species biofilm infections. This may be due 
to rapid obliteration of the epithelial tissues as seen in Figure 3.4.1, rather than a 
reflection of cell behaviour in response to such pathogens. The expression of IL-1 
was significantly increased only in two species biofilm infections compared to control, 
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Figure 2.4.4.5C: Differential P. aeruginosa gene expression in single, two species 
(S.aureus and P. aeruginosa) and five species biofilms. Ct values for genes shown in 
Figure 2.4.4.5A.
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but the magnitude of this difference was small (less than 2-fold) and highly variable. 
The biological relevance of this change is therefore questionable. 
Figure 3.4.6: Cytokine expression levels of tissues in response to denture-acrylic associated biofilm 
infections  
Mean values shown. Error bars indicate standard error of the mean. Each experiment was performed 
in triplicate with 2 experimental repeats.  
One-way ANOVA was performed with Dunnett test to compare each biofilm infection with PMMA only 
(control) group. Note – logarithmic scale 
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3.5: Discussion 
In this chapter, the model denture-acrylic associated biofilms developed in the 
previous chapter were used to explore the impact of putative respiratory pathogens 
on oral mucosal tissue damage and inflammation. Furthermore, the impact of 
interactions within microbial communities and with host tissues on the expression of 
key microbial biofilm and virulence-associated genes was explored. This involved the 
development of a novel RNA extraction process which enabled effective recovery of 
RNA from microbial biofilms. 
Examination of haematoxylin and eosin stained infected tissue sections by light 
microscopy demonstrated a low level of tissue damage sustained following 24 h 
contact with PMMA resin in the absence of microbial biofilms (Figure 3.4.1). This 
problem is well documented in the literature (Bhola et al. 2010; Gautam et al. 2012) 
and is likely due to leaching of monomeric materials which failed to polymerise during 
the curing process. Tissue disruption and chronic, low-grade inflammation of the oral 
epithelium has been proposed as a potential mechanism by which colonisation of the 
oral cavity by atypical, potentially pathogenic species may occur (Scannapieco et al. 
2001). Therefore, the observation that denture-acrylic resins induce such changes is 
important. The 3 species commensal biofilm infections demonstrated minimal tissue 
disruption overall, although as seen in Figure 3.4.1.2B, increased perturbation of 
tissues occurred in association with candidal hyphae. This observation was 
corroborated by the close similarity in LDH levels induced by both acrylic resin and 3 
species commensal biofilm infections.  The LDH enzyme is a cytoplasmic protein 
present in all cells. Release of LDH into the extra-cellular environment occurs 
following membrane permeabilization, which is a key event in apoptosis and necrosis 
(Kumar et al. 2018). Thus, the level of LDH in tissue supernatants is a reasonable 
surrogate marker for the level of cell damage.  
Biofilm infections with P. aeruginosa alone appeared to result in extensive tissue 
damage, as might be expected from such a virulent microorganism, but the addition 
of S. aureus did not appear to impact the level of local damage seen, which was in 
keeping with the relatively low levels of tissue damage noted in S. aureus single 
species biofilm infections (Figure 3.4.1.3A/B). Interestingly, although microscopic 
analysis shows considerable tissue damage in response to five species mixed biofilm 
infections, the level of LDH release was reduced at least twofold in five species mixed 
biofilm infections compared with P. aeruginosa single or two species infections. This 
may be simply due to the reduced numbers of P. aeruginosa present in such biofilms 
but may also reflect a reduction in binding sites available due to occupation by 
commensal species, offering a degree of protection from P. aeruginosa.
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Analysis of tissue infections by PNA-FISH and IHC confirmed the presence of 
extensive tissue damage following P. aeruginosa infection (Figure 3.4.2C) with 
microbial invasion seen throughout the full thickness of the tissue section. Again,  
minimal tissue disturbance in response to 3 species commensal biofilm infections 
and infection with S. aureus biofilms was noted. It was not possible to find intact 
tissues for imaging on sections of two species biofilm infections. This may be due to 
obliteration of tissues but may be artefactual loss of tissues from the slides as a result 
of the extensive and aggressive preparation methods required to enable PNA probe 
hybridisation. Mixed species tissue infections showed similar levels of microbial 
invasion to P. aeruginosa infected tissues, but the total bioburden visible was 
increased. Importantly, tissue invasion in such samples was not limited to the 
representative pathogens. Streptococcus sanguinis was clearly recognisable by its 
characteristic string of pearls morphology deep within the tissue section (Figure 
3.4.2E). Another finding of interest in both light and confocal photomicrographs is the 
absence of candidal hyphae in mixed species infections, potentially due to the 
inhibitory interactions between P. aeruginosa and C. albicans discussed in section 
2.1.3. 
Microscopic analysis of tissue infections is a convenient and effective technique to 
assess both the response of tissues to infection, and the biogeographical distribution 
of infective microbes. The highly invasive nature of P. aeruginosa in such infections 
is illustrated here. However, a number of limitations must be considered when 
evaluating such images. Firstly, while care has been taken to ensure representative 
samples have been included, the distribution and species composition of biofilms at 
the tissue surface is heterogeneous. Consequently, the effects of multispecies biofilm 
infections are challenging to capture effectively. Additionally, the sectioning and 
subsequent processing of tissues can introduce artefacts. It is possible that some of 
the observed tissue damage and invasion is actually introduced during sectioning. 
Processing artefact is a particular concern for PNA-FISH and IHC treated samples, 
as many of the reagents and conditions used are harsh, and a degree of disruption 
is required to permit effective hybridisation of the PNA probes. This is mitigated by 
the presence of control samples for comparison, and the use of LDH and cytokine 
analysis to corroborate tissue damage with molecular markers of cell death and 
inflammation.  
Tissue cytokine responses (summarised in Figure 3.4.6) to microbial infections  are 
surprising; particularly the reduced expression of IL-6 in response to biofilms 
containing P. aeruginosa. Previous research has demonstrated a marked increase in 
IL-6 expression  in airway epithelial cell-lines (Kube et al. 2001) and corneal epithelial 
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cell-lines (Zhang et al. 2005) in the presence of P. aeruginosa. It is possible that in 
the present work, rapid obliteration and killing of epithelial tissues occurred in 
response to infection with P. aeruginosa biofilms. In addition, the pseudomonal aprA 
gene encodes the enzyme alkaline protease. This enzyme can degrade a number of 
immune proteins and cytokines (Bardoel et al. 2012), and so may be directly 
responsible for the apparent reduction in IL-6 noted.  This eventuality seems likely 
when taken in the context of the tissue obliteration observed in photomicrographs 
and the high levels of LDH. The regulation of cytokine expression is a complex 
process with many interdependent interactions between different cell and tissue 
types. The tissue models used lacked immune cells, which have critical and divergent 
roles in orchestrating the cytokine response to infection in a context-dependent 
manner. For instance, neutrophils, recruited at an early stage of infection can induce 
further release of pro-inflammatory cytokines by release of alpha defensins (Van 
Wetering et al. 2002). Conversely, in longer-term infections T-regulatory cells can 
contribute to mucosal tolerance by altering the behaviour of surround immune and 
epithelial cells (Sharma and Rudra 2018). Consequently, interpretation of cytokine 
expression in a reductionist, keratinocyte-only tissue model is limited.  
Microbial gene expression levels, displayed in Section 3.4.5, is likely influenced both 
by intra and interspecies community interactions, and interactions with host cells. The 
challenges inherent to RNA extraction from microbial biofilms, particularly S. aureus, 
have been discussed in Section 2.5. This may explain the high degree of variability 
in gene expression seen in Figure 3.4.5B, although this may also relate to variation 
inherent to the heterogeneous environment in biofilms, with microorganisms close to 
the surface contacting the epithelial tissues and experiencing a drastically different 
environment to those microbes in deeper biofilm layers distant to the tissues. While 
changes in the levels of rhlR and algE were of questionable relevance given the small 
magnitude of difference in expression level, aprA, which encodes the enzyme 
alkaline protease was upregulated over 200-fold in mixed species biofilms.  This 
enzyme has well documented roles in immune evasion (Laarman et al. 2012; Pel et 
al. 2014). However, a role for this protein in inter-species interactions has not been 
documented to date. It could be that alkaline protease plays a role in competition 
during infection by degrading microbial proteins and allowing P. aeruginosa to 
dominate tissue invasion, or the aprA gene may have other functions in quorum 
sensing pathways or the regulation of other virulence factors. 
In contrast to S. aureus, P. aeruginosa is a highly motile microorganism, and so it 
might be expected that location within the biofilm is of limited consequence. Certainly, 
the impact of interaction with tissues appears to outweigh that of intermicrobial 
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interactions, as the trends in gene expression noted in Figure 2.4.4.5A are largely 
reversed in tissue infections (Figure 3.4.5A). This finding is in keeping with the 
observation that invasion of tissues appears to be instigated by P. aeruginosa almost 
exclusively among the microbes tested. Other species are only seen in deeper tissue 
layers when present in biofilms containing P. aeruginosa. This may reflect microbial 
hitchiking, described in infections with S. aureus and C. albicans (Schlect et al. 
2015), although as seen in Figure 3.4.2E, this is more likely an opportunistic process 
secondary to increased tissue permeability following damage induced by 
P. aeruginosa, as close associated of microbes is not clearly seen.  
Limitations of the methods 
This work uses both reductionist biofilm models and tissue models, which limits the 
ecological validity of the findings. The influence of changes in microbial community 
composition, or even among different strains of each species cannot be accounted 
for. Similarly, keratinocytes are closely associated with an underlying dermis rich in 
fibroblasts, while epithelial tissue is also intimately connected to dendritic cells and 
circulating polymorphonucleocytes. Cytokines released from epithelial tissues 
typically initiate a zymogen cascade, whereby leukocytes attracted by chemotaxis 
release further cytokines and chemoattractants, which have reciprocal effects on 
epithelial tissue behaviour and signalling. Replication of such intricate signal 
networks would necessitate the use of animal models, although such approaches are 
not without limitations. Similarly, humoral immune components including complement 
and antibodies are absent. Both the lack of effective clearance of microbes and lack 
of regulatory components, particularly from T-regulatory cells which are critically 
important in modulating inflammatory signals at mucosal sites, may explain the 
elevation in cytokine levels seen across all experimental conditions. Further work 
should seek to employ a more physiologically relevant model or consider the use of 
animal models to ensure such factors are accounted for. 
The lactate dehydrogenase assay undertaken did not include a positive control. It is 
possible that reduced LDH levels seen in some conditions are actually due to 
proteolytic degradation of the enzyme by microbes rather than true reductions in 
levels. Incorporation of a positive control with a known concentration of LDH enzyme 
with each experimental inoculum along the tissue models could have alleviated this 
issue. However, the trends in assay result are in keeping with what might be 
expected, with the two representative pathogens causing greater release of LDH, 
alongside increased tissue destruction seen microscopically. 
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Despite the above caveats, this work has demonstrated the utility of the simple 
denture-acrylic biofilm model incorporating respiratory pathogens developed in 
Chapter 2 in exploring the impact of such microorganisms on the oral epithelial 
environment. In particular, the role of P. aeruginosa in driving inflammation and 
invasion within the oral epithelium has been highlighted. An avenue that certainly 
warrants further exploration is the role of aprA in mixed species infections, as this 
may reveal as-yet undiscovered functions for this gene which govern microbial 
behaviour and inter-species interactions. Further work could seek to confirm thi 
finding across a range of strains, particularly clinically relevant strains associated with 
pneumonia. Subsequently, development of a more biologically relevant tissue model 
incorporating fibroblasts and immune cells may provide a more realistic insight into 
host-microbial interactions. Alternatively, animal models could be employed. 
Additionally, an ‘ex vivo’ approach to modelling biofilm infections could be applied, 
using a PMMA insert worn on the denture-fit surface or as a separate appliance to 
develop a clinically relevant biofilm to subsequently seed infections in tissue models. 
This approach has been applied to the study of Candida biofilms in rodents (Nett et 
al. 2010). Once a robust assay has been developed, use of RNA-sequencing 
approaches to perform unrestricted explorations of gene expression in host-microbial 
interactions might identify novel proteins of interest. Subsequent confirmation and 
characterisation of such proteins might yield new diagnostic markers or therapeutic 
targets. Such models could also be used to identify tissue biomarkers that are 
indicative of infection by respiratory pathogens, through evaluation of a wider range 
of cytokines at different time points. Early identification of respiratory pathogens in at-
risk individuals could allow for effective interventions to reduce pneumonia risk. 
166
CHAPTER 4: ANALYSIS OF THE DENTURE MICROBIOME - ASSOCIATION 
WITH HOST CYTOKINE PROFILES AND PNEUMONIA STATUS - A PILOT 
STUDY 
4.1: Introduction 
The human microbiome can be defined as the collective genomes of the microbes 
(composed of bacteria, bacteriophage, fungi, protozoa and viruses) that live inside 
and on the human body (Yang J 2012). As a host-microbial ecosystem, the oral 
cavity comprises some of the most diverse and rich microbial communities 
(Huttenhower et al. 2012). This is largely due to its continuity with both the 
gastrointestinal tract and the external environment, and the range of different niches 
formed by its complex assemblage of tissues. 
There is a substantial body of evidence implicating the oral microbiome as a reservoir 
for putative respiratory pathogen (PRP) colonisation in susceptible populations 
(Fourrier et al. 1998, Russell et al. 1999, Didilescu et al. 2005). The link between 
pneumonia and oral PRP carriage is clearest in ventilator-associated pneumonia 
(VAP). A recent Cochrane systematic review found evidence to support the 
effectiveness of oral care in reducing VAP incidence in mechanically ventilated 
intensive care patients (Hua et al. 2016). However, the effect size was modest, with 
high risk of bias in most included studies, and heterogeneity in oral care interventions 
provided. As is frequently found in research examining interventions for VAP, the 
reduced incidence of pneumonia did not translate into a significant reduction in 
mortality. This is likely a reflection of the overall small effect size of such treatments 
in the context of a multifaceted care regime, coupled with high mortality levels 
amongst the included intensive care patients.  
Research at the School of Dentistry, Cardiff has previously demonstrated that PRP 
colonisation of dental plaque occurs prior to colonisation of endotracheal tubes, a 
preliminary step in demonstrating a definitive causal link between perturbation of the 
oral microbiome and respiratory infection in mechanically ventilated patients (Sands 
et al. 2017). However, it is unclear if changes in oral microbial communities are driven 
solely by altered systemic health and prolonged contact with healthcare institutions, 
or also influenced by the presence of the artificial biomaterial surface of the 
endotracheal tube. In the case of the latter, endotracheal tubes and dentures may 
both act as a nidus for PRP colonisation. 
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4.1.1: The denture-associated microiome and pneumonia - summary of the 
evidence 
Building on evidence linking the oral microbiome and pneumonia, recent research 
has found that denture biomaterial surfaces are frequently colonised by PRPs. The 
first study to consider a potential link between dentures, risk of oropharyngeal 
colonisation, and subsequent pneumonia, was a cross-sectional study evaluating 
oropharyngeal colonisation by PRPs (in this case focussing on Gram negative bacilli) 
in elderly subjects, stratified by increasing reliance on care institutions (Valente et al. 
1978). In this study, a number of potential risk factors for Gram negative bacilli 
colonisation of oropharyngeal tissues were evaluated, including poor oral hygiene 
and the presence of dentures. Neither the presence of dentures nor poor oral hygiene 
were found to be significantly associated with PRP colonisation. 
Subsequently, there was a dearth of research into the presence of PRPs associated 
with dentures until the work of Russell et al. in 1999, some 21 years later. The authors 
used selective culture to identify 8 known PRPs: Staphylococcus aureus, 
Pseudomonas aeruginosa, Haemophilus influenzae, Klebsiella pneumoniae, Serratia 
marcescens, Proteus mirabilis and Escherichia coli from dental plaque, denture 
biofilms and buccal mucosal swabs in elderly patients in a chronic care facility, 
compared with a dental outpatient control group. Chronic care patients had poorer 
oral and denture hygiene, and a higher number of comorbidities compared to 
outpatient control subjects. Importantly, PRPs were detected in 25% of chronic care 
patients. In 14.3% of participants, PRPs comprised more than 12% of the total 
recovered aerobic colonies. Notably, P. aeruginosa and S. aureus were the most 
frequent isolates recovered and constituted the greatest proportion of PRPs within 
each positive sample. While frequency of PRP colonisation was equivalent between 
both chronic care and dental outpatients, all dental outpatients demonstrated low 
levels of colonisation (defined as <1% PRP colonies within each sample).  
In the following decade, a number of reports emerged detailing the presence of PRPs 
in the denture-associated microbiome of frail, elderly individuals in institutionalised 
care settings (Sumi et al. 2002, Senpuku et al. 2003, El Solh et al. 2004, Daniluk et 
al. 2006, Sumi et al. 2007). Furthermore, it was found that there was a high correlation 
between the community composition of denture biofilms and bacteria colonising the 
oropharynx, including a number of PRPs (Sumi et al. 2003). However, with the 
exception of S. aureus, microbes were identified at genus, rather than species level. 
Consequently, only guarded inferences can be made about the recovered isolates 
representing PRPs and by extension, pneumonia risk. 
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It was not until 2016 that the first report emerged using molecular techniques to 
identify and quantify PRPs in denture biofilms (O'Donnell et al. 2016). Here, the 
authors used targeted qPCR to identify a panel of 9 PRPs on the denture surfaces of 
patients attending Glasgow Dental Hospital. Of the 130 total participants, PRPs were 
identified on the dentures of 84 (64.6%) individuals. The high levels of PRPs identified 
in this study compared to others, likely reflected the use of a sonicating water bath, 
leading to more effective removal of microbes (compared to swabs used in previous 
studies). The results also underpin the increased sensitivity of molecular 
microbiological techniques over conventional culture. Of note, the authors found high 
levels of S. aureus (most prevalent; 51.2% of all samples) and P. aeruginosa (third-
most prevalent; 11.5% of all samples), with lower levels of S. pneumoniae (6.9% of 
all samples). Such pathogenic species are conventionally more typically associated 
with hospitalised patients or those in long-term institutionalised care, rather than 
individuals in a community setting.  
The increased sensitivity and accuracy in microbial identification achieved using 
contemporary molecular approaches is evident in the higher PRP recovery rates and 
species-level identification demonstrated in the above study. The use of culture-
independent methods represents an important step forward in understanding the 
association between the denture-associated microbiome and pneumonia. Such 
techniques provide an advantage in identifying PRPs, many of which are challenging 
to isolate and grow using conventional methods (Nolte 2008, Gadsby et al. 2016). 
However, any targeted approach offers only limited insight into the composition of the 
entire microbial community. Consequently, atypical or rare PRPs may be missed in 
such studies. Furthermore, our understanding of infectious diseases has progressed 
beyond traditional concepts of pathogenicity into a post-Koch era (Stacy et al. 2016), 
wherein functional changes across a community, rather than the presence or 
absence of an individual pathogenic species, are increasingly recognised as key in 
driving many diseases. This conceptual change has been widely accepted in gut 
microbiome research. Indeed, gut microbiome studies using contemporary omics 
methodologies to profile microbial communities; their collective metabolic and 
functional activities, were pivotal in expanding our understanding of the importance 
of the complex microbial populations that reside in the gastrointestinal tract, both for 
normal function and development, and in contributing to a diverse range of local and 
systemic diseases (Kinross et al. 2011). As the oral cavity is continuous with the gut, 
and therefore part of the gastrointestinal tract, it is surprising that there is a 
comparative deficit in similar research aiming to explore interactions between host 
tissues and the oral microbiome.  
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4.1.2: Community profiling of the microiota y metataxonomic sequencing 
The above studies have demonstrated the presence of PRPs in the oral cavity and 
on denture surfaces in a variety of populations. However, reliance on a targeted 
approach to identify frequently isolated respiratory pathogens is highly reductionist 
and does not account for the complexity of the oral microbiome. These studies do not 
address population shifts that may result in respiratory pathogen colonisation, nor 
allow for novel putative pathogens to be identified. In addition, the role of opportunistic 
pathobionts may be overlooked (Mazmanian et al. 2008). It is known that most 
microbially-mediated diseases are characterised by a change in microbial biodiversity 
(reduction; in all gastrointestinal diseases investigated to date), with overgrowth of 
one or several species (Petersen and Round 2014). However, in periodontal disease 
one of the most ubiquitously implicated pathogens, Porphyromonas gingivalis, rarely 
exceeds 5% of the total microbial bioburden. Reports have shown that at relatively 
low levels P. gingivalis is able to modulate the host immune response, while 
simultaneously orchestrating more virulent, invasive behaviour from the surrounding 
microbiota, to induce the connective tissue damage characteristic of the disease 
(Hashishengalis et al. 2011). Clearly there are already well-established cases in 
which a more nuanced view of interactions within microbial communities is needed 
to understand aetiopathogenesis of such diseases. 
The advent of Next Generation Sequencing (NGS) - and related fields of genomics, 
transcriptomics, and metabolomics - has revolutionised our insight into the 
importance of host-microbial ecosystems in health and disease (van Baarlen et al. 
2013). Rapidly decreasing costs and error rates, with concomitant improvements in 
sequencing accuracy, genome coverage, and read depth are leading to an explosion 
in studies relying upon such methodologies (Voelkerding et al. 2009, Park and Kim 
2016). Sequencing technologies rely on the polymerase chain reaction (PCR) to 
amplify either random genome fragments (e.g. whole genome shotgun sequencing) 
or targeted genes (e.g. 16S metataxonomic sequencing). The exponential 
amplification generated during PCR means that a relatively small starting quantity of 
bacterial DNA is required, improving sensitivity and throughput capability. 
While a number of competing technologies exist, the majority of researchers rely 
primarily on Illumina sequencing platforms for 16S metataxonomic profiling studies. 
This is largely due to Illumina platforms offering a good compromise between cost 
per run, run time, read depth, coverage and error-rates (Liu et al. 2012, Van Dijk et 
al. 2014).  Illumina sequencing relies on sequencing by synthesis (Figure 4.1.2). 
Briefly; after ligation to adapter sequences, target single-stranded genomic DNA is 
amplified using a proprietary bridge-amplification method to generate clusters of 
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identical, clonal sequences. Subsequently, sequencing proceeds in a manner 
analogous to Sanger sequencing, by addition of a specific, fluorescently labelled, 
reversible chain-terminating nucleotide. This nucleotide blocks the binding site for 
DNA polymerase, meaning no further reaction can proceed. A fluorescent camera 
detects those sequence clusters which are positively fluorescent, before the 
terminators are enzymatically cleaved, and another nucleotide can be added. Using 
this iterative approach, a reverse-strand sequence is obtained for the entire length of 
the target DNA. The strict complementarity of bases means that the original gDNA 
sequence can be inferred by substituting the complementary base with the 
sequenced base (i.e. adenine in the reverse-strand indicates thymine in the original, 
complementary gDNA strand). These reactions occur in a parallel manner, with 
millions of reactions occurring simultaneously, allowing unprecedented high-
throughput analysis; reducing both time and monetary costs, and allowing much 
improved coverage and read depth than has previously been achievable (Bentley et 
al. 2008).  
Metataxonomic sequencing differs from metagenomic sequencing in that the former 
relies solely upon the bacterial 16S ribosomal RNA gene (or internal transcribed 
spacer (ITS) gene in fungi), rather than the entire genome (Marchesi and Ravel 
2015). This gene is highly conserved across bacteria and archaea, with the exception 
of 9 "hypervariable" regions, each spanning 1-200 base pairs, which show 
remarkable heterogeneity between species. Consequently, the 16S rRNA gene is an 
ideal candidate to allow genus and often species-level discrimination of bacteria 
(Yang et al. 2016). Universal primers can be designed to span one or more 
hypervariable regions, annealing with the conserved sections of the gene. 
The latest advances in Illumina technology has permitted paired-end reads of up to 
300 base pairs (bp) to be obtained with relatively low error rates. This means that 
greater portions of the 16S gene can be sequenced, offering improved species-level 
discrimination. However, many closely related species still present a challenge. An 
important example is the respiratory pathogen Streptococcus pneumoniae, which is 
a frequent isolate in sputum samples from patients with community-acquired 
pneumonia (CAP) (Welte et al. 2012). Streptococcus pneumoniae is a member of the 
Mitis group of streptococci and features a genome almost completely identical to 
other members, such as Streptococcus mitis and Streptococcus pseudopneumoniae.
Both species are considered normal oral commensals but cannot be distinguished 
from their pathogenic counterpart by 16S sequencing alone, due to their very recent 
phylogenetic divergence (Sholz et al. 2012). In lieu of a metataxonomic sequencing 
approach, the autolysin gene (lytA) has been demonstrated to provide high specificity 
171
and sensitivity in delineating S. pneumoniae from its commensal counterparts, and is 
routinely targeted in a multiplex, TaqMan qPCR assay in diagnostic laboratories 
around the UK (Gadsby et al. 2015). 
Despite such limitations, metataxonomic sequencing represents the best available 
method for profiling diverse microbial communities where limited DNA quantity can 
be obtained. As costs decrease further, and sequencing technology continues to 
improve, whole-genome sequencing (WGS) will allow further exploration, with higher 
resolution of species and even individual strains, alongside important insights into 
genome function, which may help predict antimicrobial resistant isolates or identify 
potential novel therapeutic targets.  
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Figure 4.1.2: Illumina next generation sequencing workflow:
A - Bacterial genomic DNA is enzymatically cleaved into small (£300 BP) fragments.  
B - These fragments are ligated to adapter sequences which attach to a flowcell device coated 
with complementary oligonucleotides.  
C - PCR "bridge" amplification generates clusters of identical gDNA amplicons.  
D - Sequencing proceeds by the addition of a single fluorescently-labelled, reversible terminator 
nucleotide. A fluorescent camera detects any clusters positive for this nucleotide. The terminator 
is then washed away, and the next fluorescent nucleotide added. The process continues iteratively 
until the entire length of the strand has been sequenced. 
Image from: https://bitesizebio.com/13546/sequencing-by-synthesis-explaining-the-illumina-
sequencing-technology/ 
A 
D 
C 
B 
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4.2: Aims 
The principle aims of this work package were to: 
1. Compare the denture-associated oral microbiota in respiratorily healthy care home 
residents with hospitalised pneumonia patients. 
2. Compare the incidence of two target PRPs - Staphylococcus aureus and 
Pseudomonas aeruginosa - recovered by conventional microbiological culture 
between cohorts. 
3. Evaluate the potential of pro-inflammatory salivary cytokines as biomarkers for 
oral PRP colonisation and pneumonia status. 
Hypotheses 
• There will be an increased abundance of PRPs in pneumonia patients compared 
with care home residents (detected by both culture dependent and independent 
methods)
• There will be a reduction in microbial diversity in pneumonia patients compared 
with care home residents
• Proinflammatory salivary cytokines will be raised in patients with a high oral PRP 
load
• Proinflammatory salivary cytokines will be raised in pneumonia patients 
compared with care home residents
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4.3: Materials and Methods 
4.3.1: Ethical approval 
The approved study documents are presented in in Appendix I. This study was 
sponsored by Cardiff University. Following internal peer-review by the PhD 
supervisory team, ethical approval was obtained from Wales REC 6; reference 
number 16/WA/0317. Local R&D approval was obtained from the Cardiff and Vale 
University Health Board for recruitment of patients from the University Hospital Wales 
(UHW) and University Hospital Llandough (UHL) sites. As all included care homes 
were private institutions, no local approval was required. However, each home was 
provided with a letter of access to sign, which was countersigned by a university 
representative from the contracts department and the PhD student. This letter 
evidenced permission to enter the premises for the purposes of the study during pre-
established dates and provided a formal record to each care home. 
4.3.2: Participant recruitment 
For this pilot study, the initial intention was to recruit 100 participants, comprising 50 
care home residents and 50 hospitalised pneumonia patients. However, due to 
challenges in recruiting from respiratory wards, this was amended to 35 patients per 
cohort (70 in total). In addition to microbial samples, demographic information, 
relevant medical history and smoking status were recorded for each participant. A 
brief dental history and examination was undertaken. Information pertaining to oral 
health, such as denture cleaning habits, denture hygiene, Newton's classification of 
palatal inflammation (Newton 1962) and a Decayed, Missing and Filled Teeth score 
(Klein et al. 1938) was also included as part of the assessment for each participant. 
Both participants and caregivers were asked about oral and denture care, including 
who was normally responsible for this.  All information was recorded on a pre-
formulated data collection sheet. 
4.3.2.1: Selection of recruitment sites 
Suitable hospital wards at both University Hospital Wales (UHW) and University 
Hospital Llandough (UHL) were identified through discussion with consultants and 
R&D leads for each location. Care homes were selected from a list used in a prior 
study conducted by colleagues in the School of Dentistry, as these sites had shown 
interest in research participation previously. In total, 6 hospital wards were included 
for recruitment: a general medical ward with a focus on respiratory medicine, 2 
geriatric general medical wards, a medical-decisions ward (in UHW); a respiratory 
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ward and medical decisions ward (in UHL). Of the 24 care homes approached for 
inclusion in the study, 7 agreed to participate.  
4.3.2.2: Inclusion and exclusion criteria 
Care home residents were deemed eligible for inclusion in this study if they were over 
18 years of age, had capacity to consent (assessed on a case-by-case basis), and 
wore a removable denture (complete or partial) of any material. 
Pneumonia patients could be included if they met the above inclusion criteria and had 
a confirmed diagnosis of pneumonia, with evidence of focal consolidation on chest x-
ray. If radiographic signs were inconclusive, the opinion of the treating consultant was 
sought to confirm the diagnosis.  
Individuals who lacked capacity to consent, refused to participate in the study for any 
reason, were receiving palliative end-of-life care or had taken part in another study in 
the preceding 6 months were excluded. Also excluded were individuals who were 
severely immunosuppressed (e.g. chemotherapy recipients) or 
immunocompromised; and patients with oro-pharyngeal or lung malignancy. Care 
home patients who had been diagnosed with any form of respiratory infection in the 
preceding 30 days were excluded due to potential effects on the oral microbiota and 
salivary cytokine profiles.  
4.3.3: Sample collection and immediate processing 
A total of 7 samples were collected from each patient (Figure 4.3.3). Foam squares 
measuring 2x2 cm were dampened in phosphate buffered saline (PBS) solution 
(0.9% w/v) and pressed against the denture-fit surface, dorsal tongue and denture-
bearing palate, for 30 s each. The foam was then transferred to blood agar, imprinting 
the recovered microorganisms onto the agar surface. It was left in contact with the 
agar surface for at least 1 min, before sequential transfer to CHROMagarÔ Candida 
(CHROMagar, Paris, France), Mannitol Salt agar and Pseudomonas agar, to culture 
Candida species, staphylococci and Pseudomonades, respectively. Sterile swabs 
were similarly steeped in PBS prior to sampling from the same sites, before 
placement in Amies transport medium to preserve cell-viability and thus DNA integrity 
during transit. Finally, a sterile cotton salivette was placed in the buccal sulcus of 
each participant for at least 1 min, to collect unstimulated saliva, before recovery into 
a sterile container. Salivettes were centrifuged twice for 5 min at 3000 ´ g to recover 
decellularised saliva, which was transferred to microcentrifuge tubes and stored at         
-20°C until further use. 
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Wherever possible, all samples were obtained at least 1 h after participants had 
eaten, this was to ensure minimal contamination by foodstuffs, and to assess normal 
salivary flow. However, in some cases it was not clear when participants had last 
eaten, or for pragmatic reasons, less than 1 h had elapsed prior to sample collection. 
Figure 4.3.3: Sampling methods for this study. 
a) Foam squares pressed against the dorsal tongue for 30 s then immediately 
imprinted on to agar plates (CHROMagar Candida shown here). 
) Sterile cotton swabs passed gently over the dorsal tongue using a rolling motion 
in a standardised manner, before placement into Amies transport medium and 
subsequent extraction of bacterial genomic DNA for metataxonomic sequencing.
c) A cotton salivette, placed aseptically into the buccal sulcus for 1 min to collect 
unstimulated saliva for cytokine assessment by flow cytometry.
4.3.4: Screening of imprint cultures y conventional microiological 
techniques 
Following imprinting of foam squares on to agar surfaces to inoculate any recovered 
microorganisms, agar plates were cultured for 48 h aerobically, at 37ÊC to allow 
colony growth. Secondary isolation of morphologically distinct colonies for each site 
on selective agars was undertaken, using the plate streak method with a flame-
sterilised metal inoculation loop. Isolates presumptively identified as S. aureus and 
P. aeruginosa were further tested by biochemical methods. A representative sweep 
of blood agar colonies was collected and frozen on polypropylene beads in a 
glycerine-based cryopreservative (MicrobankÔ Bacterial and Fungal Preservation 
System, Pro-Lab Diagnostics, Birkenhead, UK). 
a) ) c)
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4.3.4.1: Identification of presumptive Candida species using CHROMagar 
Candida 
CHROMagarÔ Candida contains a proprietary chromogenic mix which enables 
differentiation of C. albicans (green), C. tropicalis (metallic blue) and C. krusei (pink).
This medium can also indicate the presence of C. glabrata (mauve-brown), but 
several other species may appear similar in colour, reducing specificity. Colonies 
which differed in colour, or in the case of cream or mauve-brown, any obvious 
morphologically distinct colonies, were isolated and subsequently cultured on 
Sabouraud Dextrose Agar (SDA) aerobically for a further 48 h at 37ºC. 
Representative colonies were emulsified in sterile distilled water on a glass slide 
surface, then heat fixed. Subsequently, fixed slides were Gram-stained by immersion 
in crystal violet for 60 s, Lugol's iodine for 60 s, acetone decolourisation for 5 s and 
counterstaining with carbol fuchsin for 30 s (washed with running tap water between 
each step). Glass 0.17mm thick (#1.5) coverslips were mounted onto the stained 
slides, which were examined by light microscopy, using a x100 oil-immersion lens. A 
control slide was prepared using a C. albicans reference strain (ATCC 90028) with 
each batch of staining. Any colonies identified as Candida-positive by CHROMagar 
and exhibiting yeast cell or hyphal morphology under microscopic examination were 
subcultured for 48 h, then stored on frozen microbank beads for future use. 
4.3.4.2: Identification of presumptive Staphylococcus species  
Colonies on MSA plates after 48 h aerobic growth were assessed based on 
morphological characteristics and mannitol metabolism. MSA contains the indicator 
phenol-red, which changes to a yellow colour in the presence of the acidic by-
products produced following the breakdown of mannitol by S. aureus. Each distinct 
colony was inoculated on tryptone-soy agar (TSA), and cultured aerobically for a 
further 48 h at 37ÊC. After culture, colonies were heat-fixed on to the surface of a 
glass slide and Gram-stained using the method described in 4.3.4.1. A control slide 
was prepared with each batch, using S. aureus CTC 6571. Isolates identified as 
Gram-positive cocci were selected for further biochemical testing. 
Presumptive S. aureus were identified using catalase and coagulase tests. Colonies 
were sampled using a sterile, plastic inoculation loop and steeped in 20% (w/v) 
hydrogen peroxide solution. Production of gas bubbles, indicating enzymatic 
breakdown of hydrogen peroxide into water and oxygen, was interpreted as a positive 
test result. Such catalase-positive isolates were tested for coagulase activity using a 
Staphaurex kit (Staphaurex Plus Latex Agglutination Test, Fisher Scientific UK Ltd, 
Loughborough, UK), according to the manufacturer's instructions. The test solution, 
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containing fibrinogen-coated latex beads, was dropped on to the test card surface, 
alongside a control solution containing a latex bead suspension, without fibrinogen. 
A plastic inoculation loop was used to transfer test colonies onto the card, and the 
bacterial colonies were mixed thoroughly to emulsify them in the latex solution for 
30 s. Latex agglutination, visible as clumping of the test solution, confirmed the 
presence of S. aureus isolates. Isolates which tested catalase-positive, but 
coagulase-negative, were identified as coagulase-negative staphylococci (CoNS). All 
staphylococcal isolates were frozen on cryo-beads, as described in section 4.3.4. 
4.3.4.3: Presumptive identification of Pseudomonas species 
Colonies present on Pseudomonas agar after 48 h aerobic growth were identified 
based on morphological distinction and Gram-stained as described in 4.3.4.1. A 
control slide was prepared with each batch, using P. aeruginosa ATCC 12923. 
Isolates identified as Gram-negative bacilli were selected for further biochemical 
testing. 
Presumptive Pseudomonades were confirmed using the oxidase test (Sigma Aldrich, 
Gillingham, UK). A sterile strip of filter paper impregnated with tetramethyl-p-
phenylenediamine was dampened with distilled water, before application of a single 
test-isolate colony using a disposable, plastic loop. Generation of indophenol 
resulting in a purple/blue colouration of the paper strip was interpreted as oxidase 
positive. A positive control (P. aeruginosa ATCC 12923) and negative control 
(S. aureus ATCC 6571) were included in every test batch. 
4.3.4.4: Phenotypic antimicroial susceptiility profiling of microial cultures 
Antimicrobial susceptibility of S. aureus and P. aeruginosa isolates was determined 
against clinically relevant antimicrobials (Table 4.3.4.4) using the EUCAST disc 
diffusion method (EUCAST 2017). Overnight cultures of test bacteria were prepared 
in Mueller-Hinton Broth (MHB), incubated aerobically at 37°C. Samples were 
centrifuged for 5 min at 5000 x g to pellet the suspended bacteria, and the 
supernatant removed. The cell-pellet was resuspended in 0.9% (w/v) PBS to a 0.5 
McFarland standard, determined by photospectrometric absorbance at 600 nm 
wavelength. An absorbance of 0.08-0.1 indicated an approximate inoculum density 
of 1-1.5x108 cells per ml. 
Standardised inocula were spread evenly across Mueller-Hinton Agar (MHA) plates 
using sterile cotton swabs to produce a lawn of bacteria. Filter-paper discs 
impregnated with a known concentration of a relevant antimicrobial agent were 
placed on the inoculated plates within 15 min of inoculation, at a set distance, using 
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an 8-cartridge antimicrobial susceptibility testing disc dispenser (OxoidÔ, 
Basingstoke, UK). MHA plates were then incubated aerobically for 24 h at 37 °C, prior 
to measurement of any zones of clearing - where no bacterial growth occurred - using 
a digital calliper. Antimicrobial susceptibility or resistance of test isolates was 
determined using breakpoint tables published by the British Society of Antimicrobial 
Chemotherapy (BSAC 2015; Table 4.3.4.4). 
 Tale 4.3.4.4: Antimicroial susceptiility testing of cultured PRPs according 
to BSAC guidance (BSAC 2015)
Species 
tested 
Antimicroial Test method Breakpoint (zone 
diameter: mm) 
S1 I2 R3
S. aureus Amoxicillin EUCAST disc-
diffusion method 
on Mueller 
Hinton Agar 
³26 - £25 
Co-Amoxiclav ³26 - £25 
Gentamicin ³20 - £19 
Fusidic acid ³30 - £29 
Erythromycin ³20 17-19 £16 
Clindamycin ³26 23-25 £22 
Cefoxitin ³22 - £21 
P. aeruginosa Amikacin EUCAST disc-
diffusion method 
on Mueller 
Hinton Agar 
³22 16-21 £15 
Gentamicin ³18 - £17 
Imipenem ³23 17-22 £16 
Pipericillin-
Tazobactam 
³25 - £24 
Ciprofloxacin ³23 13-22 £12 
Ceftazidime ³24 - £23 
4.3.5.1: DNA extraction from oral swas 
Microbial swabs were aseptically transferred to 10 ml glass Bijou bottles containing 
1 ml of PBS by cutting the swab head using flame-heated scissors. The swabs were 
vortexed vigorously at high speed for 1 min, and the resultant cell suspension 
transferred to a 1.5 ml microcentrifuge tube, cooled on ice, by pipetting. Cell 
suspensions were centrifuged for 1 min at 13300 RPM and the supernatant removed 
by pouring. The cell pellet was then resuspended in 1 ml of Qiagen PuraGene 
proprietary cell suspension solution (Qiagen, Manchester, UK). Subsequently, 
bacterial DNA extractions were performed using the Qiagen PuraGene kit, following 
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the manufacturer's protocol for Gram-positive bacteria, with DNA elution in 20 µL of 
Tris-buffered water. 
4.3.5.2: Validation of DNA extraction y PCR and agarose gel electrophoresis 
To ensure DNA extraction from microbial swabs was successful, random samples 
were amplified by PCR universal bacterial 16S rRNA gene primer pair 
27f (GTGCTGCAGAGAGTTTGATCCTGGCTCAG) and 
1492r (CACGGATCCTACGGGTACCTTGTTACGACTT) (Eurofins Genomics LLC, 
Kentucky, USA) (Dalwai et al. 2007, Zuanazzi et al. 2010). All PCR reagents were 
purchased from Promega (Southampton, United Kingdom). In a microcentrifuge tube 
the following reagents were combined: 5 µL 5× GoTaq Green FlexiBuffer solution, 
0.5 µL of dNTPs (0.2 mM), 1.25 µL of each of the forward and reverse primers (0.5 
µM), 1 µL of MgCl2 (1 mM), and 0.25 µL (1.25 Units) of Taq Polymerase; dissolved in 
14.75 µL sterile, nuclease free water. The total reaction volume of 25 µL was reached 
by adding 1 µL of bacterial genomic DNA. Negative controls contained 1 µL of 
nuclease free water in place of DNA. PCR amplification was undertaken in a 
thermocycler (G-Storm, Gene Technologies Ltd, Braintree, UK) with denaturation at 
95°C for 1 min, then 30 cycles of: 94°C, 50°C for 45 s each and 72°C for 90 s. Finally, 
samples were held at 72 °C for 5 min. Following completion of the PCR amplification, 
samples were stored at 4 °C until ready for gel electrophoresis. 
For visualisation of PCR products by gel electrophoresis, a 1% (w/v) agarose gel was 
prepared, with the addition of 10% (v/v) SafeView™ solution (NBS Biologicals, 
Cambridgeshire, UK). Ten µl of each product was loaded into the gel, with a 1 Kbp 
molecular weight ladder to allow an estimate of PCR product size. Electrophoresis 
was performed at 70 V/cm2 for 40 - 60 min in 0.5× Tris Borate EDTA (TBE) buffer. 
After completion of electrophoresis, PCR products were visualised using the BioRad 
GelDocIT UVP system (Bio-Rad Laboratories Ltd, Watford, UK). A single, well-
demarcated, positive band of approximately 1500 bp size was considered evidence 
of successful extraction and amplification of gDNA. 
4.4.5.3: Identification of Streptococcus pneumoniae y TaqMan qPCR 
Due to the near identical 16S sequences of the Mitis group streptococci, including 
S. pneumoniae, S. mitis and S. sanguinis, species-level identification of 
S. pneumoniae by metataxonomic sequencing was not possible. As this 
microorganism is responsible for a high proportion of CAP cases in the UK, a species-
specific TaqMan™ assay, targeting the autolysin-encoding gene lytA was employed. 
The primers used were:  
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(Forward primer sequence: ACGCAATCTAGCAGATGAAGCA,  
Reverse primer sequence: TCGTGCGTTTTAATTCCAGCT,  
Probe sequence: YY-TGCCGAAAACGCTTGATACAGGGAG-BHQ1).  
The primer and probe design used was published as part of a diagnostic, multiplex 
qPCR detection set of common respiratory pathogens (Gadsby et al. 2015). 
Oligonucleotides were prepared as a single tube mixture at a 20× stock concentration 
of 2 µM by Life Technologies Ltd. (Paisley, UK).  
In each reaction, 10 µL of 2x TaqMan Fast Advanced MasterMix (Applied 
Biosystems™, California, USA) was combined with 2 µL of nuclease free water; 2 µL 
of the oligonucleotide primer/probe mixture and a 6 µL aliquot of genomic DNA 
extracted as per section 4.3.5. PCR was undertaken using a QuantStudio 6 Flex 
instrument (Applied Biosystems™, California, USA). Thermocycler parameters were: 
an initial degradation stage at 95°C for 5 min, followed by 45 cycles of 95°C for 45 s 
and 60°C for 45 s. All reactions were run in duplicate in BrightWhite PCR 96 well-
plates sealed carefully using Optical adhesive seals (PrimerDesign, Camberley, UK). 
In addition to a no-template control, S. pneumoniae ATCC 49619 was used as a 
positive control for each assay. 
4.4.5.4: Confirmation of lytA assay sensitivity and specificity 
To confirm similar sensitivity and specificity to that reported in the original paper, a 
standard curve was performed using S. pneumoniae ATCC 49619. In addition, two 
Mitis group streptococci - S. gordonii ATCC 10558T and S. sanguinis ATCC 7863 
were used to confirm specificity of the assay. Test microorganisms were cultured on 
blood agar in 5% CO2 at 37 °C for 48 - 72 h. Subsequently, a single colony was 
selected using a sterile loop and added to 10 ml of brain-heart infusion medium, with 
further incubation overnight in the same conditions. A standardised inoculum was 
prepared to approximately 1x108 cells/ml from this overnight culture using a 
spectrophotometer to measure optical density at 600 nm. DNA extraction was then 
performed using the procedure detailed in section 4.3.5.1.  
Following extraction, seven 10-fold serial dilutions of genomic DNA were performed, 
to a lower limit of 10 cells/ml. Each dilution was prepared for qPCR as above and 
added to a 96 PCR well-plate (BrightWhite PCR, PrimerDesign, Camberley, UK) in 
triplicate. A no-template control was prepared using nuclease free water in place of 
gDNA.  
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4.4.5.5: Metataxonomic sequencing of acterial 16s rRNA genes 
Library preparation and next generation sequencing of genomic DNA samples was 
conducted by Research and Testing Laboratories (RTL, Texas, USA) using the 
primers 28f and 519r, which cover the V1-V3 hypervariable regions of the 16S rRNA 
gene, on an Illumina Miseq platform. Each DNA sample nucleotide concentration was 
estimated using a nanodrop (GE Genequant 1300 spectrophotometer, GE 
Lifesciences, Amersham, UK). A volume of 50 µL of each gDNA sample was 
aliquoted and packaged in dry-ice for transfer to RTL. 
Staff at RTL used a two-step amplification process for samples according to the 
laboratory standard operating procedures. Initial preamplification was undertaken 
using the Illumina i5 sequencing primer with 28f 16S primer and Illumina i7 
sequencing primer with the 519r 16S primer. Sequences for these primers can be 
seen in Table 4.3.5.5. 
Tale 4.3.5.5: Primers used for 16S amplification of acterial genomic DNA 
Primer Sequence Reference 
Illumina 
i5 
5'-CGTCGGCA 
GCGTCAGATGTGTATAAGAGACAG-3' 
Oligonucleotide 
sequences © 
2018 Illumina, 
Inc. All rights 
reserved. 
Illumina 
i7 
5'-GTCTCGT 
GGGCTCGGAGATGTGTATAAGAGACAG-3' 
28f 5'-GAGTTTGATCNTGGCTCAG-3' Fan  et al. 
(2012) 519r 5'-GTNTTACNGCGGCKGCTG-3' 
PCR amplification was undertaken using Qiagen HotStarTaq reagents (Qiagen Inc, 
California, USA). To 1 µL of template genomic DNA the following were added: 1 µL 
of each primer (at a concentration of 5 µM); 10 µL of 10´PCR buffer; 2 µL of dNTPs 
(at a concentration of 200 µM of each dNTP); 0.5 µL of HotStarTaq polymerase, and 
9.5 µL of nuclease free water, to give a total reaction volume of 25 µL. An ABI Veriti 
thermocycler (Applied Biosystems, California, USA) was used to perform the 
reactions with the following thermal cycling parameters: 95°C for 5 min, followed by 
25 cycles of 94°C for 30 s, 54°C for 40 s and 72°C for 1 min. A final cycle of 72°C for 
10 min was undertaken, with samples stored at 4°C before further use. 
After determining the amplicon concentration, a second PCR was performed, with 
sample volumes dependent on the amplicon concentration. The primers used in this 
second stage PCR were designed based on the Illumina Nextera PCR primers:  
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Forward -  5'-
AATGATACGGCGACCACCGAGATCTACAC[i5index]TCGTCGGCAGCGTC-3' and 
Reverse - 5'-
CAAGCAGAAGACGGCATACGAGAT[i7index]GTCTCGTGGGCTCGG-3'. 
Thermocycling parameters were as used for the first PCR, but only 10 cycles were 
employed. 
The eGel system (Life Technologies, New York, USA) was used for visualisation of 
PCR products.  Products were then pooled in equimolar concentrations, then size-
selected in two rounds using Agencourt AMPure XP (BeckmanCoulter, Indiana, USA) 
in a 0.7 ratio for both rounds to ensure cDNA fragments of appropriate length were 
pooled. Size-selected pools were quantified using a Quibit 2.0 fluorometer (Life 
Technologies, New York, USA) and loaded on an Illumina MiSeq (Illumina, Inc. 
California, USA) 2x300 flow cell at 10 pM. Sequencing was performed according to 
the MiSeq Reporter Metagenomics Workflow – Reference Guide (Illumina, Inc. 
2014). 
4.3.5.6: Sequence Analysis 
Sequencing data was provided as paired FASTQ files for each sample. Generation 
of 16S rRNA gene sequences was undertaken using the open-source software 
MOTHUR (Schloss PD et al. 2009). The Illumina MiSeq standard operating 
procedure was followed throughout. Paired end reads were first assembled with the 
make.contigs command. This command combines the data from the paired FASTQ 
files and provides a quality score for each file. Each contig was then filtered using the 
screen.seqs command, using the parameters: maxn = 0, maxambig = 0, maxhomop 
= 5, maxlength = 605. Reads were subsampled to 675 which resulted in the exclusion 
of 3 samples (2 from pneumonia patients, 1 from a care home resident). 
Rare OTUs (<10 reads) were excluded from further analysis and any operational 
taxonomic units (OTUs) with less than 98% coverage or 97% sequence identity to a 
known bacterial species were categorised to genus level only. After manual scanning, 
OTUs that would not be expected to occur in the oral cavity were re-examined using 
the NCBI BLASTn database. Where changes were made through BLASTn, the 
highest scoring species assignment was selected and OTUs reclassified accordingly, 
using the threshold of at least 98% coverage and 97% sequence identity.  
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4.3.5.7: Analysis of salivary cytokines y cytometric ead array using flow-
assisted cell sorting 
Saliva was obtained as described in section 4.3.3 and analysed for a panel of 6 pro-
inflammatory cytokines (Table 4.3.5.7), using a multiplex cytometric bead array kit 
(Human Inflammatory Cytokines Kit, BD Biosciences, Wokingham, UK). The 
manufacturer's protocol for supernatant samples was followed, including the 
recommended standard curve parameters.  
A flow-assisted cell sorter (BD FACSCanto II, BD Biosciences, Wokingham, UK) was 
calibrated using the proprietary setup beads to achieve appropriate laser power. All 
samples were processed at medium speed, with a total of 10000 observations per 
run. Samples were analysed in a single batch to eliminate inter-run variability.  
Tale 4.3.5.7: Assay sensitivity for cytokine detection in the multiplex 
cytometric ead array kit (according to assay handook)
Cytokine measured Assay sensitivity 
(pg/ml) 
IL-12p70 1.9 
TNF 3.7 
IL-10 3.3 
IL-6 2.5 
IL-1b 7.2 
IL-8 3.6 
Data was analysed using the FACsuite software (BD Biosciences, Wokingham, UK). 
Imported data was manually noise-filtered, and cytometric bead identities manually 
assigned to the observed clusters. A standard curve was generated, and samples 
interpolated against this using a 5-parameter logistic regression model, as per the 
manufacturer’s instructions.  
4.3.6: Statistical analyses 
Statistical analysis was conducted using R (R Core Team 2013), SPSS 21 and 
Microsoft Excel. Simple descriptive summary statistics were undertaken on 
participant demographic data and oral health scores. Age, Charlson Index (Charlson 
et al. 1987), Denture Hygiene Score, Newton’s Classification (Newton 1962) and 
DMFT scores (Klein et al. 1938) were treated as continuous variables. The remaining 
variables were analysed as categorical variables. Distribution of data was assessed 
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by visual inspection of histograms, the Kolgomorov-Smirnov test of normality (alpha 
set to p<0.05) and inspection of Q-Q plots and detrended Q-Q plots. To assess any 
difference between participant cohorts at baseline, the Kruskal-Wallis test was 
undertaken on nonparametric data, while two-way ANOVA with Bonferroni correction 
was used to analyse normally distributed continuous data. Categorical variables were 
analysed using the Chi-Squared (!) goodness of fit test.  
Alpha diversity was measured by the Chao2 and Inverse Simpson Indices. Alpha 
diversity indices were compared using the Kruskal-Wallis test and Median K-tests. 
Multivariate logistic regression was employed to assess the impact of demographic 
and oral health variables on Chao and Inverse Simpson indices using a forward 
stepwise approach. Beta diversity was evaluated from UniFrac (Unique Fraction 
metric; Lozupone and Knight 2005) Weighted distance matrices, analysed by 
principle component analysis using non-metric multidimensional scaling (NMDS) 
ordination. All diversity indices were generated using the vegan package in R 
(Oksanen et al. 2015). Permutational multivariate analysis of variance 
(PERMANOVA) was performed on this transformed data to determine the degree of 
phylogenetic dissimilarity between participant cohort samples for each oral site.  
Heatmaps were created to demonstrate the relative abundance of the top 30 genera 
and species present in each oral site, with participants clustered by a dendrogram 
according to the degree of similarity in OTU profiles.  
PRP species were assigned to 9 groupings: enterococci, Acinetobacter spp. 
Enterobacteraciae, Haemophilus spp., Klebsiella spp., P. aeruginosa, Serratia spp., 
S. aureus, and E. coli. The percentage relative abundance of PRP species was 
calculated and analysed using the Two-Stage Linear Step up Procedure of 
Benjamini, Krieger and Yekutieli (2001) to control the false discovery rate, with Q-
value set at 0.05. Fold differences between participant cohorts’ PRP relative 
abundance were calculated for each oral site, normalised to care home residents.  
Metataxonomic data was also used to explore community diversity and species 
richness. The Chao2 index (Chao 1984) uses the number of rare OTUs (singletons 
and doubletons) and the total number of unique OTUs to estimate species richness. 
It is represented by the formula: 
186
Sobs is the total number of species (OTUs) identified " is the number of singletons (OTUs identified only once in a sample) ! is the number of doubletons (OTUs identified twice in a sample) 
(Gotelli and Colwell 2011). 
The Inverse Simpson index (Simpson 1949) reflects community diversity (how evenly 
distributed the OTUs are within each sample). This index is derived from the 
calculated probability that any 2 individuals selected at random from each sample will 
represent the same OTU. Interpretation of Simpson Index values can be 
counterintuitive however, as increasing Simpson Index represents decreasing 
diversity. To allow more intuitive interpretation, the reciprocal or inverse of this value 
is used, so that increasing community diversity will lead to an increasing index value. 
Percentage relative abundance was converted to decimal data, and Linear 
discriminant analysis of Effect Size (LEfSe) conducted using the open access galaxy 
module (Segata et al. 2011), with circular cladograms generated from this analysis. 
A summary of the LEfSe algorithm is presented in Figure 4.3.6. Each column in the 
data matrix represented a sample, while each row contained a normalised OTU 
value. Samples were separated into classes by pneumonia status. Step 1 employed 
the non-parametric Kruskal-Wallis test to evaluate if the OTU values were 
differentially distributed between the participant cohorts. In step 2, those OTUs which 
differed significantly between cohorts were analysed using the Wilcoxon rank test to 
identify OTUs which followed the same trend in distribution within each class. The 
results of step 2 generated vectors, which were used to construct a Linear 
Discriminant Analysis (LDA) model, ranking OTUs by their relative difference in 
abundance, providing an effect-size linked ranking system. 
Statistical analysis of salivary cytokine profiles was undertaken using Microsoft Excel 
and Graphpad Prism 7.0. Normality was assessed using the Kolgomorov-Smirnov 
test with an alpha of 0.05. Subsequent analysis was undertaken using Mann-
Whitney U tests with Bonferroni correction applied post-hoc. The significance 
threshold selected for Bonferroni-adjusted test results was p<0.05.  
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Figure 4.3.6: LeFSe stepwise statistical algorithm (reproduced from Segata et al. 
2011): 
For this study: Class 1 = pneumonia patients; class 2 = care home residents. Alpha = 0.05.
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4.4: Results 
4.4.1: Study participant demographics 
A total of 61 participants were recruited for the study, comprising 35 care home 
residents and 26 pneumonia patients. 
A summary of participant demographics, denture hygiene and basic oral health 
indices, is provided in Table 4.4.1. The mean age of respiratory ward patients was 
84 years; a mean difference of 4 years younger compared to care home residents 
(P=0.0006). However, the clinical significance of this difference is questionable. All 
pneumonia patients received antibiotics based on British Thoracic Society protocol. 
Excluding cases of allergy, co-morbid conditions contraindicating their use, or 
blood/sputum cultures demonstrating resistant microorganisms, the first-line 
treatment for pneumonia patients was IV or oral Amoxicillin and Clarithromycin as 
deemed necessary by the treating clinician. In contrast, only 4 care home residents 
had received antibiotics in the preceding 6 months. All other demographic data and 
clinical findings were similar between included participants. A summary of the study 
methods is provided in Figure 4.4.1. 
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Figure 4.4.1: Participant sampling and analysis for this study
Sampling methods are shown in the order performed. 
Care home 
residents (n=35) 
Pneumonia patients 
(n=26) 
Imprint cultures from dorsal tongue, 
denture-bearing palate and denture-fit 
surface (to detect S. aureus, 
P. aeruginosa & C. albicans
Swabs from dorsal tongue, denture-
bearing palate and denture-fit surface for 
bacterial DNA extraction and sequencing 
/ qPCR (to detect S. pneumoniae) 
Saliva sample via salivette for cytokine 
analysis 
26 sample sets 
completed as planned 
16 sample sets 
completed as planned 
(19 samples 
inadequate saliva 
volume) 
8 sample sets 
completed as planned 
(18 samples 
inadequate saliva 
volume) 
26 sample sets 
completed as planned 
(78 total) 
6 samples failed to 
amplify for sequencing 
35 sample sets 
completed as planned 
(105 total) 
2 samples failed to 
amplify for sequencing 
35 sample sets 
completed as planned 
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Tale 4.4.1: Summary participant information 
Care home residents (n=35) Pneumonia patients (N=26)
Mean Age 
(S.D.) 
88 (7.6) 84 (8.2)
Gender (%) 15% Male, 85% Female 15% Male, 85% Female
Antibiotics 
in last 90 
days (%) 
15% (none at time of sampling) 100% (all at time of sampling)
Smoking 
History (%) 
15% current smokers
54% ex-smokers  
31% never smoked 
8% current smokers,
65% ex-smokers, 
27% never smoked 
Mean 
Charlson 
Comorbidity 
Index# (S.D.) 
5.52 (0.97) 5.125 (2.11)
Mean DMFT 
score* (S.D.) 
Decayed Missing Filled Decayed Missing Filled
1.60 
(2.00) 
24.97 
(5.33) 
2.28 (4.38) 1.80 
(1.48) 
24.31 (5.77) 3.60 
(3.06) 
Complete 
or Partial 
Denture (%) 
63% Complete
27% Partial 
(10% of participants had no denture in one 
arch) 
60% Complete
15% Partial 
(25% of participants had no denture in 
one arch) 
Acrylic or 
Cobalt 
Chromium 
Denture (%) 
91% Acrylic,
9% Cobalt Chromium 
92% Acrylic,
8% Cobalt Chromium 
Mean 
Denture 
Cleanliness 
Index+ (S.D.) 
1.83 (1.11) 1.58 (1.19)
Mean 
Newton 
Index$ (S.D.) 
0.89 (0.53) 1.10 (0.80)
# Charlson Comorbidity Index scores a number of physiological measures and diseases to provide 
estimate of 10-year survival. The Maximum score (highest mortality risk) is 33. A score of 7 or greater 
indicates a predicted 10-year survival rate of 0%. 
* A DMFT score is indicative of Decayed, Missing, Filled Teeth. Absence of a tooth, or the presence of 
any dental restoration or caries scores 1 point. The maximum score is 28. Wisdom teeth were not 
included in this score. 
+ Denture Cleanliness Index scores denture cleanliness from 0 (pristine denture surfaces) to 4 
(damaged dentures). 
$ Newton Index scores palatal inflammation from 0 (normal, healthy mucosa) to 3 (grossly 
erythematous, swollen mucosa). 
4.4.1.1: Reasons for participant exclusion 
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A detailed screening log was not kept as it was impossible to ascertain the total 
number of eligible individuals across all locations. However, common reasons for 
participant exclusion were noted and are summarised in Table 4.4.1.1. 
Tale 4.4.1.1: Common reasons for exclusion from this study 
Reason Comment
Declined to participate Many individuals declined as they felt too 
unwell to participate or did not wish to partake 
for personal reasons. 
Questionale mental capacity 
to provide valid consent 
Often, nurses or carers would rule out 
individuals deemed to lack sufficient mental 
capacity (either formally assessed or in their 
professional opinion) to provide valid consent 
for the study. In some instances, after 
discussion with individuals about the nature of 
the study, it was evident that they lacked 
capacity to consent (unable to retain, 
understand or communicate the information 
provided). In any cases where capacity was 
considered questionable, participants were 
excluded. 
Not wearing denture A number of pneumonia patients had avoided 
wearing their denture since the onset of the 
disease, as they felt it affected their breathing, 
or found it uncomfortable. A small number of 
care home residents also did not routinely wear 
their dentures. 
Medical exclusion criteria Many participants were receiving palliative 
care, most frequently for malignancies. Some 
respiratory ward patients were under 
investigation for lung cancers. A small number 
of participants were severely 
immunocompromised or immunosuppressed.  
No clear diagnosis 
(Respiratory ward only) 
Frequently, no clear diagnosis was available 
for respiratory ward patients, or a definitive 
diagnosis established only after patients had 
recovered from the pneumonia, sometimes 
over a week following admission. 
4.4.2: Analysis of microorganisms cultured from imprints 
Foam imprints from each of the 3 oral sites were sequentially transferred to Blood 
Agar, then selective agars as described in section 2.3.4.1-3. Recovery rates were 
expressed as percentages for each oral site and participant cohort. 
4.4.2.1: Recovery rates of targeted microorganisms from selective agars 
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The overall recovery of Candida species across all oral sites in all participants was 
159 out of 183 total samples (87%). Presumptive S. aureus isolates were recovered 
in 31 out of 183 samples (17%), while P. aeruginosa was recovered in 16 out of 183 
samples (9%). There was no difference in recovery rates from each oral site, nor 
between the participant cohorts (p>0.05). 
The target species recovery rates for each participant cohort and oral sites are 
summarised in Table 4.4.2.1 and Figure 4.4.2.1. 
Table 4.4.2.1 – Recovery rates N (%) of target microorganisms by culture
Microbial 
species
Candida species Staphylococcus aureus Pseudomonas 
aeruginosa 
Oral site Tongue Palate Denture Tongue Palate Denture Tongue Palate Denture
Pa
rti
cip
an
tc
oh
or
t
Overall
(n=61) 
54 (88) 51 
(83) 
(54) 88 13 (21) 8 (13) 10 (16) 6 (10) 4 (7) 6 (10)
Care home
(n=35) 
31 (89) 29 
(83) 
32 (91) 8 (23) 4 (11) 7 (20) 3 (9) 1 (3) 3 (9)
Respiratory 
ward 
(n=26) 
23 (88) 22 
(85) 
22 (85) 5 (19) 4 (15) 3 (11) 3 (11) 3 (11) 3 (11)
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Figure 4.4.2.1  Recovery rates of target microorganisms y culture 
a) Overall – combined recovery of microbes in all study participants
) Care home residents only
c) Respiratory ward patients only
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4.4.2.2: Antimicroial susceptiility testing of recovered species 
After confirmation of isolate identity by biochemical testing and phenotypic 
examination, the antimicrobial susceptibility of Staphylococcus aureus and 
Pseudomonas aeruginosa isolates was tested against a panel of relevant 
antimicrobials. A summary of test isolate resistance rates for each participant cohort 
is presented in Table 4.4.2.2.1 and Table 4.4.2.2.2. 
Table 4.4.2.2.1: Antimicrobial resistance rates (%) among cultured isolates of 
S. aureus
Care Home 
Residents 
(n = 22 
isolates)
Respiratory Ward 
Patients 
(n = 10 isolates)
Overall (n = 32 isolates)
Amoxicillin 27.27 0 18.75
Co-Amoxiclav 0 0 0
Gentamicin 4.55 0 3.13
Fusidic acid 13.64 20 15.63
Erythromycin 18.18 50 
(plus 10 intermediate) 
28.13 (plus 3.13 intermediate)
Clindamycin 13.64 50 25
Cefoxitin 4.55 0 3.13
Table 4.4.2.2.2: Antimicrobial resistance rates (%) among cultured isolates of 
P. aeruginosa
Care Home 
Residents (n = 7 
isolates)
Respiratory Ward 
Patients (n = 13 
isolates)
Overall (n = 20 
isolates)
Amikacin 0 (plus 57.40 
intermediate) 
7.69 (plus 92.31 
intermediate) 
5 (plus 80 
intermediate) 
Gentamicin 0 0 0
Imipenem 14.29 (plus 28.57 
intermediate) 
0 5 (plus 10 
intermediate) 
Pipericillin-
Tazobactam 
85.71 46.15 60
Ciprofloxacin 0 (plus 28.57 
intermediate) 
84.62 55 (plus 10 
intermediate) 
Ceftazidime 85.71 0 30
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4.4.3: Analysis of metataxonomic sequencing data 
Prior to quality control, a total number of 3,658,008 sequence reads were generated 
from a total of 178 samples (including 3 negative controls provided as a ‘dummy’ 
sample set). Eight samples did not amplify; 2 from care home residents and 6 from 
pneumonia patients. After removing all reads with ambiguous base calls, a total of 
914,503 sequence reads remained. Operational taxonomic units (OTUs) were sub-
sampled to 675 reads, which led to a further 3 samples with low read counts being 
discarded. A summary of sequence reads and quality is presented in Table 4.4.3. 
Table 4.4.3: Sequence data and quality after processing data using the 
MOTHUR pipeline
Start End Number of 
Bases  
Ambiguous 
base calls  
Polymer Number of 
Sequences
Minimum 1 35 35 0 2 1
2.5%-tile 1 492 492 0 4 91451
25%-tile 1 528 528 0 5 914503
Median 1 535 535 2 5 1829005
75%-tile 1 544 544 5 5 2743507
97.5%-tile 1 561 561 14 7 3566558
Maximum 1 602 602 268 300 3658008
Mean 1 530.109 530.109 3.59424 5.2611
In total, there were 924 unique OTUs identified, spanning 16 bacterial phyla. Removal 
of OTUs with less than 10 sequence reads reduced this number to 218 unique OTUs 
(23.6%), comprising 9 phyla (Figure 4.4.3A&B) and 82 genera. 
All oral sites in both participant cohorts were predominated by bacteria from the 
Streptococcus genus, comprising between 36-61% of all OTUs detected. There were 
more PRPs present in the 10 most abundant genera from respiratory ward patients’ 
samples (Figure 4.4.3C). In tongue samples, the Pseudomonas, Klebsiella and  
Escherichia/Shigella genera were heavily represented in pneumonia patients, with 
minimal presence in care home residents’ samples (Figure 4.4.3C). Palate samples 
demonstrated similar trends although Pseudomonas genera were similarly 
represented in both cohorts. Denture samples showed high abundance of Klebsiella, 
Escherichia and Haemophilus genera in pneumonia patients, none of which had high 
abundance in care home residents. There was a similar, low level of Pseudomonas 
genera in both cohorts. 
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Figure 4.3.3: Distribution of bacterial phyla in oral samples from care home residents and 
respiratory ward patients 
A Care home samples  B Pneumonia patient samples 
Tongue
69%  Firmicutes
14%  Bacteroidetes
8%  Proteobacteria
6%  Fusobacteria
3%  Actinobacteria
0.1%  TM7
A
Palate
77%  Firmicutes
8%  Bacteroidetes
9%  Proteobacteria
4%  Fusobacteria
0.8%  Actinobacteria
0.1%  TM7
<0.1%  Spirochaetes
Denture
82%  Firmicutes
8%  Bacteroidetes
5%  Proteobacteria
3%  Fusobacteria
2%  Actinobacteria
0.1%  TM7
<0.1%  Spirochaetes
Tongue
56%  Firmicutes
6%  Bacteroidetes
34%  Proteobacteria
1%  Fusobacteria
3%  Actinobacteria
B
Palate
57%  Firmicutes
6%  Bacteroidetes
32%  Proteobacteria
1%  Fusobacteria
3%  Actinobacteria
<0.1%  Spirochaetes
Denture
60%  Firmicutes
8%  Bacteroidetes
29%  Proteobacteria
<0.5%  Fusobacteria
3%  Actinobacteria
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Figure 4.4.3C: Top 10 most abundant genera among oral samples from care home residents and 
respiratory ward patients 
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4.4.3.1: Relative abundance of putative respiratory pathogens 
The relative abundance reflects PRP OTUs as a percentage of the total OTUs. There 
was a trend towards increased relative abundance of putative respiratory pathogens 
in pneumonia patients compared with care home residents (Figure 4.4.3.1). However, 
this only crossed the threshold of statistical significance for Enterobacteriaceae. PRP 
OTU proportions were similar in tongue and denture samples for both cohorts, while 
samples from the palate showed reduced PRP relative abundance, with the 
exception of Enterobacteriaceae, Klebsiella species, Serratia species and E. coli. 
Both P. aeruginosa and S. aureus – the target pathogens for isolation by conventional 
culture - were identified infrequently among the samples.  
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Figure 4.4.3.1:  
Relative abundance (%) of 
putative respiratory pathogens 
from each oral site 
OTUs are grouped at either 
genus or species level to collate 
bacteria associated with 
respiratory infection at the lowest 
discriminatory phylogenetic level. 
Note that the Y axis features a 
log10 scale. Mean values shown, 
error bars represent 95% 
confidence intervals. 
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4.4.3.2: Association of Putative Respiratory Pathogens with pneumonia status 
When the cumulative relative abundance of PRPs was compared between the two 
cohorts, a clear difference in pathogenic bioburden emerged (Figure 4.4.3.2a). This 
was especially pronounced in denture samples. There was a greater than 20-fold 
difference in PRP bioburden detected in denture samples of patients with pneumonia 
compared to respiratorily healthy care home residents (Figure 4.4.3.2b). 
Figure 4.4.3.2: 
A: Cumulative relative abundance (%) of PRPs identified in care home 
residents compared to respiratory ward patients. Mean values shown. Error bars 
represent 95% confidence intervals. 
B: Fold difference of PRP cumulative relative abundance in respiratory ward 
patients, normalised to care home residents. Fold difference calculated using 
mean values reported in a). 
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4.4.3.3: Association of microbiome community diversity and species richness 
with pneumonia status 
There was a statistically significant reduction in both community diversity and species 
(OTU) richness in pneumonia patients compared with care home residents, in tongue 
and denture samples only (Figure 4.4.3.3). There was no difference between palate 
samples for either richness or diversity indices.  
Multivariate regression analysis using a forward stepwise approach revealed that 
only antibiotic status had a significant impact on microbial community diversity indices 
(using denture samples as the reference indices). As all patients in the pneumonia 
cohort and only 4 care home residents had received antibiotics, there was insufficient 
statistical power to justify subgroup analysis.  
4.4.3.4: Principle component analysis of microbial communities 
The non-metric multidimensional scaling (NMDS) ordination plots for each oral site, 
separated by participant cohorts are presented in Figure 4.4.3.4a-c. PERMANOVA 
revealed a statistically significant difference in beta diversity between participant 
cohorts for tongue (p = 0.02), palate (p = 0.032), and denture samples (p = 0.019), 
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Figure 4.4.3.3 – Chao (upper panel) and Inverse Simpson (lower panel) indices for oral sites in 
each participant cohort 
Individual data points with representative box plots shown. 
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although there was considerable overlap between samples overall. There was also a 
high level of dissimilarity between individual samples within each cohort. 
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Figure 4.4.3.4: Non-metric multidimensional scaling ordination of oral 
samples 
Scatter plot points represent individual sample ordination values coloured according 
to participant cohort. Groupings are encircled at 95% confidence interval boundaries. 
a) Tongue samples 
b) Palate samples 
c) Denture samples 
4.4.3.5: Heat map of microbial communities 
Seven participants (3 care home residents, 4 pneumonia patients) were excluded 
from the analysis because metataxonomic data were not present for all 3 oral sites. 
Community diversity of the 30 most abundant genera and species in each sample set 
was analysed using the vegan package in R and the NMF package (Gaujoux and 
Seoighe 2010) was used to construct heatmaps for each oral site, comparing OTU 
clustering between participant cohorts. The ape package (Paradis et al. 2004) was 
used to construct comparative dendrograms overlaid onto heatmaps to highlight 
sample clusters with similar microbial phylogenetic profiles. 
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Heatmap data comparing OTUs between participants is presented in Figure 4.4.3.5 
at genus (4.4.3.5a-c) and species (4.4.3.5d-f) level. 
Compositional differences can be seen easily in these figures, with a tendency for 
respiratory ward patients’ samples to cluster together, typified by increased 
abundance in PRP genera and species. However, the samples did not separate 
distinctly into participant cohorts, with clusters of samples from both participant 
cohorts showing considerable homogeneity in some cases.  
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Figure 4.4.3.5: Heatmaps constructed from metataxonomic sequencing data 
demonstrating the most abundant 30 genera (A-C) and species (D-F) level 
OTUs. 
Dendrogram indicates most closely related clusters of samples. 
4.4.3.6: LeFSe analysis of microbial communities 
There was a consistent increase in the relative abundance of the proteobacteria 
phylum in pneumonia patients for all oral sites. The PRP genera Klebsiella and 
Enterobacteriaceae were among the most elevated in abundance among pneumonia 
patients compared with care home residents in all oral sites. Escherichia/Shigella
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genera were elevated in the tongue samples of pneumonia patients, while 
Pseudomonas species were also present in significantly increased abundance in all 
oral sites. 
Respiratorily healthy care home residents had significantly increased relative 
abundance of bacterial phyla and genera associated with a ‘normal’ oral microbiome. 
There was an increase in species from the Fusobacterium and Veillonella genera and 
Bacteroides class in all oral samples compared to pneumonia patients. Additionally, 
palate and denture samples revealed an increase in species from the Streptococcus
genus. The LDA scores demonstrating significant differences between participant 
cohorts for each oral site are presented in Figures 4.4.3.6a-c, and cladograms 
mapping the phylogenetic distribution of differentially abundant OTUs are shown in 
Figures 4.4.3.6d-f. It should be noted that LDA score magnitude indicates 
overabundance of the represented taxonomic level according to the class assignment 
(represent as red or green here), regardless of direction. This means that the LDA 
score of -4.7 for Bacteroidetes in Figure 4.4.3.6a indicates an overabundance of this 
phylum in care home residents (coded red), while the LDA score of +5.1 for 
Proteobacteria indicates an overabundance in pneumonia patients. 
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Figure 4.4.3.6: LeFSe analysis of differential OTU relative abundance 
between participant cohorts for each oral site 
Above: Significantly different Linear Discriminant Analysis scores for samples 
from: 
A. Tongue 
B. Palate 
C. Denture 
Note all LDA scores are transformed to log10 scale 
Below: Cladograms constructed from a-c mapping the phylogenetic 
relationships between differentially express genera: 
A. Tongue 
B. Palate 
C. Denture 
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4.4.4: Analysis of salivary cytokine profiles 
Unstimulated whole saliva was obtained from a total of 24 participants (16 care home 
residents and 8 respiratory ward patients). There was an inadequate volume of saliva 
for analysis in the remaining 37 participants. Indeed, many participants failed to 
express any detectable saliva after 2 min. 
There was no significant difference in the expression of 6 pro-inflammatory cytokines 
analysed in participants, nor any discernible trend in expression levels (Figure 4.4.4). 
There was substantial variation in expression of salivary cytokines, with up to a 1000-
fold difference in the expression of IL-8 within the respiratory ward patient cohort. 
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Figure 4.4.4: Salivary cytokine expression levels (pg/ml) measured in this study
Note that the Y axis uses a log10 scale. 
Individual points represent each sample measured, horizontal black line indicates median 
expression level for each cohort. 
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4.5: Discussion 
This was the first study to directly explore compositional shifts in the denture-
associated oral microbiome correlated with pneumonia status; using contemporary 
molecular techniques to limit selectivity bias. A compositional shift in the denture-
associated oral microbiota was evident, with a decrease in community diversity and 
species richness, and a concurrent increase in the relative abundance of putative 
respiratory pathogens.  
In contrast to a number of prior studies conducted in elderly individuals, recovery of 
S. aureus and P. aeruginosa by culture was relatively low in both participant cohorts, 
suggesting that these species may have a diminished oral prevalence in severe 
community acquired pneumonia even following hospital admission. Instead, the 
findings presented indicate that bacteria of Enterobacter and Klebsiella genera may 
be more appropriate targets for investigation in such individuals.  
More than half of all participants were unable to express adequate saliva for analysis 
of biomarkers. This alone is an important finding, as the multifaceted role of saliva in 
maintaining the normal oral microbiome, as well as tissue integrity and function is 
well documented (Lima et al. 2010). There was a high degree of inter-subject 
variability in salivary pro-inflammatory cytokine levels, suggesting that these may 
serve a limited role in identifying individuals with - or at risk of - pneumonia. 
In order to reach, colonise and infect the lungs, bacteria must either pass from an 
external source through the oral cavity, or intrinsically from the gastrointestinal tract 
(Dickson and Huffnagle 2015). Thus, any relationship between the oral microbiome 
and pneumonia status may hold diagnostic promise, due to the close anatomical 
approximation of the oral cavity with the lungs and gastrointestinal tract, and the 
interface formed with the external environment.  
It can be speculated that the findings of this study may support a potential sequential, 
if not necessarily causal process, with compositional shifts in the oral microbiome 
coinciding with pneumonia. While neither causality nor sequence can be said to have 
definitively been demonstrated in this research, it is difficult to envisage a series of 
events whereby bacteria (from either intrinsic or extrinsic sources) reach the lungs 
without previously or simultaneously colonising the oropharynx. Given the poor 
reliability of sampling the infected lung, which must be performed essentially ‘blind’, 
the ease of access to the oropharynx for microbial sampling could lead to rapid, 
reliable identification of potential causative microorganisms, and provide 
antimicrobial susceptibility profiles to aid diagnosis and treatment of pneumonia 
(Holter et al. 2015). 
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Limitations of the methods 
This study has a number of limitations, with further work required to support a causal 
relationship between compositional shifts in the oral microbiome and pneumonia. 
Due to the difficulties recruiting suitable patients within the ethical constraints of this 
study, a low sample size was achieved. Many care homes refused to enrol their 
residents, often without providing a reason. As private institutions, these sites were 
primarily concerned with the care of their residents, and likely wished to avoid any 
unnecessary disturbance of their residents that sample collection would require. 
Many care home residents suffered with cognitive impairment or frank dementia, and 
thus were excluded from the study. Similarly, pneumonia patients were frequently 
delirious due to fever, or had a background of cognitive impairment. Such age-related 
comorbidities are a major challenge to conducting research in this demographic 
(Chalmers 2000). There has been a recent move towards including primary care 
settings in research, which has typically been limited to academic centres historically 
(Palmer and Batchelor 2006). However, attempting to incentivise private 
organisations such as care homes to partake in studies presents a greater challenge 
still, as these institutions are not beholden to NHS clinical governance (Hall et al. 
2009). 
The cross-sectional design of this study was another major limitation. As recruited 
respiratory ward patients had received a diagnosis of pneumonia prior to recruitment, 
it was not possible to track changes in oral microbiome composition from respiratory 
health to disease. Similarly, there was no follow-up to examine shifts in microbial 
communities upon resolution of pneumonia. It is therefore not possible to determine 
if changes in the oral microbiome preceded pneumonia onset, a critical step in 
satisfying Bradford Hill criteria when attempting to establish a causal relationship (Hill 
1965). The nasal microbiome was not considered, but could have exerted influence 
on the development of respiratory infection. Similarly, the role of the fungal and viral 
microbiome was not explored, both of which could have a major bearing on 
pneumonia development, particularly given the known role of influenza virus on 
subsequent pneumonia risk. Again, a longitudinal design would allow for elucidation 
of the relationships between oral (and nasal) carriage of microbes and pneumonia 
risk. 
All patients with suspected pneumonia received empirical antibiotic therapy 
according to local policy, which reflects the British Thoracic Society guidelines on the 
management of severe community acquired pneumonia (Lim et al. 2009). As only a 
very low proportion of care home residents had received any antimicrobials in the 
preceding 30 days, and none had received a comparable regime to the first line 
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combination therapy of Amoxicillin/Clarithromycin used in suspected pneumonia 
patients; the importance of the potential role of antibiotic use as a confounder leading 
to altered oral microbial composition cannot be overstated. However, a number of 
factors suggest that while antibiotic use may have contributed to reduced community 
diversity and species richness, the differences cannot be entirely explained by 
antibiotic use alone. Firstly, it would be expected that denture-associated biofilms 
would be least affected by antibiotic use compared with other oral sites, due to both 
the protective effect of the biofilm in conferring antimicrobial tolerance to its 
constituents (Stewart 2015), and because antibiotics would have to cross the 
epithelial oral mucosal barrier, diffuse through the palatal microbial biofilm and then 
penetrate the denture-associated biofilm through the outer surface in sufficient 
concentration to perturb the microbial communities. It should be noted that 
Enterobacteriaceae are typically not susceptible to macrolide antibiotics such as 
Clarithromycin and are intrinsically resistant to Amoxicillin and other beta-
lactamases. The aggressive use of these antibiotic regimes in pneumonia patients 
may act as a selective pressure to suppress growth and viability of normal oral 
microbes, particularly Streptococcaceae, leading to an increased relative abundance 
of more virulent microorganisms not normally associated with the oral microbiome, 
such as Enterobacter species. Nonetheless, the finding that the difference in relative 
abundance of PRPs was most pronounced in denture samples suggests that 
antibiotic use is unlikely to be the primary contributor to the changes in microbial 
community composition. Notably, no S. aureus isolates recovered from respiratory 
ward patients were resistant to amoxicillin, compared to over one quarter of those 
from care home residents. However, macrolide resistance was more than doubled in 
respiratory ward S. aureus isolates. There were much higher rates of resistance to 
the beta-lactam antibiotic piperacillin-tazobactam in care home residents’ 
P. aeruginosa isolates compared with pneumonia patients, as was seen for the 
related cephalosporin ceftazidime. However, resistance of P. aeruginosa isolates to 
ciprofloxacin, a fluoroquinolone antibiotic, was found to be much higher among 
pneumonia patients than care home residents. While the low number of both 
S. aureus and P. aeruginosa isolates recovered precludes any reliable statistical 
evaluation, the differences in resistance patterns suggests that antibiotic treatment 
may not have exerted a major selective pressure upon the oral microbiota. This was 
particularly evident in the case of S. aureus isolates, where amoxicillin sensitive 
strains were isolated from respiratory ward patients’ samples despite aggressive 
empiric therapy with this agent. Based on the sequencing data, it appears that 
S. aureus and P. aeruginosa are poor candidates for a targeted approach as was 
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employed in this study. Future studies should instead target E. coli,
Enterobacteriacia, Klebsiella, Enterococcus and Serratia species. 
Salivary cytokines did not reflect pneumonia status, nor oral PRP colonisation. A 
better alternative to evaluate the host-microbiome interface in the oral cavity would 
be collection of tissue fluid from the palatal mucosa underlying the denture. This may 
still offer useful predictive information, as local inflammatory responses might hint at 
both the immune status of an individual and the virulence of the microbial community. 
Equally, tissue fluid would be less prone to confounding from time of day, recent food 
or drink intake and medicines affecting salivary flow.  
In future research it would be advantageous to follow participants from day of 
admission through to recovery and discharge (or death). However, this was not 
feasible within the limitations of this study due to the small clinical team, and barrier 
to participation that a longer-term study duration might create. By recruiting 
participants at admission, it would be possible to collect samples prior to antibiotic 
administration, allowing this confounder to be examined and accounted for. However, 
there are several practical challenges to achieving recruitment in this manner. Firstly, 
many patients may have already received empirical antibiotics from their GMP prior 
to, or at the time of, referral to hospital. A large number of patients are admitted with 
suspected respiratory infection, but most of the clinical signs and symptoms are non-
specific. Therefore, only a small percentage of prospectively identified admissions 
will actually receive a diagnosis of bacterial pneumonia (Khalil et al. 2007). This 
means that a large number of samples would need to be collected, necessitating a 
large research team, logistical and financial resources, and disturbing patients who 
are already unwell; with many of the samples collected being discarded. Additionally, 
many patients screened were either unwilling or unable to consent to participate in 
this study. Emergency admissions are commonly pyrexic and delirious due to their 
acute illness. These patients would thus need to be excluded, increasing the duration 
of recruitment and the resources required, or consented retrospectively, as our group 
has previously done in ICU patients (Sands et al. 2016). At the present cost of 
sequencing, the number of samples needed to track patients serially over time and 
provide sufficient discriminatory information to allow diagnostic and prognostic 
evaluation would be prohibitively expensive. 
An alternative route could be to evaluate an intervention aimed at improving oral 
health in patients at risk of bacterial pneumonia, such as care home residents, 
adequately powered to evaluate the impact of such care on pneumonia incidence. 
Secondary outcome measures including oral health measures such as plaque indices 
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and Newton’s index, and compositional changes in the oral microbiome could be 
used to indirectly correlate the effect of enhanced oral care on pneumonia with 
modulation of the oral microbiome. Previous work in this area has been highly 
promising (Yoneyama et al. 2002, Bassim et al. 2008, Juthani-Mehta et al. 2014), but 
has typically evaluated nurse or carer led interventions rather than delivered by an 
oral health professional; and has not considered microbiological outcomes, 
measured compliance and oral hygiene effects in addition to respiratory disease 
incidence. 
Despite the limitations highlighted above, this study was an important first step in 
evaluating the possible contribution of perturbations within the denture-associated 
oral microbiome to pneumonia. Having demonstrated an association between an 
altered microbiome and an increase in the bioburden of putative respiratory 
pathogens, the premise for a causal association is established. Future research 
should aim to further disentangle the relationship between oral health, the oral 
microbiome and pneumonia pathogenesis; as well as assessing the impact of 
effective oral and denture care on modulating the oral microbiome and decreasing 
pneumonia risk in susceptible individuals. 
The results of this study can be used to inform a power calculation for both further 
observational or interventional studies. For instance, to give 80% power with an alpha 
of 5% in a study for an oral health intervention with an expected reduction of 20% in 
the mean relative abundance of PRPs on denture surfaces, a total sample size of 
278 participants would be required. As the impact of oral care on PRP carriage has 
not been evaluated to date, it would be sensible to include an interim analysis at an 
early point in such a study to refine the estimate based on the effect size seen.
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CHAPTER 5: DEVELOPMENT AND OPTIMISATION OF NOVEL ANTIMICROBIAL 
SILICONES TO PREVENT DENTURE-ASSOCIATED BIOFILMS 
5.1: Introduction 
With the growing threat of antimicrobial resistance, there is an urgent need for novel 
antimicrobial agents (Roca et al. 2015). Approximately 65% of healthcare associated 
infections are estimated to be biofilm-related (NIH, 2002). Biofilms offer a protective 
niche against both the host immune response and the action of many antimicrobials 
(Lindsay and Van Holy 2006). The ‘biofilm lifestyle’ entails a change in microbial cell 
behaviour, with altered metabolism due to nutrient privation and low oxygen tension 
in deep biofilm regions, which favours a reduction in many of the metabolic and 
proliferative pathways targeted by the majority of antimicrobials (Flemming et al. 
2016). Further compounding the problem, the biofilm environment increases the rate 
of persister cell formation, wherein microbes can reside in a viable but dormant state 
and thus tolerate many antimicrobial agents regardless of resistance (Jolivet-
Gougeon and Bonnaure-Mallet 2014).  
As has been outlined in previous sections, removable dentures offer a route for the 
acquisition of environmental pathogens, which can subsequently be transferred into 
the oral cavity in a protected, stagnant environment that encourages biofilm 
formation. With age, progressive atrophy of the alveolar ridges may lead to dentures 
becoming ill-fitting and uncomfortable, limiting function and oral health related quality 
of life (Polzer et al. 2010). In many functionally limited, frail elderly individuals in 
institutional care settings, regular provision of new dentures is challenging due to 
expense, availability of dental care and a decreased capacity to tolerate new 
dentures with declining oral muscular control (Holm-Pedersen et al. 2005). A potential 
means of mitigating this problem is to reline dentures, which can be achieved using 
either the addition of acrylic, or polyvinyl-siloxane (PVS) rubber materials.  
Silicone reline materials offer the advantage of cushioning the denture to increase 
comfort, particularly in the case of atrophic ridges which result in high concentration 
of masticatory pressures on tissues (Palla et al. 2015). Additionally, silicone materials 
allow areas of undercut to be engaged which can enhance retention and stability of 
removable dental prostheses. However, these materials degrade and become porous 
over time (Hashem 2015), which encourages microbial colonisation (Bulad et al. 
2004; Taylor et al. 2008). Candidal species in particular are able to infiltrate the 
silicone rubbers, generating biofilms which are highly recalcitrant to removal (Hahnel 
et al. 2012). In order to combat this problem, a number of researchers have attempted 
to incorporate antimicrobial agents into silicone rubbers (Lefebvre et al. 2001; Geerts 
et al. 2008; Salim et al. 2012; Bueno et al. 2015). 
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5.1.1: Silver as an antimicrobial agent 
Silver and silver metal salts have a storied history of application as antimicrobial 
agents, with the use of such compounds in vessels for transporting water and in a 
variety of medical applications in ancient Egyptian, Greek and Roman civilisation 
documented (Alexander 2009). The first application of silver in modern medicine was 
the use of silver nitrate to treat wounds and ulcers, followed by the use of silver in 
suture thread. In the early 20th Century, colloidal silver (a suspension of silver 
particles in liquid, usually water) was popularised for the treatment of ophthalmic and 
other infections including bacterial sepsis (Politano et al. 2013). In modern medicine, 
silver is used in a number of applications, including dressings for chronic wounds (Lo 
et al. 2009), linings for catheters (Beattie and Taylor 2011) and endotracheal tubes 
(Li et al. 2012). More recently, interest has grown in the use of silver nanoparticles in 
the medical setting (Burduel et al. 2018). Silver nanoparticles possess antimicrobial 
properties which are independent to silver metals. Instead, these may relate to the 
shape and size of the nanoparticles leading to penetration of microbial membranes, 
release of silver (Ag+) ions and induction of oxidative stress or interference with 
intracellular signalling (Rai et al. 2009). Despite growing use of silver nanoparticles 
in a wide range of applications, there are a number of toxicity and safety concerns 
(AshaRani et al. 2008). The mechanisms of toxicity of silver nanoparticles are poorly 
understood. Furthermore, nanoparticles are readily dispersed both within tissues 
(Lankfeld et al. 2010) and across the environment (Panyala et al. 2008), meaning the 
effects of such compounds could be impactive on a global scale. Caution, therefore, 
is warranted in the use of nanoparticles over metallic silver or its ionic salts. 
A particularly attractive feature of silver as an antimicrobial is the broad range of 
microbial targets it affects.  There are at least 7 distinct cidal mechanisms of ionic 
silver which have been characterised in the literature: 
1) The Ag+ cation can bind nucleic acids to form a number of complexes which alter 
the molecular structure of DNA and RNA, increase base pair melting temperatures 
and consequently inhibiting replicative and protein synthetic pathways. (Arawaka et 
al. 2001; Kozasa et al. 2008) 
2) Inactivation of enzymes through binding to thiol groups in amino acids such as 
cysteine (Feng et al. 2000). 
3) Generation of reactive oxygen species (ROS) secondary to inhibition of respiratory 
chain enzymes in an oxygen-dependent manner. This is an effect that appears to be 
related to interaction with thiol groups in amino acids, although other mechanisms of 
direct ROS generation are plausible (Park et al. 2009). 
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4) Inhibition of ATP production through inactivation of key respiratory enzymes and 
ribosomal proteins, including cytochrome proteins. Again, this is secondary to 
interactions with thiol groups in key amino acids and proteins (Bragg and Rainnie 
1974, Yamanaka et al. 2005). 
5) Proton leakage at cell membranes through interaction with either a broad range of 
membrane-associated proteins or the membrane phospholipid bilayer (Dibrov et al. 
2002; Jung et al. 2008). 
6) Disruption of microbial adhesion through ionic interactions which interfere with 
hydrogen bonds, electrostatic and hydrophobic interactions required for attachment 
to biofilm matrix and surfaces. Although silver ions at low concentration demonstrated 
no biocidal effect against established biofilms, they did increase permeability of the 
biofilm matrix, which could enhance the effectiveness of concurrent antimicrobial 
treatments. When used as a lining material for a sterile surface, it could be expected 
that silver ions would contribute to anti-adhesive properties (Chaw et al. 2005). 
7) Inhibition of glycolytic pathways through irreversible inactivation of 
phosphomannose isomerases (Wells et al. 1995). 
The combined anti-adhesive and broad range of non-specific microbiocidal properties 
of ionic silver make its therapeutic use, particularly in medical devices attractive, as 
resistance is relatively low (Percival et al. 2008). However, overexpression of efflux 
pumps is one mechanism known to confer resistance to silver in Gram negative 
pathogens such as P. aeruginosa (Mijnendonckx et al. 2013). Additionally, the benefit 
of ionic silver against established biofilm is to increase permeability of the EPS matrix 
to other antimicrobial agents, rather than to directly kill cells (Morones-Ramirez et al. 
2013). The synthesis of silver complexes with other antimicrobial compounds has 
therefore been an area of exploration for drug development research recently. A 
particularly promising prospect is the combination of silver salts with nucleophilic 
heterocyclic carbene (NHC) compounds (Gordon et al. 2010). 
5.1.2: Functionalisation of nucleophilic heterocyclic carbenes (NHCs) and 
conjugation with transition metals  
NHCs consist of pentane rings with a strong affinity for transition metals such as 
silver, gold, mercury and palladium (Figure 5.1.2). They are typically derived from 
imidazolium salts and are a popular compound due to their stability and the relative 
ease of synthesis (Anderson and Long 2010). A wide range of complexes can be 
formed, with 1 or multiple carbene groups complexed with a metal core. Additionally, 
considerable variation of the functional groups attached to the nitrogen atoms is 
readily achievable. This affords a huge array of potential compounds, which can be 
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tailored to achieve specific biochemical effects. The use of metal-NHC complexes as 
antimicrobial agents was first investigated by Çetinkaya et al. (1996), using 
complexes with ruthenium and rhodium. Silver-carbene complexes rapidly grew in 
popularity however, due to the inherent antimicrobial activity of ionic silver and 
widespread use of silver in medicine. The compounds also offer good antifungal 
activity against Candida species (Gök et al. 2014). The Ag(I) ionic state is stabilised 
through the addition of carbene complexes, enhancing the effectiveness of silver 
(Gordon et al. 2010). 
Figure 5.1.2: Typical structure of an imidazolium-derived nucleophilic heterocyclic carbene. 
R = Functional groups which may vary. 
(Image from Majhi et al. 2014) 
Silver NHCs have been found to exhibit antimicrobial activity against a range of PRPs 
including S. aureus and P. aeruginosa (Melaiye et al. 2004). The addition of carbenes 
appears to result in slow, sustained delivery of silver ions, which enhanced 
antimicrobial activity compared to the silver nitrate control. A murine P. aeruginosa 
respiratory infection study showed up to 100% survival following treatment with silver 
NHC complexes, which suggests that such compounds can be used safely at least 
in acute infective episodes (Cannon et al. 2009). However, extensive toxicity testing 
on cell lines have been contradictory, with some studies showing detrimental effects 
on epithelial cells, hepatocytes and lymphocytes, likely due to the impacts of ionic 
silver on the respiratory chain; while a number of studies have found no cytotoxicity 
of ionic silver (Hollinger 1996; Hidalgo and Domõnguez 1998; Ghosh and Banthia 
2004; Pellei et al. 2012). The toxicity of NHCs is likely to vary with the specific 
molecular structure and functional groups present. Therefore, each compound likely 
requires testing on a relevant range of cells and tissues. 
5.1.3: Antimicrobial properties of triclosan 
Triclosan is a chlorinated phenol (Figure 5.1.3) which is widely used for its broad-
spectrum antimicrobial properties. Triclosan has been shown to be effective at 
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inhibiting S. aureus, E. coli, C. albicans, and S. pneumoniae (Regös et al. 1979), 
although it is generally ineffective against P. aeruginosa due to multi-drug efflux 
pumps and the presence of a specifc enoyl-acyl carrier protein reductase FabV (Fang 
et al. 2010). It can be found in disinfectants, soaps, dentifrices among other 
household, personal care and medical products (Suller and Russell 2000). Triclosan 
has been found to have low toxicity at the concentrations used in many of the above 
applications, which has led to its widespread use in such a broad range of settings 
(Jones et al. 2000). However, a potential consequence of the ubiquitous use of 
triclosan in products marketed directly to the general public is the dissemination of 
triclosan throughout the environment in waste water. A particular concern is the 
potential hormone and development disrupting effects on fish and marine wildlife 
(reviewed in Dann and Hontela 2011), who are first exposed to triclosan via effluence.  
However, it should be noted that at present there is no evidence to support any 
meaningful detrimental effects in ecologically relevant exposure levels. 
Triclosan has biocidal activity at high concentrations, while it is bacteriostatic at lower 
concentrations through different mechanisms (Maillard 2002; Russell 2004). 
Bactericidal mechanisms involve multiple targets; triclosan can diffuse through 
bacterial cell walls to disrupt RNA, lipid and protein synthesis through interactions 
with biosynthetic enzymes, as well as membrane disruption leading to cell lysis. At 
sublethal concentrations, triclosan appears to interact with nucleic acids in the 
cytoplasm. It is thought that in both circumstances outlined above, the primary 
effector target is the enoyl-acyl carrier protein (ACP) reductase enzyme in bacteria, 
responsible for fatty acid synthesis. A similar mechanism is likely present in fungi, 
although this has yet to be properly defined. It is unlikely that triclosan targets the 
ergosterol pathway however, as synergistic effects have been found when combining 
triclosan with Amphotericin B or Fluconazole, both of which act primarily upon 
ergosterol biosynthesis (Movahed et al. 2016). 
Triclosan resistance has been reported in S. aureus strains (Suller and Russell 2000), 
although this has yet to impact clinical care of individuals and appears to occur at a 
low level overall. More worryingly, reports have suggested that triclosan may induce 
cross-resistance to antibiotics (Yazdankhah et al. 2006). This may occur through an 
alteration of the ACP biosynthetic pathway in instances where this pathway is 
targeted by antibiotics, particularly pertinent to the development of isoniazid 
resistance in Mycobacterium tuberculosis (Russell 2004). In Gram negative 
microorganisms such as Acinetobacter or Pseudomonas species, resistance is likely 
related to high constitutive expression of efflux pumps. Worryingly, evidence 
suggests that triclosan exposure among such microorganisms may drive clones with 
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higher rates of efflux pump expression (Chuanchuen et al. 2003). The impact of 
triclosan on S. aureus is controversial, as an early study demonstrated plasmid-
mediated mupirocin resistance to also confer triclosan resistance (Cookson et al. 
1991). However, subsequent research has not found this mechanism (Suller and 
Russell 2004). Triclosan exposure may also drive selection of small-colony variants, 
which exhibit a reduced growth rate and altered metabolic behaviour due to defects 
in the electron transport chain (Seaman et al. 2006). These changes in cell 
biochemistry drive antimicrobial resistance in a manner comparable the (although 
distinct from) the antimicrobial tolerance conferred to persister cells in biofilms 
outlined in Section 1.1.3.6.  
Despite such potential concerns, triclosan remains a popular antimicrobial agent with 
an excellent record of clinical safety. 
Figure 5.1.3: Chemical structure of triclosan.  
Despite being halogenated, triclosan is considered to be essentially non-ionic, which aids biofilm matrix 
penetration. 
(Image from Hontela and Habibi 2013) 
5.1.4: Silicone as a denture biomaterial - key features and chemical properties 
Silicone is used across a wide range of biomedical applications due to its favourable 
properties: stability after autoclaving; maintenance of physicochemical properties 
over time; anti-adhesive properties, biocompatibility and imperviousness to 
degradation by the host immune cells or microbes (Quinn and Courtney 1988). 
Silicone monomers can be polymerised into rubber by a variety of catalysts and 
chemistries. The resultant polymer is a soft, flexible and elastomeric material which 
can be polymerised in moulds to permit highly customisable topographies. This 
makes them ideal materials for use as denture soft-liners, their soft, viscoelastic 
nature facilitating the distribution of occlusal forces across a wide surface area of oral 
tissue to improve comfort during masticatory function (Dootz et al. 1992). Additionally, 
their high dimensional stability and surface conformity allows an intimate association 
with the oral mucosa, include engagement of areas of undercut which can improve 
denture retention and stability (Goiato et al. 2008). 
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However, such soft denture lining materials have several disadvantages of biological 
consequence. Long-term resiliency of silicones is limited, and the materials tend to 
degrade over time, becoming permeable to microbes (Herman et al. 2008; Taylor et 
al. 2008). Candida albicans in particular has been found to readily invade silicone 
rubbers in denture liners, with penetrating hyphae proving recalcitrant to removal 
(Nevzatolu et al. 2007). Silicones also offer relatively poor resistance to abrasion, 
with degradation of the surface upon aggressive brushing, particularly if abrasive 
dentifrices or unsuitable denture cleansers are used (Jin et al. 2003). This can 
increase both surface area available for colonisation by microbes and surface 
roughness, which may generate sheltered niches for microbes to evade removal by 
chemo-mechanical cleansing. The bond between silicone and PMMA can also break 
down (Gundogdu et al. 2014). This may lead to partial detachment of the silicone 
liner to the acrylic surface which generates a nidus not only sheltered from chemo-
mechanical removal but also host immune cells and saliva. These limitations have 
reduced the effectiveness of silicones for long term use, necessitating frequent 
replacement which is costly and resource intensive. One approach to minimise 
microbial colonisation of these materials has been to incorporate antimicrobial agents 
into the silicone polymers. 
5.1.5: Antimicrobial silicones - current concepts and modalities 
Biomaterials may exhibit antimicrobial activity by one, or a combination of, two 
primary features (Francolini et al. 2017). Materials which inhibit microbial attachment 
or perturb biofilm formation without directly killing microbes or inhibiting growth can 
be termed anti-adhesive or anti-fouling. Alternatively, biomaterials may either kill 
microbes in a contact dependent manner (non-releasing materials) or by release of 
antimicrobial substances from their surface into the surrounding environment 
(releasing materials). An important consideration for releasing materials is the 
rechargeability of the antimicrobial contents if long-term activity is important. Either 
release and reattachment of the antimicrobial component must occur continuously by 
dynamic equilibrium, or it must be possible to recharge the antimicrobial reservoir 
without necessitating replacement of the entire material (Sun et al. 2012; Lv et al. 
2013). 
Much attention regarding antimicrobial silicones has fallen upon the prevention of 
infections associated with indwelling urinary catheters. These devices offer an 
attractive testing ground for antimicrobial coatings, as antimicrobial activity is typically 
required for up to 12 weeks before the catheter is changed (Crouzet et al. 2007; Wilde 
et al. 2013). Symptomatic urinary tract infections associated with long-term catheters 
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affect up to 12.6% of catheterised patients (Nicolle 2014). A number of coatings have 
been trialled to reduce the incidence of infections in catheterised patients. One large, 
multicentre UK randomised control trial (Pickard et al. 2012) compared 3 different 
catheters in normal NHS use: a PTFE-coated device (control); a silver alloy-coated 
catheter, and a nitrofurazone antibiotic-impregnated catheter. Only the nitrofurazone-
impregnated devices demonstrated a statistically significant difference in catheter-
associated urinary tract infections (CAUTIs), although these catheters resulted in 
greater discomfort during use and removal. A recent systematic review (Drekonja et 
al. 2008) examined a total of 13 randomised control trials examining the impact of 
antimicrobial catheters on the development of catheter-associated bacteriuria or 
fungiuria (CABF). None of the included studies directly examined the development of 
symptomatic infections. Interestingly, the authors noted that studies of silver-coated 
catheters conducted prior to 1995 demonstrated substantial reductions in CABF rates 
(Median relative risk 0.32; range: 0.24-0.44), while studies conducted subsequently 
failed to show a meaningful reduction in CABF rates by such devices. The reasons 
for more recent studies failing to replicate such promising earlier results is unclear. 
However, the authors speculate that one factor may be the use of latex catheters in 
the earlier studies, while later studies employed silicone or silicone-coated devices. 
This demonstrates the importance of the enhanced anti-adhesive properties of 
silicone over latex and supports the strategy of combining anti-fouling and 
antimicrobial components in such devices. In contrast, epidemiological research 
offers support for the effectiveness of silver-alloy catheters in reducing CAUTI rates. 
A report from the National Healthcare Safety Network found a 58% relative reduction 
in infection in silver-coated catheters compared to standard catheters (Lederer et al. 
2014).  
A number of alternative antibiotics and antimicrobial agents have been tested in vitro, 
but their use remains unproven in a clinical setting. Unsurprisingly, most research 
pertaining to denture lining materials has focussed on antifungal activity against 
C. albicans. To date, no clinical research has been conducted on antimicrobial 
silicones in dentistry. 
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5.2: Aims and Objectives 
The principle aims of this work package were to: 
1. Screen a range of novel imidazolium-derived NHC compounds and their silver 
complexes against relevant planktonic PRP cultures and biofilms 
2. Develop a method for incorporating such compounds into silicone biomaterials 
3. Test the antimicrobial activity and toxicity of silicones incorporating silver-NHC 
compounds 
Hypotheses 
• Imidazolium-derived NHC compounds will demonstrate antimicrobial activity 
against planktonic PRPs and biofilms
• Antimicrobial activity will be enhanced by complexing with ionic silver, with a 
reduction in the concentration of antimicrobial required and/or antimicrobial activity 
against species where previously no activity was found
• Incorporation of antimicrobial complexes into silicone materials will not adversely 
effect the physicochemical properties of the materials
• Silicones with antimicrobial complexes incorporated will demonstrate antimicrobial 
activity against the same microorganisms as the compounds in suspension
• Silicones with antimicrobial complexes incorporated will demonstrate low toxicity
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5.3: Materials and Methods 
5.3.1: Preparation of experimental compounds 
A number of NHCs were prepared by collaborators in the School of Chemistry, Cardiff 
University by deprotonation of imidazolium salts, with functional groups consisting of 
saturated or unsaturated hydrocarbon chains which varied in length, terminating in 
an alkyl group. Compound structure and purity was confirmed by the presence of 
characteristic peaks through mass spectroscopy nuclear magnetic resonance (MS-
NMR). The chemical structure of each test compound is presented in Table 5.3.1. 
Synthesised compounds were dissolved in dimethylsulfoxide (DMSO, Sigma-Aldrich, 
Gillingham, UK) at 10 mg/ml, and silver-complexes shielded from light due to photo-
reactivity in solution. Compounds were stored for up to 30 days at room temperature 
prior to use. 
Table 5.3.1: Chemical structure of test imidazolium-derived NHC compounds
Compound Chemical Formula Chemical Structure
1  
2 
3 
4 
5 
6 
7 
8 
C14H26N2O3S
Mol. Wt.: 302.43 NNC8H17
SO3-
C18H34N2O3S
Mol. Wt.: 358.54
NN
C12H25
SO3-
NS SO3-
HO
NS
C8H17
Br
HO
NN
Me C12H25
Br-
C H BrN
NN
Me C8F17
I
N N
Me
Br
C15H20N2O3S
Mol. Wt.: 308.4
C14H26BrNOS
Mol. Wt.: 336.33
C9H15NO4S2
Mol. Wt.: 265.35
C16H31BrN2
Mr 331.34
C14H10F17IN2
Mol. Wt.: 656.12
C15H27BrN2
Mol. Wt.: 315.29
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5.3.2: Selection and culture of microbial reference strains for antimicrobial 
testing 
A panel of microbial reference strains representative of pathogenic species frequently 
isolated in healthcare-associated infections was selected for evaluation (Table 5.3.2). 
This included yeast, gram-negative and gram-positive microbes to account for 
possible differences in activity of prospective antimicrobial compounds.  
Table 5.3.2: Reference strains used for in vitro biofilm model 
Microorganism Strain  Isolated from 
Candida albicans ATCC 90028 Blood 
Staphylococcus epidermidis RP62A Intravascular catheter-
associated infection 
Staphylococcus epidermidis ATCC 14990  Nose 
Staphylococcus aureus NCTC 6571 Not specified 
Staphylococcus aureus NCIMB 9518 human lesion 
Escherichia coli NCTC 12923 Faeces 
Pseudomonas aeruginosa ATCC 15692 Infected wound 
5.3.3: Screening of experimental compounds for inhibition of microbial growth 
using the broth microdilution method 
Initial screening of antimicrobial activity of test compounds was conducted using a 
minimum inhibitory concentration (MIC) assay. Test compounds were dissolved in 
dimethylsulfoxide (DMSO) at 10 mg/ ml concentration to produce stock solution. This 
stock solution was subsequently diluted 2-fold to produce a range of concentrations 
to 78 µg/ ml. DMSO dilutions were then further diluted 1 in 50 in either Mueller-Hinton 
broth (Sigma-Aldrich, Gillingham, UK) for bacterial strains or RPMI 1640 medium 
(Sigma-Aldrich, Gillingham, UK) supplemented with 2% glucose and 0.165 M 3-(N-
morpholino)propanesulfonic acid (MOPS), to produce concentrations ranging from 
200 µg/ ml to 1.56 µg/ ml in 1% DMSO solution. 
100 µl of each compound in broth was added in triplicate to a 96 well microtiter plate 
(Starstedt, Leicester, UK). DMSO was added to each respective growth medium at 
2% v/v concentration and added to two further triplicate columns in the microtiter plate 
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for positive and negative controls. Subsequently, an inoculum of the test 
microorganism was prepared. The test microbe was cultured overnight in appropriate 
growth medium aerobically at 35 ÊC. Overnight bacterial suspensions were diluted to 
a 0.5 MacFarland standard by measuring absorbance at 620 nm using a 
spectrophotometer, to give an optical density of 0.8-0.1. Candida albicans was diluted 
similarly to an inoculum optical density of 0.9-1.1. 
Standardised inocula were then diluted 1:1000, giving an approximate inoculum 
concentration of 1x105 bacterial CFU/ ml, and 1x104 Candida CFU/ ml. 100 µl of test 
microbial suspension was added to each well containing antimicrobial solution, and 
the positive control wells. 100ul of blank growth medium was added to the negative 
control wells. This resulted in a final test concentration of 100 µg/ ml to 0.78 µg/ ml of 
each compound. 
After inoculation, microtiter plates were incubated aerobically at 35 ÊC for 16-20 h. 
Absorbance was then measured at 620 nm using a plate reader (OMEGA, BMG 
Labtech, Aylesbury, UK). The negative control absorbance value was subtracted 
from all wells to correct for background absorbance. The MIC value for each 
compound was determined as 80% reduction in absorbance relative to positive 
control wells. If a compound was inhibitory against the test microbial species, the 
assay was retained for further use in testing the minimum biocidal concentration. 
Each experimental was subsequently repeated twice. 
5.3.4: Determining minimum biocidal concentrations (MBCs) of antimicrobial 
compounds 
Microtiter plates from MIC assays in which compounds had demonstrated inhibition 
of growth in the test microbial species were used for MBC testing. The liquid medium 
was removed from each well ranging from 1 concentration below the MIC value, to 
the maximum concentration, after mechanically agitating the contents with the pipette 
tip to remove adherent microorganisms from the plastic surface. The microbial 
suspension was then added to plain growth medium at a concentration of 1:20, to 
ensure that any antimicrobial compound was diluted to well below the MIC. 
Suspensions were incubated aerobically at 35 ÊC for a further 24 h, then centrifuged 
at 4000 RPM for 5 min to pellet the cells. The supernatant was discarded, and the 
cell pellet resuspended in 50 µl of PBS. The entire volume of resuspended cells was 
inoculated onto Mueller-Hinton agar using a spiral plater (Don Whitley Scientific, 
Bingley, UK). Both positive and negative control wells were processed identically. 
Plates were incubated for a further 24-48 h, until colony growth was evident in positive 
controls. The MBC value was determined as the concentration at which less than 50 
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colonies of test microorganisms were present. MBC testing followed every MIC 
repeat, and so was repeated twice. 
5.3.5: Assessing biofilm eradication potential of experimental antimicrobial 
compounds using a microtiter plate assay 
An overnight microbial suspension was prepared under the conditions described in 
section 5.3.3. The suspension was standardised to a MacFarland standard of 0.1 for 
bacteria or 1 for Candida as described previously. 100 µl of this inoculum was then 
added to a 96 well microtiter plate, in 9 triplicate wells, with blank growth medium 
added in triplicate to further wells to act as a negative control. Microtiter plates were 
incubated without shaking for 24 hours to allow biofilm formation. Following this, 
growth medium and loose, non-adherent cells were removed by pipetting, and each 
well rinsed with 100 µl PBS.  
Test compounds prepared as described in section 5.3.3 were then added to each 
well to provide a concentration ranging from 200 µg/ ml to 1.56 µg/ ml. To the positive 
and negative control wells, growth medium containing 2% v/v DMSO was added. The 
test biofilms were incubated for a further 24 h, then the antimicrobial solutions 
removed by pipetting. Wells were washed twice with 100 µl PBS, then biofilms were 
resuspended in 100 µl growth medium and mechanical agitated to ensure adequate 
resuspension. The same procedure was completed for positive and negative control 
wells to ensure equivalent treatment. 
Turbidity was measured by optical density at 620 nm using a spectrophotometer 
(BMG Labtech, Aylesbury, UK). The optical density reading from the negative control 
wells was subtracted from all test wells to compensate for absorbance of blank growth 
medium. The minimum biofilm eradication concentration (MBEC) for each compound 
was defined as the lowest concentration at which turbidity was reduced by 80% 
relative to positive controls. MBEC tests were subsequently repeated twice. 
5.3.6: Incorporation of experimental antimicrobial compounds into silicone 
materials by bulk-loading 
Silicones were mixed using a proprietary two-part mixture of base polymer Part A) 
and a catalyst containing polymer (Part B) in a 10:1 v/v ratio.  Following initial hand 
mixing to eliminate air bubbles, the silicone mixture was loaded into a rotary mixer 
and mixed under vacuum at high speed for 3 min. Silicones were then decanted into 
metal moulds and cured by heating at approximately 80ºC for 2 h. This produced 
5 mm thick sheets of silicone rubber with a uniform, macroscopically smooth surface, 
which were sectioned using a scalpel into 10 x 10 mm coupons.  
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Triclosan and triclosan acetate were dissolved in an excess volume of acetone and 
added to the silicone mixture during hand mixing. After rotary mixing under vacuum, 
excess acetone was evaporated using a rotary evaporator (Büchi Rotavap R300, 
Büchi Labortechnik AG, Flawil, Switzerland) at 50 °C and the silicones heat-cured as 
previously described.  
To dissolve test compounds while ensuring minimal solvent residue in the final 
silicone material, 100 mg of each test NHC compound and silver salt was combined 
with a 1% DMSO: 99% acetone mixture (v/v). Initial attempts to incorporate the test 
materials into silicone polymers resulted in a failure of the silicone to cure. It was 
speculated that this was likely due to interaction of NHC compounds and ionic silver 
with the platinum catalyst responsible for cross-linking of the silicone polymer and 
therefore alternative materials were explored. 
5.3.7: Incorporation of experimental antimicrobial compounds into acetoxy-
resin material 
An acetoxy resin (A-100 Type A Medical Adhesive, Technovent, Bridgend, UK) was 
trialled as an alternative material for loading of the test materials. This product has a 
history of application in the biomedical field, and bonds effectively to silicone rubbers 
and acrylic biomaterials. However, unlike PVS materials, this product cures by 
condensation upon contact with atmospheric moisture which is independent of a 
metal catalyst. 
Again, 100 mg of test NHC compounds were dissolved in 1% DMSO: 99% acetone 
v/v to a total volume of 10 ml and thoroughly hand mixed into 9.8 g of acetoxy resin 
material. Excess acetone was removed using a rotary evaporator (Büchi Rotavap 
R300, Büchi Labortechnik AG, Flawil, Switzerland) at 50 °C. Acetoxy resin materials 
were subsequently applied to silicone rubber prepared as per section 5.3.6 and cured 
over night at room temperature, protected from light. However, the viscosity of the 
material made the resultant surface finish macroscopically irregular and was 
approximately 1 mm thick, which was felt to offer unacceptable dimensional control 
for prospective clinical applications. Consequently, an alternative method of 
generating a thin, even coating of material was sought, using a dip-coating method. 
5.3.8: Formulation of acetoxy-resin silicone oil dispersion containing 
experimental antimicrobial compounds 
Acetoxy resins were combined with test compounds as described above, then 
immediately added to a silicone-based fluid (G608 Pro Bond Remover, Technovent, 
Bridgend, UK) in a 1:1 ratio. The resultant mixture was mixed vigorously by hand 
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using stainless steel mixing balls (8 mm diameter) to ensure an even dispersion was 
generated. Silicone rubber sheets were dipped into the mixture and the excess 
drained. The coated sheets were then cured on a flat, level surface overnight at room 
temperature, protected from light. A total of 3 dip coats were applied. Test materials 
were sectioned into 10 x 10 mm coupons for subsequent testing. 
All test materials were disinfected by immersion in 100% ethanol for 60 s prior to use. 
5.3.9: Screening of antimicrobial activity of materials using zone of inhibition 
assays 
Overnight suspensions of test microbial species were prepared as described 
previously and standardised to an optical density of 0.1 and 1 for bacterial and 
Candida respectively in 0.9% PBS, using absorbance measured by 
spectrophotometer at 620 nm. Prepared inocula were then added to Mueller-Hinton 
agar plates using a sterile cotton swab and spread evenly across each surface to 
produce a microbial "lawn". Within 15 min of inoculation, the test material was 
aseptically added to each plate using sterile tweezers, and gently pressed against 
the surface to ensure adequate contact. Plates were incubated aerobically at 35 ÊC 
for 16-20 h, until even microbial growth was observed across the surface. Circular 
areas in which microbial growth was inhibited were measured in full diameter using 
digital callipers, reading from the underside of each plate.  
5.3.10: Evaluating antimicrobial activity of materials using Live/Dead staining 
and quantitative analysis of CLSM imaging 
Standardised inocula in 0.9% PBS were prepared from overnight suspensions of test 
microorganisms as described in Section 5.3.9. Representative microorganisms 
selected were C. albicans, E. coli, and an S. aureus strain to represent yeasts, Gram-
negative and Gram-positive bacteria respectively. Sterilised test materials were 
placed in triplicate in 12 well microtiter plates, and 100 µl of microbial inoculum added 
by pipetting to the centre of each material. Well plates were sealed using Parafilm 
(Sigma Aldrich, Gillingham, UK) and incubated aerobically for 24 h at 37 ºC.  
After incubation, samples were labelled with the BacLight Live/Dead stain and 
imaged using a Leica SP5 confocal laser-scanning microscope as described in 
Section 2.3.8.2. 
Microscopic images were analysed using the COMSTAT 2.1 plugin in ImageJ, as 
described in Section 2.3.8.2.1, to provide surface area coverage data (µm2). 
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5.3.11: Characterisation of physico-chemical properties of antimicrobial 
materials 
A range of tests of physico-chemical properties silicone and acetoxy resin materials 
were undertaken to ensure that no adverse effects were generated through the 
incorporation of experimental compounds. The tensile strength of acetoxy resins was 
not investigated as this was applied as a coating to silicones and not intended for 
independent use. Otherwise all tests were undertaken on the selected experimental 
materials from Section 5.3.10. 
5.3.11.1: Evaluation of tensile strength and tear resistance of materials 
Unmodified silicone specimens were used as controls. A total of 10 dumbbell shaped 
specimens (10 mm x 45 mm x 2 mm) of each test material were fabricated. At the 
midpoint length of each sample, a scalpel was used to make a cut 4 mm across the 
sample, to initiate a tear.  Samples were loaded into a Mecmesin MultiTest-d machine 
(Mecmesin Ltd, Slinfold, UK) and loaded at a speed of 300 mm/min. The proprietary 
software was used to calculate the percentage elongation and maximum load for 
each material until tearing. 
5.3.11.2: Evaluation of surface roughness of materials by optical profilometry 
Test materials formulated as described in sections 5.3.6 and 5.3.8 were tested 
according to ISO 4287:1997 (Geometrical product specifications (gps) -- surface 
texture: profile method) using a white light interferometer (Micro XAM-100-HR, KLA-
Tencor, Wokingham, UK) with the assistance of Dr. E Brousseau, School of 
Engineering, Cardiff University. A total of 6 samples for each material were analysed, 
with mean Ra values (the arithmetic average of the roughness profile) calculated by 
the proprietary software. 
5.3.11.3: Evaluation of hydrophobicity of materials by dynamic contact     
angle analyser 
Test materials were prepared in 10 mm x 10 mm x 1 mm coupons, with 6 replicates 
of each material tested. Following 30 s immersion in ethanol to remove any surface 
contaminants, specimens were transferred into a Dynamic Contact Angle analyser 
(DCA-312, Thermo Cahn Instruments, Madison, USA), being careful to avoid contact 
of samples with skin. Samples were immersed in water and the advancing contact 
angle recorded.  
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5.3.12: Exploration of cytotoxicity of compounds and materials 
The following experiment was conducting in the Institute of Life Sciences 1 (ILS1) 
building, Swansea University, working in collaboration with Dr. Tom Wilkinson.  
Test materials were prepared using the experimental compounds which 
demonstrated greatest antimicrobial activity by MIC, MBC, MBEC and zone of 
inhibition tests. Materials were sterilised by immersion in ethanol, which was allowed 
to evaporate in a fume cabinet. Test materials were then aseptically transferred to 
12-well plates. Whole blood from clinically healthy donors was collected by the clinical 
research facility affiliated with Dr Wilkinsons research group and 500 µl of blood 
added to the surface of each material, taking care to ensure that the entire material 
surface area was covered. Additionally, blood was added to duplicate blank wells, to 
act as negative controls (background); plain silicone and a plain acetoxy resin-coated 
silicone were used as internal negative controls for triclosan-loaded silicones and 
silver-complex modified acetoxy resins, respectively. Lipopolysaccharide (LPS) 
derived from E. coli (Sigma Aldrich, Gillingham, UK) at a concentration of 1 µg/ml as 
a positive control. 
Incubation of blood with the test materials was conducted for 0, 2 and 4 h. For 2 and 
4 h incubations, samples were incubated aerobically at 37 °C with shaking (120 RPM) 
to prevent sedimentation of blood.  
Following incubation with test materials, blood was transferred to sterile 1.5 ml 
microcentrifuge tubes by gentle pipetting. Samples were subsequently centrifuged at 
3000 RPM for 5 min, and the platelet-free plasma supernatant transferred to new 
sterile microcentrifuge tubes. Samples were frozen at -80 °C prior to analysis of 
cytokines. Cytokine analysis was conducted using the BD Biosciences cytometric 
bead array for human inflammatory cytokines (BD Biosciences, Wokingham, UK), as 
described in Section 4.3.5.6. An outline of the screening process and subsequent 
evaluations for test compounds is displayed in Figure 5.3.12. 
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Figure 5.3.12: Screening process and evaluations for test compounds and 
materials 
Initial screening of NHC compounds (n=8) and silver 
complexes (n=5, 3 chemically unstable), silver nitrate, 
triclosan (control) and triclosan acetate by MIC testing 
Second stage screening of NHC compounds (n=3) and 
silver complexes (n=3), silver nitrate, triclosan (control) 
and triclosan acetate by MBC testing 
Third stage screening of NHC compounds (n=3) and 
silver complexes (n=2), silver nitrate, triclosan (control) 
and triclosan acetate by MBEC testing 
Incorporation of silver complexes (n=2), triclosan and 
triclosan acetate into acetoxy resins 
Surface roughness , tear 
resistance and contact 
angle evaluation 
Zone of inhibition testing 
to evaluate release of 
materials from silicones 
Direct inoculation of 
materials for L/D 
staining and CLSM 
evaluation
‘Cytotoxicity’ blood assay 
for pro-inflammatory 
cytokines by FACS 
No inhibition in:
5 NHC compounds 
2 silver complexes 
No biocidal effect in:
1 silver complex 
No biofilm eradication in:
Any compound for 
P. aeruginosa
NHC compounds (n=3) 
excluded due to narrow 
spectrum of activity 
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5.4: Results 
5.4.1: Minimum Inhibitory Concentrations (MICs) for test compounds 
The majority of tested compounds demonstrated some inhibitory activity against at 
least one of the pathogens (Table 5.4.1). There was no clear trend of modulation of 
antimicrobial activity by length of hydrocarbon chains. However, halogenated 
compounds appeared to inhibit microbial growth at lower concentrations overall. The 
addition of silver to the NHC compounds led to a greater spectrum of antimicrobial 
activity (fewer uninhibited microorganisms) but did not appear to result in a reduced 
MIC value in microorganisms against whom the NHC ligand was already effective. 
This may be due to a net reduction in the quantity of ligand present. Only one 
compound, Ag C16H31BrN2, was effective against all microorganisms at the 
concentrations tested. Several of the NHCs could not be complexed with ionic silver; 
silver particles precipitated from these solutions and sedimented at the base of the 
containers. These compounds were thus excluded from further testing. Similarly, 
compounds which all microorganisms were able tolerate at the tested concentrations 
were also excluded. Triclosan demonstrated activity against all microorganisms with 
the exception of P. aeruginosa.  
Table 5.4.1: Minimum Inhibitory Concentrations (MICs) for test compounds 
MICs for test compounds are expressed in µg/ml 
R = no inhibition observed at all concentrations tested 
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5.4.2: Minimum Biocidal Concentrations (MBCs) for test compounds 
Only those compounds which demonstrated effective inhibition of at least one 
microbial species were tested for biocidal activity (Table 5.4.2). As was observed in 
MIC tests, the complexing of the NHC ligands with ionic silver resulted in a broader 
spectrum of biocidal activity but did not alter the concentration at which this occurred 
in most cases. With the exception of S. epidermidis strains, triclosan compounds had 
minimal biocidal effects. Again, one compound, Ag C16H31BrN2, demonstrated 
biocidal activity against all strains tested.
Table 5.4.2: Minimum Biocidal Concentrations (MBCs) for test compounds  
5.4.3: Minimum Biofilm Eradication Concentrations (MBECs) for test      
compounds 
No compound was effective against P. aeruginosa biofilms (Table 5.4.3). However, 
most compounds, most notably the triclosan compounds, demonstrated anti-biofilm 
activity against the Gram-positive Staphylococci. Silver nitrate was ineffective against 
all bacterial biofilms. Again, Ag C16H31BrN2 demonstrated the broadest range of 
activity, with anti-fungal and activity against E. coli, although only at the highest 
concentration tested were E. coli biofilms affected. By comparison, the triclosan 
compounds demonstrated much greater effectiveness against Staphylococci (MBEC 
6.25 µg/ml for S. aureus strains, 3.125 µg/ml for S. epidermidis strains vs. 100 µg/ml 
and 12.5 µg/ml respectively for Ag C16H31BrN2), but no effectiveness against E. coli 
or C. albicans at the concentrations evaluated. 
Table 5.4.3: Minimum Biofilm Eradication Concentrations (MBECs) for test 
compounds 
MBCs for test compounds are expressed in µg/ml 
R = no biocidal effect noted at all concentrations tested 
X = not tested due to lack of inhibition noted in preceding MIC tests 
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5.4.4.1: Bulk-loading of antimicrobial compounds into silicones 
Attempts to incorporate both NHCs and silver-NHC complexes into silicones resulted 
in an inhibition of curing of the silicone, due to a failure in polymerisation. This 
inhibition remained regardless of whether room temperature or heat-cured silicones 
were used. There was also a strong, brown discolouration of the silicone materials. 
5.4.4.2: Incorporation of silver-NHC compounds into an acetoxy-resin silicone 
oil dispersion 
The incorporation of both NHCs and silver-NHC complexes into an acetoxy-resin 
material proved to be successful, with no effect on the normal curing time of this 
material. Subsequent formation of a dispersion by combining the test compounds and 
acetoxy-resin in a silicone oil also proved successful, with the formation of a smooth, 
thin layer of material on silicone surfaces following dip-coating. There was a brown-
red discolouration observed in these materials, but this was markedly reduced 
compared to that seen in silicones.  
5.4.5: Antimicrobial activity in silicones and acetoxy resin materials assessed 
by zone of inhibition (ZOI) assays 
Initial screening of antimicrobial activity by zone of inhibition assays demonstrated 
limited activity for silver-NHC complexes, but a strong inhibitory effect of triclosan 
compounds against Staphylococci (Table 5.4.5). The silver-NHC complexes were 
hypothesised to exert antimicrobial activity in a contact-dependent manner rather 
than by release and diffusion from materials, and so further testing by direct 
inoculation of surfaces was undertaken. 
MBECs for test compounds are expressed in µg/ml 
R = no biofilm eradication noted at all concentrations tested 
X = not tested due to lack of biocidal activity noted in preceding MBC tests 
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Table 5.4.5: Zones of Inhibition for test silicone and acetoxy-resin materials 
5.4.6: Assessment of antimicrobial activity of silicones and acetoxy-resins 
The tested materials had different effects on each of the tested species. Candida 
albicans was able to adhere to and remain viable upon all materials (Figure 5.4.6 A 
& B). While there was an approximate 50% reduction in total viable adherent 
microbes (Figure 5.4.6 B) on the Ag C16H31BrN2-modified acetoxy resin material 
compared to the control, this was neither statistically significant nor clinically relevant. 
Surprisingly, E. coli adhered very poorly to the plain acetoxy resin control, despite 
high adherence to the silver-complex modified materials and silicones (Figure 5.4.6 
D). Despite this reduced adherence, the overall viability of adherent E. coli to all test 
materials was similar, at around 40-60% (Figure 5.4.6 C). Triclosan acetate caused 
an almost 97% reduction in the proportion of viable S. aureus compared to plain 
silicone controls (Figure 5.4.6 E), with a decrease in absolute quantity of viable 
microbes of 98.8% and a decrease in the total quantity of adherent microbes (live or 
dead) of 97.8% (Figure 5.4.6 F). As was seen with E. coli, there was no impact of 
incorporation of silver-complexes in acetoxy resins on the adherence or viability of S. 
aureus. In fact, incorporation of Ag C16H31BrN2; the most promising antimicrobial in 
earlier screening, appeared to result in both greater adherence and a greater 
proportion of viable S. aureus. 
ZOIs expressed in mm corresponding to the diameter of the zone of no growth observed
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Figure 5.4.6: Antimicrobial activity of test materials as assessed by quantitative evaluation of 
Live/Dead stain of microbial inocula on material surfaces 
A) Proportion of live/dead C. albicans
B) Surface area occupied by live/dead C. albicans
C) Proportion of live/dead E. coli
D) Surface area occupied by live/dead E. coli
E) Proportion of live/dead S. aureus
F) Surface area occupied by live/dead E. coli
Mean values shown in columns. Error bars represent SEMs. All samples were tested in triplicate; N=3. 
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5.4.7: Impact of triclosan and triclosan acetate bulk-loading on physico-
chemical properties of silicone  
A notable visible effect of incorporation of triclosan materials in silicones was a white 
colouration to the material (data not shown).  
5.4.7.1: Tensile strength and tear resistance 
There was no significant effect of the addition of triclosan compounds on the 
percentage elongation of silicone materials (Table 5.4.7.1). However, both triclosan 
and triclosan acetate significantly reduced the tear resistance of materials. Despite 
strong statistical significance however, the magnitude of the difference was relatively 
small (an approximately 25% reduction). The significance of such changes in a 
clinical setting are questionable. 
Table 5.4.7.1: Tensile strength and tear resistance of silicones 
Material Mean % elongation (S.D.) Mean maximum load (N) 
before tear (S.D.)
Plain Silicone 
(control) 
435.86 (57.54) 32.20 (4.28) 
1% Triclosan 438.46 (28.29) 23.62**** (3.17) 
1% Triclosan 
Acetate 
451.98 (44.19) 25.84** (3.97) 
** P=0.0019, **** P<0.0001 (One-way ANOVA with Dunnetts test vs. plain silicone 
control group). N = 10. 
5.4.7.2: Contact angle 
The addition of triclosan compounds to silicone led to statistically significant 
increases the hydrophilicity of the materials (Table 5.4.7.2). This may be due to 
residual acetone within the material. 
Table 5.4.7.2: Contact angles for silicones measured in water
Material Contact Angle (°) (S.D.) Interpretation
Plain Silicone (control) 96.3 (6.37) Hydrophobic 
1% Triclosan 71.2**** (6.02) Weakly hydrophilic 
1% Triclosan Acetate 69.7**** (5.64) Weakly hydrophilic 
**** P<0.0001 (One-way ANOVA with Dunnetts test vs. plain silicone control group) 
N = 10. 
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5.4.7.3: Surface roughness 
The addition of triclosan compounds to silicones resulted in an approximately 3-fold 
increase in the Mean Ra values, which was statistically significant (Table 5.4.7.3). 
Table 5.4.7.3: Ra Values for silicone materials
Material Mean Ra (S.D.)
Plain Silicone (control) 0.0682 (0.018) 
1% Triclosan 0.178**** (0.008) 
1% Triclosan Acetate 0.17**** (0.012) 
**** P<0.0001 (One-way ANOVA with Dunnetts test vs. plain silicone control group) 
N = 6 
5.4.8: Impact of incorporation of silver-NHC compounds on physico-chemical 
properties of acetoxy-resin materials    
The silver-NHC compounds imparted a slight silver-brown colouration to the acetoxy 
resin materials, although this was less strong than had been seen during attempted 
bulk-loading of silicone materials. 
5.4.8.1: Contact angle 
There was no significant impact on the hydrophobicity of acetoxy resins following the 
addition of silver-NHC complexes (Table 5.4.8.1). The materials were very weakly 
hydrophilic overall. 
Table 5.4.8.1: Contact angles for acetoxy resins measured in water
Material Contact Angle (°) 
(S.D.)
Interpretation
Acetoxy Resin (control) 87.2 (4.72) Very weakly hydrophilic 
Ag C16H31BrN2 85.0 (7.14) Very weakly hydrophilic 
Ag C14H10F17IN2 88.5 (4.37) Very weakly hydrophilic 
N = 10. 
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5.4.8.2: Surface roughness 
The addition of silver-NHC complexes had no significant effect on the mean Ra value 
of the acetoxy resins (Table 5.4.8.2). The roughness of the acetoxy resin materials 
was intermediate to plain silicone and triclosan-loaded silicones. 
Table 5.4.8.2: Ra Values for acetoxy resin materials
Material Mean Ra (S.D.)
Acetoxy Resin (control) 0.117 (0.012) 
Ag C16H31BrN2 0.132 (0.033) 
Ag C14H10F17IN2 0.120 (0.017) 
N=6 
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5.4.9: Cytotoxicity of antimicrobial materials - Evaluation by a patient-sourced 
blood toxicity model 
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Figure 5.4.9: Stimulated pro-inflammatory cytokines in donor-derived whole 
blood inoculated onto material surfaces 
N = 3 
Mean values shown; error bars represent standard error of the mean (SEM). 
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None of the tested compounds demonstrated a statistically significant difference in 
eliciting pro-inflammatory cytokines from inoculated blood compared to plain silicone 
or acetoxy resin controls at any time point (Figure 5.4.9). However, most materials 
(including plain silicone) generated an increase in IL-1B from  0.1 to between 1.2-
6.035 pg/ml; IL-6 from 6.6 to between 38.4-88.0 pg/ml; TNF from 11.5 to between 
23.3-13533.1 pg/ml, and IL-8 from 25.8 to 247.9-566.3 pg/ml compared to blank 
controls at 2 h. At 4 h further differences were seen approximately 1 order of 
magnitude higher. Of note, triclosan acetate appeared to be the least inflammation-
inducing compound. For both IL-12p70 and IL-10, levels were below the threshold of 
detection for several samples, rendering meaningful comparison unfeasible. There 
was a high degree of heterogeneity in the responses, indicated by the broad error 
bars. This variability was between samples from different donors rather than within 
samples (data not shown), with over a 1000-fold difference in concentrations of 
cytokines between donors.  
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5.5: Discussion 
In addition to the clinical problem of denture-associated infections; there is growing 
concern about the possibility of denture biomaterials acting as a reservoir for 
exogenous pathogens or promoting promulgation of potential pathobionts which may 
subsequently seed infection at distant anatomical sites such as the respiratory 
tissues (Coulthwaite and Verran 2007). As tooth loss is associated with a number of 
systemic comorbidities (Felton 2016), and edentulism primarily affects the elderly, 
the risk of infection and associated morbidity and mortality is increased. This is 
particularly true for frail, elderly individuals such as those in long-term institutional 
care, for whom access to regular dentistry and the ability to tolerate extensive 
treatment may be limited (Fox 2010). A number of such individuals have decreased 
motor learning capacity, which may be due to age-related neuromuscular changes, 
or as a consequence of disease, such as neurological deficit secondary to 
cerebrovascular accident (stroke). This population also frequently suffers from 
xerostomia, which may be related to medications, systemic illnesses such as 
diabetes, or aging-associated reduction in salivary output (Nederfors 2000). As a 
result of the confluence of poor access, ill-health, xerostomia, and reduced ability to 
tolerate treatment, provision of new dentures may be highly challenging. Relining 
existing dentures is therefore an attractive alternative, as this is relatively simple to 
undertake, can be achieved in 1  2 visits, and in the case of soft denture-liners, is 
reversible in the event of poor tolerance of alterations (Kimoto et al. 2004; Pisani et 
al. 2013). Such materials also offer a cushioning effect which can increase comfort 
in individuals with atrophied ridges. 
Unfortunately, the biological impact of such materials, which are usually silicone-
based, is less favourable. Silicones are vulnerable to degradation due to friction or 
abrasion compared with PMMA resins (Hermann et al. 2008). While much of the 
literature has focussed on the permeability of silicone denture-liners to C. albicans 
hyphae (Verran and Maryan 1997; Bulad et al. 2004; Skupien et al. 2013), it seems 
likely that surface defects might be equally plausibly exploited by pathogens 
frequently encountered in institutional care settings, particularly given such species 
ability to form biofilms on other indwelling devices like catheters or endotracheal 
tubes (Percival et al. 2015). 
The most widely-explored approach to overcome the issue of denture-associated 
biofilms and infections has been to employ antimicrobials; typically, antifungal agents 
with activity against Candida species (Geerts et al. 2008; Rathore et al. 2009; Salim 
et al. 2012). It is therefore a natural extension of such an approach to employ 
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antimicrobials with broad-spectrum activity against a range of relevant pathogens to 
reduce the risk of colonisation by putative respiratory pathogens.  
In this chapter, a range of novel, nucleophilic-heterocyclic carbenes and their silver 
complexes were screened for inhibitory and biocidal activity against a range of 
relevant pathogens frequently encountered on medical devices and dentures. 
Additionally, triclosan and a novel triclosan derivative triclosan acetate, hypothesised 
to have better incorporation into silicones, were trialled against the same panel of 
microorganisms. Compounds demonstrating promising biocidal activity were 
subsequently applied to established biofilms. A method for incorporation of the most 
promising silver complexes and triclosan compounds into silicone-compatible (for the 
silver complexes) materials, or directly into silicone (for the triclosan compounds) was 
formulated. These novel materials were screened for antimicrobial activity using a 
zone of inhibition test and for anti-adherent effects by direct inoculation and 
examination using CLSM. Furthermore, the impact of addition of antimicrobial 
compounds on some basic physicochemical properties of the materials was 
examined. Finally, the cytotoxicity of materials was explored using a novel donor-
derived whole-blood assay to assess stimulation of pro-inflammatory cytokine 
release. 
The antimicrobial compounds in free solution offered considerable promise, with 
NHCs demonstrating some antimicrobial activity alone, with complementary broad-
spectrum activity provided by the complexation with ionic silver. One compound in 
particular, Ag C16H31BrN2, was effective against biofilms of all test species with the 
exception of P. aeruginosa (Table 5.4.3). However, while the triclosan compounds 
were able to be incorporated directly into silicones, attempts at bulk-loading of silver 
complexes or NHC ligands alone into silicone materials resulted in a failure of the 
silicones to polymerise. This is likely due to interaction of the NHC ligands with the 
platinum catalyst, blocking or reducing its ability to coordinate cross-linking of 
silicones. In the case of the silver complexes, this occurs by substitution of complexes 
formed with silver to platinum; a process termed transmetalation (Lalonde et al. 
2013). This phenomenon is due to the slightly increased electronegativity of platinum 
compared to silver. A potential solution could be to employ an alternative catalyst with 
reduced electronegativity to facilitate silicone cross-linking. Tin is widely used as a 
silicone catalyst for a number of applications, but has some disadvantages compared 
to platinum-cured silicones (Fawcett et al. 2013). Firstly, the degree of polymerisation 
shrinkage is increased during curing of the material, with a resultant reduction in 
dimensional accuracy (Colas and Curtis 2004). There are concerns about the use of 
tin as a catalyst due to toxic products generated, both from an environmental 
255
perspective and the possibility of direct cytotoxicity from residual tin products in 
biomedical applications (Tanzi et al. 1994; Burnell et al. 2000). One such example of 
silicones which employ tin catalysts are the acetoxy resins, which cure by 
condensation following incorporation of water from environmental moisture. In this 
work package, it was found that curing of acetoxy resins was not inhibited by the 
presence of NHC or silver-complexes, supporting the transmetalation hypothesis. A 
notable by-product of such a curing reaction is the formation of acetic acid (Colas 
2005). This was observed during curing of test materials by the generation of a 
vinegar-like smell. Acetic acid is itself antimicrobial (Ryssel et al. 2009) and 
incomplete removal of this material from the acetoxy resin control material during 
antimicrobial testing may explain the apparent antimicrobial activity of this material 
observed (Figure 5.4.6 A-F). The silver-NHC complexes failed to demonstrate any 
significant antimicrobial activity against the microbial strains tested, nor demonstrated 
an anti-adhesive effect. Previous studies have employed metals (Salvarci et al. 2016) 
or antimicrobials such as chlorhexidine to achieve antimicrobial silicone surfaces 
(Darouiche et al. 2006; Garner et al. 2015; Phuengkham and Nasongkla 2015). 
However, in the majority of cases, silicones are coated with the test compounds, 
rather than direct incorporation of the compounds into the silicones themselves. 
While some authors have found successful retention of antimicrobial activity directly 
incorporating zinc-oxide (Ozkan et al. 2015) and titanium compounds (Depan and 
Misra 2014) into silicone polymers, the metals were used in nanoparticle form. Direct 
coating of silicones by the test silver-NHC complexes was not practical in this work 
due to the photo-reactivity of the complexes rendering their application to clinical 
scenarios unrealistic. Additionally, studies employing such methods rely upon 
controlled release of antimicrobial coatings, while the present work aimed to achieve 
in situ antimicrobial activity without significant release and systemic uptake of the 
compounds. Although metallic nanoparticles offer promising antimicrobial activity, the 
effects of their biological and environmental accumulation are a growing concern 
among the scientific community (Zuzana et al. 2011).   
In contrast, triclosan and triclosan acetate both retained antimicrobial activity against 
Staphylococci. The large zones of inhibition generated by such materials suggests 
that this results at least in part by diffusion of the triclosan compounds from the 
silicone surface (Table 5.4.5). There was both a reduction in the absolute number of 
adherent microorganisms and the proportion of viable Staphylococci present on the 
surface of silicones containing 1% triclosan acetate (Figure 5.4.6 E and F). While 
concerns exist regarding the environmental effects of triclosan (Dann and Hontela 
2011), it is likely that the quantities produced in this relatively niche application would 
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have limited significance in the context of the widespread use of this compound. 
Nevertheless, such concerns may constrain the use of triclosan compounds in 
biomedical applications in future. 
All test materials showed no significant increase in stimulation of pro-inflammatory 
cytokines in a novel donor-derived whole blood assay (Figure 5.4.9). However, while 
this model is excellent for obtaining more representative data with greater biological 
validity, the high degree of variability in cytokine responses from each donor may 
mask underlying patterns. Because blood from just 3 donors was used, this variability 
results in a strong noise: signal ratio. Ideally, a larger sample size would have been 
used, but this was not possible due to financial and time constraints. An ideal 
approach would be to pair such testing with basic cytotoxicity assessments on 
relevant cell lines such as oral fibroblasts and epithelial cells, and possibly 
subsequent testing on 3D organotypic tissue models. It is possible that the low level 
of cytotoxicity exhibited by the test compounds is due to their entrapment in silicone 
cross-linked polymer chains, which may also be responsible for the lack of 
antimicrobial activity seen.  
The metal-NHC complexes had little effect on the physicochemical properties of the 
acetoxy resins. The triclosan compounds appeared to lead to a reduction in the 
contact angle of silicones, leading to more hydrophilic surfaces. This result might 
appear surprising, as triclosan, like silicone, is highly hydrophobic. The addition of 
triclosan also increased the surface roughness of silicone materials however, and the 
interaction of surface roughness and hydrophobicity may explain the observed effect 
(Teughels et al. 2006). In addition, there was a significant decrease in tear resistance, 
although the magnitude of this effect was not especially large, and so its clinical 
relevance is open to interpretation. However, given the role of surface degradation in 
facilitating infiltration of microbial biofilms in silicone surfaces, this effect should not 
be disregarded when considering the application of triclosan-modification of silicone 
for clinical applications. 
Limitations of the methods 
This work had several important limitations. Only 1-2 strains of each representative 
pathogen were used to test the antimicrobials. Some (C. albicans ATCC 90028, 
S. epidermidis RP62A, S. aureus NCIMB 9518 and P. aeruginosa ATCC 15692) were 
originally isolated from human infections, although none were associated with 
respiratory infection or the oral cavity. Furthermore, virulence and microbial 
behaviour following multiple generations of microorganisms cultured in the laboratory 
is likely to be highly different to in vivo characteristics of the original isolates. It may 
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be that the results of antimicrobial testing are therefore unapplicable to pathogens in 
the medical setting. However, as an initial screening method, this is a necessary 
pragmatic trade-off. There is no strong reason to assume that orally-derived strains 
of the same microorganisms would behave in a strongly dissimilar manner. 
Only a limited range of compounds were tested, and due to the complexity of their 
synthesis only limited quantities were available. The silver coordination complexes 
were all comprised of a 1:1 ratio of silver to NHC. For a more comprehensive 
evaluation, each basic structure would be tested with a range of hydrocarbon tail 
lengths and incorporating different positions of saturated hydrocarbons. The most 
effective compounds Ag C16H31BrN2 and Ag C14H10F17IN2 had the two longest 
hydrocarbon tail lengths. However, it is not clear from the current research if tail 
length is an important factor, or if some other aspect of the molecular structure is 
responsible for their better antimicrobial performance. 
The zone of inhibition testing and direct inoculation evaluation demonstrated minimal 
antimicrobial effectiveness of the silver complexes. It was assumed that this was due 
to a lack of release of the compounds from the material surface. However, the 
concentration gradient in the agar used for zone of inhibition testing could have been 
measured by liquid chromatography, to quantify any release and the diffusion 
properties of the compounds. Similarly, a blank inoculum with growth medium could 
have been undertaken alongside the inoculation experiments for subsequent removal 
and characterisation. This would elucidate if any compound is released from the 
surface, and if any chemical changes occur from incorporation into silicone materials. 
Future work should seek to include such testing, regardless of the effectiveness of 
materials evaluated. 
The tested compounds Ag C16H31BrN2 and Ag C14H10F17IN2 showed considerable 
promise as antimicrobial agents against a range of relevant pathogenic 
microorganisms. However, further work is required to ensure this antimicrobial 
activity is retained when such compounds are incorporated into biomaterials such as 
silicones. A method of surface-coating by which the compounds are reliably tethered 
to the biomaterial surface may be one avenue to explore in future. Triclosan and 
triclosan acetate can be successfully incorporated into silicone biomaterials, with 
strong antimicrobial activity against Staphylococci and no apparent provocation of a 
host pro-inflammatory cytokine response. However, the impact of these materials on 
the mechanical properties of silicones requires further characterisation to ensure 
these do not impart adverse clinical effects. 
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CHAPTER 6: EXPLORATION OF THE ANTI-BIOFILM POTENTIAL OF HIGHLY 
CONTROLLED DELIVERY OF MICROWAVE ENERGY USING A CAVITY 
RESONATOR OR COAXIAL PROBE  
6.1: Introduction 
6.1.1: Principles of microwave energy - generation and properties 
The term microwaves refers to electromagnetic radiation with a frequency of 
between 300 MHz and 30 GHz, corresponding to a wavelength of between 1cm and 
1m (Collin RE, 2001). While microwaves have many applications, summarised in 
Figure 6.1.1, the primary focus of this section will be their use in heating and 
disinfection. 
Figure 9: Microwave electromagnetic frequency and selected applications. 
a) Domestic microwave oven (Magnetron) 
b) Communications technology 
c) Radar 
d) Radio astronomy 
(Image adapted from NASA “Imagine the universe” URL: 
http://imagine.gsfc.nasa.gov/science/toolbox/spectra1.html)  
The application most commonly associated in the lay public with microwave energy 
is use of magnetron ovens for cooking in domestic settings. The basic theory of 
microwave generation within a magnetron oven is reviewed in Vollmer (2004). The 
generated electromagnetic waves (which are standardised to 2.45 GHz in Europe) 
cause oscillation in dipolar molecules, most notably water, due to the alternating 
electric field. The net result of this increased molecular vibration is heat generation, 
termed dielectric heating (Grant and Halstead, 1998). This form of heating contrasts 
conventional heating methods whereby heat is generated in the surrounding 
environment, with the target being heated from outside to inside. 
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The ability of microwave energy to cause heating in a material is linked to the 
propensity of the target material molecules to polarise in alignment with the electric 
field. This is determined by the dielectric properties of the material. PMMA materials 
have a low dielectric constant (the term relative permittivity is preferred), indicating a 
declivity of the constituent molecules to polarisation by application of an electric field. 
This has two important consequences: relatively low heating of the PMMA biomaterial 
in the presence of microwave electric field; and minimal interference of the PMMA 
resin with the electric field. The relevance of these properties will be discussed in 
later sections. 
The widespread use of magnetron ovens, their low cost and ease of use make them 
attractive targets for sterilisation of acrylic dentures, particularly in institutional 
settings, where chemo-mechanical methods of denture hygiene are typically under-
utilised (Gornitsky et al. 2002). However, it is important to note that any prostheses 
with metal components may not be used in such a device, as reflected microwaves 
may lead to high charge density at metal vertices and edges, leading to electrical 
arcing. Such phenomena can lead to damage to the microwave oven or denture 
components. 
6.1.2: Use of microwave energy for disinfection 
While more commonly associated with cooking in a domestic setting, the potential for 
microwave energy to be used for disinfection and sterilisation in a wide range of 
industrial settings has been explored (Chandrasekaran et al. 2015). In dentistry, 
microwave disinfection has been considered as a possible replacement for 
conventional measures such as autoclaving for processing of some waste materials 
(Cardoso et al. 2007), dental instruments (Tarantino et al. 1997), impression 
materials (Abdelaziz et al. 2004), dental casts (Berg et al. 2005) as well as dentures. 
In all such cases, the primary mechanism of microbial inactivation or killing has been 
linked to heating effects. However, it has been postulated that there may be a 
separate biological impact of microwave energy that is independent of heat 
generation.  
6.1.3: State of the evidence - disinfection of dentures by microwave ovens 
A growing body of research has been accumulated over the last two decades 
examining the potential use of domestic microwave ovens in denture sterilisation. 
However, conclusive evidence is lacking due to a failure to establish standard 
protocols and a lack of integration between microbiological outcomes and material 
properties. Studies often differ in terms of number, duration and power of microwave 
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exposures, use of dentures or smaller acrylic samples, range of microbes examined, 
methods of assessing disinfection or sterilisation, and assessments of material 
properties.  
Several studies have demonstrated the effective disinfection of a range of microbes 
on dentures using microwave exposures. For instance, Webb et al. (2005) used 
350 W for 10 min on dentures of patients with denture stomatitis as part of an effective 
treatment for this condition. Studies aimed at Candida biofilm eradication due to this 
species being implicated in denture stomatitis have also been conducted with 
variable methods, exposure times and results (Campanha et al. 2007, 
Neppelenbroek, 2008). A limitation of this method is that while microorganisms may 
be inactivated, antigenic components are not removed entirely, thus can still elicit an 
inflammatory response. Ribeiro et al. (2009) demonstrated the effectiveness of 
microwaves in sterilising dentures containing S. aureus, amongst other pathogens. 
Importantly, most of the studies use culture methods to determine effectiveness of 
sterilisation, and none use direct measures of vitality by microscopy.  
The minimum effective time and exposure able to adequately disinfect denture 
surfaces appears to be 3 min at a power of 650 W (Neppelenbroek et al. 2008, Ribeiro 
et al. 2009, Sanita et al. 2009). However, further clarification of optimal power and 
time configurations is required to optimise this approach. 
Studies investigating changes in denture materials due to microwave exposure have 
considered a range of important properties. Most authors found an improvement in 
hardness of acrylics after microwave treatment (Ribeiro et al. 2008, Konchada et al. 
2013). This may be a result of increased polymerisation of residual monomer due to 
heat generated during treatment (Klironomos et al. 2015). Impact resistance was 
largely unaffected as a result of microwave treatment also (Senna et al. 2011).  
However, detrimental effects have been noted in bond strength of denture teeth to 
the base resin (Consani et al. 2010), as well as hardness of some brands of denture 
teeth (Campanha et al. 2005, Vasconelos et al. 2013). Most importantly, microwave 
treatment was found to affect dimensional stability of denture acrylic, with 900 W 
delivered for as short as 3 min leading to significant alterations with repeated 
exposure (Senna et al. 2011).  
While insufficient evidence exists regarding the effect of microwave energy on 
dentures, it is clear that there is potential detriment to the materials, induced by 
heating, which is difficult to predict. An alternative method of delivering microwave 
energy which could avoid generation of heat and offer a more standardised approach 
to denture disinfection might mitigate these drawbacks. 
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While PMMA resin has a low relative permittivity which limits the degree of heating 
during microwave exposure, the use of microwave ovens to sterilise acrylic dentures 
appears to generate significant heating. Microwave ovens are designed to impart 
heat energy to their contents. This is achieved primarily by essentially random 
distribution of microwave energy which fluctuates over time. Not only does this result 
in difficulty achieving predictable sterilisation of denture surfaces, as different areas 
of the PMMA biomaterial surface will receive different exposures to microwaves, but 
it also necessitates high powers and prolonged exposures to ensure sufficient energy 
is delivered. Furthermore, several researchers have placed dentures in a volume of 
water prior to microwave sterilisation, with subsequent deliberate heating of the water 
to achieve microbiocidal effects.  
6.1.4: The cavity resonator - advantages in denture disinfection 
The cavity resonator (Figure 6.1.4A & B) offers a simple method of delivering 
microwave energy in a predictable and consistent manner. The cavity itself is 
bounded by metallic walls, and often contains air (although other substances may be 
used). An external power source is coupled to the cavity through a port and provides 
an electron source for excitation of electromagnetic waves. The wavelength, and thus 
frequency is determined largely by the size of the cavity. To ensure maximum 
efficiency and power delivery, it is important to match the input signal to this 
frequency. In this way, microwaves behave similarly to sound waves, with the cavity 
acting as an acoustic chamber. The various possible frequencies at which 
electromagnetic waves are able to propagate within the cavity are termed harmonic 
resonances.  
An important option when considering the application of cavity resonators for 
disinfection of dental prostheses is the ability to alter the field to accommodate the 
added impedance of the denture within the cavity. Because microwave resonance is 
determined by the geometry of the cavity, any object placed into it will modify the 
resonant frequency, which must be matched by the input signal to ensure high 
operating efficiency.  By adding a directional coupler to the input port of the cavity, 
Imtiaz et al. (2015) were able to rapidly measure perturbations of the electric field due 
to different volumes of water placed in the cavity via a novel matching network 
approach. As well as improving accuracy and speed of feedback, this approach 
reduced the size and weight of the cavity resonator system, which makes it highly 
portable. For this reason, this system will be used to optimise experimental methods 
within the project.  
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Figure 6.1.4: The cavity resonator used in the experiments presented in this chapter 
A) External view of the assembled cavity – the central opening is a viewing port 
B) The disassembled cavity showing the cylindrical internal cavity volume   
6.1.5: Strategies to reduce heat generation by microwave energy 
The possibility of athermal effects due to microwave energy is a contentious topic in 
the literature. The difficulty of accurately measuring temperature changes at a 
sufficiently small scale means there is little evidence to support or deny such effects. 
Several mechanisms have been proposed for athermal mechanisms in killing 
microbes (reviewed in Knorr et al. 1994).  
Kozempel et al. (2000) demonstrated of microwave exposure at between 5 and 6 kW 
of power at 2.45 GHz when temperature was controlled below 45 °C. This is the only 
study to date which has successfully applied high power microwave energy to 
biological samples with a concomitant mitigation of heating effects. 
In contrast, it was found that microwave irradiation demonstrated reduction of viable 
Staphylococcus aureus cell counts compared with temperature-matched controls 
(Khalil and Villota, 1988). The effects seemed to be primarily due to membrane 
damage, although altered protein expression was also noted. This follows from 
findings by Dreyfuss et al. (1980) who found that levels of certain metabolic enzymes 
were elevated in microwave treated compared with heat treated controls. However, 
these results seem to support a growth-promoting effect of low-level microwave 
power, rather than cell damage, as lactate dehydrogenase levels were unaltered. 
SEM analysis of Mycobacterium bovis following either microwave treatment for 90 s 
or immersion in boiling water for the same time revealed membrane discontinuities 
in the former which were not present in the latter (Rosaspina et al. 1994). However, 
no convincing evidence has emerged since this publication to support such findings. 
A B
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It is important to note that while the presence of non-thermal effects of microwave 
energy have important implications, for the purpose of denture sterilisation they are 
a secondary concern. The primary motivation in the sterilisation of dental prostheses 
is to achieve biofilm eradication without causing detrimental heating of the materials. 
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6.2: Aims 
This work package aimed to: 
1. Develop a simple simulation model to evaluate the interaction of microwave 
energy, PMMA material, biofilm and temperatures generated in each material 
2. Develop a method to reliably test disinfection of biofilms grown on acrylic surfaces 
using a cavity resonator 
3. Explore methods to reduce heat generation by microwave energy and evaluate 
the athermal effects of microwave energy on biofilms 
Hypotheses 
• Microwave electric field energy delivered in a cavity resonator will effectively and 
reliably kill microorganisms in biofilms on acrylic surfaces at low levels of power 
(£43 dBm)
• There will be a difference in the exposure time required to kill biofilms composed 
of different species, due to water content, cell wall rigidity and surface area: volume 
ratios
• Biocidal effectiveness of microwave energy delivery will differ with different 
orientations of biofilms in the electric field. Biofilms positioned parallel to the field 
will undergo a higher degree of polar interactions and therefore microorganisms 
will be killed at lower exposure times compared with biofilms positioned 
perpendicular to the electric field
• Reduction of microwave power or exposure time will reduce heat generation, but 
will also reduce biocidal activity
• Delivery of microwave energy in duty cycles, controlled for total exposure time, will 
reduce heat generation without impacting biocidal activity
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6.3: Materials and Methods 
6.3.1: Simulation of experimental parameters using COMSOL multiphysics 
software 
All simulation work was undertaken by a Final Year Student (Mohammed Khan) at 
the School of Engineering, Cardiff University, who was co-supervised by Joshua 
Twigg and Dr Jonathan Lees. Simulations of planned experimental exposures were 
undertaken using COMSOL Multiphysics software. A PMMA cylinder and cylindrical 
cavity resonator were modelled using the default values for physical and dielectric 
properties in the software material library. For all experiments, air was input as the 
only medium within the cavity. The biofilm was substituted with a 20 µm thick film of 
water for simplicity. 
Initial simulations were undertaken to ensure that no significant disturbance of the 
electric field (the component of microwave energy responsible for biological effects 
and heating) occurred during placement of the acrylic sample. This simulation was 
undertaken in two orientations  with the acrylic sample and biofilm perpendicular to 
the electric field axis; and with the acrylic sample and biofilm parallel to the electric 
field axis. Subsequently, the impact of heating on the biofilm sample was modelled 
over time in both orientations. 
6.3.2: Calibration of cavity resonator 
A portable microwave applicator was assembled and kindly provided by the School 
of Engineering. This applicator was capable of providing up to 43 dBm of output 
power (equivalent to 20 W). The input power was measured continuously during 
exposure through a directional coupler which directed a small proportion of the signal 
to a power meter. The remaining microwave signal terminated in a simple loop 
antenna inside the cavity resonator. Signal generation was controlled from a laptop 
connected to the microwave applicator, with simultaneous detection of output power, 
using the locally developed Micromagic software (Professor Adrian Porch, School 
of Engineering, Cardiff University). Once appropriate output power had been 
confirmed, the empty cavity was calibrated to ensure optimal coupling of the 
microwave signal. This was undertaken using a coaxial cable to measure the 
minimum reflected power (termed an S11 plot). A threshold for coupling was selected 
at -20 dB, indicative of delivery of 99% of microwave energy to the cavity. This 
process was then repeated following loading of the sample into the cavity. Coupling 
was adjusted by careful positioning and rotation of the antenna within the cavity. 
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6.3.4: Calibration of thermal imaging camera 
A thermal imaging camera (thermoIMAGER TIM QVGA, Micro-Epsilon UK Ltd, 
Birkenhead, UK) was used to provide continuous temperature measurements of the 
samples, by focussing on the sample through the access port in the cavity resonator. 
To ensure adequate focus of the camera on the sample, a disc of dry ice was loaded 
into the sample position to provide an easily demarcated point for focus of the 
camera.  
To ensure accurate measurement was being achieved using the thermal imaging 
camera, calibration was undertaken using a block heater, with simultaneous 
measurement of temperatures in 10 °C from room temperature to 80 °C recorded by 
the thermal imaging camera, a fibreoptic temperature probe and a mercury 
thermometer. 
6.3.5: Preparation of experimental acrylic biofilms for microwave exposure 
Acrylic coupons were prepared and preconditioned with artificial saliva as described 
in Sections 2.3.1 and 2.3.2. Subsequently 72 h microbial biofilms were prepared 
using the species used in Chapter 2, with the methods outlined in Section 2.3.7. 
Microbial biofilms were removed from the aerobic incubator at least 1 h prior to use 
to ensure equilibration with room temperature, then aseptically transferred to the 
cavity . Each sample was supported on a polystyrene cylinder to ensure location in 
the centre of the cavity. This was cleaned with 100% ethanol between uses. 
6.3.6: Exposure parameters and measurement of bulk temperature 
Initial exposures were undertaken at 43 dBm for durations of 0 (negative control), 2, 
5, 10 and 20 s, with samples oriented both perpendicular and parallel to the axis of 
the electric field. Subsequent exposures were undertaken with samples oriented 
parallel to the electric field as this demonstrated greater microbiocidal effects. A range 
of powers were evaluated for a duration of 10 s (the minimum exposure time which 
reliably demonstrated eradication of viable microorganisms in denture acrylic 
associated biofilms): 100% (positive control), 50%, 25%, 10%, 1% and 0% (negative 
control) of full power (43 dBm). The impact of pulsatile microwave energy delivery 
was also evaluated, with duty cycles of 100% (positive control), 50%, 25%, 10%, 1% 
and 0% (negative control) at full power (43 dBm). The total exposure time was 
controlled. For example, a 1% duty cycle was delivered over a total time of 1,000 
seconds, ensuring the same total microwave energy was imparted to the cavity for 
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each experiment. Bulk temperature changes were measured in real time during 
exposure of samples and subsequently until samples cooled below 35 °C.  
6.3.7: Evaluation of biofilm killing by swab sampling 
After cooling following microwave exposure, samples were transferred aseptically to 
new 12 well-plates using forceps and the exposed surface swabbed with a sterile 
cotton swab. Swab tips were transferred to a 1.5 ml microcentrifuge tube containing 
1 ml PBS and vortex mixed at high speed for 1 min. Subsequently, serial 1:10 
dilutions were undertaken, and suspensions inoculated onto selective agar plates for 
each species, as outlined in Table 2.3.3B, using a spiral plater (WASP  Don Whitley, 
Sheffield, UK). Agar plates were then incubated for 24-48 h aerobically at 37 °C and 
microbial colonies counted. A summary of experimental input and analyses is 
displayed in Figure 6.3.7. 
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Figure 6.3.7: Flow chart of experimental input and analyses 
Single species biofilms 
(P. aeruginosa, S. aureus and C. 
albicans). 3 replicates, 2 
subsequent repeats. 
5 species ‘mixed’ biofilm. 3 
replicates, 2 subsequent 
repeats.  
Perpendicular sample 
orientation exluded from 
further analysis. 
Exposure to microwave electric 
field at different duty cycles. 
Continuous exposure to 
microwave electric field at 
different output powers. 
Continuous exposure to 
microwave electric field in 
parallel and perpendicular 
orientations for different times. 
Culture analysis (spiral plating
after recovery from swabs) 
Continuous temperature 
monitoring (Thermal imaging 
camera) 
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6.4: Results 
6.4.1: COMSOL simulation models for microwave exposures 
6.4.1.1: Interaction of electric field and model biofilms in cavity resonator 
A simple model of the internal cavity resonator was generated (Figure 6.4.1.1A), with 
aluminium walls and air as the internal medium. A polystyrene cylinder with an acrylic 
coupon was added, with a 20 µm thick film of water simulating the biofilm. Simulations 
of microwave energy delivery at approximately 2.45 GHz demonstrated geometric 
separation of magnetic and electric field (Figure 6.4.1.1B), with strong electric field 
intensity in the cavity centre with polarisation occurring perpendicular to the cavity 
diameter. The magnetic field circulated circumferentially around the cavity perimeter. 
High electric field intensity was homogeneously distributed in the central portion of 
the cavity in a sufficient volume to ensure uniform exposure of the biofilm whether 
the surface was perpendicular (Figure 6.4.1.1C) or parallel (Figure 6.4.1.1D) to the 
electric field. 
Figure 6.4.1.1: COMSOL Multiphysics simulations of experimental setup  
A) Geometric parameters of cavity resonator showing ‘biofilm’ sample oriented to the volumetric centre 
of the cavity, with the planar surface of the biofilm perpendicular to the axis of electric field polarisation. 
B) Electromagnetic field distribution in empty cavity at approximately 2.45 GHz frequency. Red arrows 
indicated direction of electric field; black arrows indicate direction of magnetic field.  
C) Electric field intensity with sample oriented perpendicular to the axis of depolarisation. 
D) Electric field intensity with sample oriented parallel to the axis of depolarisation. 
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6.4.1.2: Impact of exposure time on heat generation  
Simulations produced at sections axial to the electric field corresponding to the planar 
biofilm surface revealed that in perpendicular orientation (Figure 6.4.1.2A), samples 
might be expected to heat from the outer circumference (Figure 6.4.1.2B) initially, 
with progressive heating towards the centre (Figure 6.4.1.2C). A maximum 
temperature of 72.6°C was seen after 10 s continuous exposure at 43 dBm (Figure 
6.4.1.2D). Importantly, a central portion of the sample remained at least 20°C below 
this temperature, however.  
Figure 6.4.1.1: COMSOL Multiphysics simulations of experimental setup  
A) Cross-sectional view of simulated ‘biofilm’ planar surface in cavity resonator, with surface 
temperature of 20°C.  
B) After 2 s of exposure to the electric field, the sample shows peripheral heating, with minimal 
temperature change of the central portion. 
C) The volume of heated area increases by 5 s, but the annular pattern of heating remains. The central 
portion of the sample has not exceeded 35°C, despite temperatures exceeding 50°C peripherally. 
D) At 10 s, significant heating has occurred across almost the entire sample surface to at least 70°C, 
but a small central volume remains below 50°C. 
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When the sample was oriented parallel to the electric field (Figure 6.4.1.2E), the 
pattern and extent of heat generation differed substantially. Initial heating occurred at 
diametrically opposing edges corresponding to the electric field poles (Figure 
6.4.1.2F). At 5 s, the distribution of heat was largely homogeneous across the sample 
surface (Figure 6.4.1.2G). After 10 s exposure to microwave electric field (Figure 
6.4.1.2H), the biofilm surface was seen to heat to over 400°C across the entire 
surface, with a thin band of greater heat intensity crossing the surface diametrically 
corresponding to the centre of the electric field.   
E) Cross-sectional view of simulated ‘biofilm’ planar surface in cavity resonator oriented parallel to the 
electric field, with surface temperature of 20°C.  
F) After 2 s of exposure to the electric field, the sample shows heating at the poles, with some heating 
of the central portion. 
C) By 5 s the entire sample volume has heated to over than 200°C. Heating is concentrated to the poles, 
with a thin diametric band seen from pole to pole. 
D) At 10 s, the surface temperature of the sample exceeds 400°C, with maximum intensity now across 
a diametric band oriented along the central portion of the electric field. 
6.4.2: Continuous exposure of acrylic biofilms to microwave energy in a cavity 
resonator – biocidal and thermal effects 
Initial experiments undertaken with continuous exposure of samples to 43 dBm 
microwave energy examined the effects of sample orientation on the microbiocidal 
effects of the electric field. Attempts to analyse samples using the Live/Dead assay 
with CLSM were unsuccessful, possibly due to deformation of the acrylic surface, or 
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debris generated during exposure of samples (data not shown). Consequently, only 
culture analysis could be undertaken. In single species biofilms, samples oriented 
parallel to the electric field showed elimination of microorganisms recoverable by 
culture after 10 s exposure (Figure 6.4.2A). When samples were oriented 
perpendicular to the electric field however (Figure 6.4.2B), both P. aeruginosa and 
C. albicans were cultured after 10 s exposure, while S. aureus was cultured in some 
samples after 20 s exposure. As was seen in previous analysis of mixed species 
biofilms, recovery of C. albicans by culture was not possible due to overgrowth of 
P. aeruginosa. Again, there was an elimination of S. aureus in samples oriented 
parallel to the electric field, while P. aeruginosa was reduced by approximately 8-log 
(Figure 6.4.2.C). In mixed biofilm samples oriented perpendicular to the electric field, 
both S. aureus and P. aeruginosa were cultured after 10 s exposure, albeit 
substantially reduced (Figure 6.4.2D). After 20 s exposure, both microorganisms 
were unable to be recovered by culture. 
Figure 6.4.2: Recovery of microorganisms by culture after exposure to microwave energy 
A) Single species biofilms oriented with the planar biofilm surface parallel to the electric field 
B) Single species biofilms oriented with the planar biofilm surface perpendicular to the electric field 
C) Mixed species biofilms oriented with the planar biofilm surface parallel to the electric field 
D) Mixed species biofilms oriented with the planar biofilm surface perpendicular to the electric field
Experiments performed in triplicate with 2 experimental repeats. Mean values shown. Error bars 
represent standard error of the mean. 0 s exposure time = negative control. 
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The impact of sample orientation and biofilm species composition on sample 
temperature was also analysed. Heating was consistently higher with increased 
exposure times (Figure 6.4.2E) regardless of sample orientation or species 
composition. The highest temperatures were seen in P. aeruginosa biofilms, with 
similar heating in both S. aureus and C. albicans biofilms. The lowest temperatures 
occurred in mixed species biofilms. Temperatures in perpendicular sample 
orientations were similar to those predicted by COMSOL modelling, while parallel 
samples showed maximum temperatures of approximately 1/6th of the predicted 
temperatures in simulations.  
The data from figure 6.4.2E was converted to show the change in temperature by 
subtracting the starting room temperature for each experimental run from the 
maximum temperature. This revealed statistically significant increases in temperature 
change in S. aureus and P. aeruginosa for samples oriented perpendicular to the 
electric field (Figure 6.4.2F). Despite failing to reach the threshold of statistical 
significance, a trend for increased temperatures in the perpendicular orientation was 
seen for C. albicans, and to a lesser extent in mixed species biofilms. There was 
considerable variability in the magnitude of temperature change for each exposure. 
Analysis of stills from thermal imaging records (Figure 6.4.2G) revealed that the 
distribution of temperature across the sample surface was similar to that predicted in 
COMSOL simulations. In parallel orientation of the sample, temperatures initially 
increased at the poles, the rapidly spread across the surface, with almost uniform 
heating by 5 s exposure. In samples oriented perpendicular to the electric field, 
heating followed an annular pattern, with initial heating occurring at the sample 
periphery, before spreading inwards towards the sample centre. As was seen in the 
COMSOL simulations, the central portion of the sample reached a lower maximum 
temperature compared to the periphery.  
Following the results from section 6.4.2 demonstrating the increased biocidal 
effectiveness of sample orientation parallel to the electric field, all subsequent 
experiments were undertaken in this orientation only. 
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Figure 6.4.2E: Maximum temperature of biofilms on acrylic surfaces following exposure to 
microwave energy 
Experiments performed in triplicate with 2 experimental repeats. Mean values shown. Error bars 
represent standard error of the mean. 0 s = negative control. 
Figure 6.4.2F: Change in temperature of biofilms on acrylic surfaces following exposure to 
microwave energy 
Experiments performed in triplicate with 2 experimental repeats. Mean values shown. Error bars 
represent standard error of the mean. P-values demonstrate adjusted significance after 2-Way ANOVA 
with Bonferroni correction. 
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Figure 6.4.2G: Distribution of temperature of biofilms on acrylic surfaces following exposure to 
microwave energy 
Upper panel shows biofilm samples oriented parallel to electric field. 
Lower panel shows biofilm samples oriented perpendicular to electric field. 
Stills captured from representative thermal imaging videos at 1 s intervals during exposure. 
6.4.3: Impact of altering power or pulsing of microwave energy delivered to 
acrylic biofilms in a cavity resonator on thermal and biocidal effects 
Both reductions in power and pulsed delivery (pulsed over a total time of 1 s in duty 
cycles; e.g. 1% duty cycle = 10 ms microwave energy, 990 ms recovery) led to a 
reduction of biocidal effects of microwave energy (Figure 6.4.3 A-D). Both methods 
of microwave energy delivery failed to eliminate all viable microbes, with an inverse 
correlation seen between either percentage power or duty cycle and biocidal effects. 
There was a very high degree of variability in microbiocidal effects seen at higher 
power settings and duty cycles, as indicated by the broad error bars. 
The impact of either modulating power of microwave energy or pulsed delivery on 
temperature was similar (Figure 6.4.3E & G). Minimal rise in temperature was seen 
at 1% power, or using 1% duty cycles, with a sharp rise to approximately 45-55 °C 
noted at 10% power or duty cycles. There was subsequently a small, proportionately 
linear increase in temperature with increasing power or pulse duration. 
As had been noted during initial experiments, there appeared to be differential effects 
of microwave energy on temperature generation, depending on the species 
composition of biofilms (Figure 6.4.3F & H). This effect only reached the threshold of 
significance in pulsed delivery experiments, although the same trend was seen in 
power modulation experiments. At lower duty cycles, mixed biofilms demonstrated 
significantly less heating than  P. aeruginosa and C. albicans biofilms. This does not 
appear to have affected the biocidal effects of microwave energy however, as 
recovery rates of P. aeruginosa is equivalent in single or mixed species biofilms 
(Figure 6.4.3B & D). 
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Figure 6.4.3: Impact of modulating power and pulsed delivery of microwave energy on recovery 
of microorganisms by culture 
A) Modulation of power delivered in single species biofilms 
B) Pulsed delivery in single species biofilms 
C) Modulation of power delivered in mixed species biofilms 
D) Pulsed delivery in mixed species biofilms 
E) Impact of modulating microwave power on temperature generation 
F) Change in temperature seen during microwave power modulation 
G) Impact of pulsed delivery of microwave energy on temperature generation
H) Change in temperature seen during pulsed microwave energy delivery 
N=3. Mean values shown. Error bars represent standard error of the mean. 
P values demonstrate adjusted significance after 2-way ANOVA with Bonferroni correction for multiple 
comparisons. 0% power/duty cycle = negative control; 100% power/duty cycle = positive control. 
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6.5: Discussion 
There are substantial challenges to providing denture sterilising in a manner that is 
easy to use, reliably effective and that does not cause detrimental effects to the 
denture biomaterial. In the institutionalised care setting, the responsibility of providing 
denture and oral hygiene may fall upon care staff, adding further barriers of a lack of 
training, failure to recognise the importance of effective denture care, and potential 
aversion to providing denture care due to its invasive, time-intensive nature coupled 
with feelings of disgust towards undertaking denture care (Wårdh et al. 2000; Miegel 
and Watchel 2009). While efforts to drive behaviour change, improve education and 
training are one approach to overcoming such barriers (Nicol et al. 2005), an 
alternative (and potentially complementary) approach is to modify the cleaning 
process itself. 
To this end, the use of a conventional microwave oven to sterilise dentures has been 
explored by several authors. This option is attractive as domestic microwave ovens 
are a cheap and familiar appliance, thus offer minimal barrier to use (Augusto 
Brondani et al. 2012). However, because of the unpredictable distribution of electric 
field within such devices, high powers and prolonged exposure times are required, 
which generate considerable heat. This may lead to damage or deformation of 
denture biomaterials, either acutely if the glass transition temperature of PMMA is 
exceeded, or over time secondary to thermocycling effects (Sartori et al. 2006).  
It was hypothesised that the capability of cavity resonators to generate a uniform, 
volumetric column of high intensity electric field would allow the use of much lower 
power, which could translate to reduced heat. Furthermore, it was anticipated that 
employing pulsed delivery could allow for a high cumulative exposure of microbes to 
the electric field, while mitigating heat generation. The simulation data presented in 
Section 6.4.1 predicted a highly efficient transfer of energy to biofilm samples, with 
concomitant heat generation. The simulation models also suggested that orientation 
of the sample within the electric field could affect the degree of energy transferred to 
samples. It was found that the cavity resonator behaved largely as predicted by the 
simulation models, with a greater biocidal effect and more even temperature 
distribution in samples oriented parallel to the electric field (Figure 6.4.2A-F). 
Modulation of power or pulsed delivery of microwave energy did mitigate heating to 
some extent, although at 10% or greater power levels or duty cycles, there was 
substantial heat generation. Both pulsed delivery and reductions in power lead to 
reduced biocidal effect, which suggests that within the limitations of this experiment, 
the biocidal effect of microwave energy is dependent on heating (Figure 6.4.3A-H). 
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While simulations of heating in samples oriented perpendicular to the electric field 
predicted the magnitude of heat generation accurately (Figure 6.4.1A-D, Figure 
6.4.2E), there was considerable disparity in the magnitude of heat generation 
predicted by simulation for samples oriented parallel to the electric field (Figure 
6.4.1E-H, Figure 6.4.2F). This is likely due to a combination of factors. Firstly, the 
COMSOL simulations did not account for conductive or convectional heat loss from 
the biofilm samples. In reality, heat transfer likely occurred through conduction to the 
underlying acrylic biomaterial, and evaporation of the sample. Furthermore, changes 
in sample volume or rapid changes in temperature could lead to loss of critical 
coupling of the microwave frequency. It was noted that achieving good quality 
coupling of frequency for samples in the parallel orientation was more challenging, 
and that this tended to reduce quite dramatically during exposure. In contrast, 
samples oriented perpendicular to the electric field suffered less reductions in 
coupling (Data not shown). Another factor which may cofound the apparent results is 
the accuracy of the thermal imaging camera in measuring each surface orientation. 
During exposures of samples perpendicular to the electric field, it was possible to 
orient the camera perpendicularly directly over the sample surface, with a wide 
aperture afforded by the cavity viewing port. However, during exposures of samples 
parallel to the field, it was necessary to view the samples at a 45° angle, through a 
much smaller aperture (approximately 1/3rd the diameter) and at approximately 
double the distance from the sample. Therefore, measurements recorded may have 
been less accurate, and more affected by reflection from the aperture periphery. 
Control of this factor could be achieved through manufacturing a cavity with viewing 
ports oriented appropriately. Regardless, the predicted distribution of heating was 
noted across the sample surface, demonstrating the validity of the COMSOL 
simulations in capturing qualitative, if not quantitative, effects of sample orientation 
within the field.  
Heating and biocidal effects are highly challenging to separate experimentally for a 
number of reasons (Shazman et al. 2007). There is an interdependence of the two 
effects: higher power levels result in greater delivery of electric field, which might be 
expected to result in greater biocidal activity, but also inevitably induces greater 
heating. Similarly, changing sample orientation provides a greater volumetric 
exposure of the bulk sample (which can be considered simply as a planar surface) to 
the electric field, which should result in stronger depolarisation effects, increasing 
both biocidal activity and heating (Eigen and Schwarz 1957). While this effect was 
not seen, with the caveats discussed above, there was a more uniform distribution of 
heating seen across the sample surface in the parallel orientation, which alone may 
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be sufficient to explain the improve biocidal activity noted. It should also be noted that 
the thermal imaging camera used offers millimetre resolution and therefore can 
measure bulk temperature changes but offers no insight regarding heating at a sub-
micron scale. The effects seen in differential heating of bulk liquids may also be 
present within microbial cells themselves, and so even if the relatively low 
temperatures measured in parallel-oriented samples are accurate, heating at specific 
points within cells may exceed such temperatures drastically. This possibility has 
been considered from a conceptual standpoint previously, where it was regarded as 
unlikely (Sastry and Palaniappan 1991), but at present there is no experimental data 
to support or refute differential temperature effects within microorganisms. 
To ensure total electric field exposure remained constant, while attempting to mitigate 
heating, both reductions in power and duty cycle were investigated. The total duration 
of exposure was kept constant, so that experimental run time increased 
proportionately with decreasing powers or duty cycles. As was hypothesised, there 
was a reduction in heating noted when power was reduced, or pulsed delivery applied 
(Figure 6.4.3E - H). However, this did not occur in a linear manner. At either 1% 
power or a 1% duty cycle, minimal heating occurred. When power or duty cycle were 
increased to 10%, there was a roughly tenfold increase in heat generation. This is 
likely due to the capacity of water to retain heat, a function of the increased strength 
of electrostatic interacting in hydrogen bonds (Silverstein et al. 2000). Consequently, 
thermal recovery did not occur sufficiently to dissipate heating over time. Beyond 10% 
power or duty cycle, there was a small, linear increase in heating. There was no 
biocidal activity seen at 1% power or duty cycle, where heating was not induced 
(Figure 6.4.3A-D). While there was a reduction in microorganisms recovered by 
culture at higher powers or duty cycles of approximately 1-log per 10% increase, the 
clinical relevance of this is questionable.  
Limitations of the methods 
The work presented in this chapter has several important limitations which would 
need to be addressed or overcome in future work to enable further development of 
microwave energy as a means of disinfecting biomedical devices which are 
temperature sensitive.  
The cavity resonator is highly tuneable to ensure maximal distribution of the electric 
field within a tightly defined volumetric column. However, this coupling is sensitive to 
changes in temperature. When coupling was remeasured after exposure on a subset 
of samples, the delivery efficiency was between 10-50% of the starting value. Such 
a substantial change would likely mean that the electric field was no longer directed 
280
in a well-defined volume, and thus the actual energy delivered to the sample may 
have been substantially less than this.  
Imaging by CLSM following Live/Dead staining of treated microorganisms proved to 
be infeasible, although the reasons for this remain unknown. It is possible that heat 
generated caused the acrylic coupons to warp slightly, preventing adequate focus. 
Alternatively, obliteration of cells by heat may explain why no cellular matter was 
visible, but this seems unlikely to be the sole reason for the finding, as it was not 
possible to focus on the acrylic biomaterial surface either. In most experimental runs, 
the observed temperatures using the thermal imaging camera were well below the 
glass transition temperature of the acrylic resin used. It could be that actual 
temperatures were higher, despite calibration of the thermal imaging camera. This 
may be due to reflection from the metallic surface of the cavity resonator, or higher 
temperatures generated in deeper regions of the acrylic away from the centre of 
focus. At present, this finding remains a conundrum, but would be important to solve 
due to the low precision and possibility of viable but non-culturable microorganisms 
providing false positive results by culture analysis. Either alternative staining and 
imaging techniques or an alternative method of reliably assessing biofilm viability may 
be required, such as a resazurin assay. 
The use of swabbing as an alternative to imaging was a crude, imprecise method 
with risk of contamination, but amenable to high throughput. Because the first 
experimental series demonstrated improved biocidal activity against biofilm in parallel 
orientation to the electric field, care was needed to ensure the swab did not contact 
the sides of the acrylic coupon. Further, while care was taken to ensure a 
standardised swabbing technique, variability due to operator error will doubtless have 
induced further variation in the results. The time between swab collection and plating 
might have affected the results, but swabs were typically processed and plated within 
5-10 min of collection, so it is unlikely that this posed a significant problem. However, 
the process is very time demanding and repetitive, which introduces higher risk of 
error. For this reason and to improve sensitivity and specificity, a direct assay on the 
acrylic surface would be preferable. 
It can therefore be concluded that while the cavity resonator offers a more efficient 
and reliable means of using microwave energy for sterilisation of biofilms on denture 
acrylics, it does not overcome the limitations of a conventional microwave oven, 
namely generation of excessive heat. There was no clear evidence to support the 
existence of an athermal biocidal effect of the microwave electric field, although there 
were a number of unavoidable experimental factors which limited the ability to assess 
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this to an ideal degree of accuracy and precision. There was a difference in the 
degree of heating in biofilms depending on the species composition. This likely 
relates to the specific cell volumes and EPS content and quantity present 
Future work could proceed down 3 primary avenues. The application of higher 
powers of microwave delivery with cavity resonators are possible, which could be 
pulsed with longer recovery intervals to allow for better heat dissipation. Alternatively, 
delivery of microwave energy could be provided through a coaxial probe, which 
removes the requirements for high fidelity frequency coupling, and offers better 
potential to scale up to the complex 3-D topography of denture surfaces. Finally, 
exploration of the impact of microwave energy delivery by cavity resonator or coaxial 
probe on the ease of chemomechanical removal of biofilms from denture acrylic 
surface could be undertaken.   
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CHAPTER 7: GENERAL DISCUSSION AND CONCLUSIONS 
The principle aims of this PhD were twofold: 
1. To develop a model of denture-associated biofilms incorporating putative 
respiratory pathogens and subsequently explore novel antimicrobial and anti-
biofilm strategies to eradicate these highly recalcitrant microorganisms. 
2. To characterise the oral bacterial communities of denture-wearing individuals in 
institutional care facilities and with active pneumonia, to evaluate whether 
changes in the denture-associated oral microbiome reflect pneumonia status. 
Initial experiments focussed on the development of a simple biofilm model, using 
clinically relevant species to represent both normal oral microbes and putative 
respiratory pathogens (PRPs). Based on previous work from Sands et al. (2016, 
2017), P. aeruginosa and S. aureus were selected as representative respiratory 
pathogens. Both microorganisms are frequently encountered in the healthcare 
environment and are responsible for a broad range of medical and device-associated 
infections including respiratory infection, diabetic foot ulcers, chronic wounds, 
ventilator-associated pneumonia and central-line associated bloodstream infections 
(Percival et al. 2015). The two selected PRPs have previously been seen to interact 
in a complex, dynamic manner in infections, occupying distinct niches within infected 
tissues (DeLeon et al. 2014). In keeping with this finding, S. aureus and P. aeruginosa 
were seen to occupy spatially distinct niches within mixed species biofilms following 
PNA-FISH labelling (Figure 2.4.3.1). Both microorganisms also have divergent 
interactions with C. albicans (Schlecht et al. 2015; Fourie et al. 2016), which was 
included in the biofilm model as a representative denture-associated yeast, given the 
high frequency of isolation of this microorganism in dentures. Staphylococcus aureus
has been shown to engage in ‘microbial hitchiking’; utilising candidal hyphae to gain 
access to tissues. In contrast, P. aeruginosa releases a number of virulence factors 
and quorum sensing molecules known to inhibit hyphal formation and can even attack 
and kill Candida in hyphal form.  
In the biofilm experiments, recovery of C. albicans from mixed species biofilms was 
rendered impossible as heavy P. aeruginosa growth occurred on the SDA plates 
used to culture the yeast. It is of note that in Live/Dead imaging (Figure 2.4.3.2B&C) 
of mixed species biofilms, there are few yeast cells evident, and the majority are 
dead. It may therefore be that the suppression of C. albicans is the result of direct 
killing by P. aeruginosa rather than simply a matter of rapid growth of P. aeruginosa
on SDA. Interestingly, the expression of virulence genes by P. aeruginosa in mixed 
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biofilms was reduced in mixed biofilms, including genes involved in the phenazine 
biosynthesis pathway thought to be responsible for inhibition of C. albicans hyphae. 
If killing of C. albicans by P. aeruginosa was a significant factor then it might be 
expected that the expression level of such genes would be increased. It is difficult to 
draw meaningful inferences from this data however, as only a small subset of relevant 
genes was analysed for pragmatic reasons. Furthermore, the translation of proteins 
does not correlate well with gene expression levels (Liu et al. 2016). This problem 
can be avoided in future work by addition of a suitable antibiotic to SDA for Candida 
culture, such as ciprofloxacin. 
It was hypothesised that preconditioning of acrylic surfaces by artificial saliva would 
have divergent effects on the attachment, adherence and subsequent biofilm 
biomass of the oral commensals compared with respiratory pathogens used in the 
biofilm model. This was seen most clearly in mixed species inocula during attachment 
and adhesion experiments, where both S. sanguinis and A. viscosus were recovered 
in much greater number from acrylic coupons compared with biomaterials 
preconditioned with water. However, this trend was not evident when biofilms were 
examined. As growth curves were not performed, this could potentially be due to 
faster growth rates of P. aeruginosa in particular, which predominated mixed species 
biofilms, occupying available niches for adhesion. Additionally, with the exception of 
A. viscosus, the strains used were not originally isolated from the oral cavity. Thus 
this finding may be of little relevance to denture-associated biofilms clinically.  
Extraction of microbial RNA from biofilms was highly challenging, as has previously 
been documented (Cury and Koo 2007; Atshan et al. 2012; Heera et al. 2015). To 
overcome this, a novel RNA extraction method was employed, utilising a combination 
of a phenol-chloroform method (FastProBlue, MP Biomedicals, Santa Ana, CA USA) 
to provide sufficient quantity of RNA and a silica gel membrane spin column (Qiagen 
RNeasy, Qiagen, Manchester, UK) to ensure high purity and to remove gDNA 
contamination from RNA. However, there are a huge array of available nucleotide 
extraction methods which vary by the target species. It is likely that to ensure optimal 
results from the very different microorganisms S. aureus and P. aeruginosa, different 
extraction processes, or at least modifications of a base process would be required. 
This is especially true in biofilms, where not only the challenge of differing cell wall 
compositions, but highly dissimilar EPS constituents, many of which can contaminate 
or inhibit the extraction process, must be overcome. Nonetheless, the method 
employed provides an excellent starting point for further optimisation of RNA 
extraction.  
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While RNA microarrays, or RNA sequencing approaches are increasingly employed 
in the examination of microbial interactions, this was beyond the remit of the current 
work. Furthermore, the utilisation of such expensive and intensive processes requires 
optimisation of RNA extraction and purification to ensure appropriate quality of data 
is generated. The potential for compound errors to arise from inherent biases in the 
extraction, reverse transcription and amplification processes is a pitfall for which there 
presently appears to be no consensus on managing (Gomez-Alvarez et al. 2009).  
Following the extensive characterisation of the biofilm model described in Chapter 2, 
subsequent experiments sought to elucidate the impact of biofilms incorporating 
PRPs on oral epithelial tissues and explore host-microbial interactions in infection. 
Initially, a full thickness oral mucosal tissue model (EpiOral FT, MatTek Corporation, 
Ashland, MA, USA) was employed for tissue infections, as it was expected that the 
presence of a lamina propria with overlying epithelium would provide a more 
biologically representative model. However, examination of control tissues 
demonstrated dysplastic appearance of the tissues, with loss of the normal epithelial 
stratification, poikilocytosis and acantholysis throughout tissues (data not shown). 
The RNA extraction protocol used to isolate microbial RNA was the phenol-
chloroform-isoamyl alcohol method previously employed with within the group for 
extraction of C. albicans RNA from mixed species biofilms (Cavalcanti et al. 2015). 
However, this method led to a very low yield of RNA, with nanodrop evaluation 
suggestive of contamination by guanidine, phenols or carbohydrates (Table 2.4.4.1). 
These contaminants could arise from reagents used in extraction, or alternative 
carbohydrates may have been derived from biofilm EPS. Analysis of cytokine profiles 
in tissues demonstrated elevated levels of pro-inflammatory cytokines in uninfected 
control tissues which had not been overlaid with PMMA resins, confirming abnormal 
behaviour of tissues. This artefactual tissue abnormality may have arisen from the 
72 h time period of tissue shipment from the USA, followed by further 24 h use for 
infection experiments, as the accompanying documentation recommends use of the 
tissues within 72 h of production (including shipping time). Consequently, data from 
the MatTek tissues was excluded from analysis and an alternative solution was 
sought.  
Although the Human Oral Epithelium (SkinEthic HOE, Episkin, Lyon, France) is a 
simpler model, consisting simply of keratinocyte layers overlying a polycarbonate 
insert, this model has been applied extensively to test microbial infections (Lu et al. 
2006; Silva et al. 2011; Morse et al. 2018). However, it should be noted that this tissue 
does not form a keratinised Stratum Corneum, meaning the tissues are far more 
permeable to microbial insult than typical tissues in denture-bearing regions. 
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Furthermore, the cells used to seed SkinEthic tissues are from the TR146 cell-line, 
which is derived from a squamous cell carcinoma. Consequently, cell behaviour may 
not be representative of normal mucosal epithelium, as metabolic and mitotic activity, 
signalling behaviour and responses, and tissue integrity may differ in cancer cells 
(Alberts et al. 2002). Despite these limitations, the SkinEthic HOE modelled offered 
an extensively validated, commercial tissue model which could be transferred from 
the manufacturer to the laboratory within 24 h. In addition, histological evaluation of 
control tissues demonstrated good tissue integrity and no evidence of the dysplastic 
changes noted in the MatTek tissues (Figure 3.4.1). However, the obliteration of 
tissues noted in response to biofilms containing P. aeruginosa is likely exacerbated 
by the lack of a resilient, impermeable keratinised layer at the tissue surface. This 
may in turn have impacted cytokine expression by tissues and explain the absence 
of the expected rise in IL-6 and IL-8 in response to infection. Alternatively, this change 
in the expected inflammatory cytokine profiles could be explained by the high 
constituent expression of such cytokines seen in SCC epithelial cells (Chen et al. 
1999), masking the impact of infection.  
Despite the above limitations, this study highlighted the key role of P. aeruginosa in 
initiation invasion of epithelial tissues, and potential opportunism was seen by normal 
oral commensal and S. aureus secondary to tissue damage induced by P. aeruginosa
(Figure 3.4.2). Furthermore, the RNA extraction method developed in experiments 
described in Chapter 2 was effective in isolating sufficient yield and purity of RNA for 
subsequent analysis of gene expression. While no clear trend was seen in S. aureus 
gene expression levels, either in biofilms or in response to contact with tissues, only 
a narrow range of genes was able to be evaluated. It was challenging to identify gene 
sequences specific to the strain of S. aureus employed in these experiments in order 
to design suitable primers. Consequently, several of the genes initially planned for 
analysis were not successfully amplified. In contrast, the P. aeruginosa genome is 
extensively mapped for multiple species, making primer design a far simpler task. 
This work highlighted the potential role of aprA, which encodes alkaline protease, in 
tissue invasion. Interestingly, expression of this gene was dramatically upregulated 
within mixed species biofilms only in tissue infections. The implications of this finding 
are unclear but may reflect competitive behaviour by P. aeruginosa to establish a 
niche deeper within the tissues. Further exploration of this observation is warranted. 
The clinical observational study aimed to characterise the oral microbiome of denture 
wearing individuals in long-term care facilities and in patients who were hospitalised 
with pneumonia. Previous studies examining the potential for denture-associated 
biofilms to harbour PRPs have employed both culture-dependent techniques (Russell 
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et al. 1999; Sumi et al. 2002; Senpuku et al. 2003; El Solh et al. 2004; Daniluk et al. 
2006; Sumi et al. 2007) and qPCR identification of species (O'Donnell et al. 2016). 
However, no studies to date have examined the oral microbiome of denture wearers 
with pneumonia, and so the composition of denture-associated microbial 
communities was unknown. Consequently, it was decided to employ a 
metataxonomic approach in this study, through next generation sequencing of the 
16S rRNA gene, to ensure maximal characterisation of the oral microbiome in these 
previously unexamined populations. Additional culture-dependent isolation of P. 
aeruginosa and S. aureus was undertaken as previous work within the group had 
demonstrated their high prevalence in dental plaque samples of intensive care 
patients (Sands et al. 2017). This also provided the opportunity to validate the biofilm 
model employed in Chapters 2 and 3. Finally, Candida species were isolated by 
culture to provide insight into the primary constituent of the mycobiome. An 
approximately 20-fold increase in PRP bioburden was found to accompany 
pneumonia status. Importantly this was limited to the denture microbiome, while 
increases in PRP bioburden in samples from the dorsal tongue and denture-bearing 
palate were much more modest in magnitude. Salivary pro-inflammatory cytokines 
were examined and correlated with pneumonia status. However, recovery of 
sufficient saliva was challenging, the variability between subjects was very high, and 
there was no difference in expression levels of pro-inflammatory cytokines seen 
between respiratorily healthy subjects and pneumonia patients. 
This study was intended to act as a pilot study, not only to provide proof-of-concept 
regarding the pathogenic potential of the denture-associated microbiome, but to 
establish the feasibility of the study protocol in addressing the research questions. 
There were a number of operational problems encountered during the study. It was 
challenging to obtain permission from care homes to access residents; only 7 of the 
24 approached assented to involvement in the study. This is unsurprising, as care 
homes in Cardiff are private institutions, and so do not prioritise clinical governance 
in the same manner as NHS institutions. Additionally, the study necessarily entailed 
disturbing residents, and placed additional burdens on care home staff, who were 
required to identify and approach prospective participants. This highlights a major 
barrier to conducting research in the primary care setting, where there is no clear 
pathway for remuneration or compensation for care staffs’ time. There is also the 
possibility of selection bias, as only institutions engaged in providing high quality care, 
which likely includes oral care, might be inclined to grant access to external 
researchers. Thus, the health status, oral and denture cleanliness, and PRP 
bioburden may have been underestimated in the control group. Similarly, access to 
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pneumonia patients was challenging. These individuals were acutely unwell, with 
competing healthcare needs that superseded the priority of sample collection for this 
study. Many patients were disinclined to participate simply due to exhaustion, feeling 
unwell and receiving multiple invasive interventions as part of their care. Both care 
home residents and pneumonia patients proved challenging to consent for the study. 
Many care home residents had cognitive impairment and assessing whether this was 
sufficient to render them unable to provide valid consent was difficult. Similarly, 
pneumonia patients had both a background of cognitive impairment in some cases, 
but a number of individuals were also acutely delirious secondary to hospitalisation 
and infection. The approach taken to consenting was likely over-cautious, and further 
training in assessing mental capacity and consent would benefit future research 
endeavours in this population.  
This study has a number of strengths which enhance the importance of the findings. 
To date, this is the first study to evaluate the denture-associated microbiome of 
patients with active pneumonia. The use of swabs to obtain site-specific samples, 
rather than an oral rinse, offers insight into the role of the denture biomaterial surface 
in harbouring PRPs. By employing culture-independent community profiling, 
compositional shifts across the entire bacteriome could be mapped, and a wide range 
of PRPs identified semi-quantitatively. This offers an ecological approach to exploring 
the role of the oral microbiome in seeding respiratory infection, which has not 
previously been undertaken. Coupling shifts in microbial community composition and 
pneumonia status with local inflammatory cytokine profiles offered the opportunity to 
explore the potential of the host response to act as an ‘immune fingerprint’ to guide 
diagnosis and therapy in pneumonia.  
It was hypothesised that PRP relative abundance would increase and the overall 
denture-associated microbial community diversity would decrease in patients with 
pneumonia. The increase in PRP abundance was not immediately apparent when 
examined at species-level, but became markedly clear when the cumulative relative 
abundance was examined. Similarly, there was a significant decrease in the Chao 
and Inverse-Simpson indices in pneumonia patients, indicative of a loss of microbial 
diversity. However, presence of S. pneumoniae, the most frequently isolated bacterial 
pneumonia pathogen, was detected in 8 care home residents and only 4 pneumonia 
patients. Similarly, isolation of S. aureus and P. aeruginosa by culture was 
approximately equal between cohorts, against expectations. Furthermore, a number 
of pneumonia patients had low relative abundances of PRPs identified by NGS, while 
several care home residents had relative abundances of PRPs in excess of 90%. 
Due to a lack of follow-up data, it is not known if any such individuals subsequently 
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developed pneumonia. This simply underpins the challenges associated with 
examining risk factors in multifactorial diseases: the presence of high levels of PRPs 
in the oral cavity may be a risk factor for pneumonia, but translocation of the bacteria 
to the respiratory tissues is a necessary event to initiate the disease. Longitudinal 
follow-up with serial sampling of oral microbes will be important for future work to 
attempt to evaluate causal relationships. 
There were several limitations associated with this study which also deserve 
examination. The cross-sectional nature of the study limits the observed increase in 
PRP colonisation of denture biomaterial surfaces to a correlational finding. It could 
be argued that this change may simply accompany hospitalisation of patients or be 
driven by selective pressures from antimicrobial therapy. However, as the control 
cohort were in long-term care facilities, and had a number of comorbid conditions, 
these individuals also had frequent contact with the hospital environment. Many of 
the recovered isolates of S. aureus were susceptible to beta-lactam antibiotics, 
despite the empirical treatment of all suspected pneumonia patients with Amoxicillin. 
In fact, there were higher beta-lactam resistance rates observed in S. aureus isolates 
cultured from the samples of care home residents. To determine a causal relationship 
between oral colonisation and development of pneumonia, one of two approaches 
would be necessary. Firstly, consecutive sampling of ‘at risk’ individuals’ oral and 
denture-associated microbiome, with subsequent follow-up to observe which 
individuals developed pneumonia. If colonisation of the oral cavity and denture 
biomaterial surface can be shown to precede development of pneumonia, this would 
offer strong support in favour of causality. It should be noted that while logistically 
challenging and expensive to undertake, some cost and resources could be saved 
by refraining from undertaking DNA extraction from microbial samples and 
subsequent sequencing until pneumonia cases had been identified. This work could 
be enhanced by matching control samples by age, gender and a number of key risk 
and lifestyle factors. Regardless, this would be a substantial undertaking for what 
remains a purely observational study. An attractive alternative would be to combine 
the observational methods employed in this study with an interventional trial. An 
enhanced programme of professionally delivered oral and denture care could be 
evaluated, with microbiological samples and oral/denture hygiene evaluations 
undertaken as proof of effectiveness of the intervention and as part of compliance 
monitoring. The control cohort would receive standard care only but undergo the 
same sampling methods. This approach could combine evaluation of the 
effectiveness of enhanced oral/denture care to reduce pneumonia risk with an 
exploration of the mechanisms of pneumonia aetiopathogenesis.  
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Salivary cytokines were hypothesised to predict pneumonia status or indicate 
individuals with a high oral bioburden of PRPs. However, neither pneumonia status 
nor PRP abundance appeared to correlate with salivary cytokines. It is possible that 
sampling palatal tissue fluid may give a better estimation of local host-microbiome 
interactions and thus pro-inflammatory cytokine levels here may more accurately 
reflect PRP abundance. Such samples have the additional advantage of not being 
affected by recent meals or drinks, which was difficult to control for in this study. It 
may still prove challenging to obtain sufficient fluid for analysis however. While the 
cytokines measured showed limited promise as diagnostic aids, biomarker discovery 
is an exciting avenue. The ease of access to the oral cavity compared with the lungs, 
and the acceptability of sampling from this site rather than invasive respiratory or 
blood samples enhances the appeal of such an approach. Unfortunately, xerostomia 
associated with age-related changes, comorbid conditions, dehydration and 
polypharmacy is a major barrier to obtaining suitable samples. It is possible that a 
brush biopsy, scraping the upper few layers of epithelium with associated tissue fluid, 
might provide a more reliable means to obtaining immune biomarkers, as these cells 
are intimately associated with PRPs in the biofilms on denture surfaces. This 
approach has been explored extensively in relation to oral cancer diagnosis and, 
while reports are mixed, some modes of brush biopsy have provided promising 
results (Alsarraf et al. 2018). 
The subsequent Chapter aimed to address one approach to reducing colonisation of 
denture biomaterial surface by PRPs: the production of an antimicrobial or 
antiadhesive soft denture-liner. As has previously been discussed in Chapter 5, these 
linings are a useful clinical option, with pertinent applications to residents in long-term 
care facilities, who often have reduced access to dental care, reduced tolerance to 
treatment and adaptive capacity, and may receive inadequate oral and denture care.  
Collaborators from the research group of Professor Ian Fallis produced a library of 
novel imidazolium derived NHC ligands and corresponding silver complexes which 
were hypothesised to yield candidate antimicrobials with a broad spectrum of activity 
against Candida, Gram positive and Gram negative bacteria. In addition, a novel 
triclosan acetate salt was produced, which was hypothesised to confer 
physicochemical advantages following incorporation of the antimicrobial into silicone 
rubbers. These compounds were screened against a range of relevant pathogens 
frequently isolated form device-associated infections, for inhibitory, biocidal and anti-
biofilm activity. The most promising compounds were subsequently loaded into 
silicone. While triclosan acetate was successfully bulk-loaded into silicone rubbers, 
the silver-NHC complexes inhibited silicone curing. Consequently, a compatible 
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material which is used in medical applications; acetoxy resin, was formulated into a 
fluid dispersion. Loading of the silver-NHC complexes into this material proved 
successful, and the dispersion was applied to silicone surfaces by dip-coating. The 
test materials showed no evidence of significant cytotoxicity. However, the 
antimicrobial activity of silver-NHC complexes was lost following incorporation into 
acetoxy resins. It is not clear if this was due to lack of release of materials or 
inactivation of the compounds due to chemical changes. Evaluation by LC would help 
to determine both the release profile and chemical structure of any released 
compounds from materials and should be considered in future work. Further work is 
needed to ensure retention of antimicrobial activity of silver-NHCs in biomaterials. A 
potential mechanism to achieve this would be immobilisation of the compounds at 
the surface using conjugation with flexible glycoprotein or peptide  ligands. 
Finally, an approach to denture sterilisation using microwave delivery was evaluated. 
The cavity resonator was employed to overcome some of the limitations of domestic 
(magnetron) microwave ovens, namely imprecise delivery of energy leading to 
variable biocidal effects, and the requirement for high powers to be employed 
resulting in excessive heat generation. It was hypothesised that delivery of 
microwave energy by cavity resonators would kill biofilm microbes on acrylic 
surfaces, and that by delivering energy in pulsed duty cycles, excessive heat 
generation could be avoided while retaining anti-biofilm activity. This mode of 
microwave delivery was found to offer massive increases in efficiency over 
conventional microwave ovens, with just 43 dBm (20 W) of power required to 
eradicate viable microorganisms from biofilms on acrylic surfaces in 20 s or less. 
Furthermore, differential effects dependant on sample orientation within the electric 
field were noted, which were not entirely explained by changes in temperature 
distribution alone. While this does not offer conclusive evidence of an athermal effect 
of microwave energy, this is an avenue that merits further investigation. 
The impact of reduced power of microwave energy delivery was explored on both 
heat generation and biocidal effect. The total electric field exposure was held 
constant, to attempt to separate thermal effects from biocidal effects. There was a 
loss of biocidal effect which was roughly proportionate to the degree of heat 
reduction. Similarly, pulsed delivery was explored, where high power ‘spikes’ of 
microwave energy were interspersed with periods of recovery. Again, biocidal effects 
were not seen in the absence of significant heat generation. The cavity resonator 
offered an excellent modality to begin exploration of highly controlled delivery of 
electric field to microbial biofilms on denture acrylic. However, future work should aim 
to explore the role of higher power microwave energy delivery, delivered by a coaxial 
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probe to overcome the limitations imposed by the requirement for high-fidelity 
coupling in the cavity resonator. This work found mixed evidence regarding the 
existence of an athermal effect of microwave energy, and an integrated approach to 
experimentation, combining high quality simulations and laboratory studies offers a 
powerful approach to iteratively explore this possible phenomenon. 
Research Conclusions: 
A simple model of denture acrylic-associated biofilms was developed incorporating 
clinically relevant representative oral commensal microbes and putative respiratory 
pathogens. This model was subsequently validated by a clinical observational study 
which verified the presence of the selected microbial species on the denture surfaces 
of long-term care residents and pneumonia patients. The model biofilms were 
extensively characterised using a range of culture-dependent and molecular 
techniques. The methods used to generate such biofilms are readily scalable to allow 
high-throughput experiments such as the screening of antimicrobials or antibiofilm 
approaches; modelling of biofilm-mediated infections; or assessment of the influence 
of environmental, nutritive or physical factors such as laminar flow. 
The biofilm models developed were used to infect epithelial tissue models and 
revealed the potential role of P. aeruginosa in driving invasion and destruction of 
tissues, in addition to opportunistic dissemination of commensal oral species and S. 
aureus. The significant upregulation of the aprA gene which encodes for alkaline 
protease in P. aeruginosa was seen in tissue infections with mixed biofilms but was 
not upregulated in mixed biofilms in the absence of host tissues. This suggests a 
potential role of this enzyme in securing a competitive advantage in tissue infection, 
which merits further investigation.  
A novel clinical observational study was undertaken to characterise the oral 
microbiome of denture wearing individuals in long-term care facilities compared with 
patients hospitalised with pneumonia. This study employed next generation 
sequencing of the bacterial 16S rRNA gene to provide an unrestricted evaluation of 
oral bacterial community profiles associated with respiratory health in a population 
at-risk of pneumonia, and in patients with active pneumonia. Denture-associated 
microbial communities showed a significant increase in the relative abundance of 
putative respiratory pathogens, as well as loss of species richness and diversity, 
which are the hallmarks of dysbiosis. The magnitude of this difference was 
substantially higher in the denture-associated microbiota compared with either the 
denture-bearing palatal mucosa or dorsal tongue, underpinning the importance of the 
denture biomaterial surface as a potential nidus for respiratory pathogens. 
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Two novel approaches to controlling colonisation of denture biomaterials were 
investigated. Triclosan and triclosan acetate were successfully incorporated into 
silicone rubbers and demonstrated strong activity against Staphylococci, with only 
slight detrimental effects to the biomaterials physicomechanical properties.. While 
novel silver-imidazole NHC complexes failed to retain antimicrobial activity once 
incorporated into biomaterials, these compounds offer promise, as broad-spectrum 
biocidal activity was seen against Gram-positive and Gram-negative bacteria and C. 
albicans. Exploration of the antibiofilm effects of microwave energy delivered in a 
highly controlled manner by cavity resonator demonstrated the biocidal effectiveness 
of this sterilisation modality. However, further work is required to optimise delivery to 
mitigate heat generation. A possible observation of an athermal effect of the electric 
field was seen, which offers an exciting avenue for further research. 
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